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Abstract	  The	  Bunyaviridae	  family	  is	  a	  group	  of	  segmented	  negative	  sense	  RNA	  viruses	  (sNSV)	  that	  cause	  severe	  disease	  in	  both	  plants	  and	  humans.	  This	  group	  of	  viruses	  is	  further	  classified	   into	   the	   Orthobunyavirus,	   Tospovirus,	   Nairovirus,	   Phlebovirus	   and	  
Hantavirus	  genera.	  	  	  Crimean-­‐Congo	   haemorrhagic	   fever	   (CCHF)	   is	   a	   potentially	   fatal	   tick	   borne	   viral	  meta-­‐zoonotic	   haemorrhagic	   disease,	   which	   is	   caused	   by	   Crimean-­‐Congo	  haemorrhagic	   fever	   virus	   (CCHFV),	   a	  member	  of	   the	  Nairovirus	   genus.	  Despite	   the	  medical	  importance	  and	  severity	  of	  disease,	  the	  molecular	  biology	  of	  CCHFV	  remains	  poorly	   understood,	   primarily	   because	   outbreaks	   are	   sporadic,	   and	   its	   handling	  requires	  the	  highest	  containment	  facilities,	  bio-­‐safety	  level	  4	  (BSL-­‐4).	  	  	  Tomato	  spotted	  wilt	  virus	  (TSWV)	   is	  a	  member	  of	   the	  Tospovirus	  genus,	  which	  are	  the	  only	  plant	  infecting	  members	  of	  the	  bunyaviruses.	  TSWV	  causes	  serious	  disease	  in	  over	  80	  plant	   families,	   including	  peppers,	  potatoes,	   lettuce	  and	  tomatos,	  causing	  approximately	  80	  million	  dollars	  worth	  of	  loss	  to	  the	  food	  industry	  per	  year.	  	  	  The	   pathogenesis	   of	   CCHFV	   and	   TSWV	   depends	   on	   the	   formation	   of	   the	  ribonucleoprotein	   (RNP)	   complex,	   in	   which	   their	   genomes	   and	   antigenome	   are	  entirely	   encapsidated	   by	   the	   virus-­‐encoded	   nucleocapsid	   (N)	   protein.	   Only	   in	   the	  form	   of	   the	   RNP	   is	   the	   genome	   replicated,	   transcribed	   and	   packaged	   into	   new	  progeny	   particles.	   This	   work	   has	   implemented	   X-­‐ray	   crystallography	   to	   better	  understand	  the	  structural	  and	  functional	  roles	  of	  the	  CCHFV	  and	  TSWV	  N	  proteins.	  	  This	  work	  presents	  the	  2.1	  Å	  crystal	  structure	  of	  the	  CCHFV	  N	  protein,	  which	  shows	  a	  high	  degree	  of	  structural	  homology	  with	  the	  N	  protein	  from	  another	  sNSV	  member	  Lassa	  virus	  (LASV),	  and	  reveals	   important	   insight	   into	  sNSV	  phylogenetics,	  and	  the	  interaction	   of	   CCHFV	   with	   the	   host	   cell.	   This	   work	   also	   includes	   the	   expression,	  purification,	   and	   crystallization	   of	   the	   TSWV	   N	   protein.	   Crystals	   generated	   from	  TSWV	  N	  protein	  diffracted	  to	  2.6	  Å	  and	  structure	  determination	  is	  ongoing.	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Abbreviations	  APS	   	   Ammonium	  persulphate	  ATP	   	   Adenine	  tri-­‐phosphate	  BCCV	   	   Black	  Canal	  Creek	  virus	  	  BSL-­‐2	   	   Bio-­‐Safety	  Level	  2	  BLAST	  	   Basic	  local	  alignment	  tool	  	  bp	   	   Base	  pair	  BTP	   	   Bis-­‐Tris	  Propane	  BUNV	  	  	   Bunyamwera	  virus	  C-­‐terminal	  	   Carboxy	  terminal	  CCHF	   	   Crimean-­‐Congo	  haemorrhagic	  fever	   	  CCHFV	  	   Crimean	  Congo	  haemorrhagic	  fever	  virus	  CD	   	   Circular	  dichroism	  	  cDNA	   	   Complementary	  DNA	  CHAPS	  	   3-­‐[(3-­‐cholamidopropyl)-­‐dimethylammonio]-­‐1-­‐propanesulfonate	  	  Da	   	   Dalton	  DEV	   	   Doubly	  enveloped	  viruses	  DNA	  	   	   Deoxyribonucleic	  acid	  DNase	  1	   Deoxyribonulcease	  1	  	  dNTP	   	   Dinucleotide	  tri-­‐phosphate	  dsDNA	  	   Double	  stranded	  DNA	  dsRNA	  	   Double	  stranded	  RNA	  DTT	   	   Dithiothreitol	  	  DUGV	   	   Dugbe	  virus	  	   	  
E.	  coli	   	   Escherichia	  coli	  EDTA	   	   Ethylyenediaminetraacetic	  acid	  eGFP	   	   Enhanced	  green	  fluorescent	  protein	  ECT	  	   	   Electron	  Cryo-­‐Tomography	  EM	   	   Electron	  microscopy	  	  ER	  	   	   Endoplasmic	  reticulum	  ERGIC	  	   ER-­‐Golgi	  intermediate	  compartment	  eV	   	   Electron	  volts	  FT	   	   Fourier	  transform	  GBNV	   	   Groundnut	  bud	  necrosis	  virus	  	  HEPES	  	   4-­‐(2-­‐hydroxyethyl)-­‐1-­‐piperazineethanesulfonic	  acid	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Hg	   	   Mercury	  hr	   	   Hour/s	  IAV	   	   Influenza	  A	  virus	  IFN	   	   Interferon	  IGR	   	   Intergenic	  region	  INSV	   	   Impatiens	  necrotic	  spot	  virus	  	  IPTG	   	   Isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside	  JUNV	   	   Junin	  virus	  K	   	   Kelvin	  kDa	  	   	   Kilo	  Dalton	  L	  	   	   Polymerase	  LACV	  	   	   La	  Crosse	  virus	  	  LASV	  	   	   Lassa	  virus	  LB	   	   Luria	  Bertani	  	  LCMV	   	   Lymphocytic	  choriomeningitis	  virus	  LEAV	   	   Leanyer	  virus	  MAD	   	   Multi-­‐wavelength	  anomalous	  dispersion	  	  MES	   	   2-­‐(N-­‐morpholino)ethanesulfonic	  acid	  MgCl2	   	   Magnesium	  chloride	  min	   	   Minute/s	   	  MIR	   	   Multiple	  isomorphous	  replacement	  MIRAS	  	   Multiple	  isomorphous	  replacement	  with	  anomalous	  scattering	  	  miRNAs	   Micro	  RNAs	  MME	   	   Monomethyl	  ether	  MOPS	  	  	   3-­‐(N-­‐morpholino)propanesulfonic	  acid	  MR	   	   Molecular	  replacement	  	  MRCA	   	   Most	  recent	  common	  ancestor	  mRNA	  	   Messenger	  RNA	  N	  	   	   Nucleocapsid	  	  N-­‐terminal	  	   Amino	  terminal	  NaCl	   	   Sodium	  chloride	  NCS	   	   Non	  crystallographic	  symmetry	  	  Ni	   	   Nickel	  	  NP	   	   Nucleoprotein	  NS	   	   Negative	  sense	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NSDV	   	   Nairobi	  sheep	  disease	  virus	  	  NSm	   	   Non-­‐structural	  M	  segment	  nsNSV	  	   Non-­‐segmented	  negative	  sense	  RNA	  viruses	  nsRNA	  	   Negative	  sense	  RNA	  NSs	   	   Non-­‐structural	  S	  segment	  NTRs	   	   Non-­‐translational	  region	  ORF	   	   Open	  reading	  frame	  OTU	   	   Ovarian	  tumor	  PAGE	   	   Polyacrylamide	  gel	  electrophoresis	  PARP	   	   Poly	  (ADP-­‐ribose)	  polymerase	  	  PCR	   	   Polymerase	  chain	  reaction	  PDB	   	   Protein	  Data	  Bank	  	  PEG	   	   Polyethylene	  glycol	  PICV	   	   Pichinde	  virus	  RdRp	   	   RNA	  dependent	  RNA	  polymerase	  RMSD	   	   Root	  mean	  standard	  deviation	  RNA	   	   Ribonucleic	  acid	  RNP	   	   Ribonucleoprotein	  complex	  RSS	   	   RNA	  silencing	  suppressor	  RStV	   	   Rice	  stripe	  virus	  RSV	  	   	   Respiratory	  syncytial	  virus	  SAD	  	   	   Single-­‐wavelength	  anomalous	  dispersion	  SDS	   	   Sodium	  dodecyl	  sulfate	  SEC	   	   Size	  exclusion	  chromatography	  SEV	   	   Singly	  enveloped	  viruses	  SIR	   	   Single	  isomorphous	  replacement	  	  SIRAS	   	   Single	  isomorphous	  replacement	  with	  anomalous	  scattering	  	  siRNAs	   Small	  interfering	  RNAs	  	  sNSV	   	   Segmented	  negative	  sense	  RNA	  viruses	  	  ssRNA	  	   Single	  stranded	  RNA	  SUMO	   	   Small	  ubiquitin-­‐related	  modifier	  	  TEMED	   Tetramethylethylenediamine	  	  THOV	   	   Thogoto	  virus	  tRNA	   	   Transfer	  RNA	  TSWV	   	   Tomato	  spotted	  wilt	  virus	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TULV	   	   Tula	  virus	  Ub	   	   Ubiquitin	  UUKV	   	   Uukuniemi	  virus	  UV	   	   Ultraviolet	  VSV	   	   Vesicular	  somatitis	  virus	  WHO	   	   World	  Health	  Organisation	  Z	   	   Matrix	  protein	  
Amino	  acids	  	  
Amino	  acid	   	   Single	  letter	  code	   Three	  letter	  code	  
	  Alanine	   	   A	   	   	   ALA	  Arginine	   	   R	   	   	   ARG	  Asparagine	   	   N	   	   	   ASN	  Aspartic	  acid	   	   D	   	   	   ASP	  Cysteine	   	   C	   	   	   CYS	  Glutamic	  acid	  	   E	   	   	   GLU	  Glutamine	   	   Q	   	   	   GLN	  Glycine	   	   G	   	   	   GLY	  Histidine	   	   H	   	   	   HIS	  Isoleucine	   	   I	   	   	   ISO	  Leucine	   	   L	   	   	   LEU	  Lysine	  	   	   K	   	   	   LYS	  Methionine	   	   M	   	   	   MET	  Phenylalanine	   F	   	   	   PHY	  Proline	   	   P	   	   	   PRO	  Serine	  	   	   S	   	   	   SER	  Threonine	   	   T	   	   	   THR	  Tryptophan	   	   W	   	   	   TRP	  Tyrosine	   	   Y	   	   	   TYR	  Valine	   	   	   V	   	   	   VAL	  
Nucleotides	  Adenine	   	   A	  Cytosine	   	   C	   	   Uracil	  	  	   	   U	  Guanine	   	   G	   	   Thymine	   	   T
	  1	  
1.	  Chapter	  -­‐	  Introduction	  to	  thesis	  
1.1	  Negative	  sense	  RNA	  viruses	  Negative	  sense	  (NS)	  RNA	  viruses	  replicate	  and	  transcribe	  their	  genomic	  RNA	  either	  in	  the	  cytoplasm	  or	  the	  nucleus	  by	  means	  of	  a	  mega-­‐dalton	  RNA-­‐protein	  complex,	  which	  serves	   to	   protect	   the	   RNA	   during	   delivery	   into	   cells	   and	   is	   the	   template	   for	   viral	  polymerase	  during	  RNA	  synthesis.	  The	  viral	  RNA	  genome	  can	  exist	  as	  non-­‐segmented	  or	   segmented,	   necessitating	   the	   classification	  of	   these	   viruses	   into	   two	  groups.	  The	  non-­‐segmented	   RNA	   viruses	   (nsNSV)	   comprise	   four	   families;	   namely	   the	  
Rhabdoviridae	   family	   (including	   vesicular	   stomatitis	   virus	   (VSV)	   and	   rabies	   virus),	  
Paramyxoviridae	   family	   (including	   measles	   virus	   and	   respiratory	   syncytial	   viruses	  (RSV)),	  Filoviridae	  family	  (including	  Ebola	  and	  Marburg	  viruses)	  and	  the	  Bornaviridae	  family	   (including	   Borna	   disease	   virus).	   The	   segmented	   negative	   sense	   RNA	   viruses	  (sNSV)	   comprise	   three	   families,	   the	   two	   segmented	   Arenaviridae	   family	   (including	  Lassa	   virus	   (LASV)	   and	   Machupo	   virus),	   the	   three	   segmented	   Bunyaviridae	   family	  (including	  CCHFV)	  and	  the	  8	  segmented	  Orthomyxoviridae	  family	  (including	  influenza	  A	  virus	  (IAV)).	  Tenuivirus	  and	  Emeravirus	  genera	  consist	  of	  four	  and	  five	  segmented	  viruses	  respectively,	  and	  are	  not	  yet	  assigned	  to	  a	  family.	  	  	  The	   pathogenesis	   of	   nsRNA	   viruses	   depends	   on	   the	   formation	   of	   the	  ribonucleoprotein	   (RNP)	   complex,	  which	   encapsidates	   the	   genome	  and	   antigenome	  by	   the	   virus-­‐encoded	   nucleocapsid	   (N)	   protein.	   Only	   in	   the	   form	   of	   the	   RNP	   is	   the	  genome	   replicated,	   transcribed	   and	  packaged	   into	   new	  progeny	  particles.	   Together	  with	  the	  viral	  RNA,	  the	  encoded	  N	  protein	  forms	  the	  RNP,	  and	  is	  central	  to	  replication	  of	  both	  sNSV	  and	  nsNSV.	  A	  common	  feature	  of	  these	  RNA	  viruses	  is	  the	  employment	  of	  RNA	  synthesis	  machinery	   comprised	  of	   the	  virally	   encoded	  RNA	  dependent	  RNA	  polymerase	  (RdRP),	  which	  travels	  along	  the	  RNP	  to	  produce	  copies	  of	  the	  viral	  RNA	  template	   in	   two	   synthetic	  modes,	   namely	  messenger	  RNA	   (mRNA)	   transcription	   or	  genome	  replication.	  	  
1.2	  Molecular	  biology	  of	  bunyaviruses	  The	   Bunyaviridae	   family	   is	   a	   large	   group	   of	   sNSVs	   and	   is	   divided	   into	   the	  
Orthobunyavirus,	   Tospovirus,	   Nairovirus,	   Phlebovirus	   and	   Hantavirus	   genera,	   which	  together	  contain	  at	  least	  350	  named	  isolates.	  Classification	  of	  this	  family	  is	  based	  on	  possession	   of	   a	   single	   stranded	   three-­‐segmented	   RNA	   genome	   of	   NS	   or	   ambisense	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polarity,	   a	   replication	   strategy	   that	   takes	   place	   in	   the	   cytoplasm,	   and	   an	   enveloped	  spherical	  virion	  of	  80-­‐120	  nm,	  that	  matures	  in	  the	  Golgi	  complex	  (Elliott,	  2009).	  The	  classification	  of	  the	  Bunyaviridae	  family	  into	  individual	  genera	  is	  based	  on	  serological	  relationships,	  and	  presence	  of	  genus-­‐specific	  biochemical	  characteristics	  of	  individual	  proteins	  such	  as	  their	  size	  and	  amino	  acid	  sequence.	  Segment	  coding	  strategy	  used	  to	  encode	  these	  proteins,	  the	  size	  of	  RNA	  segments,	  and	  presence	  of	  conserved	  sequence	  elements	  of	  the	  segment	  termini	  also	  can	  have	  implications	  for	  genera	  classification	  (Elliott,	  2009).	  	  The	   lipid-­‐enveloped	   membrane	   of	   the	   viral	   particle	   contains	   protruding	   spike	  proteins,	  consisting	  of	  disulphide	   linked	  viral	  heterodimer	  glycoproteins	  Gn	  and	  Gc.	  Both	  these	  glycoproteins	  are	  produced	  from	  a	  single	  polypeptide	  cleaved	  by	  host	  cell	  proteases	   (Bergeron	   et	   al.,	   2007b).	   Particle	  maturation	   results	   in	   infectious	   viruses	  primed	  for	  new	  rounds	  of	  replication	  in	  uninfected	  cells,	  and	  requires	  the	  assembly	  of	  viral	  genomic	  RNA,	  N	  protein	  and	  numerous	  copies	  of	  the	  polymerase	  (L)	  protein	  into	  the	  RNP	  complex	  (Figure	  1)	  (Elliott,	  1990).	  
	  Figure	   1.	   Schematic	   of	   a	   bunyavirus	   particle.	   (A)	   Generally	   bunyavirus	   virions	   comprise	   a	   spherical	  lipid	   envelope,	   with	   embedded	   spikes	   comprising	   Gn–Gc	   heterodimers	   positioned	   in	   genus-­‐specific	  arrays	   on	   the	   external	  membrane	   surface.	  Within	   the	   interior	   of	   the	   virion	   the	   bunyavirus	   genome	  comprises	  three	  RNA	  segments	  (S,	  M	  and	  L),	  wrapped	  in	  the	  viral	  N	  protein.	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1.2.2	  Bunyavirus	  genome	  structure,	  gene	  products,	  and	  RNA	  synthesis	  The	  RNA	  segments	  of	  bunyaviruses	  are	  named	  small	  (S),	  medium	  (M),	  and	  large	  (L)	  reflecting	   their	   relative	   nucleotide	   length	   (Figure	   2).	   All	   bunyaviruses	   encode	   an	  RdRp,	   or	   L	   protein	   from	   the	   L	   segment,	   an	   N	   protein	   from	   the	   S	   segment,	   and	   a	  polyprotein	  precursor	   from	  the	  M	  segment	   (Figure	  2).	  The	   interactions	  between	  all	  these	  proteins	  are	  critical	   for	  the	  formation	  of	   the	  RNP	  and	  infectious	  virus	  and	  the	  section	   starting	   from	   page	   30	   describes	   the	   structural	   biology	   of	   the	   bunyavirus	   L	  protein,	   N	   protein	   and	   glycoproteins	   to	   highlight	   the	   parallels	   and	   differences	  between	  the	  genera	  of	  the	  Bunyaviridae	  family,	  and	  several	  additional	  segmented	  and	  non	  segmented	  negative	  sense	  viruses.	  	  	  
	  	  Figure	  2.	  Schematic	  of	  the	  three	  genomic	  RNA	  segments	  from	  prototypic	  viruses	  across	  the	  five	  genera	  within	   the	  Bunyaviridae	   family.	  mRNA	   transcripts	  encoded	  by	  NS	   templates	  are	   indicated	  by	  arrows	  below	  each	  segment,	  whereas	  ambisense	  templates	  synthesized	  from	  positive	  sense	  coding	  strategies	  are	  denoted	  by	  arrows	  above	  the	  segments.	  The	  figure	  was	  adapted	  from	  (Walter	  and	  Barr,	  2011).	  	  The	   RNA	   genome	   is	   copied	   using	   two	   different	   RNA-­‐synthesis	   activities:	   mRNA	  transcription	   and	   RNA	   replication.	   RNA	   replication	   produces	   full-­‐length	  complementary	   copies	   of	   both	   the	   genomic	   and	   antigenomic	   RNA,	   whereas	  transcription	  products	  generally	  are	  truncated	  at	  their	  3′	  ends	  relative	  to	  the	  genome	  template	   and	   are	   extended	   at	   their	   5′	   ends	   by	   a	   host	   derived	   capping	  oligoribonucleotide	  (Figure	  3)	  (Walter	  and	  Barr,	  2011).	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  Figure	  3.	  Schematic	  of	  RNA	  replication	  and	  transcription	  for	  members	  of	  the	  Bunyaviridae	  family.	  (A)	  Bunyaviruses	  which	  possess	  genomic	  RNA	  segments	  that	  contain	  a	  single	  transcriptional	  unit	  flanked	  by	  non	  translational	  regions	  (NTRs)	  employ	  a	  NS	  coding	  strategy	  for	  transcription	  and	  replication.	  The	  transcriptionally	  silent	  positive	  sense	  antigenome	  is	  replicated	  to	  generate	  newly	  synthesized	  negative	  sense	  genomes,	  which	  are	  packaged	  into	  new	  virus	  particles.	  The	  transcriptional	  unit	  of	  a	  number	  of	  bunyaviruses	  consists	  of	   two	  overlapping	  open	  reading	  frames	  (ORF),	  with	  two	  alternating	   initiation	  codons.	   (B)	   Transcription	   of	   mRNAs	   from	   both	   genomic	   and	   antigenomic	   RNA	   strands	   through	   an	  ambisense	  coding	  strategy	  is	  exhibited	  by	  some	  bunyaviruses,	  with	  transcription-­‐termination	  signals	  positioned	  in	  a	  central	  intergenic	  region	  (IGR).	  The	  figure	  was	  adapted	  from	  (Walter	  et	  al.,	  2011).	  	  Contrasting	  with	  the	  nsNSVs	  -­‐	  which	  possess	  multiple	  transcriptional	  units,	  arranged	  in	   a	   linear	   array,	   and	   sequentially	   copied	   -­‐	   each	   bunyavirus	  RNA	   segment	   contains	  one	  transcriptional	  unit.	  Orthobunyaviruses	  mostly	  contain	  a	  second	  ORF	  within	  the	  S	   segment	  mRNA,	   encoding	   a	   non-­‐structural	   protein	   (Figure	   2).	   The	   significance	   of	  the	   two	  alternative	   reading	   frames	   is	   that	   two	  proteins	   can	  be	   expressed	   from	  one	  RNA	  segment,	  for	  example	  the	  orthobunyaviruses	  encode	  from	  their	  S	  segment	  an	  N	  protein	  and	  a	  non-­‐structural	  protein	  (NSs)	  (Weber	  et	  al.,	  2002).	  Alternative	  ORFs	  are	  also	  used	  by	  tospoviruses	  (S	  segment	  and	  M	  segment)	  and	  phleboviruses	  (S	  segment),	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by	  using	  an	  ambisense	  mechanism	  for	  transcription	  to	  encode	  for	  an	  additional	  viral	  protein	  (Figure	  2).	  Ambisense	  replication	  strategies	  where	  at	  least	  one	  RNA	  segment	  utilizes	  ambisense	  nucleotide	  coding	   to	  produce	  viral	  protein	  are	  employed	  by	   four	  genera	   (Arenavirus,	   Phlebovirus,	   Tospovirus	   and	   Tenuivirus),	   distributed	   between	  
Arenaviridae	  and	  Bunyaviridae	  families	  and	  a	  small	  nonclassified	  genus	  of	  plant	  	  viruses,	  the	  tenuiviruses	  (Nguyen	  and	  Haenni,	  2003,	  Bucher	  et	  al.,	  2003a).	  
Table	   1.	   Complementarity	   of	   the	   3’	   and	   5’	   terminal	   nucleotides	   from	   the	   S,	   M	   and	   L	   segments	   of	  prototypic	  bunyaviruses.	  	  Located	   at	   the	   3’	   and	   5’	   termini	   of	   the	   viral	   genome	   within	   all	   the	   genera	   of	   the	  
Bunyaviridae	   family	   each	   RNA	   segment	   strand	   contains	   non-­‐translated	   regions	  (NTRs)	   surrounding	   the	   single	   transcriptional	   unit.	   Reverse	   genetics	   systems	   have	  shown	   that	   the	   four	   animal	   infecting	   bunyaviruses	   contain	  NTRs	  which	   display	   cis	  acting	   signals	   and	   involved	   in	   the	   synthesis	   of	   RNA	   and	   segment	   packing	   (Bridgen	  and	  Elliott,	  1996,	  Dunn	  et	  al.,	  1995,	  Flick	  et	  al.,	  2003a,	  Flick	  et	  al.,	  2004,	  Flick	  et	  al.,	  2002,	   Flick	   et	   al.,	   2003b,	   Kohl	   et	   al.,	   2006,	   Lopez	   et	   al.,	   1995).	   The	   3’	   and	   5'	  nucleotides	  located	  at	  the	  extreme	  ends	  of	  the	  NTRs	  show	  complementarity	  (Table	  1),	  and	   are	   generally	   highly	   conserved	   within	   each	   genus,	   for	   example	   the	  orthobunyaviruses	   possess	   RNA	   segments	   containing	   the	   same	   11	   nucleotides	  located	  at	  their	  3’	  to	  5’	  termini	  (Table	  1)	  (Walter	  and	  Barr,	  2011).	  	  The	  nucleotide	  complementarity	  between	  the	  3′	  and	  5′	  NTRs	  of	  each	  segment	  allows	  the	   possibility	   that	   the	   NTRs	   may	   interact	   through	   canonical	   Watson–Crick	   base	  pairing	   forming	   a	   “panhandle”	   structure.	   Further	   evidence	   supporting	   the	   NTR	  
Genus	  (prototype)	   	  
Orthobunyavirus	  (Bunyamwera	  virus)	   3’	  -­‐	  UCAUACCAUG…	  5’	  -­‐	  AGUAGUGUGC…	  
Phlebovirus	  (Rift	  Valley	  fever	  virus)	   3’	  -­‐	  UGUGUUUC…	  5’	  -­‐	  ACACCAAAG…	  
Nairovirus	  (Dugbe	  virus)	   3’	  -­‐	  AGAGUUUCU…	  5’-­‐	  UCUCAAAGA…	  
Hantavirus	  (Hantaan	  virus)	   3’-­‐	  AUCAUCAUCUG…	  5’	  -­‐	  UAGUAGUAAGC…	  
Tospovirus	  (Tomato	  spotted	  wilt	  virus)	   3’	  –	  UCUCGUUA…	  5’	  –	  AGAGCAAU…	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interaction	   is	   required	   for	   segment	   function	   and	   has	   been	   reported	   through	   both	  biochemical	   techniques	   and	   direct	   visualization	   suggesting	   the	   bunyavirus	   RNA	  segments	  exhibit	  a	  circular	  appearance	  within	  infected	  cells	  and	  virus	  particles	  (Raju	  and	  Kolakofsky,	  1989,	  Obijeski	  et	  al.,	  1976,	  Pettersson	  and	  von	  Bonsdorff,	  1975).	  For	  example	   the	   RNA	   segment	   panhandle	   structure	   in	   hantaviruses	   has	   been	  demonstrated	  to	  be	  necessary	  for	  efficient	  and	  specific	  binding	  of	  the	  N	  protein	  (Mir	  and	  Panganiban,	  2004,	  2005,	  2006,	  Mir	  et	  al	  2006).	  Mir	  et	  al	  demonstrated	  that	  each	  panhandle	  is	  at	  least	  23	  nucleotides	  long	  and	  is	  bound	  to	  the	  trimeric	  N	  protein	  with	  high	  affinity	  (Mir	  and	  Panganiban,	  2004,	  Mir	  et	  al.,	  2006,	  Mir	  and	  Panganiban,	  2006,	  Mir	  and	  Panganiban,	  2005).	  	  	  Owing	   to	   complementary	   at	   the	   genomic	   termini,	   the	   3′	   and	   5′	   terminal	   sequences	  make	   up	   the	   promoters	   required	   for	   replication	   and	   transcription.	   Findings	   for	  Uukuniemi	   virus	   (UUKV)	   (phlebovirus)	   and	   Bunyamwera	   virus	   (BUNV)	  (orthobunyavirus)	   have	   shown	   the	   terminal	   interaction	   is	   strongly	   implicated	   as	   a	  functional	   requirement	   for	   RNA	   transcription	   and	   replication	   (Flick	   et	   al.,	   2004).	  Additionally	  for	  BUNV	  the	  presence	  of	  specific	  nucleotides	  located	  at	  both	  ends	  of	  the	  RNA	  template	  are	  needed	  for	  transcription,	  whereas	  replication	  of	  the	  viral	  genome	  depends	   on	   inter-­‐terminal	   complementarity	   with	   no	   apparent	   sequence	   specificity	  (Barr	   et	   al.,	   2005,	   Barr	   and	   Wertz,	   2005,	   Kohl	   et	   al.,	   2004).	   Furthermore	   the	  replication	   and	   transcription	   promoters	   mapped	   for	   BUNV	   have	   been	   shown	   to	  incorporate	   distinct	   but	   not	   overlapping	   sets	   of	   nucleotide	   sequences	   (Barr	   and	  Wertz,	   2004,	   Barr	   and	  Wertz,	   2005,	   Barr	   et	   al.,	   2005,	   Barr	   et	   al.,	   2003,	   Kohl	   et	   al.,	  2004).	  The	  internal	  region	  of	  the	  NTR	  has	  been	  shown	  to	  be	  segment	  specific	  not	  only	  between	  segments	  of	  the	  same	  virus,	  but	  also	  between	  members	  of	  the	  same	  genus.	  The	  roles	  of	  these	  segment	  specific	  sequences	  have	  been	  shown	  to	  involve	  regulation	  of	  RNA	  synthesis	  for	  both	  BUNV	  and	  Rift	  Valley	  fever	  virus	  (RVFV)	  (Barr	  et	  al.,	  2003)	  (Gauliard	  et	  al.,	  2006).	  The	  problem	  with	   these	   in	  vivo	   studies	  however	   is	   that	   they	  have	  analysed	  viral	  replication/transcription	  and	  the	  panhandle	  structure	  using	  mini-­‐genome	  systems,	  and	  involve	  naked	  RNA	  transfected	  into	  cells	  which	  does	  not	  occur	  during	  the	  bunyavirus	  life	  cycle;	  this	  is	  because	  the	  viral	  RNA	  is	  always	  coated	  by	  N	  protein.	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It	  is	  currently	  unknown	  how	  the	  bunyavirus	  N	  protein	  coated	  RNA	  can	  participate	  in	  base-­‐pairing,	  whist	   forming	  a	  panhandle	  structure	  and	  still	  be	  protected	   in	  a	  closed	  RNA	   binding	   groove	   which	   can	   allow	   the	   L	   protein	   access	   to	   the	   RNA	   during	  replication	  and	   transcription.	  One	  possibility	   is	  panhandle	   formation	  may	  occur	  via	  extensive	   protein	   rearrangements	   within	   the	   single	   stranded	   RNA	   (ssRNA)	   RNP	  complexes	  at	  the	  3’	  and	  5’	  NTRs	  after	  access	  to	  the	  RNA	  by	  the	  L	  protein	  has	  occurred,	  which	  may	  accommodate	  two	  protected	  RNAs	  inside	  a	  double	  stranded	  RNA	  (dsRNA)	  protein	  complex.	   Interestingly	   the	  binding	  of	  hantavirus	  N	  to	   the	  panhandle	   in	  vitro	  has	  been	  reported	  to	  be	  an	  entropy-­‐driven	  process,	  which	  resulted	  in	  an	  initial	  stable	  N-­‐RNA	   interaction	   followed	   by	   a	   conformational	   change	   in	   the	   N	   protein	   (Mir	   and	  Panganiban,	  2005).	  	  	  Since	  bunyaviruses	  are	  not	  capable	  of	  capping	  their	  own	  transcripts	  the	  viral	  mRNAs	  are	   not	   initiated	   de	  novo,	   and	   depend	   on	   primers	   generated	   from	   capped	   host-­‐cell	  mRNAs	   by	   the	   L	   protein	   in	   a	   cap	   snatching	  mechanism.	   All	  members	   of	   the	   sNSVs	  utilize	  a	  cap	  snatching	  mechanism	  for	  transcription.	  The	  notion	  that	  cap	  snatching	  is	  highly	  conserved	  and	  is	  a	  common	  feature	  to	  all	  members	  of	  the	  Bunyaviridae	  family,	  
Orthomyxoviridae	   family,	  and	  Arenaviridae	   family,	  has	  been	  highlighted	  by	  evidence	  which	   suggests	   tomato	   spotted	   wilt	   virus	   (TSWV)	   (tospovirus)	   and	   IAV	   share	   a	  similar	   preference	   for	   certain	   capped-­‐RNA	   primers	   (van	   Knippenberg	   et	   al.,	   2005,	  Geerts-­‐Dimitriadou	   et	   al.,	   2011).	   Initiation	   of	   transcription	   using	   these	   host	   cell	  derived	  capped	  primers	  utilizes	  a	   ‘prime	  and	  realign’	  mechanism	  in	  which	  a	  capped	  leader	   RNA	   primer	   for	   transcription	   is	   extended	   for	   a	   few	   nucleotides	   and	   then	  released.	  Progressive	  elongation	  proceeds	  only	  after	  backward	  re-­‐alignment	  by	  virtue	  of	   the	   viral	   3′	   terminal	   sequence	   repeats.	   In	   vivo	   studies	   have	   shown	   the	   TSWV	   L	  protein	   displays	   preference	   for	   cellular	   mRNA	  molecules	   containing	   residues	   with	  base	   complementary	   of	   as	   little	   as	   1	   nucleotide	   between	   the	   mRNA	   and	   the	   3′	  template	  sequence	  (Garcin	  et	  al.,	  1995,	  Duijsings	  et	  al.,	  2001).	  	  	  
1.2.3	  Non-­‐structural	  proteins	  encoded	  by	  the	  S	  segment	  Most	  members	  of	   the	  Orthobunyavirus,	  Tospovirus	   and	  Phlebovirus	  genera	   encode	   a	  NSs	  protein	  from	  the	  S	  segment,	  whose	  primary	  role	  is	  modulating	  the	  host	  cell	  anti-­‐viral	  response	  through	  diverse	  interactions	  with	  innate	  immunity	  pathways.	  Because	  of	  the	  absence	  of	  a	  second	  protein	  encoding	  ORF	  within	  hantavirus	  and	  nairovirus	  S	  segments	   it	   is	   interesting	  to	  speculate	  that	  viruses	  within	  these	  groups	  make	  up	  for	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the	  absence	  of	  the	  NSs	  protein	  by	  other	  means.	  For	  example	  the	  L	  proteins	  of	  CCHFV	  and	  Nairobi	   sheep	  disease	  virus	   (NSDV)	  have	  been	   shown	   to	   contain	  OTU	  domains	  (discussed	   below	   on	   page	   36),	  which	   have	   been	   implicated	   in	   down	   regulating	   the	  interferon	  response	  (Bakshi	  et	  al.,	  2013,	  Holzer	  et	  al.,	  2011,	  van	  Kasteren	  et	  al.,	  2012).	  There	   is	  also	  evidence	  to	  support	  the	  possibility	  that	  some	  sNSV	  N	  proteins	  contain	  additional	   features	   encoded	   by	   their	   considerably	   larger	   ORFs.	   The	   LASV	  nucleoprotein	   (NP)	   has	   been	   shown	   to	   have	   3′-­‐5′	   exoribonuclease	   and	  exodeoxyribonuclease	   activities	   to	   down	   regulate	   the	   cellular	   interferon	   response,	  whilst	   the	   hantavirus	   N	   protein	   has	   been	   shown	   to	   function	   in	   cap	   binding	   and	  replace	  the	  entire	  eIF4F	  complex	  in	  translation.	  In	  addition	  the	  CCHFV	  N	  protein	  has	  been	  shown	  to	  have	  DNA	  endonuclease	  activity,	  however	  the	  functional	  significance	  of	   this	   remains	   to	  be	  determined	  (Guo	  et	  al.,	  2012,	  Hastie	  et	  al.,	  2011a,	  Panganiban	  and	  Mir,	  2009).	  
1.2.4	  Non-­‐structural	  proteins	  encoded	  by	  the	  M	  segment	  The	   M	   segment	   of	   the	   Orthobunyavirus,	   Phlebovirus	   and	   Tospovirus	   genera	   also	  encode	  a	  non-­‐structural	  (NSm)	  protein.	  There	  is	  evidence	  suggesting	  the	  nairoviruses	  also	  generate	  an	  NSm	  protein	  through	  proteolytic	  processing	  (Bergeron	  et	  al.,	  2012,	  Bergeron	   et	   al.,	   2007b,	   Altamura	   et	   al.,	   2007).	   Whereas	   the	   orthobunyavirus	   and	  phlebovirus	  NSm	  protein	  is	  cleaved	  by	  cellular	  proteases	  from	  the	  same	  polyprotein	  precursor	  that	  yields	  the	  Gn	  and	  Gc	  proteins,	  the	  tospovirus	  NSm	  protein	  is	  translated	  from	  a	  separate	  mRNA	  encoded	  by	  the	  positive	  sense	  antigenome.	  The	  NSm	  protein	  of	  orthobunyaviruses	  is	  found	  inside	  Golgi-­‐associated	  viral	  factory	  tubular	  structures	  within	   infected	   cells	  where	   it	   is	   thought	   to	  play	  a	   role	   in	  virus	   assembly	   (Shi	   et	   al.,	  2006)	  (Fontana	  et	  al.,	  2008).	  The	  NSm	  protein	  of	  TSWV	  on	  the	  other	  hand	  is	  thought	  to	   facilitate	   the	   cell	   to	   cell	   transmission	   through	   the	   plant	   cell	   wall	   and	   the	  plasmodesmata	  (Kormelink	  et	  al.,	  1994),	  whereas	  as	  the	  phlebovirus	  NSm	  protein	  has	  been	   shown	   to	  be	  dispensable	   to	   the	  virus	   (Gerrard	  et	   al.,	   2007),	   and	   is	   thought	   to	  play	  an	  accessory	  function	  in	  the	  regulation	  of	  apoptosis	  (Won	  et	  al.,	  2007).	  
1.2.5	  Assembly	  and	  release	  One	  of	  the	  major	  distinctions	  between	  bunyaviruses	  and	  most	  other	  nsRNA	  viruses	  is	  that	  they	  are	  generally	  thought	  to	  utilize	  tube	  like	  factories	  for	  virus	  production	  that	  are	   built	   around	   the	   Golgi	   complex	   (Kikkert	   et	   al.,	   1999)	   (Kuismanen	   et	   al.,	   1984)	  (Murphy	  et	  al.,	  1973)	  (Matsuoka	  et	  al.,	  1991)	  (Novoa	  et	  al.,	  2005)	  (Figure	  4).	  For	  the	  animal-­‐infecting	  bunyaviruses,	  it	  is	  generally	  thought	  that	  particle	  assembly	  involves	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budding	  of	  RNPs	  into	  the	  vacuolised	  lumen	  of	  Golgi	  cisternae	  stacks,	  and	  to	  a	   lesser	  extent,	   the	   endoplasmic	   reticulum	   (ER)-­‐Golgi	   intermediate	   compartment	   (ERGIC)	  (Overby	   et	   al.,	   2007a).	   The	   Hantavirus	   genus	   however	   has	   been	   shown	   to	   be	   the	  exception,	  with	  reports	   that	   the	  maturation	  strategy	  of	  Sin	  Nombre	  virus	  and	  Black	  Canal	  Creek	  virus	  (BCCV)	  (New	  World	  Hantaviruses)	  facilitates	  budding	  at	  the	  plasma	  membrane	  of	  polarised	  epithelial	  cells,	  raising	  the	  possibility	  that	  hantaviruses	  utilise	  alternative	   assembly	   pathways	   (Goldsmith	   et	   al.,	   1995,	   Ravkov	   et	   al.,	   1997).	   There	  has	   also	   been	   an	   additional	   report	   that	   RVFV	   particles	   assemble	   and	   bud	   at	   the	  plasma	   membrane	   in	   primary	   liver	   cells,	   opening	   the	   question	   as	   to	   whether	  assembly	  may	   be	   cell-­‐type	   dependent	   (Walter	   and	   Barr,	   2011).	   	   In	   the	   case	   of	   the	  plant	   infecting	  TSWV,	  particle	  assembly	  in	  plant	  cells	   involves	  enwrapment	  of	  RNPs	  by	   an	   entire	  Golgi	   stack,	   leading	   to	   the	   formation	   of	   doubly	   enveloped	   virus	   (DEV)	  particles.	   Singly	   enveloped	   viruses	   (SEV)	   are	   formed	   in	   large	   membrane	   bound	  vesicles	   by	   the	   fusion	   of	   DEV	   particles	   with	   each	   other	   and	   with	   ER-­‐derived	  membranes	  (Ribeiro	  et	  al.,	  2009).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  10	  
	  	  Figure	  4.	  The	  model	  for	  bunyavirus	  entry,	  assembly	  and	  budding.	  Clathrin	  mediated	  endocytosis	  is	  the	  predominant	   route	   of	   virus	   entry	   (1),	   progression	   into	   the	   cell	   occurs	   through	   early	   and	   late	  endosomes.	   (2),	   and	   infectious	   RNPs	   are	   released	   following	   late	   endosomal	   acidification	   (3),	   and	  accumulate	  in	  the	  Golgi	  (4),	  accumulation	  of	  both	  cellular	  and	  viral	  proteins	  in	  close	  association	  with	  Golgi	   stacks	   to	   form	   viral	   factories	   (5)	   coupled	   to	   both	   mitochondria	   and	   the	   rough	   endoplasmic	  reticulum.	   The	   Golgi	   stacks	   form	   globular	   structures	   serving	   to	   protect	   viral	  mRNA	   transcripts	   and	  newly	  replicated	  S,	  M,	  and	  L	  complexes,	  which	  are	  generated	  by	  the	  viral	  polymerase.	  New	  bunyavirus	  particles	   are	   generated	   (6),	   by	   association	   of	   RNPs	   with	   Gn-­‐Gc	   glycoprotein	   heterodimers.	   Gn-­‐Gc	  heterodimers	   accumulate	   in	   the	   Golgi	   and	   pass	   through	   the	   trans-­‐Golgi	   compartment	   where	  modification	   takes	   place	   by	   the	   addition	   of	   N-­‐linked	   carbohydrates	   (7).	   Morphological	   changes	  resulting	  in	  full	  infectious	  virus	  occur	  through	  a	  period	  of	  transition	  whilst	  passing	  through	  the	  Golgi	  apparatus	  and	  upon	  secretion	  out	  of	  the	  cell	  (8).	  	  The	  figure	  was	  adapted	  from	  Walter	  and	  Barr	  (2011).	  
1.2.6	  Reverse	  genetics	  of	  bunyaviruses	  Reverse	  genetic	   systems	   capable	  of	   generating	   infectious	  bunyavirus	  particles	   from	  cloned	   complementary	   DNA	   (cDNA)	   have	   become	   reliable	   techniques	   to	   study	   this	  group	   of	   medically	   important	   viruses,	   and	   allows	   the	   identification	   of	   genetic	  determinants	   of	   transcription,	   replication,	   assembly	   and	   pathogenesis.	   For	  bunyaviruses,	   the	   viral	   genomic	   RNAs,	   as	   well	   as	   the	   minimum	   requirements	   for	  genome	  transcription,	  the	  viral	  RdRp	  and	  N	  protein	  must	  be	  provided	  to	  initiate	  the	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viral	  replication	  cycle.	  Furthermore	  full	  reverse	  genetic	  systems	  that	  allow	  the	  rescue	  of	   infectious	   virus	   have	   been	   developed	   for	   several	   members	   of	   the	   Bunyaviridae	  family	  including	  BUNV	  (Bridgen	  and	  Elliott,	  1996),	  LACV	  (Blakqori	  and	  Weber,	  2005),	  Akabane	   virus	   (orthobunyavirus)	   (Ogawa	   et	   al.,	   2007)	   and	   RVFV	   (Ikegami	   et	   al.,	  2006).	  Bacteriophage	  T7	  polymerase	  promoters	  or	  mammalian	  polymerase	   I	   (PolI)	  promoters	   that	  drive	   transcription	  of	   the	  virus	  genome	  RNA	  are	  commonly	  used	   in	  bunyavirus	   reverse	   genetics	   systems,	   to	   generate	   the	   viral	   RdRp,	   N	   protein	   and	  accessory	   proteins.	   These	   proteins	   then	   replicate,	   transcribe	   and	   package	   the	   viral	  genome,	  allowing	  rescue	  of	  infectious	  virus.	  	  	  Reverse	  genetic	  systems	  for	  rescue	  of	  infectious	  CCHFV	  and	  TSWV	  are	  not	  available.	  An	   alternative	  mini-­‐genome	   version	   for	   CCHFV	   is	  more	  widely	   used	   and	   is	   able	   to	  analyse	  replication,	   transcription	  and	  RNP	  formation	  under	  safer	  Bio-­‐Safety	  Level	  2	  (BSL-­‐2)	   conditions	   (Bergeron	   et	   al.,	   2010a).	   The	   mini-­‐genome	   system	   involves	  introducing	   a	   viral	   template,	   in	  which	   the	   viral	  M	   segment	   ORF	   is	   replaced	  with	   a	  reporter	   gene	   such	   as	   enhanced	   green	   fluorescent	   protein	   (eGFP),	   luciferase	   or	  chloramphenicol	   acetyltransferase.	  These	   reporter	  genes	  are	   flanked	  by	  viral	  NTRs,	  which	   contain	   the	   necessary	   signals	   to	   allow	   transcription,	   replication	   and	  subsequent	  encapsidation	  of	  the	  viral	  template.	  The	  system	  works	  by	  expressing	  the	  minimal	  viral	  components	  for	  virus	  replication	  and	  transcription,	  namely	  the	  N	  and	  L	  proteins,	  which	  are	  under	   the	  control	  of	   a	   strong	  PolI	  promoter	  within	  mammalian	  cells	   where	   they	   self-­‐assemble	   into	   a	   functional	   RNP.	   The	   RNP	   both	   orders	   and	  protects	  the	  viral	  RNA,	  and	  represents	  the	  active	  template	  for	  mRNA	  synthesis,	  thus	  providing	   a	   powerful	   tool	   to	   study	   these	   processes,	   without	   producing	   infectious	  virus,	  and	  enabling	  genetic	  manipulation	  of	  viral	  proteins.	  There	  is	  currently	  no	  mini-­‐genome	  system	  for	  tospoviruses.	  
1.3	  Transmission	  The	   lifecycles	  of	   the	  orthobunyaviruses,	   nairoviruses	  and	  phleboviruses	   rely	  on	   the	  natural	   replication	   in	   haematophagous	   arthropods	   (such	   as	   mosquitos,	   midges,	  sandflies	  and	  ticks),	  and	  warm-­‐blooded	  species.	  The	  tospoviruses	  are	  transmitted	  by	  the	   thrips	   species	   of	   arthropod	   and	   are	   the	   only	   plant	   pathogens	   within	   the	  
Bunyaviridae	   family,	   which	   offers	   another	   basis	   for	   classification.	   Hantaviruses	   are	  not	   vectored	   by	   arthropods	   and	   instead	  maintain	   a	   persistent	   infection	   in	   rodents	  (Elliott,	   2009,	   Asher	   et	   al.,	   1988).	   Bunyaviruses	   are	   able	   to	   multiply,	   and	   spread	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within	  all	   these	  vectors	  both	   transovarially	   (vertical	   transmission)	   (Tesh	  and	  Modi,	  1987,	  Miller	   et	   al.,	   1977)	   and	   venereally	   (horizontal	   transmission)	   (Thompson	   and	  Beaty,	  1978).	  	  
The	  aim	  of	  this	  thesis	  is	  to	  elucidate	  the	  structure	  and	  function	  the	  CCHFV	  and	  TSWV	  N	  
proteins	   and	   it	   is	   therefore	   important	   to	   introduce	   the	   Nairovirus	   and	   Tospovirus	  
genera	  to	  the	  reader.	  
1.4	  Introduction	  to	  CCHFV	  and	  the	  Nairovirus	  genus	  CCHFV	   is	   grouped	   within	   one	   of	   seven	   serogroups	   of	   the	  Nairovirus	   genus,	   which	  according	  to	   the	   latest	   International	  Committee	   for	   the	  Taxonomy	  of	  Viruses	  report	  comprise	   a	   total	   of	   34	   viruses.	   Of	   these	   viruses	   only	   CCHFV	   has	   serious	   clinical	  importance	  and	  is	  the	  only	  life	  threating	  and	  human	  disease	  causing	  nairovirus	  (Burt	  et	  al.,	  1996a).	  Dugbe	  virus	  (DUGV),	  which	  belongs	  to	  the	  Nairobi	  sheep	  disease	  group,	  has	  high	  serological	  and	  genetic	  similarity	  to	  CCHFV,	  and	  has	  been	  reported	  to	  cause	  in	  rare	  cases	  a	  mild	  febrile	   illness	  and	  thrombocytopenia	  (Burt	  et	  al.,	  1996b),	  but	   is	  not	   of	   clinical	   importance.	  Because	  DUGV	   causes	   a	   similar	  disease	   although	   lacking	  haemorrhagic	   fever	   in	   immunosuppressed	  mice	   to	   that	   of	   CCHFV	   and	   both	   viruses	  share	  a	  close	  relationship,	  DUGV	  has	  been	  suggested	  to	  be	  a	  good	  potential	  model	  for	  studying	  CCHFV	  biology	  (Coates	  and	  Sweet,	  1990).	  The	  Nairobi	  sheep	  disease	  group	  also	   contains	   NSDV,	   which	   is	   a	   pathogen	   of	   sheep	   and	   goats	   (Bakshi	   et	   al.,	   2013).	  Hazara	  virus	  has	  also	  been	  shown	  to	  be	  closely	  related	  to	  CCHFV	  (Casals	  and	  Tignor,	  1974,	  Foulke	  et	  al.,	  1981),	  and	  has	  not	  been	  reported	  to	  cause	  human	  disease	  and	  has	  also	  been	  proposed	  to	  be	  a	  good	  model	  for	  studying	  the	  cellular	  biology	  of	  CCHFV,	  in	  safer	  BSL-­‐2	  facilities	  (Dowall	  et	  al.,	  2012).	  
1.4.1	  Reservoirs	  and	  Vectors	  CCHFV	   circulates	   in	   an	   enzootic	   tick-­‐vertebrate-­‐tick	   cycle,	   infecting	   domestic	   and	  wild	  animals	  carrying	  mature	  ticks,	  which	  transmit	  the	  infection	  to	  large	  vertebrates	  such	  as	  livestock.	  Although	  infection	  in	  mammals	  can	  last	  for	  up	  to	  two	  weeks,	  they	  do	   not	   display	   any	   clinical	   symptoms	   (Figure	   5)	   (Gunes	   et	   al.,	   2011).	   CCHFV	   is	  amplified	  and	  maintained	  in	  nature	  by	  numerous	  domestic	  and	  wild	  animals	  carrying	  immature	   ticks	   (nymphs)	   (Hoogstraal,	   1979,	   Appannanavar	   and	   Mishra,	   2011)	  (Figure	  20),	  and	  has	  been	  isolated	  from	  sheep	  (Yen	  et	  al.,	  1985),	  hares	  (L'Vov	  D	  et	  al.,	  2002),	   hedgehogs	   (Whitehouse,	   2004b),	   a	  Mastomys	   spp	   of	   mouse	   (Saluzzo	   et	   al.,	  1985),	   and	   even	   domestic	   birds	   (Shepherd	   et	   al.,	   1987a,	   Shepherd	   et	   al.,	   1987b).	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Around	  31	   species	  of	   ticks	   in	   seven	  genera	  of	   the	   Ixodidae	   family	   (hard	   ticks)	  have	  been	  found	  to	  harbor	  CCHFV	  and	  the	  most	  efficient	  and	  common	  vectors	  for	  CCHFV	  appear	   to	   be	   members	   of	   the	   Hyalomma	   genus.	   Transmission	   of	   CCHFV	   also	   less	  frequently	   occurs	   by	   other	   ixodid	   ticks,	   including	   members	   of	   the	   genera	  
Rhipicephalus,	  Boophilus,	  Dermacentor,	  and	  Ixodes	  (Bell-­‐Sakyi	  et	  al.,	  2012).	  The	  factors	  involved	  in	  human	  transmission	  are	  discussed	  below	  on	  page	  19.	  
	  	  Figure	  5.	  Life	  cycle	  of	  CCHFV.	  (a)	  Tick	  cycle,	  1-­‐	  adult,	  2-­‐	  eggs,	  3-­‐	  larvae,	  4-­‐	  nymph,	  (i)	  Trans-­‐ovarian,	  (ii)	  Trans-­‐stadial,	  (b)	  Tick-­‐small	  vertebrate	  cycle,	  (c)	  Tick-­‐large	  vertebrate/bird/human	  cycle,	  (d)	  Human-­‐human	  cycle	  (community/nosocomial).	  
1.4.2	  Molecular	  and	  cellular	  biology	  of	  CCHFV	  N	  protein	  
1.4.2.1	  Subcellular	  localization	  of	  CCHFV	  N	  and	  its	  interactions	  with	  host	  cell	  partners	  Besides	  taking	  part	  in	  the	  functions	  associated	  with	  particle	  assembly,	  RNP	  formation,	  and	  viral	  RNA	  synthesis	  the	  CCHFV	  N	  protein	  interacts	  with	  several	  host	  cell	  proteins,	  including	   actin	   and	  MxA	   (Andersson	   et	   al.,	   2004b,	   Andersson	   et	   al.,	   2004a).	   In	   the	  absence	  of	   other	  virally	   encoded	  proteins	  CCHFV	  N	  protein	   localizes	   to	  perinuclear	  regions	   of	   the	   infected	   cells	   and	   following	   disruption	   of	   actin	   filaments	   using	  cytochalasin	   D,	   this	   localization	   is	   abolished.	   Furthermore	   the	   disruption	   of	   actin	  filaments	   by	   cytochalasin	   D	   during	   virus	   infection	   in	   cells	   reduced	   viral	   titres	   and	  
	  14	  
implies	   actin	   filaments	   play	   an	   important	   role	   in	   the	   assembly	   process	   of	   CCHFV.	  Similar	   results	   have	   been	   seen	   with	   another	   bunyavirus,	   the	   BCCV	   (Ravkov	   et	   al.,	  1998).	  
1.4.2.1.1	  MxA	  MxA	   has	   also	   been	   implicated	   as	   a	   binding	   partner	   for	   CCHFV	   N	   protein	   during	  infection.	  MxA	  belongs	  to	  the	  dynamin	  family	  of	  large	  GTPases,	  which	  are	  involved	  in	  a	   variety	   of	   intracellular	   transport	   processes	   (Haller	   and	  Kochs,	   2002,	   Kochs	   et	   al.,	  2002,	   Sever	   et	   al.,	   2000).	  MxA	  has	   been	   shown	   to	   inhibit	   the	   replication	   of	   CCHFV,	  through	   an	   interaction	   with	   the	   CCHFV	   N	   protein.	   Andersson	   et	   al	   used	   confocal	  microscopy	  to	  reveal	  MxA	  colocalizes	  with	  the	  N	  protein	  of	  CCHFV	  in	  the	  perinuclear	  regions	   of	   infected	   cells	   (Andersson	   et	   al.,	   2004a).	   Constitutively	   expressed	   MxA	  caused	  a	  block	  in	  viral	  genome	  replication	  in	  CCHFV	  infected	  cells,	  while	  not	  affecting	  primary	   transcription	   of	   the	   incoming	   genome	   and	   translation	   of	   viral	  mRNA.	  MxA	  has	   been	   proposed	   to	   exert	   its	   anti-­‐viral	   effects	   through	   sequestration	   of	   CCHFV	  N	  protein	  away	  from	  sites	  of	  replication,	  however	  the	  precise	  mechanism	  by	  which	  MxA	  inhibits	  CCHFV	  replication	  remains	  unclear.	  
1.4.2.1.2	  Caspase-­‐3	  protease	  cleavage	  of	  CCHFV	  N	  protein	  The	  most	  striking	  interaction	  between	  CCHFV	  N	  protein	  and	  a	  host	  cell	  protein	  is	  that	  with	  the	  caspase-­‐3	  protease	  and	  the	  DEVD	  motif,	  which	  is	  conserved	  across	  all	  CCHFV	  strains.	   In	   vivo	   analysis	   by	   Karlberg	   et	   al	   (Karlberg	   et	   al.,	   2011)	   demonstrated	   in	  multiple	   cell	   lines	   that	   during	   viral	   infection	   the	   CCHFV	   N	   protein	   is	   cleaved	   by	  caspase-­‐3	  protease	  into	  30	  kDa,	  and	  22	  kDa	  fragments	  corresponding	  to	  residues	  1-­‐265	   and	   266-­‐480	   respectively	   (Karlberg	   et	   al.,	   2011).	   The	   study	   also	   found	   that	  CCHFV	  infection	  in	  cells	  leads	  to	  the	  induction	  of	  apoptosis	  and	  cleavage	  of	  CCHFV	  N	  protein	   by	   the	   caspase-­‐3	   protease	   is	   more	   pronounced	   72	   hr	   after	   infection	  (detection	  of	  progeny	  virus	  was	  detected	  48	  hr	  after	   infection),	  which	   is	   consistent	  with	  the	  concurrent	  induction	  of	  apoptosis	  that	  was	  observed	  in	  infected	  cells	  at	  that	  time.	  It	  is	  unclear	  from	  this	  analysis	  whether	  there	  is	  a	  direct	  link	  between	  apoptosis	  induction	   as	   result	   of	   CCHFV	   replication	   in	   cells,	   or	   alternatively	   whether	   it	   is	   an	  indirect	  effect	  mediated	  by	  an	  antiviral	  response	  generated	  by	  the	  host	  cell,	  such	  as	  type	   I	   interferons	   (IFNs)	   or	   the	   dsRNA	   response,	   which	   may	   act	   as	   initiators	   of	  apoptosis.	   Furthermore	   the	   cleavage	   of	   CCHFV	   N	   protein	   was	   abrogated	   by	   the	  inhibition	  of	  apoptosis	  and	  induced	  progeny	  viral	  titers	  of	  ∼80-­‐90%,	  which	  not	  only	  highlights	   the	   link	  between	  apoptosis	   and	   caspase-­‐3	  protease	   cleavage	  of	   CCHFV	  N	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protein	  but	  also	  suggests	  the	  caspase-­‐3	  protease	  cleavage	  of	  the	  CCHFV	  N	  protein	  is	  a	  host	  cell	  defense	  mechanism.	  However	  the	  proposal	  that	  caspase-­‐3	  protease	  cleavage	  of	   CCHFV	   N	   protein	   is	   not	   beneficial	   to	   the	   virus	   does	   not	   explain	   the	   highly	  conserved	   nature	   of	   the	   DEVD	   cleavage	   site	   in	   all	   CCHFV	   strains	   studied	   to	   date.	  Although	  the	  purpose	  of	  this	  cleavage	  by	  caspase-­‐3	  protease	  is	  unknown	  it	  raises	  the	  possibility	   that	   nairoviruses	   may	   have	   evolved	   alternative	   ways	   of	   producing	  functional	   non-­‐structural	   proteins.	   One	   possible	  mechanism	   for	   caspase-­‐3	   protease	  cleavage	   of	   CCHFV	   N	   protein	   could	  maintain	   reduced	   levels	   of	   activated	   caspase-­‐3	  protease	  cleavage	  of	  cellular	  substrates	  during	  the	  initiation	  of	  apoptosis	  by	  CCHFV	  N	  protein	   acting	   as	   a	   decoy	   substrate,	   and	   in	   doing	   so	   could	   delay	   the	   downstream-­‐mediated	  signaling	  pathways,	   including	  apoptosis	  and	  the	   interferon	  response,	  with	  important	  consequences	  for	  viral	  growth.	  	  
1.4.2.2	  Genetic	  diversity	  and	  relationships	  between	  strains	  In	  recent	  years	  a	  number	  of	  studies	  have	  demonstrated	  that	  the	  genomic	  diversity	  of	  CCHFV	   is	   surprisingly	   high	   and	   has	   led	   to	   the	   genetic	   relationship	   of	   CCHFV	  worldwide	  -­‐	  based	  on	  the	  S	  segment	  -­‐	  being	  subdivided	  into	  seven	  genetically	  distinct	  groups,	   Africa	   1	   (Senegal),	   Africa	   2	   (Democratic	   Republic	   of	   the	   Congo	   and	   South	  Africa),	  Africa	  3	  typified	  by	  West	  and	  South	  African	  strains,	  Europe	  4	  (Russia,	  Turkey,	  Bulgaria,	  Kosovo	  and	  Albania),	  Europe	  2	  (Greece),	  Asia	  1	  (the	  Middle	  East,	  Pakistan	  and	   Iran)	   and	   Asia	   2	   (China,	   Uzbekistan,	   Tajikistan	   and	   Kazakhstan),	   and	   the	  European	   7	   subtype	   (Greece)	   (Hewson	   et	   al.,	   2004a,	   Deyde	   et	   al.,	   2006,	   Burt	   and	  Swanepoel,	  2005).	  These	  studies	  agree	  with	  the	  generally	  high	  rates	  of	  mutation	  and	  genetic	  diversity	  in	  RNA	  viruses	  due	  to	  the	  error-­‐prone	  nature	  of	  their	  polymerases.	  However	   they	   disagree	   with	   the	   double-­‐filter	   concept	   by	   which	   the	   evolution	   of	  arboviruses	  is	  constrained	  due	  to	  a	  need	  to	  maintain	  life	  cycles	  in	  both	  arthropod	  and	  amplifying	  vertebrate	  hosts	  (Holland	  and	  Domingo,	  1998,	  Weaver,	  2006).	  	  	  Comparative	  analysis	  of	   the	  whole	  genomes	  of	  18	  CCHFV	  strains	  estimated	  that	   the	  evolution	   rate	   of	   the	   M	   segment	   is	   3.58	   times	   higher	   than	   that	   of	   the	   S	   segment	  (Anagnostou	  and	  Papa,	  2009).	  Similarly	  another	  study	  found	  that	  the	  genomes	  of	  13	  geographically	   and	   temporally	   diverse	   virus	   strains	   were	   highly	   variable,	   with	   the	  greatest	  accumulation	  of	  mutations	  seen	  again	  in	  the	  surface	  glycoprotein	  encoding	  M	  segment,	  with	  31%	  nucleotide	  and	  27%	  amino	  acid	  divergence	  (Deyde	  et	  al.,	  2006).	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The	   high	   plasticity	   within	   the	   M	   segment	  may	   have	   arisen	   from	   positive	   selection	  operating	   in	   a	  manner	   reflecting	   immune	   surveillance,	   as	  well	   as	   increasing	   varied	  cellular	   tropism	   required	   for	   efficient	   attachment	   to	   arthropod	  and	  vertebrate	  host	  cells	  during	  different	  natural	  cycles.	  Alternatively	  lack	  of	  constraint	  may	  account	  for	  the	  high	  genetic	  diversity	  within	  the	  M	  segment,	  as	  much	  of	  the	  amino	  acid	  variation	  resides	   in	   the	   hypervariable	   mucin-­‐like	   domain,	   where	   side	   chains	   can	   be	   highly	  variable	  and	  still	  endure	  the	  O-­‐glycan	  modification	  (Sanchez	  et	  al.,	  2006,	  Deyde	  et	  al.,	  2006).	  These	  arguments	  however	  cannot	  be	  applied	  to	  the	  S	  and	  L	  segments	  (Deyde	  et	   al.,	   2006,	   Carroll	   et	   al.,	   2010,	   Anagnostou	   and	   Papa,	   2009,	   Mild	   et	   al.,	   2010b,	  Hewson	  et	  al.,	  2004a,	  Burt	  et	  al.,	  2009),	  which	  have	  also	  been	  shown	  to	  exhibit	  high	  amounts	  of	  genetic	  diversity	  between	  strains.	  	  	  Whilst	   mutation	   is	   the	   primary	   means	   of	   increasing	   RNA	   genome	   plasticity,	   RNA	  segment	  re-­‐assortment	  also	  contributes	  to	  the	  genetic	  diversity	  in	  sNSVs	  (Deyde	  et	  al.,	  2006,	  Burt	  et	  al.,	  2009).	  The	  most	  dramatic	  example	  of	  re-­‐assortment	  is	  from	  IAV,	  in	  which	   segment	   re-­‐assortment	   results	   in	   antigenic	   shift	   and	   the	   emergence	   of	  pandemic	  virus	  strains.	  Although	  re-­‐assortment	  of	  the	  CCHFV	  M	  segment	  seems	  to	  be	  the	  more	  frequent,	  examples	  of	  S	  and	  L	  segment	  re-­‐assortment	  have	  to	  a	  lesser	  extent	  also	  been	  observed	  (Deyde	  et	  al.,	  2006).	  	  	  Recently	   Chen	   et	   al	   have	   demonstrated	   that	   China	   strain	   YL04057	   and	   79121M18	  belong	  to	  lineage	  I	  based	  on	  the	  M	  and	  L	  segments	  but	  belong	  to	  lineage	  IV	  in	  the	  S	  tree,	   which	   apparently	   represented	   S	   segment	   reassortments	   (Chen,	   2013).	   One	  reason	   for	   CCHFV	   reassortments	   could	   be	   co-­‐infection	   coupled	   with	   long-­‐term	  persistent	  and	  vertical	  transmission	  in	  ticks	  (Burt	  et	  al.,	  2009,	  Shepherd	  et	  al.,	  1991).	  The	  idea	  that	  re-­‐assortments	  maintain	  fitness	  during	  transmission	  to	  a	  different	  host	  (tick-­‐vertebrate)	   is	   supported	   by	   those	   reassortments	   SPU415/85,	   SPU97/85,	  UG3010,	  ArD15786,	  HU8966,	  Baghdad	  12,	  and	  Afg09-­‐2990,	  being	  isolated	  from	  both	  human	  and	  goat	  (Chen,	  2013).	  	  The	   distinction	   of	   group	   I	   and	   III	   viruses	   of	  West	  Africa	   demonstrate	   that	  multiple	  virus	  genetic	   lineages	  can	  also	  be	   found	   in	   the	  same	  geographic	  areas	  (Deyde	  et	  al.,	  2006).	   In	   some	   regions	   such	   as	   Xinjiang	   China,	   CCHFV	   strains	   are	   derived	   from	  multiple	   origins,	   including	   those	   Xinjiang	   strains	   related	   to	   those	   of	   circulating	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Uzbekistan	   from	  the	  Asia	  1	  group	  and	  Fub90009	  strain	   in	  Asia	  2	  group.	   (Sun	  et	  al.,	  2009),	  and	  at	  least	  four	  genetic	  lineages	  of	  CCHFV	  have	  been	  detected	  in	  Iran	  (Senegal	  and	  Mauritania)(Chinikar	  et	  al.,	  2004,	  Mild	  et	  al.,	  2010b). 	  Recombination	  events	  have	  also	  been	  observed	  (Lukashev	  et	  al.,	  2008,	  Hewson	  et	  al.,	  2004b),	   and	   although	   much	   less	   frequent	   may	   also	   contribute,	   along	   with	   the	  accumulation	  of	  mutations	  and	  segment	  re-­‐assortment,	   to	  the	  high	  genetic	  diversity	  of	  CCHFV.	  	  
1.4.3	  Epidemiology	  and	  Ecology	  Phylogeographical	   analyses	   between	   viruses	   from	   different	   geographic	   regions	   has	  not	  only	  provided	  information	  as	  to	  the	  genetic	  diversity	  amongst	  CCHFV	  strains,	  but	  also	   provides	   important	   information	   about	   the	   direction	   of	   migration	   between	  endemic	   geographical	   areas.	   Collected	   phylogeographical	   analysis	   by	   Hewson	   et	   al	  (Hewson	   et	   al.,	   2004a)	  has	   revealed	   closely	   related	   viruses	   can	  be	   found	   in	  distant	  geographical	  locations.	  For	  example	  S	  RNA	  sequences	  of	  strains	  from	  the	  United	  Arab	  Emirates,	   Madagascar	   and	   Pakistan	   all	   fall	   into	   the	   Asia	   1	   group	   (Hewson	   et	   al.,	  2004b).	  Moreover	  it	  is	  interesting	  that	  Mild	  et	  al	  (Mild	  et	  al.,	  2010a)	  reported	  that	  the	  same	   genotypes	   could	   be	   found	   in	   countries	   that	   are	   very	   distant.	   For	   example,	  genotype	   1	   was	   found	   predominately	   in	   the	  Middle	   East,	   however	   was	   also	   found	  west	  in	  Madagascar,	  and	  genotype	  7	  was	  found	  in	  west	  Africa,	  South	  Africa	  and	  Iran,	  which	   suggests	   CCHFV	   is	   capable	   of	   migrating	   over	   short	   and	   long	   distances.	  Furthermore	  Mild	  et	  al	  (Mild	  et	  al.,	  2010a)	  concluded	  that	  because	  each	  genotype	  in	  the	   phylogenetic	   trees	   showed	   that	   CCHFV	   N	   did	   not	   cluster	   according	   to	   time	   of	  isolation	  (non-­‐temporal	  evolution),	  and	  that	  several	  of	  the	  sequences	  were	  identical	  despite	  sampling	  at	  different	  points	  over	  a	  30	  year	  period,	   for	  example	  genotype	  1,	  Pakistan	   1970	   and	   2002.	   And	   therefore	   through	   divergent	   evolution	   CCHFV	   has	  diversified	  into	  seven	  distinct	  genotypes	  and	  most	  likely	  has	  been	  circulating	  a	  very	  long	  time,	  an	  observation	  also	  reported	  by	  Anagnotou	  &	  Papa	  (Anagnostou	  and	  Papa,	  2009).	  	  Although	   these	   phylogeographic	   features	   can	   be	   explained	   through	   a	   number	   of	  factors;	  the	  major	  likelihood	  is	  that	  livestock	  trade	  has	  played	  an	  important	  role.	  	  For	  instance	  the	  multiple	  phylogenetic	   lineages	  of	  group	  I	  and	  III	  viruses	   in	  West	  Africa	  (Hewson	  et	  al.,	  2004a).	  Perhaps	  the	  multiple	  genetic	  lineages,	  which	  are	  found	  within	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the	  Arabian	  Peninsula,	   can	   be	   explained	  by	   the	  movement	   of	   sheep	   from	   countries	  within	  the	  Horn	  of	  Africa,	  or	  Iran	  and	  Pakistan.	  This	  view	  is	  also	  consistent	  with	  the	  genetic	   relationships	   seen	   between	   virus	   strains	   and	   detailed	   molecular	  epidemiologic	  analysis	  of	  previous	  outbreaks	  in	  the	  United	  Arab	  Emirates	  and	  Oman	  (Deyde	  et	  al.,	  2006,	  Rodriguez	  et	  al.,	  1997).	  	  	  The	  geographic	  range	  of	  CCHFV	  is	  exceptionally	  wide,	  and	  coincides	  with	  the	  global	  distribution	  of	  Hyalomma	  ticks,	  of	  which	  Hyalomma	  marginatum	  (Figure	  6)	  has	  been	  implicated	   as	   the	   principal	   vector	   of	   CCHFV	   in	   Europe.	   There	   are	   at	   least	   31	   tick	  species	  that	  have	  been	  incriminated	  in	  transmitting	  the	  virus	  in	  different	  geographic	  locations,	  including	  at	  least	  two	  species	  in	  the	  family	  Argasidae	  (soft	  ticks)	  and	  from	  at	  least	  seven	  genera	  in	  the	  family	  Ixodidae.	  For	  instance	  H.	  asiaticum	  asiaticum	  and	  H.	  
asiaticum	  kozlovi	  are	  found	  to	  principally	  harbor	  CCHFV	  in	  Xinjiang,	  China	  (Sun	  et	  al.,	  2009),	  whilst	  in	  Turkey	  the	  principal	  vector	  is	  Rhipicephalus	  bursa,	  commonly	  found	  on	   domestic	   ruminants	   (Tonbak	   et	   al.,	   2006).	   Isolates	   from	   other	   tick	   genera,	  including	  Ornithodoros,	  Boophilus,	  Dermacentor	  and	  Ixodes	  species	  may	  also	  be	  locally	  important.	  
	   	  Figure	  6.	  Dorsal	  view	  of	  an	  adult	  female	  H.	  marginatum	  tick.	  The	  figure	  was	  adapted	  from	  World	  Health	  Organization,	  http://www.who.int/mediacentre/factsheets/fs208/en/.	  
1.4.4	  Threat	  of	  CCHFV	  emergence	  and	  outbreaks	  The	  virus	  can	  be	  transmitted	  to	  humans	  through	  tick-­‐bites	  or	  by	  contact	  with	  blood	  and	   tissues	   of	   viremic	   hosts,	   such	   as	   livestock	   or	   by	   crushing	   infected	   ticks	   with	  unprotected	  hands	  (Ozkurt	  et	  al.,	  2006).	  In	  Turkey	  between	  2004	  and	  2007	  61.7	  %	  (n	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=	  1031)	  of	  CCHF	  cases	  reported	  were	   farmers,	  who	  had	  close	  contact	  with	  animals,	  whereas	  only	  9.9%	  had	  direct	  contact	  with	  animal	  blood,	  animal	  tissue	  or	  other	  body	  fluids.	  Those	  patients	  who	  had	  contact	  with	  animals	  and	   those	  who	  reported	  a	   tick	  bite	   were	   comparable,	   and	   therefore	   it	   seems	   likely	   that	   tick-­‐infected	   animals	  transmit	   ticks	   to	   humans,	   and	   that	   the	   cause	   of	   infections	   is	   probably	   due	   to	   bites	  from	   ticks.	   In	   endemic	   areas	   high	   risk	   groups	   for	   CCHFV	   infection	   include	   farmers,	  abattoir	  workers,	   veterinarians,	   people	   living	   in	   rural	   areas	   and	  handling	   livestock,	  and	  health	  personnel	  have	  also	  been	  described	  as	  the	  risk	  groups	  for	  CCHFV	  (Vorou	  et	  al.,	  2007).	  Higher	  prevalence	  of	  ticks	  within	  large	  numbers	  of	  livestock	  maybe	  the	  reason	   for	   the	   increased	   numbers	   of	   human	   CCHF	   cases	   in	   small	   villages	   in	   rural	  areas,	  and	  not	  surprisingly	  the	  seroprevalence	  for	  CCHFV	  is	  higher	  in	  persons	  living	  in	  these	  areas	  than	  in	  urban	  areas	  (Gunes	  et	  al.,	  2009).	  Although	  in	  Iran,	  for	  example	  special	  markets	   for	   animal	   trading	   are	   located	   on	   the	   outskirts	   of	   large	   cities,	   and	  CCHFV	  seroprevalence	  has	  found	  to	  be	  higher	  among	  persons	  living	  in	  urban	  areas	  of	  this	  country	  (Izadi	  et	  al.,	  2006).	  	  Due	  to	  the	  high	  titres	  of	  CCHFV	  within	  the	  blood	  of	  infected	  patients	  human	  to	  human	  transmission	  also	  poses	  a	  risk	  for	  infection	  to	  health	  workers	  and	  relatives	  who	  make	  unprotected	  contact,	  especially	  from	  those	  patients	  with	  bleeding	  in	  the	  lungs,	  nose,	  mouth,	  gums,	  and	  at	  injection	  sites	  (Athar	  et	  al.,	  2005,	  Altaf	  et	  al.,	  1998,	  Aradaib	  et	  al.,	  2010,	  Mertens	  et	  al.,	  2013).	  Additionally	   there	   is	  evidence	  reported	  by	  Gurbuz	  et	  al	  that	  transmission	  from	  one	  patient	  to	  another	  by	  sharing	  the	  same	  room	  is	  possible	  (Gurbuz	  et	  al.,	  2009).	  	  CCHFV	  is	  considered	  an	  emerging	  virus	  and	  a	  potential	  treat	  to	  non-­‐endemic	  areas	  or	  those	   countries	  where	   the	   virus	   cannot	   be	   found.	   CCHFV	   is	   endemic	   in	   the	  Middle	  East,	  Africa,	  Europe	  (Balkans:	  Kosovo,	  Bulgaria,	  the	  former	  Yugoslavia,	  and	  Albania)	  and	  Asia	  and	  continues	  to	  emerge	  and	  reemerge	  (Maltezou	  et	  al.,	  2010).	  	  There	  have	  recently	   been	   sporadic	   outbreaks	   since	   2000	   and	   an	   increasing	   number	   of	   case	  reports	  in	  Turkey,	  Kosovo,	  Albania,	  Bulgaria,	  Greece,	  Iran,	  Pakistan,	  Afghanistan,	  the	  Russian	  Federation,	  Kazakhstan,	  Tajikistan,	  Georgia,	  Mauritania,	  Kenya,	  Senegal	  and	  South	  Africa	  (Leblebicioglu,	  2010).	  Serological	  evidence	  has	  also	  been	  reported	  from	  Egypt,	  India,	  Hungary,	  Portugal,	  France	  and	  Benin.	  In	  Europe,	  CCHFV	  is	  only	  currently	  endemic	  in	  Bulgaria.	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  The	   potential	   factors	   associated	   with	   emergence	   of	   CCHFV	   in	   countries	   where	   the	  virus	  is	  not	  currently	  found	  are	  those	  such	  as	  environmental	  factors	  including	  climate	  change,	   as	  well	   as	  anthropogenic	   factors	   including	  changes	   in	   land	  use,	   agricultural	  practices	  or	  hunting	  activities,	  or	  movement	  of	   livestock	  which	  may	   influence	  host-­‐tick-­‐virus	   dynamics	   (Maltezou	   et	   al.,	   2010).	   It	   is	   also	   possible	   that	   geographic	  movement	   of	   genetic	   lineages	   and	   emergence	   of	   CCHFV	   in	   previously	   non	   CCHFV	  endemic	  countries	  could	  occur	  through	  long	  distance	  carriage	  of	  virus	  via	  migratory	  birds,	   which	   are	   either	   infected	   or	   carrying	   virus	   infected	   ticks	   (Shepherd	   et	   al.,	  1987a,	  Hewson	  et	  al.,	  2004b,	  Hewson	  et	  al.,	  2004a,	  Swanepoel	  et	  al.,	  1998,	  Zeller	  et	  al.,	  1994).	  International	  travel	  routes	  have	  also	  been	  highlighted	  as	  a	  potential	  factor	  for	  globally	  spreading	  this	  disease	  recently,	  when	  the	  first	  case	  of	  CCHFV	  in	  the	  UK	  was	  confirmed	   from	   an	   infected	   38	   year	   old	   male	   who	   arrived	   in	   Glasgow	   on	   an	  international	  flight	  from	  Afghanistan	  via	  Dubai	  (Chamberlain	  et	  al.,	  2013).	  
1.4.5	  Clinical	  Manifestations	  	  Human	   infection	  with	   CCHFV	   often	   results	   in	   severe	   haemorrhagic	   disease,	   with	   a	  high	   mortality	   rate.	   The	   severity	   of	   disease	   varies	   depending	   on	   the	   mode	   of	  transmission;	  for	  tick–human	  transmission	  mortality	  is	  10–50%,	  but	  can	  increase	  to	  80%	   in	   the	   case	  of	  nosocomial	   incidents.	  The	   reasons	   for	   this	  phenomenon	  are	  not	  known,	   but	  may	   simply	   relate	   to	   viral	   dose	   (Swanepoel	   et	   al.,	   1987,	  Hewson	   et	   al.,	  2004a).	   For	   instance	   the	   incubation	   period	   may	   be	   shorter	   with	   blood	   borne	  transmissions	  (Ergonul,	  2006).	  	  	  CCHFV	   infection	   typically	   develops	   in	   four	   distinct	   phases:	   incubation,	   pre-­‐heamorrhagic,	   heamorrhagic	   and	   convalescence	   periods.	   Sudden	   onset	   of	   fever,	  including	  headache,	  myalgia,	  and	  dizziness	   is	   typical	  of	   the	  preheamorrhagic	  period	  (Whitehouse,	  2004a).	  In	  some	  cases,	  clinical	  symptoms	  such	  as	  diarrhea,	  nausea	  and	  vomiting	   can	   also	   be	   seen	   (Rodriguez	   et	   al.,	   1997).	   Haemorrhagic	   manifestation	  develops	  rapidly,	  typically	  beginning	  between	  the	  third	  and	  fifth	  day	  and	  usually	  lasts	  for	   2-­‐3	   days.	   The	   most	   common	   bleeding	   sites	   are	   the	   gastrointestinal	   tract	  (hematemesis,	   melena,	   and	   intra-­‐abdominal),	   uterus	   (menometrorrhagia),	   urinary	  tract	   (hematuria),	   respiratory	   tract	   (hemoptysis)	   and	   nose.	   The	   most	   extensive	  clinical	  pathology	  study	  of	  CCHF	  was	  that	  of	  Swanepoel	  et	  al	  (Swanepoel	  et	  al.,	  1987)	  whose	   observations	  were	  made	   on	   50	   CCHF	   patients	   from	   South	   Africa,	   diagnosed	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between	  1981	  and	  1987.	  The	  mortality	  rate	  was	  30%,	  with	  factors	  contributing	  to	  a	  fatal	   outcome	   including	   cerebral	   heamorrhage,	   severe	   anemia,	   severe	   dehydration	  and	   shock	   associated	   with	   prolonged	   diarrhea,	   myocardial	   infarction,	   lung	   edema,	  and	   pleural	   effusion.	   For	   those	   who	   do	   not	   succumb	   to	   death,	   the	   convalescence	  period	  usually	  begins	  15-­‐20	  days	  after	  onset	  of	  illness.	  	  
1.4.6	  Treatments	  To	   date,	   there	   is	   no	   vaccine	   or	   specifically	   targeted	   treatment	   available	   to	   treat	  CCHFV	   infected	   patients.	   Ribavirin	   has	   shown	   the	   most	   promise	   and	   is	   the	   only	  antiviral	  agent	  which	  has	  been	  reported	  to	  be	  active	  in	  vitro	  (Watts	  et	  al.,	  1989).	  The	  World	  Health	  Organization	   (WHO)	   recommends	   ribavirin	   as	   the	   antiviral	   agent	   for	  CCHFV	  infected	  patients.	  Several	  case	  reports	  have	  been	  published	  that	  suggest	  oral	  or	   intravenous	   ribavirin	   is	   effective	   for	   treating	   CCHFV	   infections	   (Whitehouse,	  2004a).	   For	   example	   in	   Turkey,	   twenty-­‐two	   cases	   of	   CCHF	  were	   treated	   with	   oral	  ribavirin,	   immediately	   after	   admission.	   In	   the	   ribavirin	   group,	   admission	   times	   and	  recovery	   period	   were	   statistically	   shorter	   compared	   to	   the	   control	   group.	   Of	   sixty	  patients,	  six	  died	  (10.0%),	  two	  in	  the	  ribavirin	  and	  four	  in	  the	  control	  groups,	  and	  the	  fatality	  rate	  was	  9%	  in	  the	  ribavirin	  group	  vs	  10.5%	  in	  the	  control	  group	  (Ozkurt	  et	  al.,	  2006).	  This	  data	  shows	  Ribavirin	   is	  not	  effective	  against	  CCHFV	   infection	  and	  some	  contention	   has	   arisen	   suggesting	   the	   results	   are	   significant	   enough,	   with	   a	   recent	  report	  revealing	  that	  the	  available	  data	  in	  the	  literature	  are	  inadequate	  to	  support	  a	  claim	  of	  efficacy	  of	  ribavirin	  in	  treating	  CCHFV	  infection	  (Ascioglu	  et	  al.,	  2011).	  	  
1.5	  Introduction	  to	  TSWV	  and	  other	  tospoviruses	  Tospoviruses	  are	  plant	  viruses	  and	  have	  notoriety	  for	  causing	  devastating	  damage	  to	  plants,	   for	   the	   largest	   part	   due	   to	   their	   extensive	   host	   range	   and	   pathogenicity.	  Tospovirus	  infection	  encompasses	  more	  than	  1,000	  different	  plants	  in	  approximately	  80	  different	  plant	  families,	   including	  dicotyleydens,	  or	  those	  flowering	  plants	  whose	  seed	   typically	  has	   two	  embryonic	   leaves	  or	  cotyledons,	  and	  monocotyledons,	  which	  typically	  have	  one	  embryonic	  leaf	  (Kormelink	  et	  al.,	  2011).	  	  	  Their	  wide	  host	  range	  covers	  agricultural	  and	  ornamental	  plant	  species	  of	  economic	  importance,	   including	   tomato,	   potato,	   pepper,	   lettuce,	   ground	   nut,	   alstroemeria,	  cyclamen,	   begonia,	   impatiens,	   as	  well	   as	   numerous	  weeds	   (Kormelink	   et	   al.,	   2011).	  Primarily	   classification	   of	   tospoviruses	   is	   divided	   between	   two	   groups,	   which	   are	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based	  upon	  by	  both	  N	  protein	  gene	  sequence	  and	  biological	   features.	  Correlation	  of	  these	  two	  features	  can	  also	  be	  drawn	  with	  geographical	  distribution,	  i.e.	  an	  American	  clade	  and	  EuroAsian	  clade	  (Hassani-­‐Mehraban	  et	  al.,	  2007).	  The	  prototypic	  member	  and	  also	  the	  best	  studied	  of	  this	  group	  is	  tomato	  spotted	  wilt	  virus	  (TSWV)	  (Goldbach	  et	  al.,	  1994,	  Kormelink,	  2011).	  	  Symptoms	  of	  tospovirus	  infection	  include	  stunting,	  necrosis,	  chlorosis,	  ring	  spots	  and	  ring/line	  patterns	  affecting	  leaves,	  stems	  and	  fruit,	  and	  vary	  depending	  on	  tospovirus	  species,	  host	  plant,	  time	  of	  year	  and	  environmental	  conditions.	  Factors	  such	  as	  type	  of	  tospovirus,	   host	   plant,	   time	   of	   year	   and	   environmental	   conditions	   can	   affect	   the	  severity	   of	   the	   symptoms.	   Infection	   rates	   of	   50–90%	   lead	   to	   major	   losses	   in	  commercial	  vegetable	  crops,	  and	  it	  is	  thought	  that	  TSWV	  costs	  the	  food	  industry	  up	  to	  1	  billion	  dollars	  per	   year	   (Adkins,	   2000,	  Mumford	   et	   al.,	   1996,	  Prins	   and	  Goldbach,	  1998)	  
1.5.1	  Tospovirus	  species	  Today	  the	  tospovirus	  genus	  comprises	  more	  than	  20	  recognised	  and	  tentative	  species	  (Kormelink,	  2011),	  with	  new	  viruses	  being	  added	  to	  the	  list	  frequently.	  The	  criteria	  to	  establish	  a	  new	  tospovirus	  species	  are	  recognised	  using	  the	  sequence	  divergence	   in	  the	  N	  protein	  (>10%	  divergence	  with	  already	  classified	  tospoviruses)	  and	  species	  of	  thrips	  vector	  (Kormelink	  et	  al.,	  2011).	   Impatiens	  necrotic	  spot	  virus	  (INSV)	  was	  the	  first	   tospovirus	   virus	   to	   be	   recognised	   as	   a	   genetically	   distinct	   and	   separate	  tospovirus.	  Sequencing	  analysis	  of	  the	  INSV	  N	  protein	  revealed	   it	  exhibits	  only	  55%	  sequence	   identity	   to	   that	  of	  TSWV	  N	  protein.	   It	  was	  shown	  also	   to	  have	   limited	  but	  characteristic	   host	   range	   of	   which	   many	   are	   cultivated	   as	   ornamental	   plants,	   e.g	  
Impatiens	  spp	  (Goldbach	  et	  al.,	  1994).	  	  	  A	  basic	  outline	  of	  the	  organization	  of	  the	  TSWV	  genome	  is	  schematically	  represented	  in	  figure	  2.	  Aside	  from	  producing	  the	  viral	  proteins	  by	  transcribed	  mRNA	  from	  the	  3’	  of	   the	   genome	   in	   the	   same	   way	   as	   the	   animal	   infecting	   bunyaviruses,	   the	   plant	  infecting	   tospoviruses	   also	   transcribe	   translatable	   mRNA	   from	   the	   3’	   end	   of	  antigenome	  using	   an	   ambisense	  mechanism.	  The	   ambisense	   coding	   strategy	   occurs	  on	   the	  S	  and	  M	  segments	  and	   resulting	  mRNA	   transcripts	  encode	   for	  NSs	  and	  NSm	  proteins	  respectively.	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1.5.2	  Transmission	  Similarly	   to	  animal	   infecting	  bunyaviruses,	   transmission	  of	   tospoviruses	  occurs	   in	  a	  propagative	   manner	   by	   arthropods,	   predominantly	   thrips.	   One	   major	   difference	  however	  is	  that	  tospovirses	  are	  not	  secreted	  from	  plant	  cells	  and	  instead	  accumulate	  in	  large	  vesicles	  within	  the	  cytoplasm.	  Tospoviruses	  are	  mechanically	  transmitted	  to	  neighboring	   plants	   by	   adult	   thrips,	  where	   they	   replicate	   and	   are	   derived	   from	   two	  wingless	  larval	  stages	  that	  feed	  on	  plant	  leaves	  and	  weeds	  (Figure	  7).	  TSWV	  can	  only	  be	  acquired	  by	   thrips	  during	   the	   larval	   stage	  of	   their	  development	  and	  after	  a	  non-­‐feeding	  latency	  period	  mature	  adult	  thrips	  can	  transmit	  the	  virus	  for	  the	  rest	  of	  their	  life	  span	  (Wijkamp	  et	  al.,	  1993).	  	  	  
	  Figure	   7.	   Transmission	   of	   tospoviruses	   by	   thrips.	   (A)	  The	   immature	   nymphs	   acquire	   the	   virus	   from	  weeds	  before	  the	  fully	  developed	  adults	  transmit	  the	  virus	  to	  a	  springtime	  crop,	  like	  tomatos.	  (B)	  Adult	  dorsal	   view	   of	   a	  western	   flower	   thrip	   (Frankliniella	  occidentalis).	   The	   figure	  was	   adapted	   form	   The	  University	   of	   Agriculture,	   College	   of	   Agricultural	   &	   Environmental	   Sciences	  http://www.caes.uga.edu/topics/diseases/tswv/vegcrops/tospoviruses/thripsvectors.html#intro.	  
1.5.3	  Epidemiology	  Tospoviruses	  may	  have	  evolved	  recently	  due	  the	  expansion	  of	  its	  vectors,	  which	  are	  linked	   to	   natural	   and/or	   human	   influences.	   The	   rapid	   geographical	   emergence	   and	  expansion	   over	   the	   past	   thirty	   years	   of	   TSWV	   has	   been	   linked	   with	   the	   advanced	  expansion	   of	   the	   Western	   flower	   thrips	   (Frankliniella	   occidentalis)	   (Goldbach	   and	  Peters,	   1994).	   	   Events	   such	   as	   these	   have	   culminated	   in	   the	   expansion	   of	   the	   host	  range	  of	  TSWV	   including	  both	  horticultural	   and	  agronomic	   crops	  across	   temperate,	  subtropical	  and	  tropical	  regions	  of	  the	  world	  (Goldbach	  and	  Peters,	  1994,	  Kormelink.,	  2011).	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This	  is	  best	  characterised	  by	  the	  emergence	  of	  abundant	  F.	  occidentalis	  in	  Texas,	  and	  of	  the	  F.	  fusca	  in	  Georgia,	  which	  occurred	  in	  the	  peanut	  crop	  in	  the	  southern	  states	  of	  the	   USA.	   Similarly	   serious	   damage	   in	   groundnut	   in	   India	   can	   be	   attributed	   to	   the	  emergence	  of	  the	  groundnut	  bud	  necrosis	  virus	  (GBNV),	  which	  is	  also	  a	  tospovirus.	  It	  is	   thought	   that	   the	   expansion	   of	   irrigated	   crops	   and	   continuous	   cropping	   of	  groundnut	   and	   other	   susceptible	   hosts	   has	   led	   to	   rapid	   expansion	   of	   the	   GBNV	  (Goldbach	   and	   Peters,	   1994).	   In	   tropic	   climate	   zones	   the	  main	   vector	   of	   the	   GBNV	  virus	  is	  considered	  to	  be	  Thrips	  palmi	  (Goldbach	  and	  Peters,	  1994).	  	  	  In	  1983	  the	  introduction	  of	  F.	  occidentalis	  in	  Europe	  led	  to	  the	  emergence	  of	  TSWV	  in	  greenhouse	  cultivations	   in	  Western	  Europe,	  especially	   in	  France,	   Italy,	  Portugal	  and	  Spain	   in	   both	   field	   and	   greenhouse	   crops.	   These	   examples	   illustrate	   an	   active	  geographical	   expansion	   of	   tospoviruses,	   correlating	  mainly	   to	   the	  migration	   of	   the	  thrips	   vector,	   which	   causes	   an	   increased	   incidence	   of	   the	   disease	   (Goldbach	   and	  Peters,	  1994).	  	  
1.5.4	  Comparison	  with	  animal	  infecting	  bunyaviruses	  TSWV	   and	   other	   tospoviruses	   share	   similarities	   with	   the	   animal	   infecting	  bunyaviruses.	   Tospovirus	   particles	   are	   enveloped	   and	   spherical	  with	   a	   diameter	   of	  approximately	   80–120	  nm.	   It	   is	   worth	   noting	   that	   apart	   from	   the	   plant-­‐infecting	  rhabdoviruses	  the	  presence	  of	  an	  envelope	  membrane	  is	  unique	  among	  plant	  viruses	  (Adkins,	  2000).	  	  	  Tospoviruses	  may	  have	  emergered	  recently,	  not	  only	  through	  global	  expansion	  of	  its	  vectors,	   but	   also	   through	   re-­‐evolution	   from	   an	   animal	   bunyavirus	   that	  was	   able	   to	  infect	   thrips	   species	   and	   subsequently	   became	   adapted	   to	   plants	   instead	   of	  vertebrates.	   Firstly	   the	   idea	   that	   TSWV	   has	   descended	   from	   an	   animal	   infecting	  bunyavirus	   is	   supported	   by	   the	   seemingly	   limited	   number	   of	   tospoviruses	   able	   to	  infect	   plants	   and	   their	   low	   divergence,	   contrasting	   to	   the	   high	   number	   of	   animal	  infecting	  counterparts,	  which	  are	  highly	  divergent	  (Goldbach	  and	  Peters,	  1994).	  The	  high	   level	   of	   divergence	   between	   phleboviruses,	   hantaviruses,	   nairoviruses,	   and	  orthobunyaviruses,	   contrasting	   the	   limited	   number	   of	   tospoviruses	   capable	   of	  infecting	   plants,	   suggests	   tospoviruses	   have	   evolved	   from	   an	   animal	   infecting	  bunyavirus.	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It	   is	   unsurprising	   that	  TSWV	  and	  other	   tospoviruses	  display	   a	   high	   level	   of	   genetic	  similarity	   to	   their	   animal	   infecting	   counterparts.	   Sequence	   analysis	   has	   revealed	  TSWV	  is	  more	  closely	  related	  based	  on	  multiple	  L	  and	  N	  protein	  alignments	  to	  BUNV	  than	   BUNV	   is	   to	   hantaviruses	   and	   nairoviruses	   (Figure	   98)	   (Vieth	   et	   al.,	   2004)	  (Goldbach	   and	   Peters,	   1994).	   Secondly	   the	   broad	   plant	   host	   range	   of	   tospovirus,	  coupled	  with	   absence	   of	   any	   evolved	   natural	   resistance	   genes	   indicates	   TSWV	   and	  other	  tospoviruses	  have	  invaded	  the	  plant	  kingdom	  recently	  and	  that	  co-­‐evolution	  of	  bunyaviruses	  with	  plants	  has	  yet	  to	  start	  (Goldbach	  and	  Peters,	  1994).	  	  
1.5.5	  Cell	  to	  cell	  movement	  It	   has	   been	   observed	   that	   TSWV	   loses	   the	   production	   of	   one	   or	   both	   glycoproteins	  when	   infection	   is	  artificially	  maintained	   through	  omission	  of	   the	   thrips	  stage	  of	   the	  infection	  cycle	   (Resende	  Rde	  et	  al.,	   1991),	   suggesting	   the	  envelope	  glycoproteins	  of	  bunyaviruses	  are	  only	  involved	  in	  receptor	  recognition	  during	  infection	  of	  insects	  and	  vertebrates.	  As	  tospoviruses	  do	  not	  require	  a	  receptor	  for	  successful	  infection	  within	  plants	  they	  have	  evolved	  a	  mechanism	  to	  facilitate	  cell-­‐to-­‐cell	  movement	  of	  the	  virus	  across	   the	   otherwise	   impenetrable	   cellulose	   barrier	   of	   the	   cell	   wall.	   The	   NSm	  movement	   protein	   has	   thus	   developed	   in	   tospoviruses	   to	   facilitate	   their	   spread	  throughout	  the	  plant	  	  It	  has	  been	  demonstrated	  that	  the	  primary	  roles	  of	  the	  NSm	  protein	  is	  to	  interact	  with	  the	  N	  protein,	  bind	  ssRNA	  in	  a	  sequence-­‐nonspecific	  manner	  and	  associate	  with	  the	  plasmodesmata	   (Soellick	   et	   al.,	   2000).	   In	   vivo	   studies	   have	   demonstrated	   that	   the	  NSm	  protein	  can	  associate	  with	   itself	  and	   form	  tubular	  structures	   in	   the	  absence	  of	  other	   viral	   proteins,	   and	   emanate	   from	   the	   cell	   surface,	   altering	   the	   size	   exclusion	  limits	  of	  the	  plasmodesmata	  (Storms	  et	  al.,	  1995).	  	  	  The	  NSm	  protein	  has	  also	  been	  shown	  to	  interact	  with	  intracellular	  trafficking	  plant	  protein	  homologues	  of	  myosin,	  kinesin	  and	  DnaJ	  like	  chaperones	  (Paape	  et	  al.,	  2006)	  (Von	   Bergan).	   The	   role	   of	   the	   N	   protein	   during	   this	   process	   is	   not	   limited	   to	  chaperoning	   the	   RNA	   through	   the	   re-­‐organized	   plasmodesmata,	   but	   an	   additional	  role	   of	   contributing	   to	   the	  movement	   of	   the	  RNP	   complexes	   has	   been	   reported.	   By	  using	  a	  transiently	  expressed	  construct	  it	  was	  demonstrated	  the	  N	  protein,	  in	  absence	  of	   other	   TSWV-­‐encoded	   proteins	   could	   facilitate	   the	   long	   distance	   movement	   of	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Tobacco	  mosaic	  virus	  (TMV)	  replication	  complexes.	  Whether	  the	  N	  protein	  provides	  a	  supporting	   role	   to	   the	   NSm	   protein	   or	   can	   solely	   facilitate	   transport	   of	   infectious	  virus	  has	  yet	  to	  be	  established	  (Zhang	  et	  al.,	  2012).	  	  
1.5.6	  RNA	  silencing	  The	  NSs	   protein	   functions	   to	   escape	   the	  RNA	   interference	   (RNAi)	   antiviral	   defense	  mechanism	  (Baulcombe,	  1996,	  Fire,	  2007,	  Takeda	  et	  al.,	  2002,	  Bucher	  et	  al.,	  2003a).	  In	  plants	  RNA	  silencing	  or	  post-­‐transcriptional	  gene	  silencing	  (PTGS)	  is	  considered	  as	  the	   innate	   immunity	   mechanism	   against	   viral	   invaders,	   and	   is	   an	   evolutionary	  conserved	  process	  whereby	  dsRNA	  and	  imperfect	  hairpin	  RNAs	  (foldback	  RNAs)	  that	  are	   processed	   into	   duplex	   21-­‐24	   nucleotide	   short	   interfering	   RNA	   (siRNA)	   or	  microRNA	   (miRNA)	   by	   RNA	   III-­‐type	   DICER	   enzymes,	   to	   provoke	   a	   succession	   of	  processes	  leading	  to	  sequence	  specific	  breakdown	  of	  RNA.	  	  	  During	   infection	   viral	   dsRNA	   is	   produced	   either	   from	   replicative	   intermediates	   or	  alternatively	   due	   to	   the	   formation	   of	   secondary	   RNA	   structures.	   These	   replicative	  intermediate	  RNAs	  are	  recognized	  by	  specific	  Dicer-­‐like	  proteins	  (Dicer	  in	  insects	  and	  predominately	   DCL-­‐4	   in	   plants),	   and	   are	   processed	   into	   21	   nucleotide	   small	  interfering	  RNA	  (siRNA)	  duplex	  molecules.	  The	  guide	  strand	  of	  the	  processed	  duplex	  small	   RNAs	   are	   then	   incorporated	   into	   a	   RNP	   complex	   termed	   the	   RNA-­‐induced	  silencing	  complex	  (RISC),	  which	  functions	  to	  recognize	  and	  degrade	  complementary	  (viral)	  target	  RNA	  molecules,	  through	  the	  action	  of	  the	  core	  Argonaute	  (AGO)	  protein.	  RISC	  assembly	  involves	  guide	  strand	  incorporation	  and	  passenger	  strand	  elimination,	  by	   the	  AGO	  protein	  of	   the	  siRNA	  duplex,	   to	   subsequently	   form	   the	  single	   strandard	  siRNA	  containing	  80S	  holo-­‐RISC	  complex.	  In	  plants	  these	  21	  nucleotide	  siRNAs	  have	  been	  shown	   to	   function	  as	  primers	   for	   synthesis	  of	   secondary	  siRNAs,	  by	   the	  RdRp	  which	  converts	  RNA	  target	  sequences	  into	  new	  long	  dsRNAs.	  In	  this	  way	  silencing	  is	  not	   only	  being	   amplified	  but	   also	   spread	  along	   the	   entire	  RNA	   sequence,	   known	  as	  transitive	  silencing.	  	  Plant	   viruses,	   such	   as	   tospoviruses	   and	   tenuiviruses	   overcome	   production	   of	   the	  replicative	   intermediates,	  which	   lead	   to	   the	   induction	  of	  RNAi,	  by	  coding	   for	  a	  RNA	  silencing	  suppressor	  (RSS)	  protein	  that	  is	  able	  to	  interfere	  in	  the	  cascade	  of	  reactions	  that	  lead	  to	  viral	  RNA	  degradation	  (Bernstein	  et	  al.,	  2001,	  Lee	  et	  al.,	  2003,	  Khvorova	  et	  al.,	  2003,	  Schwarz	  et	  al.,	  2003,	  Guo	  and	  Ding,	  2002).	  RSS	  proteins	  of	  plant	  viruses	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have	  either	  shown	  to	  restrain	  RNAi	  by	  sequestering	  siRNAs	  and	  thereby	  prevent	  their	  incorporation	  into	  RISC.	  Or	  alternatively	  they	  work	  to	  avoid	  cleavage	  of	  long	  dsRNA	  into	  guide	  siRNAs	  (Diaz-­‐Pendon	  et	  al.,	  2007,	  Guo	  and	  Ding,	  2002).	  	  	  For	   tospoviruses,	   the	   NSs	   protein	   encoded	   through	   ambisense	   coding	   on	   the	   S	  segment	   has	   been	   identified	   as	   the	   RSS	   protein	   using	   a	   GFP-­‐silencing	   assay	   that	  involved	  a	   co-­‐infiltration	  of	  Agrobacterium	  tumefaciens	   containing	  a	   functional	  35S-­‐driven	  GFP	  and	  NSs	  gene	  construct	  into	  Nicotiana	  benthamiana	  leaves	  (Takeda	  et	  al.,	  2002,	   Bucher	   et	   al.,	   2003b).	   Additionally	   it	   was	   reported	   by	   Schnettler	   et	   al,	   that	  expression	  of	  an	  NSs	  gene	  construct	  in	  N.	  benthamiana	  suppresses	  the	  accumulation	  of	   GFP-­‐specific	   siRNAs	   during	   co-­‐infiltration	   with	   an	   inverted	   repeat	   GFP	   RNA	  construct,	   and	   also	   reverses	   the	   silencing	   of	   an	   eGFP	   miRNA-­‐sensor	   construct	  (Schnettler	   et	   al.,	   2010).	   Biochemical	   analysis	   has	   shown	   the	   NSs	   from	   different	  tospoviruses	  displays	  affinity	  for	  small	  RNAs,	  including	  si-­‐	  and	  mi-­‐RNAs.	  Furthermore,	  the	  TSWV	  NSs	  from	  INSV	  and	  Groundnut	  ringspot	  virus	  (GRSV)	  also	  display	  affinity	  for	  long	  dsRNAs,	  whereas	  the	  NSs	  from	  Tomato	  yellow	  ring	  virus	  (TYRV)	  did	  not.	  The	  TSWV	  NSs	  has	  shown	  in	  vitro	  inhibition	  of	  DICER	  mediated	  cleavage	  of	  long	  dsRNAs	  (Schnettler	   et	   al.,	   2010).	   Together	   the	   evidence	   suggests	   the	   that	   NSs	   from	  tospoviruses	   interferers	   in	  the	  plant	  RNAi	   innate	   immune	  response	  by	  sequestering	  siRNAs	  and	  miRNAs	  to	  hinder	  their	  uploading	   into	  their	  respective	  RISC	  complexes.	  This	  mechanism	   has	   also	   been	   supported	   recently	   by	   the	   report	  which	   has	   shown	  that	   the	  GBNV	  NSs	  protein	  displays	  NTPase	  and	  phosphatase	  activity	  (Lokesh	  et	  al.,	  2010),	   and	   it	   has	   been	   speculated	   that	   this	   activity	   could	   possibly	   be	   involved	   in	  enzymatically	   removing	   the	   5′	   phosphate	   from	   dsRNA	   and	   thereby	   prevent	   its	  cleavage	  by	  dicer	  into	  siRNAs.	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1.6	  Arenaviruses	  
The	   following	   section	   will	   focus	   on	   the	   two-­‐segmented	   arenavirus	   NP	   structure	   and	  
phylogenetics;	   it	  has	  been	  included	  into	  this	  section	  because	  there	  are	  some	  important	  
aspects	  of	  their	  biology,	  which	  will	  be	  discussed	  later	  in	  chapters	  3	  and	  4.	  	  The	   Arenaviridae	   family	   is	   distributed	   worldwide	   and	   include	   viruses	   that	   are	  significant	   human	   pathogens.	   Arenaviruses	   are	   subdivided	   based	   on	   serological	  cross-­‐reactivity,	   phylogenetic	   relations	   and	   geographical	   distribution,	   into	   the	   Old	  World	   and	   New	  World	   virus	   complexes.	   The	   New	  World	   arenaviruses	   circulate	   in	  both	  North	   and	  South	  America	   and	   include	  Whitewater	  Arroyo,	  Tamiami,	   and	  Bear	  Canyon,	  Tacaribe,	  Junin,	  Guanarito,	  Machupo	  virus	  and	  Sabia	  viruses.	  The	  Old	  World	  arenaviruses	  include	  those	  viruses	  that	  circulate	  in	  Africa,	  Europe,	  and	  Asia	  including	  lymphocytic	   choreomeningitis	  and	  LASV	   (Yun	  and	  Walker,	  2012).	  LASV	  contributes	  the	   largest	   burden	   to	   disease	   out	   of	   all	   the	   arenaviruses	   and	   causes	   approximately	  300,000	  to	  500,000	  infections	  per	  year	  in	  West	  Africa	  (Hastie	  et	  al.,	  2011b).	  	  	  Arenaviruses	  process	   a	   bisegmented,	  NS,	   ssRNA	  genome	  with	   an	   ambisense	   coding	  strategy	  to	  produce	  five	  known	  proteins;	  namely	  the	  GP-­‐1	  and	  GP-­‐2	  glycoproteins,	  a	  NP,	   a	   matrix	   protein	   (Z),	   and	   an	   L	   protein.	   The	   NP	   is	   the	   most	   abundant	   virally	  encoded	  protein	  in	  an	  infected	  cell.	  The	  RNP	  is	  assembled	  from	  the	  viral	  RNA	  and	  the	  self	  interacting	  NPs	  and	  its	  further	  association	  with	  the	  L	  protein,	  which	  participate	  in	  RNA	  replication	  and	  transcription	  (Pinschewer	  et	  al.,	  2003).	  The	  arenavirus	  NP	  also	  interacts	   with	   the	   Z	   protein	   for	   viral	   assembly	   (Eichler	   et	   al.,	   2004,	   Groseth	   et	   al.,	  2010,	  Shtanko	  et	  al.,	  2010),	  and	  also	  plays	  an	  important	  role	  in	  the	  suppression	  of	  the	  innate	  immune	  system	  (Martinez-­‐Sobrido	  et	  al.,	  2009,	  Martinez-­‐Sobrido	  et	  al.,	  2007,	  Hastie	  et	  al.,	  2011a)	  
	  The	   arenaviruses,	   bunyaviruses	   and	   orthomyxoviruses	   are	   phylogenetically	   related	  and	  not	  surprisingly	  share	  features	  of	  their	  intracellular	  replication	  cycle,	  such	  as	  cap	  snatching.	   The	   close	   phylogenetic	   relationship	   between	   arenaviruses	   and	  bunyaviruses	  was	  highlighted	  when	  Vieth	   et	   al	   (Vieth	   et	   al.,	   2004),	   used	   secondary	  structure-­‐assisted	   alignment	   of	   the	   polymerase	   region,	   allowing	   a	   reliable	  reconstruction	   of	   the	   phylogeny	   of	   all	   nsRNA	   viruses,	   and	   which	   indicated	   the	  
Arenaviridae	   family	   are	   most	   closely	   related	   to	   the	   Nairovirus	   genus	   of	   the	  
Bunyaviridae	  family	  (Figure	  8).	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  Figure	   8.	  Phylogenetic	   relationships	   among	   nsRNA	   viruses.	   Alignment	   based	   upon	   the	   secondary	  structure-­‐assisted	  prediction	  of	  polymerase	  amino	  acid	  sequences.	  The	  figure	  was	  adapted	  from	  (Vieth	  et	  al.,	  2004)	  	  
1.7	  Biology	  of	  the	  bunyavirus	  structural	  proteins	  	  
1.7.1	  Structural	  proteins	  encoded	  by	  the	  M	  segment	  For	  bunyaviruses	  to	  form	  the	  infectious	  viral	  particles	  the	  N	  protein	  assembled	  RNP	  must	   also	   crucially	   interact	   with	   the	   M	   segment	   encoded	   membrane	   embedded	  glycoproteins	   (Figure	   9).	   All	   members	   of	   the	   Bunyaviridae	   family	   encode	   a	  polyprotein	  precursor	  from	  the	  M	  segment,	  which	  is	   inserted	  co-­‐translationally	   into	  the	  membrane	  of	   the	  endoplasmic	  reticulum.	  Cleavage	  of	   the	  precursor	  by	  host	  cell	  proteases	  results	  in	  Gn	  and	  Gc	  components	  that	  form	  a	  disulphide	  linked	  heterodimer	  and	  are	  transported	  to,	  and	  retained	  in,	  the	  Golgi	  apparatus.	  	  The	  location	  of	  the	  Gn-­‐Gc	  heterodimer	  in	  the	  Golgi	  where	  it	  associates	  with	  RNPs	  to	  mediate	  assembly	  and	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budding	  of	  mature	  virus	  particles	  is	  maintained	  by	  a	  retention	  signal.	  Virus	  assembly,	  formation	   of	   the	   virus	   particle	   and	   attachment	   of	   the	   virus	   to	   new	   target	   cells	   is	  mediated	  by	  the	  Gn-­‐Gc	  heterodimer	  (Schamaljohn	  &	  Nichol,	  2006).	  
	  Figure	   9.	   Various	   bunyavirus	   surface	   glycoprotein	   architectures.	   (A-­‐C)	   Structures	   of	   Gn–Gc	  glycoprotein	   spikes	   (orange)	   are	   shown	   mapped	   onto	   the	   membrane	   surface	   (cyan).	   (A)	  Orthobunyavirus	   (BUNV),	   (B)	   Hantavirus	   (Tula	   virus;	   TULV;	   EMD-­‐170411),	   and	   (C)	   Phlebovirus	  	  (RVFV);	   EMD-­‐15507).	   Below	   each	   panel	   are	   the	   views	   of	   a	   glycoprotein	   spike	   cluster	   (left)	   and	   a	  schematic	   representation	  of	   the	  spike	  arrangement	   (right),	  with	   the	  symmetries	  of	   individual	   spikes	  annotated.	  The	  figure	  was	  adapted	  from	  (Bowden	  et	  al.,	  2013,	  Walter	  and	  Barr,	  2011).	  	  In	  general	  the	  conformational	  process	  of	  membrane	  envelopment	  of	  bunyavirus	  RNPs	  is	  likely	  triggered	  by	  an	  interaction	  between	  the	  N	  protein	  and	  glycoproteins.	  In	  line	  with	   this	   it	   is	   very	   common	   for	   enveloped	   viruses	   to	   utilize	   a	   matrix	   protein	   for	  contact	  and	  maintenance	  between	  the	  RNP	  and	  the	  viral	  envelope.	  However	  members	  of	  the	  Bunyaviridae	  family	  lack	  matrix	  protein	  and,	  by	  analogy	  to	  alphaviruses,	  which	  also	   lack	   a	   matrix	   protein,	   it	   is	   quite	   likely	   that	   the	   envelope	   glycoproteins	   of	  bunyaviruses	  organise	  and	  facilitate	  the	  interactions	  between	  the	  envelope	  and	  RNP,	  thus	  operating	  as	  surrogate	  matrix	  protein	  (Hepojoki	  et	  al.,	  2010).	  This	  has	  recently	  been	  supported	  when	  the	  crystal	  structure	  of	  the	  RVFV	  Gc	  protein	  revealed	  it	  to	  be	  a	  class	  II	  fusion	  protein,	  with	  architecture	  similar	  to	  the	  fusion	  protein	  of	  positive	  sense	  RNA	  flaviviruses	  and	  alphaviruses	  (Dessau	  and	  Modis,	  2013).	  The	  icosahedral	  T	  =	  12	  lattice	  of	  the	  RVFV	  viral	  particle	  is	  formed	  by	  the	  assembly	  of	  the	  two	  glycoproteins,	  Gn	   and	   Gc,	   which	   assemble	   around	   the	   lipid	   envelope	   where	   they	   are	   anchored	  creating	  a	  rigid	  outer	  shell,	  with	  an	  average	  diameter	  of	  103	  nm	  (Sherman	  et	  al.,	  2009,	  Huiskonen	  et	  al.,	  2009,	  Overby	  et	  al.,	  2008).	  Analysis	  using	  electron	  cryo-­‐tomography	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(ECT)	   has	   suggested	   the	   cytoplasmic	   tails	   of	   the	   UUKV	   Gn	   and	   Gc	   directly	   interact	  with	  the	  RNP,	  which	  was	  visualized	  as	  a	  punctuated	  moiety,	  fully	  occupying	  the	  inner	  core	   of	   the	   virion	   (Figure	   10)	   (Overby	   et	   al.,	   2008).	   Furthermore	   one	   of	   the	  characteristics	  of	  Phlebovirus	  genus	  particle	  formation,	  maturation	  and	  RNP	  packing	  is	  its	  dependence	  on	  the	  binding	  interaction	  between	  the	  Gn	  protein	  cytoplasmic	  tail	  and	  N	  protein	  (Overby	  et	  al.,	  2007a).	  
	  Figure	  10.	  ECT	  analysis	  of	  the	  UUKV	  particles.	  (A)	  UUKV	  particles	  displaying	  icosahedral	  2-­‐fold	  axis	  of	  symmetry.	  Each	  column	  represents	  data	  from	  a	  single	  particle,	  with	  isosurfaces	  rendered	  at	  1.5σ	  above	  the	  mean	  density.	  (B)	  Consecutive	  8	  nm-­‐thick	  slices	  through	  the	  tomogram,	  24	  nm	  apart,	  are	  shown	  for	  the	  particles	  displayed	  in	  A.	  On	  the	  left	  the	  icosahedrally	  symmetrised	  version	  of	  the	  particle	  is	  shown	  within	   each	   panel,	   with	   the	   unsymmetrised	   denoised	   particle	   on	   the	   right	   for	   comparison.	   Arrows	  indicate	  the	  RNP	  interactions	  with	  the	  membrane.	  The	  figure	  was	  adapted	  from	  (Overby	  et	  al.,	  2008)	  	  Additional	   ECT	   data	   of	   Hantaan	   virus	   (HTNV)	   and	   of	   Tula	   virus	   (TULV)	   (both	  hantaviruses)	   has	   revealed	   that	   the	   RNP	   associates	   with	   the	   viral	   envelope,	  suggesting	   that	   a	   direct	   interaction	   between	   the	  RNP	   and	   the	   spike	   complex	   exists	  (Huiskonen	  et	  al.,	  2010,	  Battisti	  et	  al.,	  2011).	  The	  exterior	  arrangement	  of	  the	  TULV	  particle	   revealed	   ordered	   patches	   of	   tetrameric	   spike	   complexes	   on	   the	   lipid	  membrane,	  with	  each	  spike	  consisting	  of	  Gn-­‐Gc	  heterodimers	   (Bowden	  et	  al.,	  2013,	  Huiskonen	  et	  al.,	  2010)(Figure	  9B).	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In	  contrast	  to	  the	  arrangement	  of	  the	  glycoprotein	  spike	  complexes	  for	  hantaviruses,	  the	   orthobunyavirus	   particle	   was	   observed	   to	   have	   no	   significant	   areas	   of	   the	  membrane	   lacking	   spikes	   (Huiskonen	   et	   al.,	   2010)	   (Figure	   9C).	   Similar	   to	  phleboviruses	  and	  hantaviruses,	  the	  BUNV	  viral	  membrane	  surrounds	  an	  inner	  RNP	  core.	   ECT	   of	   BUNV	   virions	   identifies	   density	   connecting	   the	   RNP	   core	   to	   the	  membrane,	   and	   most	   likely	   points	   to	   a	   direct	   interaction	   between	   glycoprotein	  cytoplasmic	  tails	  and	  the	  N	  protein/RNA	  complex	  (Bowden	  et	  al.,	  2013).	  	  Observation	   of	   a	   similar	   interaction	   between	   the	   cytoplasmic	   tails	   of	   the	  glycoproteins	  and	  N	  protein	  during	  TSWV	  maturation	  has	  also	  been	  reported	  (Snippe	  et	  al.,	  2007,	  Ribeiro	  et	  al.,	  2009).	  None	  of	  these	  hallmarks	  have	  yet	  to	  be	  identified	  for	  nairoviruses	  and	  the	  structural	  biology	  of	  particle	  maturation	  in	  this	  group	  remains	  poorly	  understood.	  However	  despite	  this	  there	  have	  been	  reports	  that	  the	  Gn	  protein	  of	  CCHFV	  (nairovirus)	  localizes	  to	  the	  Golgi	  complex,	  a	  process	  mediated	  by	  retention	  signals	  in	  the	  cytoplasmic	  domain	  and	  ectodomain	  of	  this	  protein	  (Haferkamp	  et	  al.,	  2005,	   Bertolotti-­‐Ciarlet	   et	   al.,	   2005).	   This	   data	   is	   consistent	   with	   the	   intracellular	  targeting	  of	  most	  animal	  bunyavirus	  glycoproteins	  to	  the	  Golgi	  complex	  and	  strongly	  suggest	   this	   as	   the	   assembly	   site	   for	   CCHFV	   and	   other	   nairoviruses.	   Additionally	  DUGV	   particles,	   have	   been	   shown	   to	   assemble	   by	   budding	   at	   the	   Golgi	   complex,	  where	   the	  glycoprotein	  G1	  accumulated	   in	  vesicles	  originating	   from	  Golgi	   cisternae	  (Booth	  et	  al.,	  1991).	  	  
1.7.2	  Viral	  proteins	  encoded	  by	  the	  L	  segment	  The	  L	  segments	  of	  all	  members	  of	  the	  Bunyaviridae	   family	  encode	  a	  single	  L	  protein	  (Walter	   and	   Barr,	   2011).	   The	   size	   of	   the	   bunyavirus	   RdRps	   vary	   and	   are	   genus	  specific,	  with	   the	   largest	   displayed	  by	  nairoviruses	   and	   tospoviruses	  (Figure	  2)	   (de	  Haan	  et	  al.,	  1991)	  (Honig	  et	  al.,	  2004)	  (Marriott	  and	  Nuttall,	  1996)	  (van	  Poelwijk	  et	  al.,	  1997).	  Through	  alignment	  and	  comparison	  with	  RdRps	  from	  various	  other	  groups	  of	  nsRNA	  viruses	  the	  well-­‐known	  and	  defined	  polymerase	  module	  (region	  3),	  has	  been	  shown	  to	  exist	  within	  bunyavirus	  RdRps	  across	  the	  entire	  family	  (Muller	  et	  al.,	  1994,	  Kinsella	   et	   al.,	   2004,	   Poch	   et	   al.,	   1990).	   The	   bunyavirus	   polymerase	   module	  encompasses	  motifs	  A	  through	  D,	  which	  has	  been	  identified	  as	  conserved	  among	  all	  RdRps	  examined	  to	  date	  (Kinsella	  et	  al.,	  2004).	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An	   additional	   two	   motifs,	   designated	   motif	   pre-­‐A	   and	   motif	   E,	   have	   also	   been	  identified	  and	  only	  found	  in	  RdRps	  for	  RNA	  viruses	  (Figure	  11).	  The	  pre-­‐A	  motif	  can	  be	   found	   in	   RdRps	   of	   positive	   sense	   RNA	   viruses,	   whilst	   motif	   E	   is	   thought	   to	   be	  present	   only	   in	   sNSVs	   (Honig	   et	   al.,	   2004).	   Furthermore	   the	   polymerase	   module,	  which	   can	   be	   found	   across	   the	   Bunyaviridae	   family	   can	   also	   be	   found	   in	   the	   PB1	  polymerase	   subunit	   of	   IAV	   and	   the	   two-­‐segmented	   arenavirus	   LASV	   (Vieth	   et	   al.,	  2004)	  (Biswas	  and	  Nayak,	  1994).	  	  
	  
Figure	   11.	   Schematic	   of	   the	   polymerase	   topology	   for	   sNSVs.	   The	   arrangement	   of	   the	   polymerase	  protein	  from	  different	  genera	  known	  or	  suspected	  to	  use	  cap	  snatching	  are	  represented	  as	  bars	  (not	  drawn	   to	   scale).	   The	   number	   of	   RNA	   genome	   segments	   and	   a	   sample	   of	   species	   are	   indicated	   in	  brackets.	  The	  amino	  acid	   length	  of	   each	  polymerase	   is	   labelled	  at	   the	   right	  hand	  side.	  Endonuclease	  domains	   are	   coloured	   in	   red	   and	   the	   particular	   motif	   of	   that	   genus	   written	   above.	   For	   CCHFV	   the	  catalytic	  motif	   for	   the	   putative	   endonuclease	   domain	   is	   coloured	   light	   blue.	   Blue	   bars	   represent	   the	  conserved	  polymerase	  domain	  in	  the	  central	  region.	  The	  three	  separate	  PA,	  PB1	  and	  PB2	  domains	  for	  orthomyxoviruses	   are	   represented	   in	   co-­‐linear	   fashion.	   The	   green	   bar	   represents	   the	   cap-­‐binding	  domain,	  which	  possibly	  indicates	  the	  location	  of	  this	  domain	  in	  the	  C-­‐terminal	  region	  of	  the	  L	  proteins	  of	  bunyaviruses	  (question	  mark).	  The	  figure	  was	  adapted	  from	  (Reguera	  et	  al.,	  2010).	  The	  La	  Crosse	  virus	  (LACV)	  (orthobunyavirus)	  L	  protein	  has	  been	  found	  to	  utilize	  an	  N-­‐terminal	   endonuclease	   domain	   to	   cleave	   off	   small-­‐capped	   primers	   from	   host	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derived	  mRNAs	  (Reguera	  et	  al.,	  2010).	  The	  structure	  of	  the	  LACV	  L	  protein	  N-­‐terminal	  endonuclease	  domain	  revealed	  a	  catalytic	  core	  containing	  metal	  binding	  and	  catalytic	  lysine	   residues.	   Alignment	   analysis	   of	   this	   catalytic	   core	   motif	   with	   amino	   acid	  sequences	   from	   other	   sNSVs	   indicate	   that	   homologous	   L	   protein	   N-­‐terminal	  endonuclease	   domains	   also	   exist	   not	   only	   in	   other	   members	   of	   the	   Bunyaviridae	  family,	  but	  also	  in	  members	  of	  arenaviruses,	  emaraviruses	  (5-­‐segmented	  viruses)	  and	  tenuiviruses	  (four-­‐segmented	  viruses)	  (Figure	  11).	  	  Furthermore	   the	   endonuclease	   domain	   of	   LACV	   L	   protein	   has	   been	   shown	   to	   be	  structurally	  related	  to	  the	  IAV	  endonuclease	  domain	  present	  within	  the	  N-­‐terminal	  of	  the	   PA	   subunit.	   Knowing	   that	   the	   size	   of	   the	   orthobunyavirus,	   phlebovirus,	   and	  hantavirus	  L	  protein	  amino	  acid	  sequences	  are	  similar	  to	  the	  length	  of	  the	  three	  IAV	  polymerase	   subunits	   (Figure	   11),	   an	   interesting	   question	   can	   be	   raised	   to	  whether	  the	  topological	  arrangement	  of	  the	  L	  protein	  domains	  are	  in	  any	  way	  homologous	  to	  a	  concatamer	   arrangement	   of	   the	   IAV	   three-­‐polymerase	   subunits	   PA,	   PB1,	   PB2.	   This	  arrangement	   is	   supported	   in	   recent	   electron	   microscopy	   (EM)	   images	   of	   the	   IAV	  polymerase,	  which	  suggests	  the	  location	  of	  the	  polymerase	  module	  in	  the	  IAV	  PB1	  is	  sandwiched	   between	   the	   PA	   and	   PB2	   (Coloma	   et	   al.,	   2009a,	   Torreira	   et	   al.,	   2007)	  (Area	   et	   al.,	   2004)	   (Figure	   12).	   However	   without	   any	   structure	   or	   knowing	   the	  location	  of	  the	  PB2	  cap	  snatching	  domain	  homologue	  in	  the	  bunyavirus	  L	  protein,	  and	  due	  to	  no	  obvious	  cross-­‐genera	  motifs	  in	  the	  C-­‐terminus	  such	  a	  comparison	  cannot	  be	  made.	  The	  concept	   that	   the	   location	  of	   the	  cap-­‐binding	  domain	  might	  vary	  between	  that	   of	   IAV	   and	   the	   bunyaviruses,	   or	   even	   within	   the	   Bunyaviridae	   family	   is	   also	  supported	  by	  evidence	  that	  the	  distance	  between	  the	  cleavage	  site	  and	  the	  5’	  cap	  can	  be	   variable	   amid	   the	   cap-­‐snatching	   viruses	   (Duijsings	   et	   al.,	   2001).	   Intriguingly	  evidence	  has	  suggested	  the	  hantavirus	  N	  protein	  could	  play	  this	  role	  and	  directly	  bind	  5’	   capped	  RNA,	   suggesting	  mechanisms	  of	   cap	   snatching	  may	  be	  genus	   specific	   and	  bringing	   the	   cap	   binding	   capability	   of	   the	   hantavirus	   L	   protein	   into	   question	  (Panganiban	  and	  Mir,	  2009).	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  Figure	   12.	   Cryo-­‐EM	   reconstruction	   of	   the	   IAV	   polymerase	   complex.	   (A)	   The	   insert	   shows	   the	   three-­‐dimensional	  reconstruction	  for	  the	  IAV	  polymerase	  complex	  reported	  by	  Area	  et	  al	  (Area	  et	  al.,	  2004).	  Next	   to	   the	   insert	   is	   the	   IAV	  polymerase	   complex	   reconstruction	  at	  higher	   resolution	   (Coloma	  et	   al.,	  2009a).	  The	  individual	  domains	  of	  the	  IAV	  polymerase	  complex	  are	  indicated	  for	  the	  PB1	  (green),	  PB2	  (red)	   and	   PA	   (violet)	   subunits.	   (B)	   An	   identical	   view	   of	   the	   IAV	   polymerase	   shown	   in	   A	   with	   the	  docking	  of	  the	  PA	  (C-­‐terminal)-­‐PB1	  (N-­‐terminal)	  dimer.	  The	  N-­‐terminal	  PB1	  peptide	  is	  labelled	  with	  an	  arrow	  and	  highlighted	  in	  green.	  	  RdRps	   belonging	   to	   members	   of	   the	   Tospovirus	   and	   Nairovirus	   genera	   are	  considerably	   larger	   than	   those	   of	   other	   bunyaviruses,	   with	   predicted	   molecular	  masses	   of	   330	   kDa	   and	   450	   kDa,	   respectively	   (de	   Haan	   et	   al.,	   1991)	   (Honig	   et	   al.,	  2004)	   (Marriott	   and	   Nuttall,	   1996)	   (van	   Poelwijk	   et	   al.,	   1997)	   (Figure	   2).	   These	  additional	  sequences	  therefore	  offer	  additional	  coding	  capacity	  and	  should	  comprise	  multiple	  functional	  domains.	  This	  is	  observable	  when	  examining	  the	  sequence	  of	  the	  N-­‐terminal	  end	  of	  the	  CCHFV	  L	  protein,	  which	  displays	  strong	  similarity	  to	  a	  cysteine	  de-­‐ubiquitating	   protease	   motif	   within	   the	   ovarian	   tumor	   (OTU)	   super-­‐family.	  Recently	  the	  structure	  of	  the	  OTU	  protein	  covalently	  bound	  to	  ubiquitin	  propylamine,	  a	   suicide	   substrate	   of	   the	   enzyme,	   was	   elucidated	   to	   1.7	   Å	   utilizing	   X-­‐ray	  crystallographic	   techniques,	   and	   which	   revealed	   unique	   structural	   elements	   that	  define	   this	   new	   subclass	   of	   the	   OTU	   superfamily	   (Akutsu	   et	   al.,	   2011,	   James	   et	   al.,	  2011,	   Capodagli	   et	   al.,	   2011).	   This	   work	   demonstrated	   the	   OTU	   domain	   is	   able	   to	  remove	  both	  ubiquitin	  (Ub)	  and	  Ub-­‐like	  ISG-­‐15	  modifications	  from	  target	  proteins.	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The	   RIG-­‐I-­‐like	   receptors	   (RLR),	   RIG-­‐I	   and	   MDA-­‐5	   are	   responsible	   for	   the	   cellular	  response	  for	  recognizing	  viral	  RNA.	  The	  RIG-­‐I	  and	  MDA-­‐5	  protein	  sensors	  respond	  to	  the	  presence	  of	  viral	  RNA	  through	  the	  binding	  of	  the	  mitochondrial	  antiviral-­‐signaling	  protein	   (MAVS),	   and	   activate	   two	   divergent	   signaling	   pathways.	   The	   first	   is	  orchestrated	  by	  the	  activation	  of	  TRAF3,	  which	  triggers	  the	  subsequent	  activation	  of	  the	  TBK1-­‐IκB	  kinase	  (IKKε)	  complex,	  leading	  to	  the	  phosphorylation	  of	  IRF3,	  allowing	  dimerization.	  Dimerized	  IRF3	  then	  relocated	  to	  the	  nucleus	  to	  initiate	  transcription	  of	  the	   gene	   encoding	   IFN-­‐β	   (type	   1	   IFNs).	   Downstream	   of	  MAVS	   the	   second	   pathway	  involves	   the	   TRAF6	   adaptor	   protein	   and	   activation	   NEMO-­‐IKKα/β	   complex.	   Once	  activated	   the	  NEMO-­‐IKKα/β	   complex	   is	   responsible	   for	  phosphorylation	  of	   IκB	   and	  subsequent	   release	   of	   NF-­‐κB	   and	   subsequent	   translocation	   to	   the	   nucleus.	   Once	  inside	   the	  nucleus	  NF-­‐κB	   initiates	   transcription	  of	  genes	  encoding	  proinflammatory	  cytokines,	  such	  as	  such	  as	  TNF-­‐α.	  	  The	  production	  of	  IFN-­‐β	  and	  binding	  to	  its	  receptor	  activates	  the	  Janus	  kinase-­‐signal	  transducer	   and	   activator	   of	   transcription	   (JAK/STAT),	   through	   autocrine	   and	  paracrine	   pathways,	   which	   induces	   the	   transcription	   of	   numerous	   interferon-­‐stimulated	   genes	   (ISGs).	   ISGs	   encode	   RIG-­‐I	   and	   MDA5,	   and	   the	   antiviral	   response	  molecules	   OAS,	   PKR,	   ISG15,	   and	   the	   Mx	   proteins,	   whose	   activation	   leads	   to	   an	  antiviral	   response	  and	   limits	   the	  spread	  of	  viral	   infection	  (Bowie	  and	  Unterholzner,	  2008,	  Sadler	  and	  Williams,	  2008).	  	  	  Apart	  from	  phosphorylation	  the	  signaling	  pathways	  involved	  in	  innate	  immunity	  also	  rely	  on	  extensive	  regulation	  through	  ubiquitination.	  ISG15	  is	  a	  15	  kDa	  ubiquitin-­‐like	  protein	  with	  two	  ubiquitin-­‐like	  domains,	  and	  is	  processed	  from	  a	  17	  kDa	  precursor,	  and	  is	  one	  of	  the	  most	  importantly	  expressed	  ISGs	  (Blomstrom	  et	  al.,	  1986,	  Haas	  et	  al.,	  1987).	   ISG15	   is	   primarily	   expressed	  upon	   the	   activation	  of	   the	   JAK/STAT	  pathway,	  has	  been	  implicated	  in	  functioning	  in	  a	  direct	  or	  indirect	  antiviral	  effect	  (Harty	  et	  al.,	  2009).	  	  Recent	  evidence	  has	  suggested	  that	  one	  of	  the	  major	  roles	  of	  the	  CCHFV	  OTU	  domain	  involves	   deubiquitinating	   the	   RIG-­‐I	   protein,	   and	   thereby	   down	   regulation	   of	   RIG-­‐I-­‐mediated	   innate	   immune	   signaling	   and	   the	   antiviral	   response	   (van	   Kasteren	   et	   al.,	  2013).	  Evidence	  also	  exists	  to	  suggest	  the	  closely	  related	  NSDV,	  and	  Ganjam	  viruses	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(Genus	  nairovirus)	   also	  utilize	   an	  OTU	  domain	   to	  block	   the	   induction	  of	   type	  1	  and	  type	  2	   IFNs	  (Begum	  and	  Wissesman,	  1970,	  Holzer	  et	  al.,	  2011).	  The	  OTU	  domain	  of	  the	   L	   protein	   from	   DUGV	   has	   also	   been	   shown	   to	   possess	   deubiquitinating	   and	  deISGylating	   activity	   and	   inhibits	   both	   the	   TNF-­‐α/NF-­‐κB	   and	   JAK/STAT	   pathways	  (Bakshi	  et	  al.,	  2013).	  	  It	  has	  also	  been	  speculated	  that	  the	  relatively	  small	  OTU-­‐like	  domain	  may	  be	  involved	  in	  auto-­‐proteolytically	  cleaving	  the	  remainder	  of	  the	  nairovirus	  L	  protein	  N-­‐terminal	  end	   (Bergeron	   et	   al.,	   2010a).	   This	   cleavage	   could	   potentially	   generate	   the	   active	   L	  polymerase	  along	  with	  numerous	  additional	  protein	  modules	  predicted	  by	  sequence	  alignments,	  to	  include	  transcription	  factors,	  a	  gyrase	  (an	  enzyme	  that	  relieves	  strain	  while	  double	  stranded	  DNA	  (dsDNA)	   is	  being	  unwound	  by	  helicase)	   (Kinsella	  et	  al.,	  2004),	   helicase	   (separate	   two	   annealed	   nucleic	   acid	   strands)	   and	   a	   topoisomerase	  (regulates	  the	  over	  winding	  or	  under	  winding	  of	  DNA)	  domains	  (Honig	  et	  al.,	  2004).	  Collectively	   these	  proteins	  are	  dispensable	   for	  RNA	  polymerization	   functions	   in	   the	  context	  of	  a	  model	  RNA	  segment	  (Bergeron	  et	  al.,	  2010b).	  	  
1.7.4	  Functions	  of	  bunyavirus	  N	  proteins	  in	  addition	  to	  RNA	  binding	  The	   multifunctional	   N	   protein	   of	   bunyaviruses	   not	   only	   provides	   structural	  uniformity	   to	   the	   RNA	   genome,	   but	   also	   forms	   crucial	   interactions	   with	   the	  membrane	   glycoproteins	   Gn	   and	   Gc	   during	   particle	   assembly.	   The	   N	   protein	   also	  provides	   a	   platform	   by	   facilitating	   both	   the	   interactions	   with	   the	   viral	   RdRp	   and	  allowing	  the	  necessary	  access	  to	  the	  viral	  genome	  (Overby	  et	  al.,	  2007a,	  Overby	  et	  al.,	  2007b,	  Ribeiro	  et	  al.,	  2009).	  One	  of	  the	  long-­‐standing	  conundrums	  in	  nsRNA	  virology	  is	   how	   the	   RNPs	   are	   able	   to	   regulate	   both	   transcription	   and	   genome	   replication	  during	   infection.	  Recent	   analysis	  of	  BUNV	  N	  protein	  has	   suggested	   the	  N	  protein	   is	  able	  to	  differentially	  affect	  replication	  and	  transcription	  activities	  of	  assembled	  RNPs,	  suggesting	   it	   plays	   a	   key	   role	   in	   allowing	   the	   correct	   recognition	  of	   the	  bunyavirus	  RNA	  template	  by	  the	  L	  protein	  (Eifan	  and	  Elliott,	  2009),	  although	  how	  it	  achieves	  this	  is	  presently	  unclear.	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1.8	  Architecture	  of	  the	  RNPs	  from	  segmented	  and	  non-­‐segmented	  negative	  sense	  
viruses.	  
1.8.1	  RSV	  and	  VSV	  The	  mechanim	   of	   RNA	   encapsidation	   by	   nsNSVs	   has	   been	   elucidated	   through	   high	  resolution	  models	   of	   the	   N	   protein/RNA	   complexes	   from	   the	  Rhabdoviridae	   family	  members	  VSV	   (Green	  et	  al.,	   2006),	   and	   rabies	  virus	   (Albertini	   et	   al.,	   2006),	   and	   the	  
Paramyxoviridae	   family	  (Genus	  Pneumovirus)	  member	  RSV	  (Tawar	  et	  al.,	  2009).	  The	  N	   protein	   structures	  within	   each	   family	   are	   highly	   homologous,	   and	   therefore	   VSV	  has	  been	  chosen	  to	  represent	  rhabdoviruses	  and	  RSV,	  has	  been	  chosen	  to	  represent	  paramyxoviruses.	   Cryo-­‐EM	   has	   been	   used	   to	   directly	   visualize	   authentic	   RNPs	   and	  allowed	  superpositioning	  of	  the	  crystal	  structures	  to	  allow	  for	  a	  much	  more	  detailed	  model	  of	  RNP	  structure.	  Tawar	  et	  al	   (Tawar	  et	  al.,	  2009)	  reported	  the	  right-­‐handed	  helical	  EM	  structure	  of	  the	  RSV	  N	  protein/RNA	  complex	  (Figure	  13A	  B	  C,	  and	  D).	  Ge	  et	  al	   (Ge	  et	  al.,	  2010)	   reported	   the	  cryo-­‐EM	  reconstruction	  of	   the	  entire	  bullet	   shaped	  VSV	  virion,	  which	  included	  the	  RNP	  complex,	  surrounded	  by	  a	  layer	  of	  matrix	  protein	  (Figure	  13E	  and	  F).	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  Figure	   13.	   Molecular	   architecture	   of	   nsNSV	   RNPs.	   (A)	   Electron	   micrograph	   of	   negatively	   stained	  recombinant	  RSV	  N	  protein	  helices.	   Scale	  bar,	   50	  nm.	   (B)	  Three-­‐dimensional	   reconstruction	   at	   26	  Å	  resolution	  of	  RSV	  helices	  from	  negative	  stain	  cryogenic	  images.	  The	  helix	  has	  a	  pitch	  of	  69	  Å,	  with	  9.8	  N	  protein	  subunits	  per	  turn.	  (C)	  The	  RSV	  N	  protein	  crystal	  structure	  modeled	  using	  the	  contacts	  into	  the	  helix	  ring,	  using	  a	  pitch	  of	  69	  Å	  which	  results	  in	  10.35	  N	  subunits	  per	  turn	  (coloured	  yellow	  for	  the	  N-­‐terminal	  domain	  and	  red	  for	  the	  C-­‐terminal	  domain,	  the	  remaining	  RSV	  N	  proteins	  are	  represented	  by	  surface	  representation	  in	  gray).	  (D)	  Illustration	  of	  the	  location	  of	  the	  RSV	  3’	  RNA	  within	  the	  modeled	  RSV	  RNP	  (nucleotides	  1	  to	  11,	  red)	  and	  initial	  gene-­‐start	  (GS)	  elements	  (nucleotides	  45	  to	  54,	  yellow),	  illustrates	  how	  the	  RNA	  is	  accessible	  for	  the	  RSV	  polymerase	  complex.	  (E)	  Cryo-­‐EM	  reconstruction	  in	  3D	  of	  the	  VSV	  virion	  displaying	  the	  M	  protein,	  N	  protein	  layer,	  and	  numbers	  1	  and	  2	  label	  the	  outer	  and	  inner	   leaflets	  of	   the	  phospholipid	  bilayer	   envelope.	   (F)	  One	   complete	   repeat	  of	   the	  N	  and	  M	  protein	  helices,	  involving	  75	  helical	  AUs	  in	  two	  turns.	  The	  figure	  was	  adapted	  from	  (Tawar	  et	  al.,	  2009,	  Ge	  et	  al.,	  2010).	  In	  comparison	  all	  these	  N	  proteins	  form	  linear	  complexes,	  which	  arrange	  into	  helical	  structures.	  Along	  the	  linear	  N	  protein	  complexes	  the	  RNA	  is	  wrapped	  within	  an	  RNA	  cavity	  located	  between	  the	  N-­‐	  and	  C-­‐terminal	  lobes	  of	  each	  subunit,	  which	  sequesters	  the	  nucleotides	  through	  base	  stacking.	  The	  bases	  of	  nucleotides	  1-­‐4	  in	  rhabdoviruses	  are	   stacked	   and	   face	   the	   solvent	   side	   of	   the	   RNA	   cavity,	   and	   the	   bases	   from	  nucleotides	  5,	  7	  and	  8	  are	  also	  stacked,	  but	  face	  the	  interior	  of	  the	  N	  protein.	  The	  RSV	  N	  protein	  uses	  a	  similar	  mechanism,	  involving	  stacking	  of	  bases	  from	  nucleotides	  2-­‐4	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which	   face	   the	  solvent	  side	  of	   the	  RNA	  cavity,	  whereas	  bases	  of	  nucleotides	  5-­‐7	  are	  stacked	  and	  face	  towards	  the	  centre	  of	  the	  N	  subunit	  (Green	  et	  al.,	  2014b).	  	  
	  Figure	  14.	  The	  crystal	  structures	  of	  the	  N	  proteins	  from	  VSV	  and	  RSV	  of	  the	  order	  Mononegavirales.	  (A)	  VSV;	  (PDB	  code:	  2GIC),	  and	  (B)	  RSV	  (PDB	  code:	  2WJ8).	  RSV	  and	  VSV	  crystal	  structure	  rings	  are	  shown	  in	  two	  different	  orientations,	  and	  each	  subunit	  is	  represented	  by	  a	  different	  colour.	  The	  RSV	  and	  VSV	  rings	   become	   truncated	   and	   form	   single	   helical	   RNPs	   in	   which	   the	   RNA	   is	   wrapped	   around	   for	  protection.	  The	  figure	  was	  generated	  using	  QtMG.	  The	   position	   of	   the	   RNA	   within	   the	   helix	   however	   differs	   between	   the	   N	   protein	  structures	  from	  VSV	  and	  RSV.	  In	  VSV	  the	  N	  protein	  forms	  a	  cavity	  within	  the	  inside	  of	  the	  helix,	  whereas	  for	  RSV	  the	  RNA	  cavity	  is	  positioned	  facing	  the	  exterior	  of	  the	  helix	  (Figure	  14).	  
	  
Figure	   15.	   Surface	   representation	   displaying	   the	   VSV	   and	   RSV	   N	   protein	   interfaces	   involved	   in	  oligomerization.	  (A)	  VSV,	  and	  (B)	  RSV	  are	  shown	  for	  three	  subunits.	  Each	  N	  protein	  subunit	  has	  been	  radially	  spaced	  to	  display	  the	  surfaces	  that	  contribute	  to	  N-­‐N	  protein	  interactions.	  The	  three	  N	  proteins	  are	  coloured	  red,	  green	  and	  yellow	  while	  residues	  that	  contact	  the	  adjacent	  protomers	  are	  depicted	  in	  black.	  The	  figure	  was	  adapted	  from	  (Green	  et	  al.,	  2014a).	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Figure	   16.	  Molecular	   architecture	   of	   the	   IAV	  RNP.	   (A)	   The	   three-­‐dimensional	  model	   of	   the	   IAV	  RNP	  complex	  shows	  the	  anti-­‐parallel	  double	  helix.	  The	  data	  was	  derived	   from	  an	  ECT	  reconstruction	  and	  sub	   volume	   averaging	   of	   infectious	   RNPs	   into	  which	   (B)	   the	   crystal	   structure	   of	   the	  monomer	  was	  modeled	  (PDB	  code:	  4BBL).	  The	  IAV	  RNPs	  wind	  two	  antiparallel	  RNAs	  in	  opposite	  directions	  along	  its	  entire	  length.	  The	  figure	  was	  generated	  using	  QtMG.	  
1.8.3	  Similarities	  and	  differences	  between	  IAV,	  RSV	  and	  VSV	  Each	  of	   the	  RNPs	   from	   IAV,	  RSV	  and	  VSV	  are	  packaged	   inside	   a	   lipid	   envelope	   and	  appear	  structurally	  distinct	  depending	  on	  the	  virus.	  The	  RNP	  inside	  the	  envelope	  of	  paramyxoviruses	   is	   filamentous,	   in	   rhabdoviruses	   it	   forms	   a	   bullet	   shape,	   and	   in	  orthomyxoviruses	   the	   RNP	   adopts	   a	   double	   helical	   structure.	   The	   N	   proteins	   from	  RSV	  and	  VSV	  form	  linear	  complexes	  utilising	  both	  the	  N-­‐	  and	  C-­‐	  terminal	  regions	  to	  interact	   with	   neighbouring	   N	   protein	   subunits	   in	   each	   direction	   along	   the	   helix	  respectively	  (Figure	  15).	  Whereas	  in	  IAV	  the	  extended	  loop	  in	  the	  C-­‐terminal	  region	  interacts	   with	   the	   C-­‐terminal	   domain	   of	   the	   next	   N	   protein.	   It	   has	   not	   yet	   been	  determined	  whether	   the	   IAV	  NP	  N-­‐terminal	   domain	   is	   involved	   in	   the	   interactions	  with	  adjacent	  N	  protein	  subunits.	  The	  RNP	  structures	  from	  IAV,	  RSV	  and	  VSV	  reveal	  N	  molecules	  encapsidate	  the	  RNA	  by	  sequestering	  nucleotides	  into	  a	  protein	  cavity.	  The	  architecture	   of	   the	   RNA	   within	   the	   RNP	   in	   IAV	   adopts	   a	   closed	   conformation	   by	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interaction	  of	   both	   ends	  with	   the	  polymerase.	  Whereas	   the	  RNA	  within	   the	  RNP	  of	  VSV	  and	  RSV	  adopts	  an	  open	  conformation,	  with	  both	   the	  5’	   and	  3’	   ends	   located	  at	  opposite	  ends	  of	  the	  helix.	  
1.9	  Architecture	  of	  bunyavirus	  RNPs	  	  The	  pathogenesis	  of	  all	  bunyaviruses	  depends	  on	  the	  formation	  of	  a	  RNP	  complex,	  in	  which	  the	  genome	  and	  antigenome	  are	  always	  associated	  and	  entirely	  encapsidated	  during	  the	  virus	  life	  cycle	  by	  the	  S	  segment	  encoded	  N	  protein.	  	  Furthermore,	  as	  with	  all	  nsRNA	  viruses,	   this	  association	   is	   critical	  and	   the	  Bunyaviridae	   family	  genome	   is	  only	   able	   to	   participate	   in	   either	  RNA	   synthesis	   or	   segment	  packaging	  when	   in	   the	  form	  of	  the	  RNP.	  	  
1.9.1	  Phlebovirus	  N	  protein	  crystal	  structures	  The	   crystal	   structure	   of	   RVFV	   (phlebovirus)	   N	   protein	   was	   the	   first	   bunyavirus	   N	  protein	  for	  which	  high	  resolution	  data	  was	  available;	  solved	  to	  a	  resolution	  of	  1.92	  Å	  (Raymond	   et	   al.,	   2010a).	   The	   RVFV	   N	   protein	   model	   displayed	   N-­‐	   and	   C-­‐terminal	  helical	   lobes,	   separated	  by	  a	   short	   linker	  helix.	   Interestingly	   the	   folds	  of	  both	   lobes	  were	  novel,	  with	  neither	  showing	  structural	  homology	  with	  any	  of	  the	  other	  nsRNA	  virus	  N	  protein	  previously	  solved.	  Raymond	  et	  al	  used	  denaturation	  and	  refolding	  to	  remove	   the	   RNA	   from	   the	   size	   exclusion	   chromatography	   (SEC)	   purified	   N	  protein/RNA	  multimer	  complex,	  which	  resulted	   in	  predominately	  monomeric	  RVFV	  N	   protein	   and	   found	   a	   non-­‐helical	   appearance	   of	   the	   RVFV	   N	   protein	   within	   the	  symmetry	  of	  the	  resulting	  crystal.	  The	  observations	  of	  no	  obvious	  extended	  terminal	  loops	   involved	   in	   interacting	   with	   adjacent	   monomers	   and	   no	   positively	   charged	  binding	   groove,	   suggested	   at	   the	   time	   that	   RVFV	   utilizes	   a	   novel	   strategy	   of	   RNP	  assembly.	  	  	  The	   mechanism	   for	   oligomerization	   of	   the	   RVFV	   N	   protein	   was	   uncovered	   when	  Ferron	  et	   al	   (Ferron	  et	   al.,	   2011),	   solved	   the	  RVFV	  N	  protein	   to	  1.6	  Å	   in	  hexameric	  oligomer	   form	   with	   a	   distinct	   helical	   arrangement	   of	   the	   N	   protein	   with	  crystallographic	  6-­‐fold	  and	  3-­‐fold	  symmetry.	  These	  ring-­‐shaped	  hexamers	   formed	  a	  functional	   RNA	   binding	   site,	   which	   was	   assessed	   using	   mutagenesis	   experiments.	  Additionally,	   EM	   analysis	   demonstrated	   that	   the	   RVFV	   N	   hexamer	   oligomer	   in	  complex	   with	   RNA	   also	   forms	   rings	   in	   solution,	   and	   the	   single	   particle	   EM	  reconstruction	   of	   the	   hexamer	   N	   protein/RNA	   complex	   is	   consistent	   with	   the	  crystallographic	  N	  protein	  hexamers.	  The	  ring	  like	  organization	  of	  the	  RVFV	  N	  protein	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hexamers	  in	  the	  crystal	  is	  stabilized	  by	  circular	  interactions	  of	  the	  N-­‐terminal	  of	  the	  adjacent	  RVFV	  N	  protein	  monomer,	  which	  by	  extending	  the	  N-­‐terminal	  arm,	  binds	  to	  a	  hydrophobic	  pocket	   in	  the	  core	  domain	  (Ferron	  et	  al.,	  2011)	  (Figure	  17).	  The	  two	  structures	   also	   revealed	   the	   presence	   of	   a	   hydrophobic	   pocket	   at	   the	   interface	  between	  the	  two	  lobes,	  which	  was	  highly	  conserved	  among	  other	  phleboviruses,	  and	  is	  proposed	  to	  represent	  the	  site	  of	  the	  previously	  described	  interaction	  with	  the	  viral	  glycoproteins	   (Overby	   et	   al.,	   2006).	   Consistent	   with	   this	   observation,	   the	   RNPs	  harvested	  from	  infectious	  virus	  particles	  show	  little	  evidence	  of	   the	  compact	  helical	  RNPs	  that	  are	  characteristic	  of	  members	  of	  the	  order	  Mononegavirales	   (Raymond	  et	  al.,	   2010a).	   These	   observations	   have	   led	   to	   the	   “beads	   of	   a	   string”	   model	   for	  encapsidation.	  	  
	  
Figure	   17.	   RVFV	   N	   protein	   hexamer	   represented	   in	   cartoon	   format.	   (A)	   Alternating	   protomers	   are	  coloured	  dark	  purple	  and	  light	  blue,	  with	  the	  N-­‐terminal	  arm	  in	  white	  extending	  from	  the	  globular	  core	  domain,	   which	   fits	   into	   the	   hydrophobic	   pocket	   in	   the	   surface	   of	   the	   adjacent	   subunit	   to	   form	   the	  multimer.	   (B)	  RVFV	  N	  hexamer	  rotated	  90°	   to	  reveal	   the	  N-­‐	  and	  C-­‐terminal	  domain	   interfaces	  of	   the	  individual	  protomers,	  where	  the	  arm	  domain	  binds.	  The	  figure	  was	  adapted	  from	  (Ferron	  et	  al.,	  2011).	  The	  figure	  was	  generated	  using	  QtMG.	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The	  “beads	  on	  a	  string”	  model	  for	  RVFV	  RNP	  formation	  has	  been	  strongly	  supported	  by	  three	  more	  recent	  structures,	  of	  an	  RNA	  bound	  tetramer,	  pentamer	  and	  hexamer	  (Figure	  18,	  tetramer	  PDB	  code:	  4H5P,	  pentamer	  PDB	  code:	  4H5O,	  and	  hexamer	  PDB	  code:	  4H5Q).	  The	  non–perfect	  symmetry	  of	  the	  RNA	  bound	  multimers	  demonstrated	  the	   flexibility	   of	   the	   arm,	  which	   bridge	   adjacent	  multimers	   (Raymond	   et	   al.,	   2012).	  The	  core	  subunit	  domain	  displays	  a	  narrow	  deep	  RNA-­‐binding	  slot,	  which	  becomes	  a	  continuous	   groove	   and	   sequesters	   four	   nucleotides	   within	   the	   groove	   and	   3	  nucleotides	  (2	  for	  hexamers)	  at	  the	  N/N	  protein	  interface	  by	  base	  stacking,	  so	  that	  the	  bases	  are	  nestled	   into	   the	  slot	  and	   the	  phosphate	  backbone	   is	  directed	   towards	   the	  core.	   This	   ensures	   that	   the	   RNA	   is	   fully	   encapsidated,	   including	   those	   nucleotides	  between	  subunits.	  	  	  
	  	  Figure	   18.	   Phlebovirus	  N	   protein/RNA	   complexes.	   (A)	   RVFV	   hexamer	   bound	  with	   35	   nucleotides	   of	  ssRNA.	   (B)	  RVFV	  pentamer	  with	  35	  nucleotides	  of	   ssRNA.	   (C)	  RVFV	   tetramer	  with	  28	  nucleotides	  of	  ssRNA.	  N	  protomers	  are	  represented	  in	  cartoon	  format.	  Oligomerization	  is	   facilitated	  by	  wrapping	  of	  the	  helical	  arm	  of	  one	  protomer	  to	  the	  outside	  of	  the	  adjacent	  protomer.	  The	  ssRNA	  is	  represented	  in	  stick	   and	   ball	   format	  with	   black	   carbon	   atoms	   and	   binds	   to	   the	   RNA	   binding	   groove	  with	   all	   bases	  facing	   towards	   the	   N	   protein.	   (D)	   EM	   visualization	   of	   single	   particle	   class	   averages	   from	   hexamer,	  pentamer,	  and	  tetramer	  multimers,	  which	  are	  representative	  of	  multimers	  released	  from	  viral	  RNPs	  by	  RNase	  digestion.	  The	  figure	  was	  adapted	  from	  (Raymond	  et	  al.,	  2012). 	  The	   phlebovirus	   RNP	   complex	   requires	   very	   few	   protein-­‐protein	   interactions	   from	  neighboring	   N	   proteins.	   Presumably	   the	   mechanism	   of	   oligomerization	   allows	   the	  phlebovirus	  N	  protein	  to	  become	  contiguously	  elongated	  during	  RNP	  formation	  along	  the	  length	  of	  the	  viral	  RNA	  to	  form	  a	  long	  string.	  In	  this	  model	  the	  RNA	  is	  protected	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through	  a	  continuous	  N	  protein	  pocket,	  forming	  the	  “beads	  on	  a	  string“	  like	  structures	  seen	  observations	  using	  EM	  (Raymond	  et	  al.,	  2010b)	  (Figure	  19).	  	  
	  	  Figure	  19.	  Model	  for	  RVFV	  RNP	  formation.	  (A)	  Authentic	  RVFV	  RNPs	  isolated	  from	  virus	  infected	  cells	  visualized	  by	  EM	  with	  enlarged	  images	  to	  compare	  with	  the	  hexameric	  structure	  of	  RVFV	  N	  protein	  (C)	  and	   (D).	   (B)	   The	   “beads	   on	   a	   string”	  model	   for	   RVFV	   RNP	   formation	   is	   likely	   achieved	   through	   the	  successive	   assembly	   of	   the	   monomer-­‐sized	   N	   protein/RNA	   building	   block.	   The	   figure	   was	   adapted	  from	  (Raymond	  et	  al.,	  2012).	  
1.9.2	  Orthobunyavirus	  N	  protein	  crystal	  structures	  The	  crystal	  structures	  of	  the	  orthobunyavirus	  N	  protein	  from	  BUNV	  (Figures	  20	  and	  22B,	  tetramer	  PDB	  code:	  3ZLA),	  LACV,	  Schmallenberg	  virus	  (SBV)	  and	  Leanyer	  virus	  (LEAV)	  displayed	  a	  novel	  fold	  for	  an	  RNA	  binding	  protein	  (Ariza	  et	  al.,	  2013,	  Li	  et	  al.,	  2013,	  Reguera	  et	  al.,	  2013,	  Niu	  et	  al.,	  2013,	  Dong	  et	  al.,	  2013b).	  All	   structures	  were	  crystallized	  as	  tetramers	  as	  RNA	  free	  complexes	  or	   in	  association	  with	  RNA	  derived	  from	   the	  Escherichia	  coli	   (E.	  coli)	   expression	  hosts.	  For	   the	  N	  protein/RNA	  complex	  each	  monomer	  binds	  11	  nucleotides,	  which	  sit	  within	  an	  RNA	  binding	  pocket,	  located	  at	   the	   junction	   of	   the	   C-­‐	   and	  N-­‐terminal	   lobes.	   RNA	   sequestration	   occurs	   primarily	  from	   electrostatic	   and	   hydrophobic	   interactions	   within	   the	   large	   RNA	   pocket.	   The	  structures	  showed	   that	  within	   the	  RNA	  binding	  pocket	   there	  are	  positively	  charged	  residues	  that	  twist	  three	  bases	  stacked	  consecutively	  on	  each	  other	  (2	  to	  4)	  and	  base	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stacking	   of	   F178	   (LEAV;	   PDB	   code:	   4J1G)	   dramatically	   twists	   the	   RNA	   backbone	  further,	  giving	  rise	  to	  a	  pseudo-­‐right	  handed	  helical	  structure	  (Niu	  et	  al.,	  2013).	  The	  RNA	   is	   kept	   inside	   the	   ring	   by	   a	   sharp	   turn	   in	   the	   RNA	   backbone,	   which	   is	  accommodated	  by	  the	  last	  base	  of	  the	  eleventh	  nucleotide	  stacking	  against	  the	  second	  base	  of	  the	  next	  protomer.	  
	  Figure	   20.	   Crystal	   structure	   of	   BUNV	   N	   protein.	   Cartoon	   representation	   of	   the	   monomer	   BUNV	   N	  protein,	  with	  N-­‐	  and	  C-­‐termini	  marked	  with	  a	  blue	  and	  red	  sphere,	  respectively.	  Dashed	  lines	  represent	  the	  disordered	  region	  in	  the	  crystal	  structure.	  The	  figure	  was	  generated	  using	  QtMG.	  	  The	   orthobunyavirus	   N	   protein	   structures	   also	   revealed	   a	   novel	   mechanism	   for	  oligomerization.	  The	  interactions	  between	  adjacent	  monomers	  on	  either	  side	  involve	  extensions	   from	   both	   the	   C-­‐	   and	   N-­‐termini	   in	   a	   head	   to	   tail	   arrangement	   of	  multimerization.	  Two	  models	   for	  RNA	  encapsidation	  and	  RNP	   formation	  have	  been	  proposed	  based	  on	  the	  comparison	  of	  N	  protein	  crystal	  structures	  and	  EM	  images	  of	  authentic	  orthobunyavirus	  RNPs	  purified	  from	  infected	  cells	  (Figure	  21A	  and	  B).	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  Figure	   21.	   Model	   for	   orthobunyavirus	   RNP	   formation.	   (A)	   EM	   visualization	   of	   LACV	   RNPs	   from	  disrupted	  virions.	  The	  size	  of	  the	  RNP	  shown	  is	  ∼160	  ×	  75	  nm.	  	  Displayed	  in	  some	  areas	  the	  LACV	  RNP	  display	  regions	  of	  flexibility	  and	  in	  others	  apparent	  helical	  characteristics.	  Helical	  areas	  are	  highlighted	  in	  the	  green	  box	  and	  shown	  in	  close	  up,	  whilst	  a	  flexible	  area	  is	  shown	  in	  the	  blue	  box.	  (B)	  EM	  image	  of	  negative	  stained	  BUNV	  RNP	  extracted	  from	  BUNV	  infected	  cells.	  The	   inset	   frames	  represents	  regions	  that	  look	  similar	  to	  RVFV	  RNPs	  and	  fit	  the	  “beads	  on	  a	  string”	  model	  for	  RNP	  formation.	  (C)	  The	  crystal	  packing	  of	  LACV	  N	  protein	  in	  a	  41	  helix	  as	  observed	  in	  the	  P41	  crystal	  form.	  The	  width	  and	  pitch	  of	  the	  helix	   is	   indicated.	  Modeling	  of	   the	  RNA	  is	  represented	  as	   tubes	   in	  orange	  tube	  enwrapped	   inside	  the	  internal	  surface	  of	  the	  helix.	  This	  was	  achieved	  with	  successive	  11	  nucleotides	  RNA	  segments,	  which	  are	   positioned	   by	   superposing	   on	   the	   core	   of	   each	   helix	   protomer	   the	   B	   subunit	   from	   the	   tetramer	  together	  with	  its	  bound	  11	  nucleotides	  of	  RNA.	  The	  continuity	  of	  the	  RNA	  segments	  indicates	  a	  helical	  model	  of	  RNP	  assembly,	  in	  which	  a	  much	  longer	  RNA	  could	  be	  enclosed	  within	  an	  extended	  helix.	  (D)	  Upper	   view	   of	   LACV	  N	   41	   helical/RNA	  model	   showing	   resemblance	   to	   the	   tetramer.	   The	   figure	  was	  adapted	  from	  (Ariza	  et	  al.,	  2013,	  Li	  et	  al.,	  2013,	  Reguera	  et	  al.,	  2013)	  	  The	   first	   model	   proposes	   the	   “beads	   on	   a	   string”	   scenario	   similar	   to	   that	   of	   the	  filamentous	  phlebovirus	  RNPs.	  The	  second	  model	  proposes	  a	  supercoiling	  scenario	  in	  which	   stacking	   of	   truncated	   proto-­‐helical	   tetramers,	   forms	   a	   protective	   groove	   for	  RNA	  binding	  within	  the	  inside	  of	  a	  continuous	  symmetrical	  helix.	  This	  model	  has	  been	  supported	  by	  the	  closely	  matched	  dimensions	  of	  both	  width	  and	  pitch	  of	  the	  helical	  N	  protein	  filaments	  in	  EM	  images	  for	  infectious	  LACV	  RNPs	  and	  those	  of	  proto	  helices	  of	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RNA	   free	   tetramers	   in	   a	   crystal	   structure,	   presumably	   truncated	   during	   crystal	  formation	  (Reguera	  et	  al.,	  2013)	  (Figure	  21C	  and	  D).	  The	  proto	  helices	  in	  the	  crystal	  structure	   are	   stacked	   using	   P41	   crystal	   symmetry.	   In	   this	   study	   successive	   11	  nucleotide	  RNA	  segments	  were	  superimposed	  on	  to	  the	  core	  of	  each	  helix	  promoter	  using	   the	   RNA	   bound	   subunit	   from	   the	   closed	   tetramer	   (Figure	   21C	   and	   D).	   The	  modeling	   revealed	   that	   the	   11	   nucleotide	   segments	   join	   up	   to	   form	   a	   continuous	  helical	   arrangement	   of	   RNA,	  with	   44	   nucleotides	   per	   54-­‐pitch	   Å	   of	   RNP	   helix.	   It	   is	  possible	  that	  both	  models	  are	  required	  for	  different	  stages	  of	  the	  virus	  life	  cycle.	  For	  instance,	   highly	   condensed	   helical	   RNPs	   may	   facilitate	   viral	   RNA	   packaging	   into	  infectious	  particles	  whereas	  extended	  RNPs	  may	  be	  required	  for	  viral	  RNA	  synthesis.	  	  	  
	  Figure	  22.	  Orthobunyavirus	  and	  phlebovirus	  N	  protein/RNA	  tetramer	  complexes.	  (A)	  and	  (B)	  display	  the	  structures	  of	  the	  N	  protein/RNA	  tetramers	  from	  (RVFV;	  PDB	  code:	  4H5P),	  and	  BUNV	  (BUNV;	  PDB	  code:	   3ZLA)	   respectively.	   RVFV	   and	   BUNV	   crystal	   structure	   rings	   are	   shown,	   and	   each	   subunit	   is	  represented	   by	   either	   one	   of	   two	   alternating	   colours,	   (dark	   purple	   or	   light	   blue).	   For	   RVFV	   the	   N-­‐terminal	  arm	   is	   coloured	   in	  white	  and	   interact	  with	   the	  adjacent	  protomer.	  RVFV	  and	  BUNV	  protein	  rings	  become	  truncated	  and	  form	  single	  helical	  RNPs	  in	  which	  the	  RNA	  is	  wrapped	  around.	  The	  figure	  was	  generated	  using	  QtMG.	  	  Analysis	   of	   the	   BUNV	   and	   RVFV	   N	   protein	   crystal	   structures	   has	   allowed	   a	  preliminary	   functional	   map	   to	   be	   constructed	   showing	   regions	   involved	   in	  oligomerization,	  polymerase	  binding,	  and	  RNP	  assembly	  into	  virus	  particles	  (Ariza	  et	  al.,	   2013,	   Li	   et	   al.,	   2013,	   Reguera	   et	   al.,	   2013,	   Niu	   et	   al.,	   2013,	   Dong	   et	   al.,	   2013b)	  (Raymond	  et	  al.,	  2012).	  The	  BUNV	  and	  RVFV	  N	  protein	  crystal	  structures	  revealed	  the	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stoichiometritry	   between	   N	   protein/RNA	   complexs	   within	   bunyaviruses	   can	   vary	  (Figure	  22).	  The	  structures	  of	  the	  BUNV	  and	  RVFV	  N	  protein	  crystal	  structures	  were	  also	  distinct	  from	  nsRNA	  virus	  N	  protein/RNA	  complexes	  solved	  to	  date,	  suggesting	  the	  overall	  architecture	  of	  the	  RNP	  of	  bunyaviruses	  is	  likely	  different	  to	  those	  of	  IAV	  (Coloma	  et	  al.,	  2009b),	  RSV	  (Tawar	  et	  al.,	  2009),	  VSV	  (Green	  et	  al.,	  2006)	  (Figures	  13,	  14,	  15	  and	  16),	  and	  measles	  virus	  (Desfosses	  et	  al.,	  2011).	  	  
1.9.3	  Hantavirus	  and	  tospovirus	  N	  proteins	  In	  contrast	  with	  the	  phlebovirus	  and	  orthobunyaviruses,	  homotypic	  oligomerization	  of	   the	   hantavirus	   N	   protein	   has	   been	   proposed	   to	   involve	   interactions	   of	   adjacent	  monomers	  in	  ‘head-­‐to-­‐head’	  and	  ‘tail-­‐to-­‐tail’	  arrangements.	  The	  hantavirus	  N	  protein	  also	  forms	  higher	  order	  oligomers,	  (predominantly	  trimers)	   in	  vivo	  and	   in	  vitro,	  and	  interacting	  domains	  have	  been	  mapped	  to	  both	  N-­‐and	  C-­‐terminal	  regions	  (Alfadhli	  et	  al.,	  2001,	  Kaukinen	  et	  al.,	  2001,	  Kaukinen	  et	  al.,	  2004,	  Kaukinen	  et	  al.,	  2003,	  Mir	  and	  Panganiban,	   2004).	   The	   NMR	   and	   X-­‐ray	   crystallography	   data	   show	   the	   coiled	   coil	  domains	   in	   the	   N-­‐terminal	   region	   of	   the	   hantavirus	   N	   protein	   are	   insufficient	   for	  trimerization,	   implying	  important	  involvement	  of	  the	  C-­‐terminal	  regions	  (Boudko	  et	  al.,	  2007,	  Wang	  et	  al.,	  2008).	  	  
 Multimerization	  of	  the	  TSWV	  N	  protein	  was	  proposed	  to	  involve	  a	  different	  head-­‐to-­‐tail	   dimer	   arrangement,	   with	   hydrophobic	   interacting	   domains	   restricted	   to	   the	  extreme	   terminal	   regions,	   however	   the	   subsequent	   identification	   of	   additional	  interacting	  residues	  within	  central	  regions	  of	  the	  N	  protein	  suggests	  that	  higher	  order	  structures	  such	  as	  tetramers	  may	  be	  the	  predominant	  form	  (Kainz	  et	  al.,	  2004,	  Uhrig	  et	   al.,	   1999).	   The	   differences	   in	   the	   structure	   and	   preferred	   oligomeric	   states	   of	  bunyavirus	   N	   proteins	   may	   reflect	   significantly	   different	   mechanisms	   of	   RNP	  formation.	  
1.9.5	  Structure	  of	  the	  LASV	  NP	  The	  crystal	  structure	  of	  LASV	  NP	  has	  recently	  been	  elucidated	  in	  RNA	  bound	  and	  RNA	  free	  forms	  and	  has	  provided	  insight	  into	  the	  mechanism	  for	  arenavirus	  RNP	  assembly.	  The	  RNA	   free	  LASV	  NP	  was	  crystallized	  as	  a	   trimer,	  and	  displayed	  characteristic	  N-­‐	  and	  C-­‐terminal	  domains.	   	  The	  N-­‐terminal	  domain	  folds	  into	  a	  novel	  structure	  with	  a	  deep	  cavity,	  which	  was	  initially	  thought	  to	  bind	  m7GpppN	  but	  was	  later	  suggested	  to	  represent	  a	  binding	  pocket	   involved	   in	   the	   interaction	  with	  a	   single	  nucleotide	  of	   a	  bound	   RNA	   strand,	   whereas	   the	   C-­‐terminal	   domain	   contains	   3′-­‐5′	   exoribonuclease	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and	   exodeoxyribonuclease	   activities	   thought	   to	   be	   involved	   in	   suppressing	   innate	  immune	  responses	  (Qi	  et	  al.,	  2010,	  Brunotte	  et	  al.,	  2011)	  (Figure	  23).	  	  The	  RNA	  bound	   form	  of	   the	   LASV	  NP	  was	   crystallized	   using	   the	   partial	  N-­‐terminal	  RNA	  binding	  domain	  in	  complex	  with	  ssRNA	  and	  showed	  RNA	  binds	  in	  a	  basic	  crevice	  located	  entirely	  within	  the	  N-­‐terminal	  domain	  (Figure	  23).	  Hastie	  et	  al	  (Hastie	  et	  al.,	  2011b)	   proposed	   that	   upon	   RNA	   binding,	   the	   C-­‐terminal	   domain	   of	   NP	   rotates	  slightly	  away	  from	  its	  position	  in	  the	  RNA	  free	  trimer,	  allowing	  helices	  α5	  and	  α6	  to	  open	   away	   from	   the	   RNA-­‐binding	   crevice	   to	   reveal	   the	   positive	   charges	   residues	  involved	   in	   RNA	   binding.	   The	   gating	   mechanism	   proposed	   may	   not	   be	   unique	   to	  nsRNA	  viruses.	  The	   concept	  of	   a	   flexible	   arm	  being	   involved	   in	   gating	  RNA	  binding	  has	   also	  been	  proposed	   for	  phleboviruses,	   and	  orthobunyaviruses,	   involving	   the	  N-­‐terminal	  arm	  interacting	  with	  an	  adjacent	  monomer	  upon	  RNA	  binding,	  which	  could	  be	   triggered	  by	  an	  as-­‐yet	  unidentified	   factor	  or	  perhaps	   the	  viral	  genome	   itself,	  not	  only	   to	   allow	   for	   oligomerization,	   but	   also	   expose	   the	   hydrophobic	   RNA	   pocket	  (Ferron	  et	  al.,	  2011).	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1.2	  Summary	  of	  thesis	  aims	  	  During	   this	   project	   I	   have	   implemented	   a	   structural	  molecular	   biology	   approach	   to	  investigate	   the	   architecture	   of	   two	   bunyavirus	   N	   proteins.	   The	   N	   proteins	   chosen	  were	  those	  encoded	  by	  CCHFV	  and	  TSWV.	  The	  overall	  aim	  of	  the	  project	  was	  to	  use	  X-­‐ray	   crystallography	   to	   highlight	   important	   structure/function	   relationships,	   which	  could	  be	  further	  analysed	  using	  molecular	  biology	  techniques.	  	  Before	  the	  recent	  publication	  of	  the	  phlebovirus	  and	  orthobunyavirus	  N	  protein/RNA	  crystal	   structures,	   there	  was	   very	   limited	   structural	   information	   characterizing	   the	  bunyavirus	  N	  proteins.	  This	  new	  information	  has	  greatly	  improved	  the	  understanding	  of	   functions	   such	   as	   RNA	   binding,	   oligomerization	   and	   assembly	   of	   the	   infectious	  RNPs.	   Structural	   elucidation	   of	   the	   nairovirus	   and	   topsovirus	   N	   proteins	   could	  address	  important	  questions	  about	  the	  biology	  of	  the	  Bunyaviridae	  family	  such	  as:	  	  
• How	  do	  the	  nairovirus	  and	  tospovirus	  N	  proteins	  homotypically	  interact	  with	  each	  other	  and	  bind	  RNA?	  	  
• How	  do	  the	  nairovirus	  and	  tospovirus	  N	  proteins	  assemble	  into	  the	  RNP?	  	  
• Why	  does	  the	  caspase-­‐3	  protease	  cleave	  the	  CCHFV	  N	  protein?	  	  
• How	  does	   the	   caspase-­‐3	  protease	   cleavage	  of	   the	  CCHFV	  N	  protein	   affect	   its	  architecture	  and	  function?	  	  
• What	   information	   do	   the	   structures	   of	   the	   nairovirus	   and	   tospovirus	   N	  proteins	  provide	  about	  the	  evolution	  of	  bunyaviruses?	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2.	  Chapter	  2	  -­‐	  Materials,	  Methods,	  and	  X-­‐ray	  Crystallography	  theory	  
2.1	  Bacterial	  strains	  
E.	  coli	  DH5α	  Genotype:	  F-­‐,	  Φ80dlacZΔM15,	  endA1,	  recA,	  hsdA1,	  (rk-­‐,	  mk+),	  supE44,	  thi1,	  
deoR,	   gyrA96,	   relA1,	   (ΔlacZYA-­‐argF),	   U169,	   λ-­‐,	   were	   made	   competent	   in	   house	   and	  used	  for	  cloning	  purposes.	  	  	  
E.	  coli	  Gold	  BL21	   (DE3)	  Genotype:	  F-­‐	  ompT,	  hsdSB,	   	   (rB-­‐	  mB-­‐),	  gal	  dcm	  endA	  (DE3),	  (Stratagene),	  were	  made	  competent	  in	  house	  and	  used	  for	  protein	  expression.	  	  	  
E.	  coli	  Star	  BL21	  (DE3)	  Genotype:	  	  F-­‐	  ompT,	  hsdSB,	  	  (rB-­‐	  mB-­‐),	  gal	  dcm	  rne131,	  (DE3)	  (Stratagene),	  were	  made	  competent	  in	  house	  and	  used	  for	  protein	  expression.	  	  Rosetta™	   2	   host	   strains	   are	   BL21	   (DE3)	   derivatives	   designed	   to	   enhance	   the	  expression	   of	   eukaryotic	   proteins	   that	   contain	   codons	   rarely	   used	   in	  E.	   coli.	   These	  strains	  supply	  tRNAs	  for	  7	  rare	  codons	  (AGA,	  AGG,	  AUA,	  CUA,	  GGA,	  CCC,	  and	  CGG)	  on	  a	  compatible	  chloramphenicol-­‐resistant	  plasmid.	  Genotype:	  F-­‐	  ompT,	  hsdSB,	  (rB-­‐	  mB-­‐
),	  gal	  dcm	  pRARE2	  (CamR)	  (DE3).	  	  Rosetta™	  host	  strains	  are	  BL21	  (DE3)	  derivatives	  designed	  to	  enhance	  the	  expression	  of	  eukaryotic	  proteins	  that	  contain	  codons	  rarely	  used	  in	  E.	  coli.	  These	  strains	  supply	  tRNAs	  for	  AGG,	  AGA,	  AUA,	  CUA,	  CCC,	  GGA	  codons	  on	  a	  compatible	  chloramphenicol-­‐resistant	  plasmid.	  The	  tRNA	  genes	  are	  driven	  by	  their	  native	  promoter.	  DE3	  indicates	  that	  the	  host	  is	  a	  lysogen	  of	  λDE3,	  and	  therefore	  carries	  a	  chromosomal	  copy	  of	  the	  T7	  RNA	  polymerase	  gene	  under	  control	  of	  the	  lacUV5	  promoter.	  Such	  strains	  are	  suitable	  for	  production	  of	  protein	  from	  target	  genes	  cloned	  in	  pET	  vectors	  by	  induction	  with	  Isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside	  (IPTG).	  Genotype:	  F-­‐	  ompT,	  hsdSB,	  (rB-­‐	  mB-­‐),	  
gal	  dcm	  pRARE	  (CamR)	  (DE3).	  	  BL834	  (DE3)	  Methionine	  deficient	  E.	  coli	  cells	  Genotype:	  F-­‐	  ompT,	  hsdSB	  ,	  (rB-­‐	  mB-­‐),	  
gal	  dcm	  met	  (DE3).	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2.2	  Plasmid	  vectors	  	  The	  plasmid	  pET-­‐28a-­‐SUMO	  (made	  in	  house	  in	  Dr.	  Thomas	  Edwards	  lab)	  containing	  the	  CCHFV	  N	  cDNA	  was	  used	  for	  expression	  of	  fusion	  His6-­‐SUMO	  CCHFV	  N	  protein	  in	  BL21	   (DE3)	   E.	   coli	   cells,	   and	   was	   provided	   by	   Roger	   Hewson	   (Health	   Protection	  Agency,	   Porton	   Down,	   United	   Kingdom).	   It	   carries	   a	   kanamycin	   resistance	  marker.	  The	  pET-­‐15b	  containing	  the	  TSWV	  N	  gene	  was	  a	  kind	  gift	  form	  Mark	  Kainz	  at	  Ripon	  College,	  Wisconsin,	  USA.	  The	  plasmid	  pET-­‐28a-­‐SUMO	  (made	  in	  house)	  containing	  the	  TSWV	  N	   gene	  was	   used	   for	   the	   expression	   of	  His6-­‐SUMO	  TSWV	  N	   protein	   in	   BL21	  (DE3)	  E.	  coli	  cells.	  
2.3	  Manipulation	  of	  recombinant	  DNA	  	  
2.3.1	  Primers	  	  DNA	  oligonucleotides	  were	  purchased	  from	  MWG	  Biotech.	  A	   list	  of	  primers	  appears	  in	  the	  appendix,	  page	  198.	  
2.3.2	  Polymerase	  Chain	  Reaction	  (PCR)	  	  PCRs	  were	  performed	  using	  Phusion	  DNA	  polymerase	  (New	  England	  Biolabs)	  with	  50	  
µl	  volumes	  in	  thin	  walled	  0.2	  ml	  PCR	  tubes	  as	  follows:	  5	  x	  Phusion	  Buffer,	  2	  µl	  DMSO,	  1.6	   µl	   of	   a	   dNTP	   mix	   containing	   2.5	   mM	   of	   each	   dNTP,	   2’-­‐deoxyadenosine	   5’-­‐triphosphate,	   2’-­‐deoxycytidine	   5’-­‐triphosphate,	   2’-­‐deoxyguanosine	   5’-­‐triphosphate,	  2’-­‐deoxythymidine	   5’-­‐triphosphate,	   10-­‐20	   ng	   template	   of	   DNA,	   1	   µmol	   of	   the	  appropriate	   forward	   and	   reverse	   primers,	   1	   unit	   of	   Phusion	   DNA	   polymerase	   and	  ddH20	  to	  make	  up	  final	  volume	  to	  50	  µl.	  A	  cycling	  reaction	  consisted	  of	  denaturation	  at	  95	  °C	  for	  5	  min,	  30	  x	  (denaturation	  at	  95	  °C	  for	  30	  sec,	  annealing	  using	  a	  gradient	  50	  °C	  to	  70	  °C	  for	  30	  sec,	  and	  elongation	  at	  72	  °C	  for	  1	  min).	  	  
2.3.3	  PCR	  and	  enzyme	  digestion	  cleanup	  The	  Zymoclean	  clean	  and	  concentrator	   (Zymo	  Research),	  was	  used	   to	  clean	  up	  PCR	  reactions	   and	   enzyme	   digestions.	   Briefly	   the	   mixture	   was	   transferred	   to	   a	   Zymo-­‐Spin™	  Column2	  in	  a	  collection	  tube	  and	  centrifuged	  for	  30	  sec	  to	  remove	  flowthrough.	  Wash	  and	  elution	  buffers	  were	  pre-­‐supplied	  and	  protocol	  conditions	  were	   followed	  according	  to	  the	  manufacturer’s	   instructions	  (Zymo	  Research).	  Typically	   the	  elution	  volume	  of	  the	  DNA	  sample	  was	  6	  μl.	  
2.3.4	  Generation	  of	  DNA	  fragments	  by	  restriction	  endonuclease	  digestion	  PCR	  products	  and	  plasmids	  were	  digested	  with	  restriction	  endonuclease	  enzymes	  to	  generate	  5’	  and	  3’	  overhangs.	  This	  was	  performed	  using	  1	  unit	  of	  enzyme	  per	  μg	  of	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DNA	   (by	   definition,	   1	   unit	   of	   restriction	   endonuclease	  will	   digest	   1	   μg	   of	   substrate	  DNA	  in	  a	  50	  μl	  volume	  in	  60	  min).	  Buffers	  and	  reaction	  conditions	  were	  provided	  and	  followed	  according	  to	  the	  manufacturer’s	  instructions	  (New	  England	  Biolabs),	  which	  typically	   contained	   10x	   Buffer	   4	   (recommended	   for	   BamHI	   and	   XhoI	   double	  digestion),	  10x	  BSA	  and	  ddH2O	  to	  make	  up	  the	  final	  volume.	  Reactions	  were	  carried	  out	  for	  2	  hr	  at	  37	  °C.	  Digestion	  was	  carried	  out	  for	  PCR	  diagnostic	  purposes	  and	  for	  recombinant	  DNA	  manipulation,	  which	  typically	  contained	  between	  1-­‐2	  µg	  and	  20-­‐30	  μg	  DNA	  respectively.	  
2.3.5	  Purification	  of	  DNA	  fragments	  	  Using	   a	  UV	  box	  DNA	  bands	  were	   visualized	  using	   long	  wavelength	  UV,	   and	   excised	  from	   the	   gels	   with	   a	   sterile	   scalpel.	   Gel	   slices	   were	   transferred	   to	   a	   1.5	  ml	  micro-­‐centrifuge	  tube	  and	  weighed.	  The	  QIAquick	  gel	  extraction	  kit	  protocol	  (Qiagen)	  was	  used	   to	  extract	  and	  purify	   the	  DNA.	  Briefly	   the	  gel	   slice	  was	  mixed	  with	  1:3	  w/v	  of	  buffer	  QG	  and	  heated	  at	  50	  °C,	  until	  the	  gel	  slice	  dissolved.	  Buffers	  were	  pre-­‐supplied	  and	  protocol	  conditions	  were	   followed	  according	  to	  the	  manufacturer’s	   instructions	  (Qiagen).	  
2.3.6	  Analysis	  of	  DNA	  concentration	  The	   Thermo	   Scientific	   NanoDropTM	   1000	   Spectrophotometer	  was	   used	   to	  measure	  the	  concentration	  of	  purified	  DNA	  samples.	  The	  DNA-­‐50	  function	  was	  chosen,	  at	  260	  nm,	  where	  an	  A260	  of	  1.0	  =	  50	  µg	  ml-­‐1	  pure	  DNA.	  The	  machine	  was	  blanked/reblanked	  by	  adding	  1	  µl	  of	  ddH2O	  and	  elution	  buffer	  (Qiagen)	  respectively	  to	  the	  pedestal.	  1	  µl	  DNA	  was	  analyzed	  and	  the	  concentration	  was	  given	  in	  ng/µl.	  	  
2.3.7	  Ligation	  of	  DNA	  fragments	  	  Ligation	   reactions	   were	   performed	   using	   T4	   DNA	   ligase	   (New	   England	   Biolabs).	  Insert	   versus	   vector	   DNA	   were	   used	   for	   ligation	   in	   molar	   ratios	   of	   15:1	   or	   3:1.	  Typically	  1	  µl	  of	  T4	  DNA	  ligase	  was	  added	  to	  20	  µl	  of	  reaction,	  including	  10	  x	  T4	  DNA	  ligase	  reaction	  buffer	  (New	  England	  Biolabs)	  (50	  mM	  Tris-­‐HCl,	  10	  mM	  MgCl2,	  10	  mM	  DTT,	   1	  mM	  ATP,	   pH	   7.5)	   and	   ddH2O	   to	  make	   up	   the	   20	  µl	   total	   volume.	   Reactions	  were	   incubated	   at	   25	   °C	   for	   2	   hr	   or	   overnight	   at	   25	   °C.	   Successful	   ligations	   were	  determined	   by	   transformation	   into	   competent	   E.	   coli	   cells	   under	   appropriate	  antibiotic	  selection.	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2.4	  Transformation	  of	  chemically	  competent	  E.	  coli	  bacterial	  cells	  
2.4.1	  Star	  BL21	  (DE3),	  Gold	  BL21	  (DE3),	  Rosetta	  BL21	  (DE3),	  Rosetta2	  BL21	  (DE3),	  and	  
DH5α 	  in	  house	  competent	  E.	  coli	  cells	  Frozen	  competent	  E.	  coli	  cells	  were	  thawed	  in	  ice	  (50	  µl	  aliquots).	  10-­‐100	  ng	  DNA	  was	  then	  added	   in	  1	  µl	   volume	   for	  maximum	  efficiency	   and	   incubated	   for	  30	  min.	   Cells	  were	  then	  heat	  shocked	  in	  a	  water	  bath	  at	  42	  °C	  for	  45	  sec,	  and	  then	  immediately	  put	  on	  ice	  for	  2	  min.	  250	  µl	  of	  Luria	  Bertani	  (LB)	  medium	  (Novagen)	  was	  then	  added	  and	  the	  cells	  and	  were	  incubated	  at	  37	  °C	  for	  one	  hour.	  Cultures	  were	  plated	  onto	  LB	  agar	  plates	  (1%	  (w/v)	  tryptone,	  1%	  (w/v)	  NaCl,	  0.5%	  yeast	  extract,	   [pH	  7.0])	  containing	  100	   μg/ml	   of	   appropriate	   antibiotic.	   Typically	   200	   µl	   and	   50	   µl	   were	   plated	   out	  respectively,	  using	  aseptic	  technique.	  Plates	  were	  incubated	  at	  37	  °C	  for	  16	  hr.	  	  
2.4.2	  Controls	  of	  chemically	  competent	  E.	  coli	  cells	  To	  control	  whether	  these	  cells	  were	  adequately	  competent	  a	  pUC	  plasmid	  containing	  the	   ampicillin	   resistance	   gene	   was	   used	   in	   transformation	   experiments.	   Negative	  controls	  included	  a	  transformation	  protocol	  that	  did	  not	  include	  pUC	  plasmid	  DNA.	  
2.5	  Growth	  of	  bacterial	  cultures	  and	  preparation	  of	  plasmid	  DNA	  
2.5.1	  Purification	  of	  plasmid	  dsDNA	  from	  E.	  coli	  cells	  A	  single	  colony	  of	  transformed	  E.	  coli	  cells	  from	  ampicillin	  plates	  was	  transferred	  to	  5	  ml	  LB	  medium	  in	  a	  sterile	  20	  ml	  universal	  bottle,	  containing	  100	  µg/ml	  ampicillin	  and	  grown	  overnight	  at	  37	  °C.	  Plasmid	  extraction	  and	  purification	  was	  achieved	  using	  the	  plamid	  miniprep	  extraction	  kit	  (Qiagen).	  All	  reaction	  reagents	  were	  provided	  and	  the	  protocol	  was	  followed	  according	  to	  the	  manufacturer’s	  instructions.	  	  
2.5.2	  dsDNA	  sequencing	  	  GATC	  Biotech	   carried	   out	  DNA	   sequencing	   commercially.	   For	   regular	   plasmids,	   30-­‐100	  ng/µl	  DNA	  (30	  µl	  total)	  was	  required.	  Primers	  were	  provided	  by	  the	  sequencing	  service	   and	   DNA	   sequences	   were	   assessed	   using	   the	   software	   program	   4peaks	  (Mekentosj.com).	  	  
2.6	  Protein	  biochemistry	  
2.6.1	  Transformation	  of	  bacterial	  expression	  strains	  with	  pET28a-­‐SUMO	  CCHFV	  N	  Bacterial	  expression	  cells	  were	  transformed	  with	  pET28a-­‐SUMO	  CCHFV	  N,	  plated	  out	  on	  kanamycin	  and	  chloramphenicol	  selective	  media,	  and	  incubated	  overnight	  at	  37	  °C.	  Negative	   controls	   included	   a	   transformation	   protocol	   with	   a	   pET28a-­‐SUMO	   vector	  
	  58	  
which	  did	  not	  include	  the	  CCHFV	  N	  gene.	  Colonies	  were	  picked	  and	  grown	  overnight	  in	  culture,	  containing	  5	  ml	  LB	  medium.	  	  
2.6.2	  Small	  scale	  expression	  of	  CCHFV	  N	  protein	  4	  ml	  of	  the	  overnight	  culture	  were	  subsequently	  used	  to	  inoculate	  400	  ml	  of	  LB	  and	  grown	   at	   37	   °C	   until	   the	   OD600	   reached	   0.6-­‐0.7.	   Expression	   was	   induced	   by	   the	  addition	  of	  100	  mM	  or	  100	  µM	  IPTG,	  and	   incubation	  for	  a	   further	  12	  hr	  at	  18	  °C	  or	  37	   °C.	   Cells	  were	   harvested	   by	   centrifugation	   at	   6000	   rpm	   for	   15	  min	   in	   a	   Sorvall	  RC5B	   Plus	   centrifuge	   using	   a	   Sorvall	   SLA-­‐1500	   rotor.	   The	   resulting	   pellet	   was	   re-­‐suspended	  in	  25	  ml	  of	  lysis	  buffer,	  (500	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  0.1	  %	  Triton,	  pH	  7),	  and	  stored	  on	  ice.	  	  Cell	  lysis	  was	  performed	  using	  one	  slow	  freeze	  thaw	  cycle	  at	  -­‐80	   °C	   and	   two	   fast	   sequential	   freeze	   thaw	   cycles	  using	   liquid	  nitrogen.	   The	   soluble	  fraction	   was	   purified	   typically	   from	   individual	   1	   ml	   volumes	   of	   cell	   lysates,	   which	  were	  clarified	  by	  centrifugation	  in	  an	  Eppendorf	  5415	  centrifuge	  at	  13000	  rpm	  for	  15	  min.	  
2.6.3	  Large	  scale	  expression	  of	  CCHFV	  N	  protein	  To	   express	   optimum	   concentrations	   of	   His6-­‐SUMO	   CCHFV	   N	   suitable	   for	  crystallization	   Rosetta2	   E.	   coli	   BL21	   (DE3)	   were	   transformed	   with	   pET28a-­‐SUMO	  CCHFV	   N,	   plated	   out	   on	   kanamycin	   and	   chloramphenicol	   selective	   media,	   and	  incubated	  overnight	  at	  37	  °C.	  Colonies	  were	  picked	  and	  grown	  overnight	   in	  culture,	  containing	   5	   ml	   LB	   medium.	   The	   next	   day	   4	   ml	   of	   the	   overnight	   culture	   was	  subsequently	  used	   to	   inoculate	  6	  L	  of	  LB	  media	  and	  grown	  at	  37	   °C	  until	   the	  OD600	  reached	   0.6-­‐0.8.	   Expression	   was	   induced	   by	   the	   addition	   of	   100	   µM	   IPTG	   (final	  concentration),	   and	   incubated	   for	  a	   further	  12	  hr	  at	  18	   °C.	  Cells	  were	  harvested	  by	  centrifugation	   at	   6000	   rpm	   for	   15	   min	   in	   a	   Sorvall	   RC5B	   Plus	   centrifuge	   using	   a	  Sorvall	   SLC-­‐6000	   rotor.	   Each	  pellet	  was	   re-­‐suspended	   in	  25	  ml	   of	   lysis	   buffer	   (500	  mM	   NaCl,	   20	   mM	   Tris-­‐HCl	   (pH	   7),	   0.1%	   Triton	   X-­‐100,	   5%	   v/v	   glycerol,	   62.5	   µl	  chicken-­‐egg	  white	  lysozyme	  solution	  (10	  mg	  ml-­‐1),	  1	  Unit	  (U)	  of	  deoxyribonuclease	  1	  (DNAse	  1)	  (1	  U/µl)	  (Invitrogen),	  25	  U	  of	  benzonase	  (25	  U/µl)	  (Novagen),	  20	  µl	  MgCl2	  (50	  mM)),	  and	  stored	  in	  a	  50	  ml	  falcon	  tube	  on	  ice.	  	  Each	   25	   ml	   suspension	   was	   subject	   to	   cell	   lysis,	   which	   was	   performed	   in	   20	  sequential	  cycles	  at	  18	  microns	  amplitude	  sonication;	  each	  cycle	  consisted	  of	  10	  sec	  on	   and	   5	   sec	   off,	   using	   a	   soniprep	   150	   (MSE).	   The	   sample	  was	   incubated	   at	   room	  temperature	   for	   10	  min	   and	   lysates	  were	   subjected	   to	   an	   additional	   cell	   lysis	   step	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using	   one	   slow	   freeze	   thaw	   cycle	   at	   -­‐80	   °C.	   Finally	   soluble	   and	   insoluble	   fractions	  were	  separated	  by	  centrifugation	  using	  a	  Sorvall	  RC5B	  Plus	  centrifuge	  and	  an	  SS-­‐34	  rotor	  at	  14000	  rpm	  for	  15	  min.	  	  
2.6.4	  Nickel	  (Ni)	  Superflow	  Plus	  resin	  protein	  purification	  To	  assess	  the	  ability	  of	  the	  Rosetta2	  E.	  coli	  BL21	  (DE3)	  expressed	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  to	  bind	  to	  the	  Ni-­‐Superflow	  Plus	  resin	  (Generon),	   the	  desktop	  spin	  protocol	  was	  implemented	  using	  micro-­‐spin	  columns	  (Thermo-­‐Scientific).	  Initially	  50	  
µl	  of	  Ni	  resin	  was	  added	  to	  the	  column,	  and	  washed	  to	  remove	  any	  residual	  ethanol	  with	  200	  µl	  of	  ddH2O	  by	  centrifugation	  at	  500	  rpm	  for	  30	  sec	  in	  an	  Eppendorf	  5415	  D	  tabletop	   centrifuge.	   The	   resin	  was	   subsequently	  washed	   as	   in	   the	   previous	   step	   in	  binding	  buffer	  (500	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  pH	  7),	  following	  subsequent	  addition	  of	   50	  µl	   of	   the	   supernatant	   from	   1ml	   of	   cell	   lysate.	   Ni-­‐bound	   protein	   was	   washed	  sequentially	   in	   wash	   buffers	   (500	   mM	   NaCl,	   20	   mM	   Tris-­‐HCl,	   pH	   7),	   and	   (50	   mM	  imidazole,	  500	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  pH	  7).	  The	  bound	  protein	  was	  eluted	  using	  elution	  buffer	  (500 mM	  imidazole,	  300 mM	  NaCl,	  20 mM	  Tris-­‐HCl	  pH	  7).	  	  Large-­‐scale	   purification	   of	   His6-­‐SUMO	   CCHFV	   N	   protein	   involved	   a	   first	   step	  purification	  method	   using	   Ni-­‐Superflow	   Plus	   resin	   (Generon).	   Typically	   2	  ml	   of	   Ni	  resin	  was	  added	  to	  the	  supernatant	  of	  each	  25	  ml	  cell	  lysis	  suspension	  and	  left	  to	  bind	  on	  a	  	  blood	  mixer	  for	  2	  hr	  at	  4	  °C.	  	  The	  suspension	  was	  centrifuged	  at	  2500	  rpm	  for	  3	  min,	   the	   supernatant	   fraction	   was	   collected	   and	   the	   remaining	   resin	   pellet	   was	  washed	  with	  binding	  buffer	  (500	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  pH	  7),	  on	  a	  blood	  mixer	  as	  described	  in	  the	  previous	  step.	  This	  was	  repeated	  with	  3	  subsequent	  wash	  steps,	  which	   included	   (50	  mM	   imidazole,	   500	  mM	  NaCl,	   20	  mM	  Tris-­‐HCl,	   pH	   7),	   (90	  mM	  imidazole,	  500	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	   pH	  7),	   and	   (102	  mM	   imidazole,	  500	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  pH	  7).	  ).	  The	  bound	  protein	  was	  eluted	  using	  typically	  15	  ml	  of	  elution	   buffer	   (300 mM	   imidazole,	   300 mM	  NaCl,	   20 mM	  Tris-­‐HCl	   pH	   7)	   and	   50	  µl	  from	   the	   elution	   was	   collected	   and	   re-­‐suspended	   in	   SDS-­‐PAGE	   sample	   buffer	   for	  analysis.	  	  
2.6.5	  Dialysis	  of	  imidazole	  from	  CCHFV	  N	  protein	  To	  remove	  imidazole	  from	  the	  nickel	  purified	  protein	  the	  15	  ml	  elution	  sample	  was	  added	  to	  Snakeskin	  dialysis	  tubing	  (Thermo	  Scientific)	  and	  dialyzed	  overnight	  at	  4	  °C	  against	  dialysis	  buffer	  (500	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  10	  mM	  EDTA,	  pH	  7).	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2.6.6	  Proteolysis	  using	  the	  SUMO	  protease	  The	  SUMO	  protease	  was	  used	  to	  separate	  the	  His6-­‐SUMO	  moiety	  from	  the	  His6-­‐SUMO	  CCHFV	   N	   fusion	   protein	   to	   produce	   native	   CCHFV	   N	   protein.	   Typically	   the	  concentration	   of	   SUMO	   protease	   added	   was	   1:100	   to	   His6-­‐SUMO	   CCHFV	   N	   fusion	  protein	  and	  incubation	  was	  for	  12	  hr	  at	  4	  °C	  in	  a	  dialysis	  bag.	  	  
2.6.7	  Size	  exclusion	  chromatography	  (SEC)	  SEC	  was	  performed	  using	  an	  Akta	  Purifier	   (GE	  Healthcare).	  S75	  and	  S200	  superdex	  gel	   filtration	  preparative	  columns	  were	  used	  for	  purification	  of	  TSWV	  and	  CCHFV	  N	  proteins.	   The	   S75	   analytical	   column	  was	   used	   for	   analyzing	   CCHFV	  N	   protein.	   The	  unicorn	   program	   was	   used	   to	   operate	   all	   steps	   of	   the	   purification,	   which	   were	  performed	   at	   4	   °C.	   Briefly	   the	   column	   was	   equilibrated	   overnight	   using	  filtered/degassed	  running	  buffer	  (10	  mM	  EDTA,	  20	  mM	  Tris-­‐HCl,	  100	  mM	  NaCl,	  pH	  7),	  with	   a	   flow	   rate	   of	   0.5	   ml	   min−1,	   until	   the	   absorbance	   trace	   at	   280	   nm	   reached	   a	  steady	  baseline.	  	  The	  injection	  loop	  was	  washed	  using	  running	  buffer	  to	  remove	  any	  contaminant	   protein	   and	   injected	   with	   5ml	   of	   protein	   sample,	   after	   which	   the	  injection	  valve	  was	  selected	  to	   inject.	   	  The	   flow	  rate	  was	  set	   to	  1	  ml	  min−1	  until	   the	  sample	  reached	  the	  top	  of	  the	  column,	  which	  typically	  took	  7	  ml	  and	  subsequently	  the	  injection	   valve	   was	   set	   to	   load	   and	   flow	   rate	   increased	   to	   2.5	   ml	   min−1.	  Spectrophotometer	   readings	  were	   taken	   at	   both	   260	   nm	   and	   280	   nm	   and	   purified	  protein	  was	  collected	   in	  3	  ml	   fractions.	  Fractions	  were	  analyzed	  using	  SDS-­‐PAGE	  to	  check	  for	  purity.	  	  
2.6.8	  Sodium-­‐dodecyl	  sulphate	  polyacrylamide	  gel	  electrophoresis	  (SDS-­‐PAGE)	  SDS-­‐PAGE	   was	   used	   to	   analyse	   purified	   protein	   fractions	   using	   a	   minigel	   system	  (Biorad	   mini-­‐Protean	   III).	   Resolving	   gel	   solution	   (15%	   acrylamide	   (v/v),	   0.375	   M	  Tris-­‐HCl	   [pH	   8.8],	   0.1%	   SDS	   (w/v),	   0.1%	   APS	   (w/v),	   0.01%	   N,N,N',N'-­‐Tetramethylethylenediamine	   (TEMED)	   (v/v))	  was	  poured	  between	   the	  glass	  plates,	  until	  four	  fifths	  full.	  A	  layer	  of	  isopropanol	  (100%)	  was	  added	  to	  ensure	  the	  gel	  had	  a	  flat	  upper	  surface	  after	  initial	  polymerization	  at	  room	  temperature.	  Isopropanol	  was	  removed	  by	  washing	  with	  ddH2O.	  Stacking	  gel	  (5%	  acrylamide,	  0.126	  M	  Tris-­‐HCl	  (pH	  6.8),	   0.1%	   SDS	   (w/v),	   0.1%	  APS	   (w/v),	   0.01%	  TEMED	   (v/v))	  was	   poured	   onto	   the	  surface	  of	   resolving	  gel,	  whilst	   a	  10	  or	  15	  well	   comb	  was	  placed	  between	   the	  glass	  plates	   before	   polymerisation	   was	   allowed	   to	   occur	   and	   removed	   afterwards.	   2x	  Laemmli	   loading	  buffer	  was	  added	  to	  the	  protein	  sample	  (70	  mM	  Tris-­‐HCl	  (pH	  6.8),	  4%	  SDS	  (w/v)	  15%	  glycerol	  (v/v)	  10	  mM	  DTT,	  1%	  β	  -­‐	  mercaptoethanol	  (w/v),	  0.01%	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bromophenol	   blue	   (w/v))	   and	   heated	   at	   95	   °C	   for	   5	  min	   prior	   to	   loading.	   Samples	  were	  applied	  to	  gels	  suspended	  in	  1	  X	  SDS-­‐PAGE-­‐running	  buffer	  (50	  mM	  Tris-­‐HCl	  (pH	  8.3),	   3.84	   mM	   glycine,	   0.1%	   SDS).	   1%	   (v/v).	   6	   µl	   of	   SeeBlue	   Plus2	   pre-­‐stained	  molecular	  weight	  markers	  (Invitrogen)	  was	  used	  to	  determine	  size	  (kDa)	  of	  protein	  species.	   Gels	   were	   run	   at	   15	   V	   constant	   until	   markers	   were	   separated	   to	   a	   good	  resolution.	  
2.6.9	  Coomassie	  brilliant	  blue	  R-­‐250	  staining	  	  Acrylamide	   gels	   were	   immersed	   in	   Coomassie	   brilliant	   blue	   R-­‐250	   stain	   (50%	  methanol	  (v/v),	  10%	  glacial	  acetic	  acid	  (v/v),	  0.2%	  (w/v)	  Coomassie	  brilliant	  blue	  R-­‐250)	  for	  2	  hr	  under	  constant	  rocking	  at	  room	  temperature.	  Destaining	  was	  achieved	  using	   a	   gel	   destaining	   solution	   (50%	  methanol	   (v/v),	   10%	   acetic	   acid	   (v/v))	   until	  protein	  bands	  were	  visible.	  
2.6.10	  Bio-­‐Rad	  assay	  The	   protein	   concentration	   throughout	   purification	   was	   measured	   using	   a	  spectrophotometer	   and	   the	   colourimetric	   Bradford	   assay	   (Biorad).	   The	  spectrophotometer	  was	  blanked	  at	  wavelength	  595	  nm	  using	  a	  1/5	  dilution	  of	  Bio-­‐Rad	   dye	   with	   ddH2O	   in	   a	   1.5	   ml	   cuvette.	   1	   µl	   of	   protein	   sample	   was	   added	   in	   a	  separate	  dilution,	  transferred	  to	  a	  cuvette	  and	  after	  colour	  development	  the	  reading	  at	  wavelength	  595	  nm	  was	  recorded.	  
2.6.11	  Circular	  dichroism	  The	  CCHFV	  N	  protein	  was	  subjected	  to	  circular	  dichroism	  (CD)	  to	  obtain	  insight	  into	  its	  secondary	  structure.	  Recombinant	  CCHFV	  N	  protein	  was	  diluted	  to	  a	  concentration	  of	  0.5	  mg	  ml-­‐1	   in	  50	  mM	  sodium	  phosphate	  buffer	  pH	  7.5.	  200	  ml	  of	  filtered	  protein	  solution	   was	   placed	   in	   a	   1	   mm	   path-­‐length	   far-­‐	   and	   near-­‐UV	   CD	   cuvette	   (Hellma	  precision	  cells,	  synthetic	  far-­‐UV	  quartz).	  CD	  spectra	  were	  measured	  between	  260	  nm	  and	   180	   nm	   at	   a	   scanning	   speed	   of	   1	   nm	   s-­‐1	   using	   a	   Chirascan	   CD	   spectrometer	  (Applied	   Photo-­‐physics).	   Two	   spectra	   were	   recorded	   and	   averaged,	   followed	   by	  baseline	   correction	   via	   subtraction	   of	   the	   buffer	   spectrum.	   The	   mean	   residue	  ellipticity	  was	  calculated	  and	  expressed	  in	  units	  of	  deg	  cm2	  dmol-­‐1.	  
2.6.12	  Mass	  spectrometry.	  	  	  Samples	   (10	   µM	   in	   water)	   were	   diluted	   to	   50%	   acetonitrile/0.1	   formic	   acid,	   and	  analysed	   by	   Z-­‐spray	   nanoelectrospray	   ionisation	   MS	   using	   a	   quadrupole-­‐IMS-­‐orthogonal	  time-­‐of-­‐flight	  MS	  (Synapt	  HDMS,	  Waters	  UK	  Ltd.,	  Manchester,	  U.K.)	  using	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in-­‐house	   fabricated	   gold/palladium	   coated	   nanospray	   capillaries.	   The	   MS	   was	  operated	  in	  positive	  TOF	  mode	  using	  a	  capillary	  voltage	  of	  1.2	  kV,	  cone	  voltage	  of	  20	  V,	  nanoelectrospray	  nitrogen	  gas	  pressure	  of	  0.1	  bar,	  backing	  pressure	  of	  2.47	  mbar	  and	  a	  trap	  bias	  of	  4	  V.	  The	  source	  and	  desolvation	  temperatures	  were	  set	  at	  80	  °C	  and	  150	  °C,	  respectively.	  	  During	  TOF-­‐MS	  acquisition,	  Argon	  was	  used	  as	  the	  buffer	  gas,	  at	  a	  pressure	  of	  4.0	  ×	  10-­‐3	  mbar	   in	  the	  trap	  and	  transfer	  regions.	  Mass	  calibration	  was	  performed	  by	   a	   separate	   injection	   of	   sodium	   iodide	   at	   a	   concentration	   of	   2	   µg	   µl-­‐1.	  Data	  processing	  was	  performed	  using	   the	  MassLynx	  v4.1	  suite	  of	  software	  supplied	  with	  the	  mass	  spectrometer.	  
2.6.13	  Phenol	  and	  chloroform	  extraction	  of	  RNA	  from	  CCHFV	  N	  protein	  The	   RNA	   binding	   ability	   of	   the	   CCHFV	   N	   protein	   complex	   was	   analysed	   by	   RNA	  extraction	   using	   equal	   volumes	   of	   phenol	   and	   chloroform,	   followed	   by	   ethanol	  precipitation.	  Typically	  700	  µl	  of	  purified	  protein	  (1	  mg	  ml-­‐1)	  was	  added	  to	  700	  µl	  of	  phenol	   and	   vortexed.	   The	   aqueous	   phase	  was	   then	   taken,	   and	   an	   equal	   volume	   of	  chloroform	  was	  added	  and	  the	  mixture	  was	  vortexed	  again.	  The	  aqueous	  phase	  was	  again	  harvested,	  whilst	  10	  µl	  of	  4	  M	  NaCl	  and	  1	  ml	  of	  100%	  ethanol	  were	  added.	  RNA	  was	   precipitated	   by	   incubation	   for	   2	   hr	   at	   –80	   °C.	   To	   determine	   the	   size	   of	   the	  harvested	  RNA,	  samples	  were	  electrophoresed	  on	  1.5%	  TBE	  non-­‐denaturing	  agarose	  gel	   and	   compared	   to	   the	   mobility	   of	   low	   range	   RNA	   size	   markers	   (New	   England	  Biolabs)	   run	   in	   adjacent	   lanes.	   RNA	   was	   stained	   with	   ethidium	   bromide	   and	  visualized	  using	  long	  wavelength	  UV.	  
2.7	  In	  vitro	  caspase-­‐3	  protease	  cleavage	  and	  analysis	  Previously	   published	  methods	  were	   used	   to	   express	   and	   purify	   caspase-­‐3	   protease	  (Denault	   and	   Salvesen,	   2003).	   The	   caspase-­‐3	   protease	   (Gene	   ID:	   836)	   expression	  plasmid	  was	  purchased	  from	  Addgene	  and	  designed	  so	  that,	  when	  expressed,	  the	  C-­‐terminal	   end	  of	   the	  protein	  would	  possess	   a	  His6	  tag	   (Zhou	  et	   al.,	   1997).	   SDS-­‐PAGE	  analysis	   confirmed	   caspase-­‐3	   protease	   expression	   and	   the	   concentration	   estimated	  by	   the	   Bradford	   assay	   (Bio-­‐Rad	   Protein	   Dye	   Reagent;	   Bio-­‐Rad),	   against	   a	   BSA	  standard	   concentrated	   to	   10	  mg	  ml-­‐1.	   The	   caspase-­‐3	   protease	   purified	   protein	   was	  concentrated	  to	  10	  mg	  ml-­‐1.	  	  	  Various	   in	   vitro	   reactions	   to	  measure	   the	   caspase-­‐3	   protease	   cleavage	   of	  wild-­‐type	  CCHFV	   N	   protein	   (DEVD),	   and	   CCHFV	   N	   protein	   mutants	   (DEVE	   and	   DEVG),	   were	  performed	  using	  different	  molar	  ratios	  of	  caspase-­‐3	  protease	  and	  CCHFV	  N	  protein.	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Briefly	  reactions	  were	  performed	  in	  1.5-­‐ml	  microcentrifuge	  tubes	  containing	  caspase-­‐3	   protease	   digestion	   buffer	   200	   mM	   NaCl	   20%	   sucrose,	   0.2%	   (w/v)	   3-­‐[3-­‐cholamidopropyl)-­‐dimethylammonio-­‐1-­‐propanesulfonate	   (CHAPS),	   2	   mM	   EDTA,	   to	  reach	   the	   desired	   total	   volume	   of	   40	   μl,	   and	  were	   incubated	   at	   room	   temperature	  overnight.	  The	  caspase-­‐3	  protease	  digestion	  of	  CCHFV	  N	  protein	  was	  analyzed	  using	  SDS-­‐PAGE	   and	   confirmation	   of	   caspase-­‐3	   protease	   activity	   was	   achieved	   by	  monitoring	  digestion	  of	   a	   flurogenic	   substrate	   IX	   (Merck),	   derived	   from	  poly	   (ADP-­‐ribose)	  polymerase	  (PARP),	  using	  a	  FLUOstar	  Optima	  plate	  reader	  (BMG	  Labtech)	  at	  excitation	   and	   absorption	   wavelengths	   of	   485	   nm	   and	   520	   nm,	   respectively.	   The	  CCHFV	   N	   protein	   cleavage	   products	   were	   analyzed	   using	   an	   SEC	   S200	   10/300	   GL	  analytical	   column	   (GE	   Healthcare),	   which	   was	   preequilibrated	   in	   buffer	   (100	   mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  and	  1	  mM	  EDTA,	  pH	  7.5),	  at	  a	  flow	  rate	  of	  0.5	  ml	  min−1,	  with	  UV	  absorbance	  monitored	  at	  280	  nm.	  	  
2.8	  Phylogenetic	  analysis	  CCHFV	  N	  amino	  acid	  sequences	  MEGA6	  (Tamura	  et	  al.,	  2013)	  was	  used	  to	  analyze	   the	  phylogenetic	  relationships	  of	  CCHFV	  N	  and	  L	  protein	  sequences	  with	  those	  of	  other	  nsRNA	  viruses	  	  with	  the	  default	  settings	   for	  multiple	  sequence	  alignment	  analyses	  using	  the	  CLUSTALW	  (Thompson	  et	   al.,	   1994)	   algorithm	   using	   the	   BLOSUM	   (Henikoff	   and	   Henikoff,	   1992)	   protein	  weighting	  matrix.	  Phylogenitic	   trees	  were	  generated	  using	   the	  maximum	   likelihood	  statistical	   method	   and	   the	   Dayhoff	   substitution	   model	   (Dayoff	   et	   al.,	   1978).	   Rates	  amoung	   sites	  were	  gamma	  distributed	   in	  5	   categories	   and	  95%	  partial	  deletion	   for	  site	  coverage	  cutoff	  was	  implemented.	  The	  nsRNA	  viruses	  used	  in	  the	  comparative	  N	  protein	   sequence	  phylogeny	  were	  DUGV,	  LCMV,	  LASV,	  Pichinde	  virus	   (PICV),	  TACV,	  BUNV,	   LACV,	  RVFV,	  HTNV,	   rice	   stripe	   virus	   (RStV),	   IAV,	   and	  Thogoto	   virus	   (THOV)	  and	  TSWV.	  In	  total	  500	  bootstrap	  trials	  were	  conducted	  on	  each	  submitted	  alignment	  file.	  Virus	  species	  abbreviations	  (GenBank	  accession	  numbers)	  are	  as	  follows:	  DUGV	  (P15190.1);	  CCHFV	  (AAB48503.1);	  LCMV	  (AAX49342.1);	  LASV	  (ADY11071.1);	  PICV,	  (AAC32282.1);	   TCRV,	   Tacaribe	   virus	   (AAA47903.1);	   BUNV	   (P16495.1);	   LACV	  (AAM94389.1);	  RVFV,	   (ABP88854.1);	  HTNV	  (AFA36178.1);	  RStV	   (P68559.2);	  TSWV	  (AAW48185.1);	  IAV	  (VHIVX1);	  and	  THOV	  (YP_145809.1).	  The	  amino	  acid	  sequences	  of	  14	  viral	  polymerases,	  including	  those	  from	  six	  bunyaviruses	  and	  four	  arenaviruses,	  were	   also	   aligned	  using	   the	   same	  method	  as	   for	   the	  N	  protein	   sequences.	  GenBank	  accession	  numbers	  for	  the	  L	  protein	  sequence	  are	  as	  follows:	  DUGV,	  Q66431;	  CCHFV,	  AAQ98866.1;	   LCMV,	   AB196829.1;	   LASV,	   CCA30313;	   PICV,	   AAL16099.1;	   TCRV,	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AAA47901.1;	   BUNV,	   P20470;	   LACV,	   Q8JPR2;	   RVFV,	   P27316;	   HTNV,	   AAG10042.1;	  RStV,	   ADE60705.1;	   VSV,	   AAA48371.1;	   IAV,	   AAA43639.1;	   and	   THOV,	   O41353.	   The	  resultant	   phylogens	   were	   generated	   using	  M6	   Tree	   Explorer.	   The	   percentage	   each	  branch	  was	  obtained	  is	  indicated	  at	  the	  base	  of	  each	  branch.	  
2.10	  Crystallization	  
2.10.1	  Preparing	  N	  protein	  for	  crystallization	  trials	  The	   CCHFV	   N	   protein	   pure	   fractions	   were	   combined	   into	   one	   sample	   and	  concentrated	   to	   500	   µl	   using	   centrifugal	   filter	   units	   with	   a	   20,000	   Da	   molecular	  weight	   cut	   off	   point	   (Generon).	   To	   cryo-­‐protect	   the	   CCHFV	  N	  protein	   10%	  glycerol	  (v/v)	   was	   added	   and	   the	   concentrated	   sample	   separated	   into	   aliquots	   of	   50	   µl	  volumes	   in	  1.5	  ml	  Eppendorf	   tubes,	  which	  were	   snap	   frozen	   in	   liquid	  nitrogen	  and	  stored	  at	  -­‐80	  °C.	  The	  TSWV	  N	  protein	  pure	  fraction	  were	  combined	  into	  one	  sample	  and	  concentrated	  to	  750	  µl	  using	  centrifugal	  filter	  units	  with	  a	  20,000	  Da	  molecular	  weight	  cut	  off	  point	  (Generon).	  Purified	  TSWV	  N	  protein	  was	  stored	  at	  4	  °C.	  
2.10.2	  Crystallization	  factorial	  screens	  CCHFV	  and	  TSWV	  N	  protein	  factorial	  crystal	  screens	  using	  the	  sitting	  drop	  method	  of	  crystallization	   were	   made	   using	   five	   crystal	   screening	   kits,	   which	   included	   crystal	  screen,	   crystal	   screen2,	   index,	   salt	   (Hampton	   research),	   wizard	   1	   and	   wizard	   2	  (Emerald	  BioSystems).	  Initially	  1	  ml	  of	  each	  condition	  was	  added	  to	  a	  96	  well	  starter	  block,	  which	  was	   the	  stock	  solution	  used	   to	   transfer	  60	  µl	  of	  mother	   liquor	   to	  MRC	  plates	  (Molecular	  Dimensions).	  The	  96	  well	  starter	  blocks	  were	  sealed	  with	  foil	  and	  kept	  at	  4	  °C.	  The	  Oryx	  6	  Douglas	  crystallization	  robot	  (Douglas	  Instruments)	  was	  then	  used	  to	  pipette	  a	  0.2	  µl	  drop	  consisting	  of	  0.1	  µl	  of	  mother	  liquor	  and	  0.1	  µl	  purified	  CCHFV	  N	  (40	  mg	  ml-­‐1),	  and	  TSWV	  N	  (15	  mg	  ml-­‐1)	  protein	  on	  to	  each	  of	  the	  two	  wells	  next	  to	  each	  individual	  crystallization	  screen	  condition,	  which	  would	  then	  equilibrate	  over	  59.9	  µl	  well	  solution.	  The	  wasp	  and	  front	  panel	  programs	  were	  used	  to	  operate	  all	  steps	  of	   the	  preparation	  and	  automation	  of	   the	  crystallization	  robot.	  Plates	  were	  subsequently	   sealed	   with	   transparent	   microplate	   sealer	   (Greiner	   bio-­‐one)	   and	  incubated	  at	  25	  °C	  for	  two	  weeks.	  
2.10.3	  Optimization	  of	  crystals	  
2.10.3.1	  Optimization	  of	  the	  CCHFV	  N	  protein	  crystals	   	  	  To	   improve	   the	   quality	   of	   initial	   crystals	   produced	   by	   screening,	   optimization	  was	  implemented	  using	  the	  hanging	  drop	  method	  of	  crystallization.	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1	  ml	   of	  mother	   liquor	   (100	  µl	   of	   2	  M	  NaCl,	  mixed	  with	   the	   chosen	   amount	   of	   50%	  PEG-­‐600,	  and	  made	  up	  to	  1	  ml	  with	  1	  M	  bis-­‐Tris	  propane	  at	  varied	  pH)	  was	  added	  to	  each	  well	  of	  a	  24	  well	  plate.	  	  Typically	  2.5	  µl	  of	  purified	  CCHFV	  N	  protein	  and	  2.5	  µl	  of	  mother	   liquor	   was	   placed	   on	   to	   a	   coverslip.	   The	   drop	   was	   equilibrated	   over	   the	  corresponding	   well,	   which	   was	   sealed	   with	   the	   underside	   of	   the	   coverslip,	   using	  vacuum	  grease.	  Plates	  were	  typically	  incubated	  at	  25	  °C	  for	  two	  weeks.	  	  
2.10.3.2	  Optimization	  of	  the	  TSWV	  N	  protein	  crystals	  For	  TSWV	  N	  protein	  1	  ml	  of	  mother	  liquor	  (25%	  PEG-­‐550	  mono	  methyl	  ether	  (MME),	  made	  up	  with	  0.5	  M	  2-­‐(N-­‐morpholino)	  ethanesulfonic	  acid	  (MES),	  was	  added	  to	  each	  well	   of	   a	   24	   well	   plate.	   Typically	   the	   best	   crystals	   would	   grow	   from	   mixing	   3	   µl	  purified	  TSWV	  N	  protein	   at	   15	  mg	  ml-­‐1,	   and	   1	  µl	   of	  mother	   liquor	   into	   a	   drop	   and	  suspending	  on	  a	  cover	  slip.	  The	  drop	  was	  equilibrated	  over	  the	  corresponding	  well,	  which	   was	   sealed	   with	   the	   underside	   of	   the	   coverslip	   using	   vacuum	   grease.	   Well	  diffracting	  TSWV	  N	  protein	  crystals	  appeared	  after	  9	  hr	  at	  25	  °C.	  
2.11	  X-­‐ray	  diffraction	  data	  collection	  for	  CCHFV	  and	  TSWV	  N	  protein	  crystals	  
2.11.1	  CCHFV	  N	  protein	  crystals	  Native	  C2	  X-­‐ray	  diffraction	  data	  were	  collected	  from	  CCHFV	  N	  protein	  crystals	  cryo-­‐preserved	  at	  100	  K	  on	  beamline	  I04-­‐1	  at	  Diamond	  Light	  Source	  using	  12,658	  electron	  volts	  (eV)	  X-­‐rays	  at	  wavelength	  0.9713	  Å	  with	  a	  Pilatus	  6M	  detector.	  Native	  P212121	  X-­‐ray	  diffraction	  data	  were	  collected	  from	  CCHFV	  N	  protein	  crystals	  cryo-­‐preserved	  at	   100	   K	   on	   beamline	   I02	   using	   12,658	   eV	   X-­‐rays	   at	   wavelength	   0.9795	   Å	   with	   a	  Pilatus	   6M	   detector.	   Derivative	   X-­‐ray	   diffraction	   data	   were	   collected	   for	   CCHFV	   N	  crystals	  soaked	  with	  thimerosal	  cryo-­‐preserved	  at	  100	  K	  on	  beamline	  I02	  at	  Diamond	  Light	   Source	   using	   12,658	   eV	   X-­‐rays	   at	   wavelength	   0.9795	   Å	   with	   a	   Pilatus	   6M	  detector.	  Native	  and	  derivative	  data	  were	  indexed	  and	  integrated	  using	  the	  MOSFLM	  package	  (Leslie,	  2006)	  and	  scaled	  using	  SCALA	  (Evans,	  2006b)	   from	  the	  CCP4	  suite	  (Winn	  et	  al.,	  2011).	  	  
2.11.2	  TSWV	  N	  protein	  crystals	  Native	  X-­‐ray	  diffraction	  data	  were	  collected	  from	  crystals	  cryo-­‐preserved	  using	  30%	  PEG-­‐550	  MME,	  and	  70%	  150	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl,	  at	  100	  K	  on	  beamline	  I02	  at	  Diamond	  Light	  Source	  using	  12,647	  eV	  X-­‐rays	  at	  wavelength	  0.9803	  Å	  with	  a	  Pilatus	  6M	  detector	  and	  0.5°	  oscillations.	  Data	  were	  indexed	  with	  POINTLESS	  (Evans,	  2011)	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and	  integrated	  with	  	  XDS	  and	  scaled	  and	  merged	  with	  XSCALE	  (Evans	  and	  Murshudov,	  2013)	  using	  the	  automated	  program	  XIA2	  (Winter	  et	  al.,	  2013,	  Kabsch,	  2010).	  
2.12	  Selenomethionine	  derivative	  protein	  	  Expression	  of	  TSWV	  and	  CCHFV	  N	  protein	  containing	  selenomethionine	  was	  achieved	  by	  transforming	  the	  pET28a-­‐SUMO	  CCHFV	  or	  TSWV	  N	  and	  pRARE	  plasmids	  into	  the	  BL834	   (DE3)	   E.	   coli	   expression	   cells,	   which	   are	   unable	   to	   synthesize	   their	   own	  methionine.	   Methionine	   deficient	   bacterial	   cells	   expressing	   selenomethionine	  derivative	   TSWV	   and	   CCHFV	   N	   proteins	   were	   grown	   in	   M9	   minimal	   media	   and	  nutrients	   that	  were	   pre-­‐made	   by	  Molecular	   Dimensions,	  with	   conditions	   that	  were	  followed	  according	  to	  the	  manufacturer’s	  instructions	  (Molecular	  Dimensions).	  
2.13	  Phasing	  Phases	   contain	   more	   information	   than	   the	   diffraction	   intensities,	   and	   therefore	  estimating	   them	   is	   vital	   for	   constructing	   the	   electron	   density.	   Determination	   of	   a	  marker	  atom	  substructure	  is	  the	  most	  common	  way	  of	  calculating	  phases	  lost	  due	  to	  the	   physical	   process	   of	   measuring	   X-­‐rays	   by	   a	   detector.	   Traditionally	   the	   most	  common	   method	   for	   calculating	   phases	   is	   by	   exploiting	   the	   large	   electronic	  differences	  provided	  by	  heavy	  atoms	  in	  reference	  to	  the	  isomorphous	  structure.	  The	  electronic	  differences	  cause	  intensity	  changes	  relative	  to	  the	  reference	  structure	  and	  the	  differences	  between	  the	  calculated	  structure	  factor	  amplitudes	  can	  be	  used	  to	  find	  the	   source	   of	   the	   electronic	   difference,	   the	   marker	   atom.	   Differences	   can	   be	  introduced	  by	  soaking	  heavy	  atoms	  into	  the	  crystal,	  or	  through	  protein	  engineering,	  such	   as	   selenium	   being	   introduced	   into	   selenomethionine.	   As	   a	   consequence	   of	  dispersive	   differences	   at	   different	   wavelengths	   and	   anomalous	   scattering	   factor	  contributions,	   intensity	  differences	   can	  also	  arise	   from	  native	  heavy	  atoms,	   such	  as	  those	  from	  metal	  binding	  proteins.	  	  	  For	   heavy	   atom	   derivatives	   the	   measurable	   changes	   in	   reflection	   intensities,	   are	  considerable	  enough	  to	  estimate	  phases.	  The	  additive	  affect	  from	  contributions	  of	  all	  atoms	   which	   make	   up	   the	   intensity	   of	   a	   reflection,	   means	   each	   complex	   structure	  factor	  of	  the	  derivatives	  FPA	  is	  the	  complex	  (vector)	  sum	  of	  the	  partial	  structure	  factor	  contributions	  from	  the	  marker	  atom	  FA	  and	  from	  the	  protein	  Fp	  (Figure	  24).	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  The	  amplitude	  of	  the	  heavy	  atom	  alone	  is	  given	  by	  	  (𝐹! = 𝐹!" − 𝐹!)	  	  The	  phase	  angle	  of	  the	  heavy	  atom	  can	  then	  be	  applied	  to	  the	  find	  the	  phase	  angle	  of	  
Fp.	  	  	  
	  Figure	  24.	  Schematic	  of	  the	  complex	  structure	  factors	  for	  protein	  with	  and	  without	  heavy	  atoms.	  The	  complex	  structure	  factors	  for	  the	  derivative	  FPA	  is	  the	  vector	  sum	  of	  the	  native	  structure	  factor	  for	  the	  protein	   alone	   Fp	   and	   the	   heavy	   atom	   structure	   factor	   FA.	  The	   figure	  was	   adapted	   from	  Biomolecular	  Crystallography	  -­‐	  Bernard	  Rupp	  
2.13.1	  Isomorphous	  replacement	  The	  classical	  sources	  of	  electronic	  differences	  are	  heavy	  atoms,	  which	  are	  commonly	  soaked	   into	   the	   crystal.	   The	   intensity	   differences	   between	   that	   of	   the	   native	   and	  derivative	   crystals	   are	   exploited	   for	   substructure	   solution	   and	   the	  method	   is	   called	  either	   single	   isomorphous	   replacement	   (SIR)	  or	  multiple	   isomorphous	   replacement	  (MIR),	   depending	   on	   how	  many	   derivatives	   are	   used.	   However	   when	   using	   SIR	   or	  single-­‐wavelength	  anomalous	  dispersion	  (SAD)	  (see	  below),	  on	  their	  own	  the	  phase	  angle	   is	   ambiguous	   because	   of	   the	   two	   fold	   degeneracy	   and	   hand	   uncertainty	  (Matthew,	   1966)	   (Figure	   25).	   This	   can	   be	   resolved	   by	   using	   additional	   anomalous	  signal	   from	   anomalous	   scattering	   of	   derivative	   atoms	   at	   certain	   absorbance	  wavelengths,	  and	  thus	  the	  so	  called	  single	  isomorphous	  replacement	  with	  anomalous	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scattering	  (SIRAS),	  or	  multiple	  isomorphous	  replacement	  with	  anomalous	  scattering	  (MIRAS)	  are	  standard	  methods	  to	  break	  phase	  ambiguity.	  	  	  
	  Figure	  25.	  Representation	  of	  the	  phase	  equation.	  The	  complex	  structure	  factor	  for	  protein,	  derivative,	  and	  heavy	  atom	  are	   related	   for	  a	  generic,	   centric	   reflection	  hkl.	  Determination	  of	   the	  position	  of	   the	  derivative	   is	  given	  by	   two	  possible	  solutions	  of	   the	  protein	  phase	  angle	   for	  each	  reflection	  produced	  from	  the	  entire	  complex	  structure	  factor	  for	  the	  heavy	  atoms	  FA.	  However	  one	  phase	  angle	  (φ2)	  will	  be	  incorrect;	   the	   other	   one	   (φp)	   will	   be	   correct.	   The	   figure	   was	   adapted	   from	   Biomolecular	  Crystallography	  -­‐	  Bernard	  Rupp	  
2.13.2	  Anomalous	  scattering	  Anomalous	  scatterers	  provide	  anomalous	  differences	  within	  a	  data	  set	  and	  dispersive	  differences	  between	  data	  sets	  of	  the	  same	  crystals	  recorded	  at	  different	  wavelengths.	  Besides	  selenomethionine	  protein	  or	  other	  heavy	  atoms	   introduced	  by	  soaking	   into	  native	  crystals,	  another	  source	  of	  anomalous	  signal	  can	  be	  natively	  present	  atoms	  in	  proteins	  such	  as	  zinc,	  iron,	  sulphur	  etc.	  Anomalous	  scattering	  takes	  advantage	  of	  the	  ability	   of	   heavy	   atoms	   to	   absorb	   X-­‐rays	   at	   different	   wavelengths	   and	   promote	   the	  breakdown	  of	  Friedel’s	  Law.	  	  	  Friedel's	  Law	  states	  that	  the	  intensities	  associated	  with	  two	  reciprocal	  points,	  given	  by	   the	   indices	   (h,k,l)	   and	   (-­‐h,-­‐k,-­‐l)	   are	   equal,	   unless	   in	   the	   presence	   of	   anomalous	  scattering	  which	  will	  produce	  a	  small	  difference	  in	  intensity.	  Thus	  the	  structure	  factor	  amplitudes	  are	  symmetric	  about	  the	  real	  axis	  in	  the	  absence	  of	  anomalous	  scattering	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contributions.	   However	   in	   the	   presence	   of	   anomalous	   scattering	   the	   Friedel	   pair,	  instead	   of	   having	   identical	   amplitudes	   becomes	   a	   Bijvoet	   pair	   with	   different	  intensities	   F+	  and	   F-­‐	   for	   the	   related	   reflection.	   This	   breaks	   the	   centrosymmetry	   of	  reciprocal	  space;	  with	  both	  the	  magnitude	  and	  phase	  of	  the	  reflections	  in	  the	  Bijvoet	  pair	  distinctly	  different	  from	  each	  other	  and	  from	  this	  disparity	  the	  phase	  information	  can	  be	  extracted.	  
2.13.3	  Dispersive	  differences	  Atomic	   scattering	   at	   different	   absorption	  wavelengths	   can	   exploit	   the	   fact	   different	  diffraction	   intensities	   can	   be	   measured	   for	   the	   same	   reflection.	   Giving	   rise	   to	  dispersive	   differences,	   which	   can	   together	  with	   anomalous	   scattering	   be	   used	   in	   a	  multi-­‐wavelength	   anomalous	   dispersion	   (MAD)	   or	   (SAD).	   MAD	   takes	   advantage	   of	  both	   orthogonal	   dispersive	   and	   anomalous	   scattering	   from	   the	   same	   crystal	   to	  resolve	   the	   phase	   ambiguity,	   where	   the	   largest	   anomalous	   differences	   between	  Bijvoet	   pairs	   are	  measured	   at	   the	   peak	  wavelengths	   of	   the	   derivative	   heavy	   atom.	  Dispersive	  differences	  can	  also	  be	  collected	  from	  data	  sets	  recorded	  at	  the	  inflection	  peak,	  and	  remote	  (below	  the	  peak).	  However,	  the	  loss	  of	  symmetry	  in	  the	  diffraction	  pattern	  due	   to	   the	  breakdown	   in	  Friedel’s	  Law	  means	   that	   the	  average	  redundancy	  needed	   will	   increase,	   and	   radiation	   damage	   may	   then	   come	   in	   play	   for	   recording	  three	  complete	  datasets	  at	  different	  wavelengths	  sets	  from	  one	  crystal.	  
2.13.4	  Structure	  determination	  The	  CCHFV	  N	  protein	  structure	  was	  solved	  by	  single	  isomorphous	  replacement	  with	  anomalous	   scattering	   (SIRAS)	   using	   a	   mercury	   derivative	   obtained	   by	   soaking	  natively	   grown	   CCHFV	   N	   protein	   crystals,	   suspended	   under	   the	   original	  crystallization	  conditions,	  with	  5	  mM	  thimerosal	  for	  20	  min	  and	  back	  soaking	  for	  10	  min	  to	  remove	  any	  non-­‐specific	  binding	  which	  might	  cause	  unwanted	  absorption	  of	  X-­‐rays	  (Carter	  et	  al.,	  2012a).	  The	  derivative	  data	  sets	  were	  combined	  with	  the	  native	  data	  set	  using	  CAD	  (1994),	  and	  scaled	  using	  SCALEIT	  (1994),	  and	  the	  Hg	  substructure	  positions	   were	   determined	   by	   generating	   an	   isomorphous	   difference	   map	   in	  Patterson	  space.	  Eight	  prominent	  Hg	  peak	  sites	  were	  found	  and	  the	  sites	  were	  input	  into	   autoSHARP	   for	   phase	   calculation,	   improvement,	   and	   phase	   extension	   to	   2.1	   Å	  (Vonrhein	  et	  al.,	  2007).	  Density	  modification	  was	  implemented	  by	  PARROT	  (Cowtan,	  2010),	   after	   which	   the	   automated	   model	   building	   program	   BUCCANEER	   (1994,	  Cowtan,	  2006)	  was	  used	  to	  build	  85%	  of	  the	  model.	  The	  model	  was	  then	  subjected	  to	  iterative	   cycles	   of	   manual	   building	   in	   COOT	   (Emsley	   and	   Cowtan,	   2004)
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refinement	   in	  REFMAC	  (Murshudov	  et	  al.,	  1997)	  with	  TLS	  parameters	  applied	  until	  98%	   of	   the	   protein	   molecules	   had	   been	   modeled.	   The	   TLS	   parameters	   were	  determined	   by	   the	   TLSMD	   server	   (Murshudov	   et	   al.,	   1997),	   which	   defined	   the	  globular	  and	  arm	  domains	  as	  separate	  rigid	  bodies.	  The	  ARP/wARP	  solvent	  program	  (Lamzin	  and	  Wilson,	  1997)	  was	  used	  to	   initially	   locate	  the	  bulk	  of	  water	  molecules,	  followed	  by	  manual	  building	  of	   the	   remaining	  solvent	  molecules	   in	  COOT.	  The	   fully	  refined	  model	  has	  an	  Rfactor	  value	  of	  18.4%	  and	  an	  Rfree	  value	  of	  23.4%	  (Table	  3)	  and	  was	  validated	  using	  MolProbity	  (Chen	  et	  al.,	  2010).	  
2.14	  Crystallization	  and	  X-­‐ray	  diffraction	  theory	  X-­‐ray	  crystallography	  is	  one	  method	  of	  analysing	  macromolecular	  structure	  at	  atomic	  resolution.	  Major	  advances	  in	  computing,	  physics,	  biology,	  and	  chemistry	  has	  lead	  to	  an	   exponential	   growth	   of	   structures	   being	   solved	   and	   deposited	   into	   the	   world’s	  largest	  repository	  for	  macromolecular	  structures	  solved	  using	  experimental	  data,	  the	  Protein	  Data	  Bank	  (PDB).	  The	  PDB	  holds	  currently	  approximately	  90,000	  models	  and	  roughly	   79,000	   of	   these	   are	   protein	   and	   nucleic	   acid	   models	   obtained	   by	   X-­‐ray	  crystallography.	   The	   methods	   and	   theory	   involved	   in	   macromolecular	  crystallography	   have	   been	   well	   documented	   in	   a	   number	   of	   textbooks	  (Crystallography	  made	  Crystal	  Clear	  –	  Gale	  Rhodes	  and	  Biomolecular	  Crystallography	  -­‐	   Bernard	   Rupp).	   The	   aim	   of	   this	   section	   is	   to	   provide	   a	   basic	   overview	   of	   how	  researchers	  use	  X-­‐ray	  crystallography	  to	  obtain	  macromolecular	  structures	  (Rhodes,	  2006,	  Rupp,	  2010).	  
2.14.1	  Crystallization	  Owing	   to	   the	   fact	   that	  one	   single	  molecule	   is	   a	  very	  weak	   scatterer	  of	  X-­‐rays	  and	  a	  lens	  is	  unable	  to	  focus	  X-­‐rays	  it	  is	  not	  possible	  to	  produce	  a	  focused	  image	  of	  a	  single	  molecule	  in	  the	  way	  we	  can	  see	  an	  object	  with	  visible	  light	  waves.	  The	  latter	  problem	  can	   be	   overcome	   by	   using	   a	   computer	   to	   simulate	   the	   lens,	   whereas	   to	   solve	   the	  problem	  of	  the	  weak	  scattering	  of	  one	  molecule	  and	  to	  generate	  sufficient	  scattering	  measurements	   to	   feed	   into	   the	  computer,	   it	   is	  necessary	   to	  analyse	  diffraction	   from	  crystals,	  with	   repeating	   units,	  which	   can	   be	   used	   to	   amplify	   the	   signal,	   rather	   than	  individual	  molecules.	  	  X-­‐ray	  crystallographic	  determination	  of	  a	  protein	  structure	  requires	  diffraction	  of	  X-­‐rays	   from	   a	   crystal	   containing	   many	   identical	   copies	   in	   an	   ordered	   array	   of	   the	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structure	   under	   investigation.	   The	   crystals	   serve	   to	   generate	   an	   identical	   repeating	  unit	  or	  lattice	  in	  three	  dimensions,	  which	  acts	  to	  amplify	  the	  strength	  of	  the	  diffracted	  X-­‐rays.	   The	   first	   main	   obstacle	   is	   to	   grow	   crystals	   that	   generate	   sufficient	   X-­‐ray	  diffraction	  for	  structural	  determination	  and	  this	  entails	  growing	  high-­‐quality	  crystals	  from	  highly	  pure	  and	  mono-­‐disperse	  protein.	  	  The	  two	  common	  approaches	  that	  are	  widely	  used	  for	  growing	  reproducible	  crystals	  are	   the	  hanging	  drop	   and	   sitting	  drop	   vapour	  diffusion	  methods	   (McPherson	   et	   al.,	  1982).	   Both	   these	  methods	   involve	  mixing	   soluble	   pure	   protein	  with	   a	   precipitant,	  such	   as	   polyethylene	   glycol	   or	   ammonium	   sulphate,	   at	   a	   concentration	   of	   the	  precipitant	   that	   is	   just	  below	   that	  necessary	   to	  precipitate	   the	  protein.	   In	  principal,	  precipitation	  of	  the	  protein	  is	  achieved	  by	  saturating	  the	  concentration	  of	  the	  protein	  with	  precipitant	  in	  a	  drop	  by	  removing	  water	  by	  controlled	  evaporation.	  The	  volume	  of	   the	  drop	   is	  made	   from	  an	  amount	  of	   soluble	  protein	  and	  an	  amount	  of	   reservoir	  solution	  so	  that	  the	  resulting	  drop	  has	  approximately	  50%	  of	  the	  precipitant	  required	  to	   cause	   supersaturation	   and	   eventual	   crystallization.	   The	   drop	   is	   then	   suspended	  underneath	  a	  cover	  slip	  (hanging	  drop)	  or	  dispensed	   in	  a	  well	   (sitting	  drop),	  which	  are	  closed	  in	  a	  container	  containing	  a	  much	  larger	  volume	  of	  the	  reservoir	  solution	  or	  100%	  of	  the	  precipitant	  to	  cause	  supersaturation.	  Vapour	  diffusion	  is	  induced	  in	  this	  closed	  system	  with	  the	  net	   transfer	  of	  water	   from	  the	  drop	  to	   the	  reservoir	  mother	  liquor,	  until	  the	  precipitant	  concentration	  is	  the	  same	  in	  both	  solutions	  (Figure	  26).	  
	  	  Figure	   26.	   The	   hanging	   drop	   and	   sitting	   drop	   methods	   of	   vapour	   diffusion	   for	   crystallization.	   The	  figure	  was	  adapted	  from	  Biomolecular	  Crystallography	  -­‐	  Bernard	  Rupp	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When	   the	   combination	   of	   protein	   and	   precipitation	   exceeds	   threshold	   values	   the	  precipitant	   concentration	  moves	   into	   the	   nucleation	   phase,	   as	   shown	   in	   the	   phase	  diagram	   (Figure	  27),	   and,	   in	   theory,	   precipitation	   should	  occur.	   In	   some	   conditions	  this	  allows	  formation	  of	  molecular	  clusters,	  which	  act	  as	  nucleation	  sites	  from	  which	  crystals	   can	   grow.	   Slow	   precipitation	   is	   more	   likely	   to	   produce	   larger	   crystals,	  whereas	  rapid	  precipitation	  produces	  more	  nucleation	  sites	  and	  many	  small	  crystals,	  or	   worse	   (and	   in	   most	   cases)	   an	   amorphous	   solid.	   	   As	   nuclei	   form	   the	   protein	  concentration	   in	   the	   drop	   decreases	   moving	   the	   conditions	   into	   the	   metastable	  growth	  region	  (McPherson,	  1990).	  	  
	  Figure	  27.	  Phase	  diagram	  of	  crystal	  growth	  (A)	  for	  a	  hypothetical	  protein	  showing	  the	  relationship	  of	  protein	   solubility	   as	   a	   function	   of	   precipitant	   concentration.	   Unsaturated	   area	   represents	  concentrations	   of	   protein	   and	   precipitant	   at	   which	   the	   solution	   is	   not	   saturated	   with	   protein.	  Metastable	  and	  labile	  regions	  are	  unstable	  solutions	  and	  are	  supersaturated	  with	  protein.	  Metastable	  region	  supports	  crystal	  growth	  only,	  whilst	  the	  labile	  region	  supports	  nucleation	  and	  growth.	  (B)	  In	  an	  ideal	  crystal	  growing	  experiment,	  once	  vapour	  diffusion	  allows	  the	  protein	  to	  become	  supersaturated	  and	   reach	   the	   region	   of	   spontaneous	   nucleation,	   nuclei	   will	   form,	   and	   a	   crystal	   may	   start	   to	   grow,	  depleting	  the	  protein	  solution	  and	  allowing	  the	  solution	  into	  the	  metastable	  region	  for	  optimal	  growth.	  The	  figure	  was	  adapted	  from	  Biomolecular	  Crystallography	  -­‐	  Bernard	  Rupp.	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Usually	   screening	   for	   crystallization	   conditions	   for	   structural	   determination	   of	  untested	   proteins	   involves	   a	   sparse	   matrix	   of	   different	   solutions	   using	   the	   sitting	  drop	   vapour	   diffusion	  method	   (Carter,	   1990).	   This	   allows	  hundreds	   of	   conditions	   -­‐	  different	  buffers,	  salts,	  precipitants	  and	  organics	  -­‐	  to	  be	  analyzed	  simultaneously	  for	  their	   ability	   to	   promote	   crystal	   growth	   in	   small	   drops.	   These	   types	   of	   screens	  typically	   produce	   hits,	   allowing	   initial	   crystallization	   to	   be	   optimized	   using	   the	  hanging	  drop	  method,	  which	   is	  amenable	   to	   larger	  drops	  hanging	   from	  a	  cover	  slip	  and	  typically	  produce	  larger	  crystals	  with	  improved	  diffraction.	  
2.15	  X-­‐ray	  diffraction	  theory	  
2.15.1	  Symmetry	  and	  the	  unit	  cell	  lattice	  In	  1912	  William	  Lawrence	  Bragg	  discovered	  that	  the	  angle	  in	  which	  diffracted	  beams	  emerge	  from	  a	  crystal	  is	  related	  to	  the	  spacing	  of	  equivalent	  planes	  of	  atoms	  (Bragg,	  1913).	   This	   is	   important	   because	   it	   is	   the	   planes	   within	   the	   repeating	   unit	   of	   the	  crystal	   that	   allow	   the	   conditions	   for	   diffraction	   to	   satisfy	   Bragg’s	   Law	   (see	   below).	  There	  exists	  numerous	  planes	  within	  a	  crystal,	  and	  all	  planes	  are	  those	  defined	  by	  the	  faces	   of	   the	   three-­‐dimensional	  minimum	   repeating	   unit	   of	   the	   crystal,	   the	   unit	   cell.	  The	   dimensions	   of	   the	   unit	   cell	   are	   defined	  by	   six	   parameters,	   the	   lengths	   of	   three	  unique	  edges	  a,	  b	  and	  c;	  and	  three	  unique	  angles	  α	  β	  and	  ϒ	  (Figure	  28).	  	  The	   three-­‐dimensional	   stacking	   of	   the	   unit	   cells	   define	   the	   lattice	   planes	   in	   three	  directions	   or	   three	   axes,	   in	  which	   the	  a	   vector	   defines	   the	   x	   axis	   of	   the	   lattice	   and	  similarly	  the	  y	  and	  z	  axes	  are	  formed	  in	  the	  b	  and	  c	  directions	  respectively.	  The	  lattice	  planes	   of	   the	   unit	   cell	   and	   all	   others	   can	   be	   thought	   of	   as	   equally	   spaced	   parallel	  planes,	  which	  can	  cut	  into	  the	  lattice	  planes	  and	  crucially	  contribute	  to	  the	  conditions	  of	  diffraction	  (discussed	  below).	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  Figure	  28.	  Schematic	  showing	  a	  orthorhombic	  unit	  cell,	  with	  edges	  a,	  b,	  c	  and	  angles	  α,	  β,	  and	  ϒ.	  The	  figure	  was	  adapted	  from	  Crystallography	  made	  Crystal	  Clear	  –	  Gale	  Rhodes.	  	  These	   a,	   b	   and	   c	   axes	   underlie	   the	   three	   Miller	   indices	   (hkl),	   which	   identify	   a	  particular	  set	  of	  equivalent	  parallel	  planes	  within	  a	  unit	  cell	  and	  can	  be	  thought	  of	  as	  defining	  how	  many	  planes	  exist	   and	   their	  direction,	  or	   alternatively,	   the	  number	  of	  parts	  into	  which	  the	  set	  of	  planes	  cut	  the	  edge	  surface	  of	  each	  unit	  cell.	  For	  example	  a/1,	  a/2	  a/3	  or	  b/1,	  b/2,	  b/3	  etc.	  The	  whole	  number	  describes	  how	  many	  times	  the	  same	  equivalent	  plane	  cuts	  at	  the	  a,	  b	  or	  c	  vectors	  and	  are	  therefore	  characterised	  as	  the	  a/h,	  b/k,	  c/l	  pieces	  (Figure	  29).	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  Figure	  29.	  Schematic	  of	  an	  orthorhombic	  unit	  cell	  with	  the	   intersection	  (022)	  of	   two	  planes.	  a	   into	  0	  parts,	   b	   into	   two	   equivalent	   parts,	   and	   c	   into	   two	   equivalent	   parts.	   The	   figure	   adapted	   from	  Crystallography	  made	  Crystal	  Clear	  –	  Gale	  Rhodes.	  	  The	   overall	   symmetry	   of	   the	   unit	   cell	   is	   fundamental	   to	   assigning	   the	   unit	   cell	  dimensions.	  The	  proper	  assignment	  of	  the	  unit	  cell	  is	  that	  which	  provides	  the	  highest	  symmetry	  given	  by	   the	  Bravais	   lattice,	   and	  describes	   the	  geometric	  arrangement	  of	  the	  lattice	  points,	  and	  thereby	  the	  translational	  symmetry	  of	  the	  crystal	  (Mois	  et	  al.,	  2006).	  Because	   there	  are	   theoretically	   several	  different	  ways	   to	  define	   the	  unit	   cell	  from	   one	   particular	   lattice,	   the	   working	   unit	   cell	   that	   is	   most	   symmetrical	   for	   the	  atomic	  arrangement	  of	   the	  crystal	   should	  be	  chosen.	  The	  simplest	  cell	   contains	  one	  lattice	   point	   and	   is	   designated	   primitive	   and	   with	   the	   addition	   of	   body	   and	   face	  centered	  cells,	  there	  are	  13	  allowable	  lattices	  (Mois	  et	  al.,	  2006)	  (Figure	  30).	  	  	  	  
	  76	  
	  Figure	  30.	  Centered	  and	  non-­‐centered	  cubic	  unit	  cells.	  Cubic	  primitive	  (P),	  body-­‐centered	  or	   internal	  (I),	  and	  face	  centered	  (F)	  unit	  cells.	  The	  figure	  was	  adapted	  from	  Crystallography	  made	  Crystal	  Clear	  –	  Gale	  Rhodes.	  
	  Table	   2.	   The	   seven	   crystal	   systems.	   The	   table	   was	   adapted	   from	   Biomolecular	   Crystallography	   -­‐	  Bernard	  Rupp	  	  Designation	  of	  the	  space	  group,	  which	  describes	  both	  overall	  and	  internal	  symmetry,	  is	  achieved	  by	  a	  symbol	  (for	  example	  P21).	  This	  symbol	  assigns	  the	  type	  of	  lattice	  by	  the	  capital	  letter.	  The	  first	  number	  describes	  the	  point	  group	  or	  rotational	  symmetry	  operations	  –	  without	  translational	  contributions	  -­‐	  of	  the	  crystal	  system.	  The	  subscript	  number	  assigns	  additional	  screw	  symmetry	  operations	  of	  the	  unit	  cell.	  The	  allowable	  symmetry	   operations	   governed	   by	   the	   point	   group	   must	   be	   compatible	   with	   the	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translational	   requirements	   for	   a	   specific	   lattice.	   The	   simplest	   symmetry	   operations	  are	   translation	   and	   rotation	   (only	   2,	   3,	   4	   or	   6	   fold).	   Combinations	   of	   these	   can	  produce	   screw	   axes	   and	   glide	   planes.	   Because	   of	   the	   chiral	   nature	   of	   biological	  molecules	  symmetry	  operations	  such	  as	  mirror	  planes	  and	  inversion	  centres	  are	  not	  allowed.	  	  The	  allowed	  symmetry	  operations	  of	  a	  point	  group	  within	  the	  crystal	  lattice	  that	  can	  be	  carried	  out	  without	  changing	  the	  appearance	  of	  the	  unit	  cell	  dictate	  which	  one	  of	  the	  seven	  systems	  the	  crystal	  relates	  to	  (Table	  2).	  The	  asymmetric	  unit	  (AU)	  is	  the	   smallest	   element	   within	   the	   unit	   cell	   that	   upon	   application	   of	   symmetry	  operations	  defined	  by	  the	  space	  group	  can	  generate	  the	  entire	  crystal	  structure.	  
2.15.2	  Diffraction	  basics	  
2.15.2.1	  X-­‐ray	  waves	  X-­‐rays	  are	  electromagnetic	  waves	   that	   consist	  of	   electromagnetic	   radiation	  and	   can	  be	   described	   as	   a	   self-­‐propagating	   transverse	   oscillating	   waves	   of	   electric	   and	  magnetic	  fields,	  which	  are	  always	  in	  phase	  with	  each	  other	  (Figure	  31).	  	  	  
	  Figure	  31.	  Schematic	  of	  an	  X-­‐ray	  wave	  (electric	  field).	  The	  electric	  field	  oscillates	  perpendicular	  to	  the	  propagation	  vector	  So,	  and	  has	  a	  magnitude	  of	  λ.	  At	  any	  point	  of	  the	  wave	  the	  position	  can	  be	  expressed	  with	  reference	  to	  the	  periodic	  origin	  node	  in	  terms	  of	  phase	  shift	  Δφ	  ranging	  from	  0	  to	  2π	  (in	  units	  of	  radians	   or	   rad,	   1	   rad	   =	  !"#! 	  degrees).	   The	   figure	   was	   adapted	   from	   Biomolecular	   Crystallography	   -­‐	  Bernard	  Rupp.	  	  The	  aim	  of	  an	  X-­‐ray	  diffraction	  experiment	  is	  to	  produce	  an	  X-­‐ray	  diffraction	  pattern.	  The	  intensity	  and	  positions	  of	  the	  reflections	  (spots)	  within	  this	  pattern	  are	  used	  as	  the	  raw	  data	  to	  calculate	  an	  electron	  density	  map,	   in	  which	  an	  atomic	  model	  can	  be	  fitted.	  The	  experiment	  is	  complete	  when	  the	  model	  is	  refined	  to	  match	  the	  observable	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data	  as	  closely	  as	  possible.	  It	  is	  imperative	  to	  have	  an	  understanding	  of	  the	  way	  X-­‐ray	  radiation	   interacts	  with	  the	  molecules	  within	  the	  crystal	  at	  an	  atomic	   level	   in	  order	  for	  this	  to	  be	  carried	  out.	  	  The	  way	   in	  which	   the	   atom	  scatters	   the	  X-­‐rays	   is	   important	   for	   the	   resultant	  X-­‐ray	  photon	  to	  become	  detectable	  and	  produce	  a	  reflection	  (spot).	  When	  X-­‐ray	  radiation	  collides	   with	   an	   atom	   the	   electrons	   oscillate	   and	   emit	   secondary	   waves.	   If	   the	  oscillation	   is	   at	   a	   frequency	   identical	   to	   that	   of	   the	   first	   electromagnetic	   wave	   the	  result	   is	   the	   emission	   of	   radiation	   of	   a	   wavelength	   and	   frequency	   identical	   to	   the	  incident	   waves.	   This	   is	   called	   elastic	   scattering.	   However	   if	   the	   electron	   accepts	  momentum	  from	  the	  incoming	  photon	  the	  result	  is	  that	  the	  wavelength	  of	  the	  emitted	  secondary	  wave	  will	   have	   increased.	   This	   is	   called	   inelastic	   scattering.	   	   The	  waves	  emitted	   from	  elastic	   scattering	   interfere	  with	  each	  other	  and	  give	   rise	   to	   the	  Bragg	  reflection,	  which	  is	  detected	  in	  the	  diffraction	  pattern.	  Most	  of	  the	  X-­‐rays	  go	  straight	  through	  the	  crystal	  and	  the	  incident	  beam	  is	  hardly	  reduced.	  	  	  
	  	  Figure	  32.	  Schematic	  of	  X-­‐ray	  scattering	  by	  an	  atom.	  The	  scattering	  vector	  of	  partial	  waves	  emanating	  from	  a	  two-­‐electron	  system	  ρ(r)	  of	  an	  atom.	  The	  red	  shading	  shows	  the	  spherically	  symmetric	  electron	  density.	   The	   two	   incoming	   X-­‐ray	   photons	  S0	  at	  wavelength	   λ,	   emanating	   from	  O	   and	  P,	  will	   each	   be	  scattered	  by	  one	  electron	  and	  diffract	  with	  the	  same	  angle	  of	  incidence	  S1,	  but	  will	  have	  different	  path	  lengths.	   The	   path	   difference	   Δp	  between	   the	   lower	   path	   through	  O	   and	   the	   shorter	   upper	   path	   P	   is	  given	  by	  the	  difference	  between	  scalar	  vector	  products	  𝒓 ∙ 𝑺𝟎	  and	  𝒓 ∙ 𝑺𝟏.  The	   figure	  was	  adapted	   from	  Biomolecular	  Crystallography	  -­‐	  Bernard	  Rupp	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2.15.2.2	  Scattering	  of	  an	  atom	  When	   considering	   a	   two-­‐electron	   system	  with	   one	   electron	   located	   at	   the	   origin	   O	  and	  the	  other	  at	  P,	   the	  distance	  between	  them	  is	  r	   (Figure	  32).	  The	  scattering	  of	  X-­‐rays	   by	   an	   electron	   is	   fundamental	   to	   the	   diffraction	   process.	   Partial	  waves,	  which	  emanate	  from	  the	  ring	  of	  electrons	  within	  the	  atom,	  have	  phase	  differences	  due	  to	  the	  electric	   field	  vector	  of	   the	  photon	  scattering	   from	  electrons	   in	   the	  back	  of	   the	  atom	  and	  those	  in	  the	  front.	  The	  path	  length	  can	  be	  calculated	  by	  the	  following	  equation.	  	  	  	  	   	   	   	   	   	   Equation	  1.1	  Δ𝑝 = 𝐒𝟏 −   𝐒𝟎 ∙ 𝐫𝜆 = 𝐒   ∙ 𝐫𝜆	  	  	  	  	  The	  phase	  difference	   caused	  by	   the	  path	  differences	  of	   the	  diffracted	  waves	   can	  be	  expressed	  by:	  	  	   	   	   	   	   	   Equation	  1.2	  Δ𝜑 = 2𝜋 𝐒𝟏 −   𝐒𝟎 ∙ 𝒓 =   2𝜋𝐒 ∙ 𝐫	  	  Where	   	  	   	  𝐒 = (𝐒𝟏 − 𝐒𝟎)	  	  Equation	   1.2	   introduces	   the	   term	   S,	   which	   is	   the	   scattering	   vector.	   The	   scattering	  vector	  is	  the	  vector	  difference	  between	  incoming	  and	  scattered	  wave	  vector	  (Figure	  33	  and	  34).	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  Figure	   33.	   Schematic	   showing	   the	   relationship	   between	   S1,	  S0	   and	   S.	   The	   figure	   was	   adapted	   from	  Biomolecular	  Crystallography	  -­‐	  Bernard	  Rupp.	  	  The	  atomic	  scattering	  factor	  is	  a	  measurement	  of	  the	  scattering	  angle	  of	  the	  atom	  and	  is	   dependent	   on	   the	   number	   and	   position	   of	   electrons	   within	   the	   electron	   cloud.	  Representation	   of	   all	   partial	   emanating	  waves	   from	   the	   atom	   results	   in	   a	   complete	  wave	   integrated	  over	   the	   total	  volume	  of	   the	  electron	  cloud.	  Therefore	  each	  partial	  wave	  emanating	  from	  ρ(r)	  is	  an	  exponential	  wave	  vector	  exp(iφ)	  with	  relative	  phase	  difference	  φ=2πSr.	  	  	   	   	   	   	   	   Equation	  1.3	  
𝐹! = 𝑓! =    𝜌(!  (!"#$)! 𝐫) exp 2𝜋𝑖𝑺𝒓 𝑑𝒓	  	  The	  Fs	  function	   is	   the	  atomic	  scattering	   factor,	  which	  describes	   the	  scattering	  of	   the	  entire	  electron	  cloud	  of	  the	  atom	  as	  a	  function	  of	  the	  scattering	  direction	  or	  angle.	  As	  the	   scattering	   angle,	   2θ,	   increases	   there	   is	   increasing	   destructive	   interference	  between	  the	  X-­‐rays	  scattered	  by	  different	  parts	  of	  the	  electron	  cloud	  and	  the	  intensity	  of	  the	  scattered	  X-­‐rays	  will	  decrease	  with	  increasing	  scattering	  angle.	  The	  Fs	  function	  is	   proportional	   to	   the	   square	   root	   of	   the	   intensity	   of	   the	   scattered	   X-­‐ray	   photons	  recorded	  within	  the	  X-­‐ray	  diffraction	  pattern.	  	  From	   equation	   1.3	   it	   can	   be	   seen	   that	   the	   Fourier	   transform	   (FT)	   of	   the	   electron	  density	  ρ(r)	  of	  the	  atom	  is	  fs,	  so	  therefore	  the	  atomic	  scattering	  factor	  has	  the	  form	  of	  an	   integral.	   This	   concept	   is	   important	   when	   considering	   the	   superposition	   of	   all	  partial	  waves	   from	  all	  atoms	   in	  a	  molecule	  and	  can	  be	  applied	   to	  calculate	  electron	  density	  of	  an	  entire	  crystal	  structure.	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2.15.2.3	  Bragg’s	  Law	  of	  diffraction	  It	   was	   mentioned	   earlier	   that	   the	   angle	   at	   which	   diffracted	   waves	   emerge	   from	   a	  crystal	  is	  related	  to	  the	  spacing	  of	  equivalent	  planes	  of	  atoms	  within	  the	  crystal.	  The	  Bragg	   equation	   expresses	   X-­‐ray	   diffraction	   as	   reflections	   of	   incident	   X-­‐rays	   from	  planes	  of	  atoms	  within	  the	  crystals	  lattice.	  In	  figure	  34	  it	  can	  be	  seen	  that	  the	  incident	  angle	   of	   the	   approaching	   wave	   equals	   the	   angle	   of	   reflection,	   and	   the	   angle	   of	  diffraction	   from	   multiple	   equivalent	   parallel	   planes	   waves	   is	   dependent	   on	   the	  distance	  between	  these	  planes.	  This	  is	  known	  as	  the	  Bragg	  Law	  of	  diffraction.	  	  	   	   	   	   	   	   Equation	  1.4	  𝑛λ = 2𝑑!!"   sin𝜃  	  Where	  𝜃=angle	   incident	   radiation	   makes	   with	   lattice	   planes,	   d	   =	   distance	   between	  lattice	  planes,	  λ	  =	  wavelength	  and	  n	  is	  an	  integer.	  	  From	  the	  equation	  1.4	  and	  figure	  34	  it	  can	  be	  seen	  that	  Bragg’s	  Law	  is	  only	  satisfied	  when	  n	  is	  an	  integer,	  in	  that	  the	  additional	  distance	  travelled	  by	  B	  between	  the	  planes	  is	  an	  integral	  multiple	  of	  the	  wavelength	  and	  therefore	  wave	  A	  and	  B	  (Figure	  34),	  will	  interfere	   coherently	   to	   produce	   a	   strong	   diffracted	   X-­‐ray	   beam	   (Bragg,	   1913).	   For	  other	   angles	   of	   incidence,	   which	   do	   not	   satisfy	   this	   Law,	   waves	   emerging	   from	  successive	  planes	  are	  out	  of	  phase	  and	  will	  cause	  destructive	  interference.	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  Figure	   34.	   Schematic	   of	   Bragg’s	   Law	   of	   diffraction.	   Representation	   of	   X-­‐ray	   diffraction	   as	   partial	  reflections	   from	   two	   separate	   sets	   of	   planes	   within	   a	   crystal	   allows	   interpretation	   of	   the	   Bragg	  equation.	  The	  two	  excited	  partial	  waves	  have	  total	  path	  difference	  of	  2𝑑!!" ∙ sin𝜃,	  which	  must	  always	  equal	   to	   maximum	   of	   n	   for	   maximum	   constructive	   interference.	   The	   figure	   was	   adapted	   from	  Biomolecular	  Crystallography	  -­‐	  Bernard	  Rupp.	  
2.15.2.4	  Scattering	  of	  an	  entire	  molecule	  The	   scattering	   factor	   of	   an	   entire	   molecule	   is	   the	   superposition	   of	   the	   partial	  scattering	  contribution	  from	  each	  atom	  j.	  In	  equation	  1.3	  ρ(r)	  represents	  the	  electron	  density	  at	  point	  r	  and	  the	  integration	  is	  carried	  out	  over	  the	  entire	  space	  r.	  However	  many	   atoms	   at	   positions	   rj	   within	   a	   unit	   cell	   contribute	   to	   the	   scattering	   from	   an	  entire	  molecule.	  The	  partial	  wave	  summation	  with	  respect	  to	  the	  origin	  describes	  the	  scattering	  of	  the	  unit	  cell	  and	  is	  given	  by	  the	  equation:	  	   	   	   	   	   	   Equation	  1.5	  
𝐅𝐒 =    𝑓!"!!"#$%!!! ∙ exp  (2𝜋𝑖𝑺𝒓𝒋)	  	  Where	  Fs	  is	  the	  scattering	  function	  or	  structure	  factor	  of	  an	  entire	  molecule.	  	  The	   term  𝑓!"! 	  is	   the	  scattering	   factor	  of	  atom	  j.	  The	  atom	  j	   is	  still	   treated	  as	  a	  simple	  sphere	  of	  an	  electron	  density.	   	  The	  scattering	   function	  of	  a	  molecule	  will	  eventually	  repeat	   in	   certain	   directions	   of	   the	   crystal.	   In	   the	   direction	   a,	   the	   phase	   difference	  between	  unit	  cells	  is	  given	  by	  2πSa.	  The	  scattering	  function	  in	  direction	  a	  is:	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   Equation	  1.6	  
𝐅𝐬𝐚 =    𝐅!!"##!!!!!! ∙ exp  (2𝜋𝑖(𝑢𝐒𝐚)	  	  The	  scattering	  function	  of	  an	  entire	  crystal	  will	  repeat	  in	  certain	  directions	  along	  the	  three	  lattice	  directions	  due	  to	  translational	  equivalents,	  u	  in	  a,	  v	  in	  b,	  and	  w	  in	  c.	  For	  instance	   the	   002	   planes	   along	   the	   c	   axis	  will	   be	   repeated	   in	   the	   adjacent	   unit	   cell.	  Where	  these	  repeats	  are	  exact	  integers	  along	  the	  unit	  cell	  vectors	  and	  have	  the	  same	  phase,	  where	  S	  =	  integers	  u,	  v,	  w	  along	  the	  respective	  axis	  the	  vectors	  Fs	  will	  add	  up	  in	  exactly	   the	   same	   direction.	   These	   are	   known	   as	   the	   Laue	   conditions.	   The	   total	  scattering	  is	  therefore	  amplified	  proportionally	  with	  increasing	  number	  of	  repeating	  units	  and	  is	  expressed	  by	  three	  sumations:	   	   	   	   	   	   	  	   	   	   	   	   	   Equation	  1.7	  
𝐅𝐬𝒄𝒓𝒚𝒔𝒕 = 𝐅𝐬𝒄𝒆𝒍𝒍 ∙    𝐅𝐬𝒄𝒆𝒍𝒍!!!!!! ∙ exp  (2𝜋𝑖(𝑢𝐒𝐚) ∙    𝐅𝐬𝒄𝒆𝒍𝒍
!!!
!!! ∙ exp  (2𝜋𝑖(𝑣𝐒𝐛) ∙    𝐅𝐬𝒄𝒆𝒍𝒍
!!!
!!! ∙ exp  (2𝜋𝑖(𝑤𝐒𝐜)	  	  	  Laue	  conditions	  are	  created	  when	  𝐚 ∙ 𝑺	  is	  equal	  to	  an	  integer	  h,	  𝐛 ∙ 𝑺	  an	  integer	  k	  and	  𝐜 ∙ 𝑺	  an	  integer	  l	  and	  no	  scattering	  is	  observed	  from	  a	  crystal	  unless	  these	  conditions	  are	  obeyed.	  These	  diffraction	  conditions	  form	  the	  basis	  of	  the	  Bragg	  equation	  and	  can	  be	  written	  to	  derive	  the	  following	  relationship	  equation:	  	   	   	   	   	   	   Equation	  1.8	  𝒅∗ = 1𝑑!!" 	  	  Where	  d*	   is	  equal	  to	  the	  reciprocal	   lattice	  vector	  that	   is	  perpendicular	  to	  the	   lattice	  plane	   in	   real	   space,	   and	   defined	   in	   length	   as	  !!	  (the	   reciprocal	   of	   the	   inter	   planer	  distance	   vector	   dhkl).	   The	   length	   of	   this	   vector	   is	   designated	   as	   a*	   b*	   c*	   for	   the	  respective	  planes.	  The	  reciprocal	  lattice	  is	  a	  second	  theoretical	  lattice,	  which	  consists	  of	  axes,	  which	  are	  collinear	  with	  the	  real	  space	  axes	  of	  a	  unit	  cell	  and	  are	  designated	  
a*	  b*	  and	  c*,	  so	  a*	  =	  !!.	  
2.15.2.5	  Ewald	  sphere	  Together	  with	  the	  construction	  of	  the	  Ewald	  sphere	  the	  reciprocal	   lattice	  is	  a	  useful	  concept	   and	   permits	   understanding	   of	   how	   certain	   reflections	   from	   sets	   of	   planes	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satisfy	  Bragg’s	  Law	  and	  produce	  a	  reflection,	  which	  can	  be	  measured	  by	  a	  detector.	  The	  Ewald	  sphere	   is	  created	  with	  radius	  !!  	  where	  λ	   is	  wavelength	  of	   the	   incident	  X-­‐ray	   beam	   So	   passing	   through	   crystal	   C	   at	   its	   centre	   towards	   O,	   the	   origin	   of	   the	  reciprocal	  lattice	  at	  its	  surface	  (Figure	  35).	  	  
	  Figure	  35.	  Schematic	  of	  Bragg	  diffraction	  in	  reciprocal	  space.	  S1	  emerges	  from	  the	  crystal	  when	  lattice	  point	  P	  intersects	  the	  Ewald	  sphere.	  More	  intersects	  come	  into	  contact	  with	  the	  sphere	  as	  the	  crystal	  is	  rotated.	  The	  figure	  was	  adapted	  from	  Biomolecular	  Crystallography	  -­‐	  Bernard	  Rupp.	  	  By	   rotating	   the	   crystal	   about	   B,	   reciprocal	   lattice	   points	   dhkl	   with	   indices	   hkl	   are	  brought	  into	  contact	  with	  the	  circle	  of	  radius	  !!.	  When	  this	  happens	  the	  lines	  OP	  and	  BP	  can	  be	  drawn.	  The	  angle	  of	  BPO	  is	  θ.	  	  	  The	   direction	   of	   the	   diffracted	   X-­‐ray	   beam	   is	   described	   by	   the	   line	   BP.	   The	   line	  represents	  a	  plane	   in	   the	   set	   that	   reflect	   the	  X-­‐ray	  beam	  and	   lines	  parallel	   to	   it	   are	  separated	  an	  integral	  multiple	  of	  dhkl.	  If	  the	  wave	  vector	  S	  drawn	  is	  perpendicular	  to	  this	   plane	   and	   its	   endpoint	   is	   touching	   the	   surface	   on	   the	   sphere	   (at	   point	   P	   for	  example)	  then	  BP	  represents	  the	  scattered	  beam	  S1.	  The	  direction	  of	  the	  beam	  BP	  is	  given	  by	  the	  diverging	  beam	  at	  angle	  2θ	  and	  precisely	  takes	  it	  through	  point	  P.	  	  	  With	  the	  purpose	  of	  collecting	  a	  full	  set	  of	  reflections	  from	  the	  diffracting	  crystal	  for	  structural	   determination,	   it	   is	   necessary	   to	   bring	   all	   lattice	   points	   of	   the	   reciprocal	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lattice	  into	  contact	  with	  the	  Ewald	  sphere.	  This	  is	  achieved	  by	  rotating	  the	  crystal	  so	  that	  all	  lattice	  points	  satisfy	  diffracting	  conditions	  on	  the	  surface	  of	  the	  Ewald	  sphere.	  	  
2.15.2.6	  Calculating	  electron	  density	  From	  a	  crystal	  irradiated	  with	  X-­‐rays	  in	  a	  given	  direction	  h	  the	  scattering	  function	  is	  given	  by	  a	  complex	  structure	  factor	  Fh.	  The	  structure	  factor	  amplitudes	  are	  directly	  obtainable	  from	  measured	  reflections,	  as	  the	  amplitude	  of	  Fhkl	   is	  proportional	  to	  the	  square	  root	  of	   the	  reflection	   intensity	   Ihkl.	  Fourier	   integration	  of	   the	  scattering	   from	  all	  electrons	  within	  the	  unit	  cell	  is	  given	  by	  the	  following	  modification	  eqauation	  1.5:	  	  	   	   	   	   	   	   Equation	  1.9	  
𝐅(𝐬) =    𝜌 𝐫 ∙ exp 2𝜋𝑖𝐒𝐫 𝑑𝑟!  (!"##)! 	  	  The	  fractional	  coordinates	  x,	  y,	  z	  of	  the	  unit	  cells	  and	  V	  the	  volume	  can	  be	  expressed	  by	  dv.	  Where	  ρ(r)	  is	  the	  electron	  density	  at	  point	  r	  within	  the	  unit	  cell.	  	  The	  direction	   of	   scattering	   is	   added	   to	   this	   equation	  with	   the	   reciprocal	   and	  direct	  space	  positions.	  	  	   	   	   	   	   	   Equation	  2.0	  𝐒 = ℎ𝐚∗ + 𝑘𝐛∗ + 𝑙𝐜∗	  	  	   	   	   	   	   	   Equation	  2.1	  At	  position	  	   𝐫 = 𝑥𝐚+ 𝑦𝐛+ 𝑧𝐜	  	  	   	   	   	   	   	   Equation	  2.2	  Giving	  	   𝐒𝐫 = 𝒉𝒙 = 𝒌𝒚 = 𝒍𝒛	  	  	  The	  complex	  structure	  factor	  F(h),	   is	   the	  Fourier	  transform	  which	  can	  be	  computed	  from	  the	  contents	  of	  the	  crystallographic	  unit	  cells	  by	  summation	  of	  scattered	  partial	  waves	  emanating	  from	  all	  atoms	  in	  the	  unit	  cell,	  where	  ρ(x,	  y,	  z)	  is	  the	  position	  of	  the	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atoms	  real	  space	  electron	  density	  at	  point	  x,	  y,	  z.	  This	  is	  then	  integrated	  in	  real	  space	  over	  the	  entire	  unit	  cell	  (in	   fractional	  coordinates)	  and	  allows	  the	  calculation	  of	   the	  diffraction	  pattern	  using	  equation	  2.4.	  	   	   	   	   	   	   Equation	  2.3	  




!!! 	  	  With	  a	  back	  transformation	  reciprocal	  R’	  to	  real	  space	  R:	  We	  obtain.	  	  	  	   	   	   	   	   	   Equation	  2.4	  
𝑝 𝑥,𝑦, 𝑧 =    1𝑉 𝐅 ℎ𝑘𝑙 ⋅ exp(−2!!!!!!!!!!!!!!!!!! 𝜋𝑖(𝒉𝒙+ 𝒌𝒚+ 𝒍𝒛)	  	  Normalization	   of	   the	   volume	  !!	  preceding	   the	   discrete	   Fourier	   summation	   provides	  correct	  units	  of	  !!Å! 	  for	  the	  electron	  density.	  	  	  By	   separating	   the	   complex	   structure	   factor	   F(h)	   into	   an	   explicit	   amplitude	   term	  𝐹!  and	  phase	  angle	  𝛼!	  term	  using	  the	  Euler	  relation.	  	   	   	   	   	   	   	  	   	   	   	   	   	   Equation	  2.5	  𝐅(ℎ) = 𝐹! ⋅ exp  (𝑖𝛼!)	  And	  	   	   	   	   	   	   Equation	  2.6	  
𝜌 𝑥 = 1𝑉 𝑭! ⋅!!!!!!   exp  (  𝑖𝛼!) ⋅ exp  (−2𝜋𝑖 𝒉𝒙 )	  	  The	   Fourier	   coefficients	  𝑭! 	  given	   in	   this	   final	   form	   summation	   for	   the	   electron	  density	   include	   both	   the	   structure	   factor	   amplitude	   and	   its	   associated	   phase.	  However,	  these	  originate	  from	  different	  sources	  during	  X-­‐ray	  crystallographic	  work.	  
Fh	  is	  proportional	  to	  the	  intensity	  of	  the	  diffracted	  X-­‐rays	  and	  can	  thus	  be	  quantified	  from	   the	   X-­‐ray	   diffraction	   pattern.	  During	   an	   X-­‐ray	   diffraction	   experiment	   only	   the	  intensities	  of	  the	  diffracted	  waves	  are	  measured	  and	  the	  phases	  are	  lost.	  In	  order	  to	  compute	   ρ(x,y,z)	   fully	   the	   phase	   information	   (αhkl)	   must	   be	   recovered	   by	   different	  means	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2.15.3	  Data	  collection	  When	   preparing	   an	   X-­‐ray	   diffraction	   experiment,	   important	   consideration	   about	  crystal	  preparation,	  exposure	  of	  the	  crystal	  to	  X-­‐radiation	  and	  data	  collection,	  need	  to	  be	   carried	   out	   to	   ensure	   the	   amount	   and	   quality	   of	   data	   collected	   is	   sufficient	   for	  structure	  determination.	  	  
2.15.3.1	  Crystal	  mounting	  Successful	   data	   collection	   begins	   with	   proper	   harvesting,	   cryoprotection	   and	  mounting	  of	  the	  protein	  crystals.	  These	  steps	  are	  implemented	  to	  prevent	  mechanical	  destruction	  of	  the	  crystal	   lattice,	  and	  minimize	  radiation	  damage	  caused	  by	  ionising	  X-­‐rays.	  	  	  	  Capillary	  mounting	   and	   cryo-­‐mounting	   using	   a	   loop	   are	   two	   harvesting	   techniques	  employed	  to	  reduce	  these	  negative	  affects.	   	  Capillary	  mounting	  is	  the	  most	  common	  method	   for	   harvesting	   crystals	   for	   collecting	   diffraction	   data	   at	   room	   temperature.	  The	   capillary	   is	   used	   to	   suck	   up	   a	   crystal	   together	  with	   a	   droplet	   of	  mother	   liquor	  leaving	   just	   enough	   solvent	   around	   the	   surface	   of	   the	   crystal	   to	   keep	   the	   crystal	  hydrated	  and	  provide	  some	  surface	  tension	  to	  adhere	  the	  crystal	  to	  the	  inner	  wall	  of	  the	   capillary.	   The	   benefits	   of	   capillary	   mounting	   are	   important	   if	   problems	   occur	  during	  cryo-­‐cooling,	  such	  as	  damage	  to	  the	  crystal	  lattice	  during	  freezing,	  which	  can	  lead	  to	  an	  unacceptable	  increase	  in	  anisotropy,	  mosaicity	  and	  poor	  diffraction.	  	  	  Exposing	   crystals	   to	   X-­‐rays	   at	   room	   temperature	   can	   rapidly	   result	   in	   primary	   and	  secondary	  radiation	  damage,	   leading	  to	  the	  formation	  of	   free	  radicals	  from	  both	  the	  macromolecules	  within	  the	  crystal	  and	  the	  solvent.	  The	  integrity	  of	  the	  repeating	  unit	  of	  the	  crystal	  is	  compromised	  by	  free	  radicals	  directly	  altering	  the	  protein,	  or	  altering	  the	  surrounding	  solvent,	  changing	  the	  size	  of	  the	  unit	  cell,	  which	  rapidly	  destroys	  the	  quality	  of	  the	  diffraction.	  	  Preserving	  crystals	  at	  cryogenic	  temperatures	  throughout	  the	  data	  collection	  process	  reduces	  the	  diffusion	  of	  free	  radicals	  through	  the	  crystal	  caused	  by	  collecting	  data	  at	  room	   temperature,	   particularly	   at	   the	   high	   intensity	   synchrotron	   sources	   and	   can	  dramatically	  increase	  the	  amount	  and	  quality	  of	  the	  data	  obtainable.	  This	  means	  that	  a	  full	  dataset	  can	  be	  collected	  from	  a	  single	  crystal.	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The	  routine	  method	  for	  harvesting	  crystals	  is	  by	  flash	  cooling	  crystals	  harvested	  by	  a	  nylon	  loop	  in	  liquid	  nitrogen	  at	  100K.	  In	  this	  method	  the	  crystal	  is	  harvested	  within	  a	  nylon	   loop	   and	   is	   directly	   quenched	   in	   liquid	   nitrogen	   if	   there	   is	   sufficient	   cryo-­‐protectant	  already	  in	  the	  mother	  liquor.	  Alternatively	  the	  loop	  containing	  the	  crystal	  is	   transferred	   in	   the	   correct	   percentage	   of	   a	   cryoprotectant	   and	   subsequently	   flash	  frozen	  in	  liquid	  nitrogen.	  The	  antifreeze	  properties	  of	  the	  cryo-­‐protectant	  prevent	  the	  mother	   liquor	  water	   from	   crystallizing	   around	   the	   surrounding	   area	   of	   the	   crystal,	  which	  invariably	  destroys	  the	  diffraction	  quality.	  The	  most	  common	  cryo-­‐protectants	  are	  glycerol,	  ethylene	  glycol,	  MPD,	  sucrose,	  and	  low	  molecular	  weight	  PEGs.	  	  
3.15.3.2	  X-­‐ray	  sources	  The	  reliable	  production	  of	  high	  intensity	  monochromatic	  X-­‐rays	  is	  a	  prerequisite	  for	  any	   X-­‐ray	   diffraction	   experiment.	   	   Generation	   of	   X-­‐ray	   radiation	   is	   commonly	  achieved	  using	  two	  modes:	  laboratory	  rotating	  anode	  generators	  and	  the	  synchrotron.	  Rotating	   anode	   sources	   produce	   X-­‐rays	   through	   electron	   bombardment	   of	   a	   metal	  target	  (most	  commonly	  copper).	  When	  a	  high-­‐energy	  electron	  collides	  with	  the	  target	  metal	  it	  displaces	  a	  core	  electron	  and	  a	  core	  hole	  is	  generated.	  Subsequently	  a	  higher	  orbital	  electron	  drops	  in	  to	  replace	  and	  it	  emits	  the	  excess	  energy	  as	  an	  X-­‐ray	  photon	  with	  a	  frequency	  characteristic	  of	  the	  metal	  target.	  	  	  Sources	   using	   metal	   targets	   such	   as	   copper	   or	   molybdenum	   will	   produce	   two	  emissions	   of	   distinct	   wavelengths.	   This	   is	   not	   suitable	   for	   X-­‐ray	   crystallography	  because	  this	  would	  result	  in	  two	  Ewald	  spheres	  at	  1/λ	  and	  two	  amalgamated	  sets	  of	  reflections.	  Monochromatic	  X-­‐rays	  (single-­‐wavelength)	  are	  produced	  by	  filtering	  out	  the	  secondary	  Kβ	  radiation.	  For	  copper-­‐rotating	  anode	  generators	  this	  is	  achieved	  by	  using	  nickel	   filters,	  which	  absorb	  strongly	  at	  the	  wavelength	  for	  the	  CuKβ	  emission,	  and	  allow	  transmission	  of	  CuKα.	  	  Synchrotron	   sources	   produce	   substantially	   higher	   intensity	  monochromatic	   X-­‐rays.	  	  The	  giant	  ring	  of	  the	  synchrotrons	  allows	  electrons	  or	  positrons	  to	  circle	  in	  an	  orbit	  with	   the	  effect	  of	   radiation	   loss.	  Electrons	  are	  produced	   in	  an	  electron	  gun	  and	  are	  pre-­‐accelerated	   in	  a	   linear	  accelerator,	  by	  high	  radio	   frequency	  electrical	   fields.	  The	  linear	  accelerator	   then	   injects	   these	  electrons	   into	   the	   storage	   ring	   in	  bunches,	   and	  they	   are	   further	   accelerated	   to	   nearly	   the	   speed	   of	   light.	   The	   electrons	   travel	   in	   a	  closed	  path	  in	  an	  ultra	  high	  vacuum	  and	  are	  maintained	  in	  circular	  motion	  by	  bending	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magnets	   and	   kept	   stable	   by	  multi-­‐pole	   steering	   electromagnets.	   The	   emission	   of	   X-­‐radiation	  occurs	  through	  deflection	  of	  accelerated	  electrons	  into	  a	  curved	  motion	  by	  the	  bending	  magnets.	  Even	  more	  powerful	  devices	  called	  undulators	  or	  wigglers	  use	  high	  alternating	  magnetic	  fields	  to	  wiggle	  electrons	  resulting	  in	  additional	  bending	  of	  the	  beam,	  which	  produces	  very	  intense	  and	  focused	  radiation.	  	  Monochromatic	   X-­‐rays	   are	   produced	  by	   focusing	   the	   polychromatic	   radiation	   (by	   a	  set	  of	  mirrors)	  onto	  a	  silicon	  crystal	  monochromator,	  which	  disperses	  the	  X-­‐rays	  by	  diffraction	   angle	   according	   to	   Braggs	   Law.	   Only	   the	   desired	  wavelength	   is	   selected	  through	  narrow	  slits	  into	  a	  collimator.	  The	  collimator	  also	  allows	  only	  parallel	  X-­‐rays	  with	  low	  divergence	  to	  exit,	  directed	  towards	  the	  sample	  crystal.	  	  The	   high	   flux	   of	   X-­‐ray	   photons	   and	   collimation	   of	   the	   beam	   produced	   from	  synchrotron	   radiation	  allows	  collection	  of	  weak	   reflections,	  which	  would	  otherwise	  be	   too	   weak	   to	   be	   collected	   using	   a	   laboratory	   X-­‐ray	   source,	   and	   dramatically	  increases	  speed	   in	  which	  the	  data	   is	  collected.	   In	  addition	  the	  optimal	   tuning	  of	   the	  beam	  size	  allows	  collection	  that	  optimizes	  the	  signal	  to	  noise	  ratio	  for	  micron	  or	  sub-­‐micron	  sized	  crystals	  and	  can	  reduce	  the	  consequences	  of	  radiation	  damage.	  
2.15.3.3	  Data	  processing	  Following	  data	  collection	  the	  images	  are	  processed	  to	  produce	  the	  hkl	  Miller	  indices	  and	  intensity	  of	  each	  reflection.	  The	  two	  programs	  used	  to	  process	  the	  reflections	  in	  the	  diffraction	  patterns	   produced	   in	   this	   project	  were	  MOSFLM	   (Leslie,	   2006)	   	   and	  XDS	   (Kabsch,	   2010).	   Parameters	   such	   as	   radiation	   wavelength,	   crystal	   to	   detector	  distance,	  oscillation	  angle	  and	  the	  position	  of	  the	  beam	  must	  be	  accurately	  recorded	  during	   data	   collection	   and	   input	   into	   the	   program.	   Indexing	   assigns	   reciprocal	   hkl	  miller	   indices	   to	   each	   reflection	   and	   also	   determines	   the	   space	   group,	   unit	   cell	  parameters	   and	   estimates	   the	   mosaicity	   of	   the	   crystal.	   Typically	   MOSFLM	   (Leslie,	  2006)	   uses	   two	   to	   four	   images	   all	   offset	   by	   90°	   to	   detect	   full	   reflections	  which	   are	  marked	  with	  a	   red	  cross,	  whilst	  partial	   reflections	  are	  yellow.	  The	  Fourier	   indexing	  algorithm	   lists	   the	   possible	   lattice	   types	   ranked	   by	   a	   penalty	   score.	   Each	   lattice	  produces	   coloured	   boxes,	   which	  mark	   the	   spot	   predictions	   according	   to	   the	   initial	  indexing.	  The	  correct	  lattice	  is	  chosen	  as	  the	  one	  with	  the	  highest	  symmetry	  and	  with	  spots	  falling	  into	  predicted	  spot	  positions.	  The	  mosiacity	  of	  the	  crystal	  is	  also	  adjusted	  to	  optimise	  the	  fit	  of	  the	  predicted	  and	  observed	  pattern.	  The	  mosiacity	  is	  a	  measure	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of	  the	  alignment	  of	  the	  unit	  cells	  within	  the	  crystal.	  A	  larger	  mosiacity	  value	  indicate	  a	  large	  distribution	  of	  mis-­‐orientation	  angles	  of	  the	  unit	  cells	  in	  the	  crystal	  and	  has	  the	  effect	   of	   broadening	   diffraction	   spots	   between	   slices	   as	   the	   crystal	   is	   rotated.	  Therefore,	  diffraction	  spots	  from	  crystals	  displaying	  high	  mosiacity	  will	  be	  observed	  in	  the	  diffraction	  condition	  longer	  than	  ones	  with	  low	  mosiacity.	  Over	  a	  wide	  rotation	  range	  each	  diffraction	  spot	  will	  be	  more	  likely	  to	  overlap	  with	  other	  diffraction	  spots	  and	  in	  such	  a	  case	  fine	  slicing	  may	  improve	  processing.	  Another	  additional	  problem	  is	  mosaicity	  of	  a	  crystal	  can	  also	  smear	  spots	  radially,	  that	  is	  along	  a	  line	  drawn	  from	  the	  spot	  to	  the	  center	  of	  the	  diffraction	  image.	  	  In	   the	   next	   stage	  MOSFLM	   refines	   the	   cell	   constants	   and	   experimental	   parameters,	  using	  around	  20-­‐25	   images.	  This	   then	   leads	   to	   the	   integration	  of	  all	  partial	  and	   full	  indexed	  intensities	  from	  all	  images	  with	  the	  refined	  unit	  cell	  parameters	  and	  correct	  mosiacity.	  The	   integrated	   intensities	   are	   then	  merged	   to	  produce	   a	   list	   of	   averaged	  intensities	  using	  the	  program	  SCALA	  (Evans,	  2006a),	  which	  also	  provides	  a	  number	  of	  useful	   statistics	   and	   analysis.	   Because	   of	   a	   variety	   of	   factors	   relating	   to	   detector,	  crystal	   and	   diffracted	   beam,	   and	   incident	   beam	   the	   volume	   intensities	   from	   each	  image	  in	  a	  data	  set	  are	  are	  not	  all	  on	  the	  same	  scale.	   	  These	  factors	  can	  be	  grouped	  together	   into	   a	   single	   correction	   factor	   dependent	   scale,	   or	   “BATCH	   SCALE”.	   Scala	  scales	   together	   multiple	   symmetry	   related	   observations	   of	   reflections,	   and	  merges	  multiple	   observations	   into	   an	   average	   intensity.	   The	   appropriate	   scales	   are	   applied	  when	  merging	  symmetry	  equivalent	  reflections,	   so	   that	  outliers	  can	  be	  rejected,	   for	  example	  those	  symmetry	  related	  reflections	  whose	  intensities	  are	  too	  different	  from	  the	  others.	  	  Together	  with	  the	  error	  associated	  with	  all	  compared	  measurements,	  and	  the	   agreement	   between	   multiple	   measurements	   of	   the	   same	   reflection	   SCALA	   can	  correctly	  measure	  the	  partiality	  of	  each	  reflection	  and	  convert	  this	  to	  an	  estimate	  of	  the	  reflections	  full	  intensity.	  All	  reflection	  intensities	  are	  then	  merged	  to	  produce	  an	  averaged	  intensity	  Ihkl	  and	  the	  quality	  of	  the	  data	  is	  analysed	  with	  various	  statistics.	  
2.15.3.4	  Completeness	  SCALA	   expresses	   the	   number	   of	   unique	   crystallographic	   reflections	  measured	   in	   a	  data	   set	   as	   the	   percentage	   of	   the	   total	   number	   of	   possible	   reflections	   present	   at	   a	  given	   resolution.	   The	   completeness	   is	   therefore	   the	   ratio	   between	   the	   total	   data	  theoretically	  possible	   in	  the	  AU	  of	  the	  reciprocal	  space	  and	  the	  number	  of	  observed	  unique	  reflections.	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2.15.3.5	  R-­‐merge	  This	  is	  a	  measure	  of	  agreement	  among	  multiple	  measurements	  of	  the	  same	  reflection,	  with	  different	  measurements	  being	  in	  different	  frames	  of	  data	  or	  different	  data	  sets.	  R-­‐merge	   being	   the	   traditional	   measure	   of	   agreement	   between	   observed	   and	  calculated	  data	  is	  poorly	  suited	  for	  determining	  the	  high	  resolution	  limit	  and	  current	  standard	  protocols	  discard	  much	  useful	  information.	  	  	  	   	   	   	   	   	   Equation	  2.7	  𝑅!"#$" =    |𝐼!(ℎ𝑘𝑙)!!!! − 𝐼(ℎ𝑘𝑙)|!!" 𝐼!   (ℎ𝑘𝑙)!!!!!!" 	  	  However	   the	  data	  quality	  R-­‐values	   are	  not	   comparable	   to	   the	  R	   values	   from	  model	  refinement	  and	  recently	  a	  statistic	  that	  estimates	  the	  correlation	  of	  an	  observed	  data	  set	   with	   the	   underlying	   (not	  measurable)	   true	   signal;	   CC*,	   has	   been	   introduced	   to	  provide	  a	  single	  statistically	  valid	  guide	   for	  deciding	  which	  data	  are	  useful	  (Karplus	  and	  Diederichs,	  2012).	  
2.15.3.6	  Multiplicity	  Overlapping	  symmetry	  related	  and	  equivalent	  reflections	  contribute	  to	  redundancy	  in	  a	   crystallographic	   data	   set.	   Multiplicity	   therefore	   calculates	   average	   number	   of	  independent	   measurements	   of	   each	   reflection	   in	   a	   crystallographic	   data.	   The	  symmetry	  of	  the	  crystal	  results	   in	  the	  presence	  of	  equivalent	  reflections	  in	  different	  regions	   of	   reciprocal	   space,	   and	   also	   overlapping	   regions	   of	   the	   three-­‐dimensional	  diffraction	  pattern,	  resulting	  in	  multiple	  measurements	  of	  the	  same	  reflection.	  	  
2.15.4	  Non	  crystallographic	  symmetry	  (NCS)	  Local	  symmetry	  is	  present	  when	  more	  than	  one	  identical	  object	  is	  present	  in	  the	  AU.	  Identical	  molecules	   exhibiting	   symmetry	   relationships,	   other	   than	   those	   connected	  with	  crystal	  symmetry	  do	  not	  display	  additive	  diffractive	  contributions.	  By	  knowing	  and	  applying	  the	  non-­‐crystallographic	  relationship	  of	  these	  molecules	  in	  the	  unit	  cell	  the	   experimentally	   phased	   electron	   density	   maps	   can	   be	   used	   to	   add	   the	   signals	  together	  and	   improve	  the	  signal	   to	  noise	  ratio	  and	  map	  quality	  within	  the	  AU.	  Non-­‐crystallographic	  symmetry	  restraints	  can	  be	  applied	  throughout	  the	  refinement.	  	  
2.15.5	  Molecular	  Replacement	  Molecular	   replacement	   (MR)	   is	   a	   way	   of	   calculating	   the	   phases	   of	   the	   protein	  structure	   under	   study	   using	   a	   model	   of	   a	   known	   related	   structure.	   Typically	   the	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known	  structure	  needs	  to	  have	  30%	  or	  higher	  sequence	  identity.	  In	  MR	  the	  structure	  is	   rotated	  and	   translated	   in	   the	  unit	  cell	  or	  AU	  so	   that	   the	  model	  molecule	   is	   in	   the	  same	  orientation	  and	  position	  in	  the	  unit	  cell	  as	  the	  unknown	  molecule.	  	  	  The	   phases	   are	   then	   calculated	   from	   the	   positioned	  model	   and	   combined	  with	   the	  measured	  Fobs	  obtained	   from	  the	  diffraction	   intensities	  measured	   from	  the	  crystal.	  Six-­‐dimensional	  molecular	  replacement	  searches	  or	  the	  so	  called	  brute	  force	  methods,	  break	  the	  orientation	  of	  the	  model	  into	  three	  angles	  of	  rotation	  about	  the	  orthogonal	  axes	  x,	  y	  and	  z,	  with	  their	  origins	  at	   the	  centre	  of	   the	  model	  and	  search	  all	  possible	  orientations	   along	   each	   translational	   grid	   point.	   However	   searching	   with	   three	  rotational	   and	   three	   translational	   degrees	   of	   freedom	   of	   an	   entire	   macromolecule	  with	  the	  present	  computing	  power	  is	  impractical	  because	  the	  sheer	  numbers	  of	  trials	  are	  too	  great.	  	  	  A	  more	  computationally	  efficient	  method	  takes	  apart	  the	  6-­‐dimensional	  searches	  into	  a	   more	   efficient	   3-­‐dimensional	   rotation	   search,	   followed	   by	   a	   3-­‐dimensional	  translational	  search	  once	  the	  correct	  rotation	  has	  been	  solved.	  The	  rotational	  search	  is	  allowed	  because	   it	   is	  possible	   to	  search	   for	   the	  best	  orientation	   independently	  of	  location	   using	   the	   Patterson	   function.	   The	   Patterson	   function	   is	   essentially	   the	  Fourier	   transform	  of	   the	   intensities	   rather	   than	   the	   structure	   factors	   and	  describes	  both	   a	   set	   of	   intra	   and	   intermolecular	   vectors,	   which	   are	   unique	   for	   each	   protein,	  however	  related	  proteins	  have	  similar	  vector	  distributions.	  	  	  	  By	  rotating	  the	  Paterson	  map	  of	  the	  known	  structure	  around	  the	  origin	  in	  the	  unit	  cell	  using	  three-­‐dimensional	  rotational	  searches	  the	  intramolecular	  distance	  vectors	  can	  be	  compared	  and	  depend	  only	  on	  the	  orientation	  of	  the	  molecule,	  not	  its	  translational	  position.	   The	   rotation	   function	   can	   therefore	   be	   used	   to	   determine	   the	   highest	  correlation	   between	   the	   intramolecular	   Patterson	   vectors	   for	   various	   model	  orientations	  and	  compare	  them	  with	  the	  Patterson	  map	  of	  the	  desired	  protein.	  	  Once	   the	   orientation	   of	   the	   molecule	   has	   been	   found	   it	   can	   then	   be	   translated	   to	  search	  for	  the	  best	  position,	  by	  correlating	  the	  observed	  intensities	  and	  the	  Patterson	  map	   intermolecular	   vectors	   using	   the	   symmetry-­‐related	   molecules	   of	   the	   known	  structure	  as	  it	  is	  moved	  within	  the	  cell.	  
	  93	  
It	  should	  be	  noted	  that	  because	  phases	  contain	  more	  information	  than	  intensities	  and	  the	   electron	   density	   reconstruction	   is	   generated	   entirely	   from	   the	   phases	   from	   the	  replaced	  search	  model,	  the	  electron	  density	  map	  is	  highly	  susceptible	  to	  model	  bias.	  There	   are	   various	   Fourier	   syntheses	   available	   to	   generate	  maps	   to	  minimize	  phase	  bias	  and	  improve	  the	  model;	  these	  are	  discussed	  below.	  
2.15.6	  Model	  building	  and	  refinement	  Once	  initial	  phases	  have	  been	  obtained	  an	  electron	  density	  map	  can	  be	  created,	  and	  the	  process	  of	  building	  a	  model	  into	  the	  map	  can	  be	  undertaken.	  This	  is	  not	  too	  much	  of	  a	  problem	  with	  accurate	  phases	  and	  high	  resolution,	  however	  at	  lower	  resolution	  model	  building	  becomes	  more	  challenging	  and	  it	  is	  important	  when	  building	  a	  model	  into	  poor	  maps	  to	  avoid	  introducing	  into	  the	  electron	  density	  any	  model	  bias.	  	  If	  the	  phases	  are	  good	  enough	  to	  create	  an	  interpretable	  mapi	  t	  is	  possible	  to	  begin	  to	  fit	   amino	   acid	   residues	  manually	   using	  model	   building	   programmes	   such	   as	   COOT	  (Emsley	  and	  Cowtan,	  2004)	  or	  by	  using	  automated	  model	  building	  programmes	  such	  as	   BUCCANEER	   (Cowtan,	   2006).	   This	   entails	   many	   cycles	   of	   adjusting	   the	   atomic	  coordinates	   to	   improve	   the	  agreement	  between	  amplitudes	   from	  the	  current	  model	  and	  the	  original	  measured	  amplitudes	  in	  the	  native	  data	  set.	  	  Global	   reciprocal	   space	   restrained	   refinement	   is	   carried	   out	   throughout	   the	  model	  building	   process	   of	   the	  model	   and	   aims	   to	   improve	   the	   agreement	   of	   the	   observed	  and	   calculated	   structure	   factor	   amplitudes	   (Fobs	   –	   Fcalc).	   After	   the	   experimental	  phases	  have	  been	  used	  to	  generate	  the	  initial	  map,	  subsequent	  phases	  are	  calculated	  from	  the	  refined	  model	  itself,	  using	  the	  reverse	  Fourier	  transform.	  Depending	  on	  the	  quality	   of	   the	   initial	  map	   these	   phases	   should	   be	  more	   accurate	   and	  more	   density	  should	  appear,	  improving	  the	  quality	  of	  the	  electron	  density	  maps	  for	  the	  next	  round	  of	  building.	  	  During	  refinement,	  restraints	  are	  applied	  to	  the	  movement	  of	  atoms	  in	  the	  molecule	  based	  on	  local	  stereochemical	  and	  conformational	  parameters,	  and	  B	  factors.	  Overall	  parametres	  are	  also	  applied,	   such	  as	  scale	   factor	  and	  overall	  B	  factors,	  bulk	  solvent	  corrections,	  and	  anisotropy	  corrections.	  These	  are	  all	  refined	  against	  all	  experimental	  data	   to	   produce	   the	   best	   agreement	   between	   the	   observed	   structure	   factor	  amplitudes	  and	  model	  structure	  factor	  amplitudes.	  
	  94	  
	  To	  overcome	  incorrect	  phases	  dominating	  the	  electron	  density	  reconstruction	  2Fobs-­‐Fcalc	  maps	  are	  created	  to	  let	  the	  intensity	  data	  influence	  improvement	  of	  the	  model.	  This	  helps	  to	  overcome	  any	  model	  bias	  that	  may	  be	  generated	  from	  the	  use	  of	  simple	  Fobs	   maps.	   2Fobs-­‐Fcalc	   maps	   highlight	   regions	   of	   the	   model	   that	   are	   inconsistent	  with	  the	  observed	  structure	  factors	  amplitudes.	  	  The	   more	   widely	   used	   Sigma	   A	   figure	   of	   merit	   weighted	   map	   (2mFo-­‐DFc)	   is	   the	  maximum	  likelihood	  estimate	  of	  the	  full	  model	  map	  (i.e.	  the	  best	  map	  possible)	  or	  its	  simple	   modification	   of	   2Fo-­‐Fc	   map	   where	   Fo/Fc	   are	   replaced	   by	   their	   maximum	  likelihood	  estimates	  for	  each	  model	  phase	  (m),	  and	  of	  atomic	  coordinate	  errors	  in	  the	  current	  model	   (D),	  which	   is	   the	  most	  accurate	  way	   to	   reveal	   the	  ambiguities	  which	  are	  in	  conflict	  with	  the	  current	  model.	  	  Difference	   maps	   are	   calculated	   by	   subtracting	   the	   calculated	   structure	   factor	  amplitudes	  (|Fcalc|)	   from	  some	  multiple	  of	  the	  observed	  amplitudes	  (|Fobs|)	  within	  each	  Fourier	  term.	  The	  difference	  between	  each	  term	  is	  highlighted	  in	  the	  difference	  electron	   density	  maps	   (Fobs-­‐Fcalc),	   depending	   on	  whether	   Fobs	   or	   Fcalc	   is	   larger.	  Resulting	   in	   either	   negative	   or	   positive	   density.	   Positive	   density	   corresponds	   to	  regions	  where	  more	   electron	  density	   should	  be	  present	   than	   implied	  by	   the	  model	  and	  negative	  density	  implies	  the	  opposite.	  	  This	  allows	  changes	  to	  be	  made	  to	  the	  model	  in	  an	  iterative	  manner,	  aiming	  each	  time	  to	   improve	   the	   agreement	  between	   the	  Fobs	   and	  Fcalc.	  The	  quality	  of	   the	  model	   is	  assessed	  after	  each	  round	  of	  refinement.	  This	  is	  based	  on	  a	  pair	  of	  statistics	  known	  as	  Rfactor	  and	  Rfree,	  which	  are	  calculated	  by	  the	  following	  equation.	  	  	   	   	   	   	   	   Equation	  2.9	  𝑅 =    |𝐹!"#(ℎ𝑘𝑙)!!" −   𝐹!"#!(ℎ𝑘𝑙)|𝐹!"#(ℎ𝑘𝑙)!!" 	  	  R-­‐free	   and	   Rfactor	   compare	   the	   overall	   agreement	   between	   the	   amplitudes	   of	   the	  model	   and	   native	   data.	   The	   agreement	   between	   observed	   and	   calculated	   data	  improves	  as	  the	  accuracy	  of	  the	  model	  increases,	  and	  therefore	  the	  R	  factor	  decreases.	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Because	  the	  Rfactor	  statistic	  can	  be	  made	  arbitrarily	  low	  for	  models	  having	  sufficient	  parameters	  to	  overfit	  the	  data,	  Brunger	  introduced	  Rfree	  (Brunger,	  1992).	  The	  Rfree	  is	   calculated	   in	   the	  same	  manner	  as	   the	  Rfactor,	  but	   is	  based	  only	  on	  a	  small	   set	  of	  randomly	  chosen	  intensities;	  usually	  5%	  are	  set	  aside	  and	  not	  used	  during	  refinement.	  The	   Rfree	   measures	   how	   well	   the	   model	   can	   predict	   this	   subset	   of	   the	   measured	  reflection	  intensities	  and	  if	  the	  model	  is	  genuinely	  correct	  the	  Rfree	  should	  agree	  with	  the	  Rfactor,	  which	  has	  used	  the	  remaining	  95%	  of	  the	  data.	  The	  final	  values	  for	  the	  R	  factors	  are	  dependent	  on	  the	  resolution	  of	  the	  data	  and	  a	  desirable	  target	  R-­‐factor	  for	  a	  protein	  model	  refined	  with	  data	  to	  2.5	  Å	  is	  around	  0.2.	  Once	  the	  Rfactor	  and	  Rfree	  cannot	   be	   improved	   any	   further	   by	   alteration	   and	   refinement,	   the	   model	   must	   be	  validated	  before	  being	  finalised.	  MOLPROBITY	  (Davis	  et	  al.,	  2004)	  is	   just	  one	  server	  that	  can	  carry	  out	  validation	  on	  a	  structure.	  This	  service	  highlights	  bad	  contacts	  and	  unrealistic	  geometry	  in	  both	  side	  chains	  and	  main	  chains.	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3.	  Chapter	  3	  -­‐	  Structural	  determination	  and	  functional	  analysis	  of	  the	  CCHFV	  N	  
protein	  
3.1	  Introduction	  	  	  	  
• CCHFV	   is	   a	   tick-­‐borne	   zoonotic	   virus	   responsible	   for	   serious	   human	   disease	  characterized	  by	  haemorrhagic	  manifestations	  and	  multiple	  organ	  failure,	  and	  is	  associated	  with	  a	  fatality	  rate	  of	  up	  to	  50%	  (1,	  2).	  	  	  
• CCHFV	  is	  a	  member	  of	  the	  Bunyaviridae	  family,	  and	  together	  with	  members	  of	  the	   Arenaviridae	   and	   Orthomyxoviridae	   families	   these	   viruses	   are	   known	   as	  segmented	  negative	  sense	  RNA	  viruses	  (sNSV)	  by	  virtue	  of	  their	  multistranded	  genomes.	  	  	  sNSVs	  genomes	  do	  not	  exist	  as	  naked	  RNAs,	  but	  instead	  are	  encapsidated	  by	  the	  viral	  N	  protein	   to	   form	  RNP	  complexes.	  RNPs	  associate	  with	   their	   cognate	  RdRp	   to	   form	  active	   templates	   for	   viral	   RNA	   synthesis,	   resulting	   in	   generation	   of	   encapsidated	  replication	  products	  and	  unencapsidated	  mRNAs.	  RNP	  formation	  is	  thus	  essential	  for	  virus	  multiplication,	  and	  therefore	  represents	  a	  potential	  therapeutic	  target.	  	  The	   objective	   of	   this	   project	   was	   to	   express	   and	   purify	   homogeneous	   CCHFV	   N	  protein	   for	   X-­‐ray	   crystallography	   analysis.	   This	   was	   firstly	   achieved	   by	   finding	   a	  suitable	  recombinant	  expression	  tag	  and	  E.	  coli	  strain	  in	  which	  to	  produce	  abundant	  and	   soluble	   CCHFV	   N	   protein.	   Next	   Ni-­‐Superflow	   Plus	   resin	   using	   His6	   trap	  methodology	  was	  used	  to	  purify	  the	  CCHFV	  N	  recombinant	  protein	  away	  from	  E.	  coli	  contaminants.	  SEC	  was	  employed	  to	  look	  at	  the	  oligomeric	  state	  of	  the	  native	  CCHFV	  N	   protein,	   and	   purify	   the	   CCHFV	   N	   protein	   into	   a	   homogeneous	   state	   suitable	   for	  crystallization	  trials.	  Crucially	  for	  solving	  the	  atomic	  structure	  of	  the	  CCHFV	  N	  protein,	  this	   project	   required	   growing	   reproducible	   CCHFV	  N	  native	   protein	   crystals,	  which	  diffracted	  to	  high	  resolution,	  and	  a	  means	  to	  obtain	  phases.	  	  The	  aim	  of	  this	  project	  was	  to	  implement	  X-­‐ray	  crystallography	  to	  understand	  better	  the	  structural	  and	  functional	  roles	  of	  the	  CCHFV	  N	  protein,	  such	  as	  RNA	  binding	  and	  oligomerization.	  This	  will	  then	  aid	  in	  the	  design	  of	  experiments	  and	  functional	  assays	  to	  support	  these	  findings	  and	  crucially	  elucidate	   important	  targets	   for	  rational	  drug	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design	  to	  inhibit	  important	  process	  crucial	  to	  the	  virus	  life	  cycle,	  offering	  therapeutic	  interventions	  to	  the	  treat	  the	  disease	  (Wade,	  1997).	  
3.2	  Cloning	  
3.2.1	  Constructing	  the	  His6-­‐SUMO	  CCHFV	  N	  ORF	  expression	  plasmid	  The	   project’s	   first	   key	   objective	   was	   to	   create	   a	   plasmid	   construct,	   designed	   to	  express	  the	  CCHFV	  N	  protein	  fused	  to	  both	  small	  ubiquitin-­‐related	  modifier	  (SUMO)	  (type3)	   and	   His6	   tag	   via	   the	   N-­‐terminus	   (Figure	   36).	   The	   SUMO	   tag	   was	   used	   to	  overcome	  any	  expression	  and	  solubility	  issues,	  which	  are	  common	  when	  expressing	  recombinant	   mammalian	   protein	   in	   bacterial	   cells,	   whilst	   the	   His6	   tag	   was	  implemented	  for	  affinity	  purification	  purposes,	  before	  eventual	  cleavage	  of	  the	  His6-­‐SUMO	  moiety	   using	   the	   SUMO	   protease	   to	   yield	   the	   near	   native	   CCHFV	   N	   protein	  (Figure	  36).	  
	  Figure	  36.	  Schematic	  of	  the	  pET28a-­‐SUMO	  CCHFV	  N	  expression	  construct.	  Designed	  to	  express	  CCHFV	  N	  protein	  N-­‐terminally	  fused	  to	  His6	  and	  SUMO,	  and	  containing	  a	  SUMO	  protease	  cleavage	  site.	  SUMO	  protease	  cleavage	  site	  is	  shown	  boxed.	  	  
3.2.2	  Cloning	  of	  pet28a-­‐SUMO	  plasmid	  Initial	   cloning	   aimed	   to	   create	   a	   construct	   suitable	   for	   expression	   of	   His6-­‐SUMO	  CCHFV	  N	  protein	  in	  E.	  coli.	  This	  involved	  using	  PCR	  to	  amplify	  the	  CCHFV	  N	  gene	  from	  an	  existing	  pET28a	  clone	  containing	  the	  CCHFV	  cDNA	  ORF,	  whilst	  flanking	  the	  5’	  and	  3’	  ends	  with	  BamHI	  and	  XhoI	  sites	  respectively.	  These	  sites	  would	  then	  be	  utilized	  to	  ligate	   the	   amplified	   gene	   into	   the	   multiple	   cloning	   site	   of	   the	   expression	   plasmid	  pET28a-­‐SUMO,	  using	  compatible	  ends.	  The	  position	  of	  the	  5’	  end	  BamHI	  site	  enables	  the	   CCHFV	  N	   protein	   to	   be	   N-­‐terminally	   flanked	   by	   the	   SUMO	  moiety	   and	   His6	  tag	  when	   expressed	   and	   after	   purification	   allows	   subsequent	   cleavage	   of	   this	   moiety	  using	  SUMO	  protease,	  whilst	  leaving	  only	  a	  serine	  on	  the	  N-­‐terminal	  of	  the	  CCHFV	  N	  protein.	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  PCR	   amplification	   of	   the	   CCHFV	  N	   cDNA	   gene	   fragment	   using	   forward	   and	   reverse	  primers	   (appendix)	   was	   confirmed	   by	   analyzing	   the	   reaction	   sample	   using	   1%	  agarose	  gel	  electrophoresis,	  which	  revealed	  a	  band	  of	  approximately	  1500	  bp,	  which	  corresponded	  to	  the	  expected	  size	  of	  the	  CCHFV	  N	  cDNA	  gene	  (1497	  bp)	  (Figure	  37A).	  Before	  BamHI	   and	  XhoI	   restriction	   enzymes	  were	   added	   to	   produce	   the	   respective	  sticky	   ends	   flanking	   the	   CCHFV	   N	   cDNA	   required	   for	   ligation	   the	   PCR	   was	  concentrated	  using	  a	  clean	  up	  column	  (Zymo	  Research).	  	  To	   introduce	   compatible	   ends	   into	   the	   pET28-­‐SUMO	   plasmid	   single	   digestion	  reactions	  using	  BamHI	   and	  XhoI	   enzyme	  respectively	  were	   implemented	   to	  confirm	  each	   enzyme	   was	   working	   sufficiently	   (Figure	   37B).	   The	   single	   digestion	   of	   the	  pET28a-­‐SUMO	   plasmid	   was	   analyzed	   using	   agarose	   gel	   electrophoresis	   and	   the	  activity	  of	  each	  enzyme	  was	  confirmed	  by	  the	  change	  in	  migration	  from	  supercoiled	  to	   linear	   species	   of	   pET28a-­‐SUMO	   cDNA	   (Figure	   37B).	   The	   pET28a-­‐SUMO	   plasmid	  and	   PCR	   fragment	   were	   subsequently	   double	   digested	   with	   both	   BamHI	   and	   XhoI	  digestion	   enzymes	   and	   the	   band	   corresponding	   to	   the	   cleaved	   plasmid	   and	   PCR	  fragment	  were	  respectively	  gel	  purified	  to	  be	  finally	  cleaned	  up	  in	  a	  gel	  extraction	  kit.	  Ligation	   of	   the	   double	   digested	   PCR	   fragment	   containing	   the	   CCHFV	  N	   gene	   in	   the	  pET28-­‐SUMO	  was	  successful	  and	  DNA	  sequencing	  confirmed	  the	  un-­‐mutated	  CCHFV	  N	  ORF	  was	  cloned	  into	  the	  correct	  position	  within	  the	  pET28a-­‐SUMO	  vector.	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  Figure	  37.	  PCR	  amplification	  of	   the	  CCHFV	  N	  cDNA	  from	  pET28a	  and	   ligation	   in	  the	  multiple	  cloning	  site	  of	  pET28a-­‐SUMO.	  1%	  agarose	  gel	  electrophoresis	  analysis	  of	  single	  and	  double	  restriction	  digest	  of	  the	  pET28-­‐SUMO	  plasmid	  using	  XhoI	  and	  BamHI	  enzymes.	  (A)	  DNA	  markers	  (Bioline)	  (Lane	  S),	  Double	  digested	  pET28a-­‐SUMO	  (Lane	  1),	  PCR	  amplification	  of	  the	  CCHFV	  N	  cDNA	  (Lane	  2).	  Single	  digestions	  were	  carried	  out	  to	  test	  the	  activity	  of	  each	  enzyme.	  (B)	  DNA	  markers	  (Bioline)	  (Lane	  S),	  Supercoiled	  pET28a-­‐SUMO	   plasmid	   (Lane	   1),	   Single	   digestion	   of	   the	   pET28a-­‐SUMO	   using	   the	  BamHI	   restriction	  enzyme	  (Lane	  2),	  Single	  digestion	  of	  the	  pET28a-­‐SUMO	  using	  the	  XhoI	  restriction	  enzyme	  (Lane	  3).	  	  
3.3	  CCHFV	  N	  protein	  expression	  and	  purification	  
3.3.1	  Expression	  of	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  in	  E.	  coli	  BL21	  (DE3)	  cells	  Expression	   screens	  were	   initially	  made	   to	   determine	   the	   ability	   of	   different	  E.	   coli	  cells	  to	  express	  the	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein.	  The	  expression	  of	  His6-­‐SUMO	  CCHFV	  N	   fusion	   protein	  was	   tested	   by	   screening	   200	  ml	   LB	   induced	  with	   200	  µM	  IPTG	  overnight	  at	  30	  °C	  with	  Rosetta,	  Rosetta2,	  Gold	  and	  Star	  E.	  coli	  BL21	  (DE3)	  cells,	  which	   were	   transformed	   with	   the	   pET28a-­‐SUMO	   CCHFV	   N	   plasmid.	   The	   CCHFV	   N	  protein	  was	   expressed	   abundantly	   using	   Rosetta	   and	   Rosetta2	   cells.	   No	   significant	  expression	  of	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  was	  seen	  whilst	  inducing	  in	  the	  Star	  or	  Gold	  cells	  (Figure	  38).	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  Figure	   38.	   Analysis	   of	   expression	   of	   His6-­‐SUMO	  CCHFV	  N	   protein.	   By	   screening	   a	   range	   of	   bacterial	  expression	  cells	  transformed	  with	  pET28a-­‐SUMO	  CCHFV	  N	  and	  induced	  with	  IPTG.	  SDS-­‐PAGE	  analysis	  followed	  by	  Coomassie	  stain	  of	  whole	  cell	  lysates	  of	  Gold	  BL21	  (DE3)	  cells	  (Lane	  1),	  Star	  BL21	  (DE3)	  cells	  (Lane	  2),	  Rosetta	  BL21	  (DE3)	  cells	  (Lane	  3),	  and	  Rosetta2	  BL21	  (DE3)	  cells	  (Lane	  4).	  Molecular	  weight	  markers	  (kDa)	  (Lane	  S).	  	  Comparison	   of	   cultures	   transformed	   with	   pET28a-­‐SUMO	   CCHFV	   N	   and	   an	   empty	  pET28a-­‐SUMO	   plasmid	   confirmed	   the	   identity	   of	   a	   unique	  ~70	   kDa	   species,	  which	  expressed	  abundantly	   in	   the	  Rosetta2	   cells	   (Figure	  39),	   and	  matched	   closely	   to	   the	  expected	  molecular	  weight	  of	  the	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein.	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  Figure	  39.	  Analysis	  of	  His6-­‐SUMO	  CCHFV	  N	  protein	  expression	  in	  Rosetta2	  E.	  coli	  cells	  using	  a	  negative	  control.	   (A)	   SDS-­‐PAGE	   followed	   by	   Coomassie	   stain	   of	   whole	   cell	   lysate	   of	   Rosetta2	   E.	   coli	   cells	  transformed	  with	  pET28a-­‐SUMO	  CCHFV	  N	  and	  induced	  with	  IPTG	  (Lane	  1)	  and	  pET28-­‐SUMO	  plasmids	  and	  induced	  with	  IPTG	  (Lane	  2).	  Molecular	  weight	  markers	  (kDa)	  (Lane	  S).	  	  
3.3.2	  Solubility	  of	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  It	  was	  found	  that	  cultures	  induced	  at	  30	  °C,	  with	  200	  mM	  IPTG,	  expressed	  completely	  insoluble	   protein	   for	   both	   Rosetta	   and	   Rosetta2	   expression	   cells	   (Figure	   40).	   The	  solubility	  of	  the	  Rosetta,	  and	  Rosetta2	  expressed	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  was	  assessed	  by	  analyzing	  soluble	  and	  insoluble	  fractions	  using	  SDS-­‐PAGE.	  CCHFV	  N	  protein	   solubility	   was	   best	   achieved	   by	   inducing	   cultures	   with	   200	   µM	   IPTG	  overnight	  at	  18	  °C	  (Figure	  41).	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  Figure	  40.	  Analysis	  of	   soluble/insoluble	   fractions	  of	  Rosetta	  and	  Rosetta2	  E.	  coli	  cells	  expressing	   the	  His6-­‐SUMO	  CCHFV	  N	  protein.	  Using	  SDS-­‐PAGE	   followed	  by	  Coomassie	   stain.	   (A)	  The	   soluble	   fraction	  (Lane	   1),	   and	   insoluble	   fraction	   (Lane	   2)	   of	   Rosetta2	   cells	   induced	   with	   200	   mM	   IPTG	   at	   30	   °C.	  Molecular	  weight	  markers	   (kDa)	   (Lane	   S).	   (B)	   The	   soluble	   fraction	   (Lane	   1),	   and	   insoluble	   fraction	  (Lane	  2)	  of	  Rosetta	  cells	  induced	  with	  200	  μM	  IPTG	  at	  30	  °C,	  Molecular	  weight	  markers	  (kDa)	  (Lane	  S).	  	  By	  comparison	  the	  Rosetta2	  bacterial	  cells	  expressed	  more	  soluble	  His6-­‐SUMO	  CCHFV	  N	   fusion	   protein	   than	   the	   Rosetta	   bacterial	   cells	   (Figure	   41),	   and	   therefore	   the	  Rosetta2	   E.	   coli	   cell	   line	   was	   implemented	   for	   all	   further	   expression	   experiments	  (Figure	  41).	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  Figure	  41.	  Analysis	  of	  solubility	  of	  His6-­‐SUMO	  CCHFV	  N	  protein	  expressed	  using	  Rosetta	  and	  Rosetta2	  expression	  E.	  coli	  cells.	  SDS-­‐PAGE	  followed	  by	  Coomassie	  stain	  analysis	  of	  soluble	  (Lanes	  1,	  3,	  5,	  and	  7),	  and	   insoluble	   fractions	   (Lanes	   2,	   4,	   6,	   and	   8)	   of	   200	   ml	   lysates	   from	   pET28-­‐SUMO	   CCHFV	   N	  transformed	  Rosetta	  and	  Rosetta2	  cells,	  induced	  with	  200	  μM	  IPTG	  at	  18	  °C.	  Molecular	  weight	  markers	  (kDa)	  (Lane	  S).	  	  	  
3.3.3	  Purification	  of	  CCHFV	  N	  protein	  with	  Ni-­‐Superflow	  Plus	  resin	  The	   soluble	   fraction	   from	   an	   induced	   200	  ml	   culture	   of	   Rosetta2	   was	   analyzed	   to	  determine	  to	  what	  degree	  the	  expressed	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  bound	  to	  nickel	   resin.	   The	   spin	   protocol	  was	   implemented	   in	   this	   case	   because	   only	   a	   small	  amount	  of	   soluble	   fraction	  was	  being	  analyzed.	  The	  majority	  of	   the	  expressed	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  successfully	  bound	  to	   the	  resin	  and	  was	  eluted	   from	  the	  spin	  column	  using	  500	  mM	  imidazole,	  whilst	  also	  being	  purified	  away	  from	  most	  of	  the	  non-­‐specific	  bound	  contaminants	  with	  washes	  using	  binding	  buffer	  and	  50	  mM	  imidazole	  washes	  (Figure	  42).	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  Figure	  42.	  Analysis	  of	  nickel-­‐affinity	  purification	  of	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  using	  the	  spin	  protocol.	  	  Fractions	  of	  the	  elution	  profile	  were	  analysed	  using	  SDS-­‐PAGE	  followed	  by	  Coomassie	  stain.	  Soluble	  fraction	  (Lane	  1),	  Insoluble	  fraction	  (Lane	  2),	  Flowthrough	  (Lane	  3),	  Binding	  buffer	  wash	  (Lane	  4),	   50	  mM	   imidazole	  wash	   (Lane	  5),	   500	  mM	   imidazole	   elution	   (Lane	  6),	  Molecular	  weight	  markers	  (kDa)	  (Lane	  S).	  	  	  
3.3.4	  Large-­‐scale	  purification	  of	  CCHFV	  N	  protein	  with	  Ni-­‐Superflow	  Plus	  resin	  Expression	   and	  purification	  of	   high	  quantities	   of	   protein	   suitable	   for	   crystallization	  trials	  was	  initially	  achieved	  with	  2	  L	  culture	  of	  Rosetta2	  bacterial	  cells	  containing	  the	  pET28a-­‐SUMO	   CCHFV	   N	   plasmid.	   For	   meeting	   the	   requirement	   of	   even	   higher	  quantities	   of	   His6-­‐SUMO	   CCHFV	   N	   fusion	   protein	   this	   was	   later	   increased	   to	   a	   6	   L	  culture.	   The	  majority	   of	   the	   soluble	   fraction	   containing	  His6-­‐SUMO	  CCHFV	  N	   fusion	  protein	  bound	   to	   the	  Ni-­‐Superflow	  Plus	   resin.	  After	  washes	  with	  binding	  buffer,	  50	  mM	   imidazole,	   90	  mM	   imidazole,	   and	   120	  mM	   imidazole,	   the	  majority	   of	   the	   non-­‐specific	  contaminants	  were	  removed.	  The	  His6-­‐SUMO	  CCHFV	  N	  fusion	  protein	  bound	  was	   eluted	   from	   the	   resin	   and	   purified	   away	   from	  most	   of	   the	   contaminants	   using	  300	  mM	  imidazole	  (Figure	  43).	  Typically	  the	  elution	  volume	  of	  the	  His6-­‐SUMO	  CCHFV	  N	   fusion	   protein	   was	   15-­‐20	   ml,	   which	   was	   dialyzed,	   cleaved	   with	   SUMO	   protease	  overnight	  and	  filtered	  to	  avoid	  precipitation	  when	  concentrating.	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  Figure	   43.	   Analysis	   of	   nickel-­‐affinity	   purification	   of	   His6-­‐SUMO-­‐CCHFV	   N	   fusion	   protein	   using	   Ni-­‐Superflow	   Plus	   resin.	   Fractions	   of	   the	   elution	   profile	   were	   analysed	   using	   SDS-­‐PAGE	   followed	   by	  Coomassie	   stain.	   SDS-­‐PAGE	   followed	   by	   Coomassie	   stain	   analysis	   of	   elution	   profile	   of	   soluble	   His6-­‐SUMO	  CCHFV	  N	  purified	  using	  the	  Ni-­‐Superflow	  Plus	  resin.	  Molecular	  weight	  markers	  (kDa)	  (Lane	  S).	  Insoluble	   fraction	   (Lane	   1),	   Flowthrough	   (Lane	   2),	   Binding	   buffer	  wash	   (Lane	   3),	   50	  mM	   imidazole	  wash	  (Lane	  4),	  90	  mM	  imidazole	  wash	  (Lane	  5),	  300	  mM	  imidazole	  elution	  (Lane	  6).	  	  	  
3.3.5	  Purification	  of	  CCHFV	  N	  protein	  using	  SEC	  Typically	   60-­‐100	   mg	   of	   CCHFV	   N	   protein	   from	   each	   2	   L	   culture	   was	   purified	   and	  concentrated	   to	   5	  ml,	  which	  was	   required	   for	   SEC.	   The	   SEC	   chromatogram	   elution	  profile	  of	  the	  CCHFV	  N	  protein	  produced	  three	  distinct	  peaks	  (Figure	  44A).	  The	  main	  peak	  2	  was	  calibrated	  to	  be	  approximately	  52	  kDa,	  which	  closely	  corresponded	  to	  a	  CCHFV	  N	  monomer	   (54	   kDa),	  whilst	   the	  much	   shallower	   and	   faster	   eluting	   species	  (peak	  1)	  was	  calibrated	  to	  be	  approximately	  107	  kDa,	  which	  corresponded	  to	  a	  dimer	  (108	  kDa).	   In	  addition	  the	  260/280	  nm	  ratio	  of	   the	  monomer	  peak	   indicated	  that	   it	  does	  not	  contain	  any	  nucleic	  acid,	  whilst	  the	  260/280	  nm	  ratio	  of	  the	  dimer	  indicated	  that	  it	   likely	  bound	  nucleic	  acid.	  Fractions	  corresponding	  to	  the	  center	  of	  both	  main	  peaks	  for	  both	  CCHFV	  N	  protein	  species	  were	  analyzed	  using	  SDS-­‐PAGE	  gel	  for	  purity	  (Figure	  44B).	  The	  native	  CCHFV	  N	  eluted	  with	  no	  apparent	  contamination	  from	  other	  non-­‐specific	  proteins	  brought	  through	  from	  the	  Ni-­‐Superflow	  Plus	  resin	  purification.	  Peak	  3	  corresponded	  to	  cleaved	  SUMO	  protease	  (Figure	  44A).	  
	  106	  
	  Figure	   44.	   Analysis	   of	   the	   CCHFV	   N	   protein	   using	   SEC.	   (A)	   Bacterially	   expressed	   fusion	   CCHFV	   N	  protein	  was	  purified	  by	  nickel-­‐affinity	  chromatography,	  after	  which	  the	  His6-­‐SUMO	  tag	  was	  removed	  by	  SUMO	  protease	  and	  applied	  to	  a	  Superdex	  S75	  gel	  filtration	  column	  at	  a	  flow	  rate	  of	  2.5	  ml	  min−1.	  The	  elution	  profile	  of	   the	  CCHFV	  N	  protein	   is	   shown	   in	  blue	  and	  dashed	  red	  at	  280	  nm	  and	  260	  nm	  wavelengths	  respectively.	  (B)	  SDS-­‐PAGE	  followed	  by	  Coomassie	  stain	  analysis	  of	  elution	  profile	  CCHFV	  N	  protein	  following	  purification	  using	  a	  Superdex	  S75	  gel	  filtration	  column.	  Orange	  lines	  indicate	  the	  peak	  2	  fractions	  analysed	  on	  SDS	  PAGE	  correspond	  to	  the	  S75	  elution	  profile.	  
3.4	  RNA	  Binding	  The	  RNA	  binding	  content	  of	  the	  CCHFV	  N	  monomer	  protein	  peak	  was	  analyzed	  using	  phenol/chloroform	  extraction,	  and	  subjected	  to	  electrophoresis	  on	  a	  1%	  agarose	  gel	  alongside	  ssRNA	  size	  markers.	  Controls	  for	  the	  experiment	  were	  also	  run	  in	  adjacent	  lanes	   and	   included	   running	   both	   RNA	   harvested	   from	   non-­‐RNase	   treated	   BUNV	  tetramer	   protein	   and	   RNase	   treated	   BUNV	   N	   tetramer	   protein.	   There	   was	   no	  apparent	   RNA	   harvested	   from	   the	   CCHFV	   N	   protein	   monomer	   peak	   (Figure	   45),	  whilst	  an	  expected	  sized	  band	  appeared	  from	  the	  non-­‐RNase	  treated	  BUNV	  tetramer	  protein	  peak	  (Mohl	  and	  Barr,	  2009).	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  Figure	   45.	   RNA	   binding	   analysis	   of	   the	   CCHFV	  N	   protein	   purified	   by	   SEC.	   RNA	  was	   harvested	   from	  purified	  CCHFV	  N	  protein	  monomers	  and	  subjected	  to	  electrophoresis	  on	  a	  1%	  agarose	  gel	  (Lane	  3),	  alongside	  ssRNA	  size	  markers	  (Lane	  S).	  Positive	  controls	  included	  non-­‐RNase	  treated	  BUNV	  N	  protein	  extracted	  from	  a	  SEC	  tetramer	  peak	  (Lane	  1),	  and	  the	  negative	  control	  included	  RNase	  treated	  BUNV	  N	  protein	   from	   the	   same	   SEC	   tetramer	   peak	   (Lane	   2).	   This	   figure	  was	   generated	  with	   the	   help	   of	   Dr.	  Cheryl	  Walter,	  University	  of	  Leeds.	  
3.5	  Crystallization	  of	  CCHFV	  N	  protein	  
3.5.1	  Factorial	  crystal	  screens	  Fractions	   collected	   from	   the	   centre	   of	   the	   SEC	  purified	   CCHFV	  N	  monomer	   protein	  peak	  were	  pooled	  together	  and	  concentrated	  until	  the	  concentration	  reached	  15	  mg	  ml-­‐1	   in	  approximately	  500	  µl	  volume.	  The	  concentration	  and	  purity	  of	   the	  CCHFV	  N	  protein	  was	  deemed	  sufficient	  to	  attempt	  crystallization	  trials	  using	  the	  sitting	  drop	  method.	   Crystals	   grew	   in	   0.2	   M	   magnesium	   acetate	   tetrahydrate,	   0.1	   M	   sodium	  cacodylate	  trihydrate	  pH	  6.5,	  20%	  w/v	  polyethylene	  glycol	  (PEG)	  8,000,	  (Figure	  46).	  
	  Figure	   46.	   Crystallization	   of	   CCHFV	   N	   protein	   using	   the	   sitting	   drop	   vapour-­‐diffusion	   method	   and	  carried	   out	   at	   25	   °C	   (Scale	   bar	   =	   15	   μm).	   Crystals	   grown	   in	   condition	   18	   from	   the	   crystal	   screen	  (Hampton	  Research)	  crystallization	  screening	  kit.	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3.5.2	  Optimization	  of	  factorial	  CCHFV	  N	  protein	  crystals	  To	   improve	   the	   quality	   of	   these	   crystals,	   several	   rounds	   of	   screening	   using	   the	  hanging	   drop	   method	   were	   carried	   out,	   using	   a	   range	   of	   PEGs,	   different	   buffers	  (MOPS,	  MES,	  BTP),	  and	  salts,	  and	  ultimately	  diffraction	  quality	  crystals	  were	  grown	  in	  0.2	  M	  NaCl,	  25%	  v/v	  PEG-­‐600,	  1	  M	  Bis-­‐Tris	  Propane	  (BTP)	  pH	  6.5	   (Figure	  47).	  The	  best	   drop	   ratio	   was	   found	   to	   be	   2.5	   μl	   of	   CCHFV	   N	   protein	   and	   2.5	   μl	   reservoir	  solution,	  using	  a	  CCHFV	  protein	  concentration	  of	  40	  mg	  ml-­‐1.	  
	  Figure	  47.	  Optimization	  of	  CCHFV	  N	  protein	  crystals	  using	  the	  hanging	  drop	  vapour-­‐diffusion	  method.	  Optimization	  produced	  crystals	  that	  diffracted	  to	  at	  least	  2.1	  Å	  and	  was	  carried	  out	  at	  25	  °C.	  Crystals	  were	  produced	   in	  drops	  containing	  0.2	  M	  NaCl,	  25%	  v/v	  PEG-­‐600,	  1	  M	  BTP	  pH	  6.5	  (Scale	  bar	  =	  150	  μm).	  
3.6	  X-­‐ray	  diffraction	  of	  CCHFV	  N	  protein	  crystals	  
3.6.1	  X-­‐Ray	  diffraction	  of	  factorial	  CCHFV	  N	  protein	  crystals	  Crystals	   grown	   using	   the	   sitting	   drop	   vapour-­‐diffusion	   method	   (Figure	   46),	   were	  analyzed	  for	  X-­‐ray	  diffraction	  at	  the	  Diamond	  Light	  source	  on	  beamline	  I02.	  Crystals	  diffracted	  to	  a	  maximum	  Bragg	  spacing	  of	  4.5	  Å	  and	  belonged	  to	  space	  group	  P212121,	  with	  unit-­‐cell	  parameters	  a	  =	  73.84,	  b	  =	  86,	  c	  =	  264.00	  Å,	  α=	  90°,	  β=	  90°	  γ=	  90°.	  This	  data	   set	  was	   indexed	  and	   integrated	  using	   the	  Xia2	  package	   (Kabsch,	  2010)	   (1994)	  from	  the	  Diamond	  synchrotron	  suite	  of	  automated	  programs.	  These	  data	  were	  scaled	  with	  a	  maximum	  Bragg	  spacing	  of	  4.5	  Å	  with	  an	  R-­‐merge	  of	  12%.	  In	  the	  P212121	  space	  group	  there	  are	  three	  CCHFV	  N	  proteins	  per	  AU	  with	  a	  solvent	  content	  of	  56%.	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3.6.2	  X-­‐Ray	  diffraction	  of	  optimized	  CCHFV	  N	  protein	  crystals	  The	  native	   data	   set	   used	   for	   structure	   solution	  was	   generated	   from	   crystals	   grown	  using	  the	  hanging	  drop	  vapour-­‐diffusion	  method,	  (Figure	  47).	  Freezing	  these	  crystals	  straight	   out	   of	   the	   drop	   was	   sufficient	   to	   give	   the	   best	   quality	   diffraction	   with	  maximum	  Bragg	  spacing	  of	  2.1	  Å	  diffraction	  (Figure	  48).	  The	  crystals	  belonged	  to	  the	  space	  C2,	  with	  unit-­‐cell	  parameters	  a	  =	  149.8,	  b	  =	  71.9,	  c	  =	  102.0	  Å,	  α=	  90°,	  β=	  111.2°,	  γ=	  90°.	   It	  was	   calculated	  by	   the	   strategy	   function	  within	   the	  MOSFLM	  package	   that	  rotating	   this	   C2	   space	   group	   crystal	   120°	   with	   0.5°	   oscillations	   was	   sufficient	   to	  collect	   a	   full	   X-­‐ray	   diffraction	   data	   set	   of	   the	   CCHFV	   N	   protein,	   and	   produced	   240	  images.	   This	   data	   set	   was	   indexed	   and	   integrated	   using	   MOSFLM	   package	   (Leslie,	  2006)	  and	  scaled	  using	  SCALA	  (Evans,	  2006b)	  from	  the	  CCP4	  suite	  (Winn	  et	  al.,	  2011).	  The	  data	  was	  scaled	  with	  a	  maximum	  Bragg	  spacing	  of	  2.1	  Å	  with	  an	  R-­‐merge	  of	  57%.	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  Figure	   48.	   X-­‐ray	   diffraction	   pattern	   of	   CCHFV	  N	   protein	   crystals.	   A	   0.2°ჼoscillation	   X-­‐ray	   diffraction	  pattern	  collected	  from	  beamline	  I04-­‐1	  using	  12,658	  eV	  X-­‐rays	  at	  wavelength	  0.9795	  Å	  with	  a	  Pilatus	  6M	  detector.	  Reflections	  are	  observed	  to	  beyond	  2.1	  Å.	  The	  insert	  boarded	  in	  red	  shows	  the	  zoomed	  in	  image	  (x2)	  of	  the	  diffraction	  pattern	  boxed	  in	  red.	  
3.7	  Self-­‐rotation	  analysis	  Self-­‐rotation	   functions	   were	   calculated	   with	   the	   MOLREP	   program	   (Vagin	   and	  Teplyakov,	   2010).	   The	   two	   strongest	   peaks	   κ=180°	   at	   (ϕ	   =	   180°)	   and	   (ϕ	  =	   0°)	   are	  derived	  from	  the	  crystallographic	  two-­‐fold	  symmetry	  axes.	  The	  two	  additional	  peaks	  observed	   on	   the	   κ=180°	   plot	   correspond	   to	   NCS	   twofold	   symmetry	   (Figure	   49).	  Considering	  the	  Matthews	  co-­‐efficient	  (2.38	  Å3	  Da-­‐1	  with	  48.35%	  solvent)	  (Matthews,	  1968),	   and	   in	   conjunction	   with	   the	   twofold	   NCS	   in	   the	   self-­‐rotation	   function,	   two	  CCHFV	  N	  protein	  molecules	  are	  likely	  to	  be	  present	  in	  the	  AU.	  There	  was	  no	  evidence	  of	   four	   fold	   or	   six	   fold	   crystallographic	   symmetry	   for	   κ=90°	   (Figure	   49)	   or	   κ=60°	  (data	  not	  shown).	  Tetrameric	  or	  hexameric	  complexes	  similar	  to	  those	  seen	  for	  other	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bunyaviruses	  do	  not	  appear	  to	  be	  present,	  unless	  a	  combination	  of	  AUs	  results	  in,	  for	  instance,	   a	   tetramer	   (Mohl	   and	   Barr,	   2009).	   It	   is	   also	   possible	   that	   apo	   CCHFV	   N	  protein	   does	   not	   oligomerize,	   or	   that	   the	   twofold	  NCS	   is	   unrelated	   to	   higher	   order	  RNP	  assemblies.	  
	  Figure	  49.	  Self-­‐rotation	  function	  calculated	  by	  MOLREP	  (Vagin	  and	  Teplyakov,	  2010)	  using	  the	  CCHFV	  N	  protein	  C2	  spacegroup	  crystals.	  Self-­‐rotation	  searches	  with	  κ=	  180°	  and	  κ=	  90°	  were	  used	  to	  identify	  twofold	  and	  fourfold	  rotation	  angles,	  respectively.	  
3.8	  Circular	  dichroism	  Analysis	   of	   the	   CD	   spectrum,	   displaying	   a	   characteristic	   positive	   band	   at	  ~190	   nm	  and	   the	   negative	   band	   at	   208	   nm,	   suggested	   a	   predominately	   α-­‐helical	   content	  (Figure	  50).	  The	  high	  proportion	  of	  α-­‐helices	  in	  the	  CCHFV	  N	  protein	  is	  common	  for	  many	  nsRNA	  virus	  N	  proteins	  and	  is	  consistent	  with	  the	  crystal	  structure	  of	  the	  RVFV	  and	   othobunyavirus	   N	   proteins	   (Ferron	   et	   al.,	   2011,	   Ariza	   et	   al.,	   2013,	   Dong	   et	   al.,	  2013b,	  Niu	  et	  al.,	  2013,	  Reguera	  et	  al.,	  2013,	  Li	  et	  al.,	  2013).	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3.9	  The	  Structure	  of	  CCHFV	  N	  protein	  
3.9.1	  Molecular	  replacement	  Initial	   attempts	   to	   determine	   initial	   phase	   information	   by	   molecular-­‐replacement	  approaches	   using	   Phaser	   and	  MOLREP	   (McCoy,	   2007,	   Vagin	   and	   Teplyakov,	   2010),	  with	  the	  RVFV	  N	  protein	  (Raymond	  et	  al.,	  2010;	  Ferron	  et	  al.,	  2011)	  as	  a	  search	  model	  failed	  (the	  only	  bunyavirus	  N	  protein	  at	  the	  time	  available).	  By	  searching	  for	  CCHFV	  N	  sequence	  similarity	  using	  the	  basic	  local	  alignment	  tool	  (BLAST)	  tool,	  (Altschul	  et	  al.,	  1990),	  no	  model	  in	  the	  PDB	  with	  sequence	  identity	  above	  20%	  was	  found.	  All	  of	  the	  remaining	   N	   proteins	   from	   nsNSV	   and	   sNSV	   for	   which	   there	   are	   high	   resolution	  structures	   also	   failed	   as	   molecular	   replacement	   models	   with	   none	   displaying	  sequence	  identity	  above	  20%	  with	  the	  CCHFV	  N	  protein.	  	  
3.9.2	  Selenomethionine	  CCHFV	  N	  protein	  	  By	  replacing	  the	  sulphurs	  in	  methionine	  residues	  with	  selenium	  atoms	  in	  the	  CCHFV	  N	   protein	   the	   initial	   phases	   needed	   for	   substructure	   solution	   can	   be	   generated,	  without	   the	   need	   for	   soaking	   heavy	   atoms	   into	   native	   crystals.	   This	   offers	   the	  assurance	   that	   the	   heavy	   atoms	   are	   contained	   within	   the	   protein	   and	   in	   known	  positions	  within	   the	  amino	  acid	  sequence,	  and	   is	  advantageous	   for	  phasing	  because	  the	  heavy	  atoms	  will	  be	  fully	  occupied	  in	  each	  repeating	  unit	  of	  the	  crystal.	  	  Bacterial	   expression	   of	   the	   CCHFV	   N	   protein	   containing	   selenomethionine	   was	  achieved	   using	   BL834	   (DE3)	   E.	   coli	   expression	   cells,	   which	   are	   methionine	  auxotrophs,	   grown	   in	  M9	  minimal	  media.	   Using	   the	   same	   induction	   conditions	   for	  expression	   as	   for	   the	   native	   CCHFV	   N	   protein	   sufficient	   amounts	   of	   protein	   were	  produced	   for	   crystallization.	   Mass	   spectrometry	   analysis	   of	   the	   native	   and	  selenomethionine	   derivative	   CCHFV	   N	   proteins	   confirmed	   selenomethionine	   had	  been	   successfully	   incorporated.	   The	   major	   species	   for	   the	   native	   CCHFV	   protein	  identified	   by	   mass	   spectrometry	   was	   54,044	   Da,	   closely	   corresponding	   to	   the	  predicted	   mass	   of	   54,045	   Da	   (Figure	   51A).	   The	   major	   species	   for	   the	  selenomethionine	  protein	  was	  54,643	  Da,	  which	  corresponded	  to	  the	  predicted	  mass	  of	  54,644	  Da	  for	  selenomethionine	  CCHFV	  N	  protein	  (Figure	  51B).	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  Figure	   51.	   Mass	   spectrometry	   analysis	   of	   CCHFV	   N	   selenomethionine	   protein	   of	   native	   (A)	   and	  selenomethionine	  derivative	  (B)	  CCHFV	  N	  proteins,	  identified	  peak	  at	  54,044	  Da	  and	  54,653	  Da,	  which	  closely	  matched	  the	  predicted	  mass	  of	  54,045	  Da	  and	  54,654	  Da	  respectively.	  	  Selenomethionine	   derivative	   CCHFV	   N	   protein	   crystals	   were	   found	   to	   grow	   in	   the	  same	   crystallization	   conditions	   for	   the	  native	  CCHFV	  protein	   (0.2	  M	  NaCl,	   25%	  v/v	  PEG-­‐600,	   1	  M	  BTP	  pH	  6.5),	   however	   the	   quality	   of	   diffraction,	   completeness	   of	   the	  datasets	   and	   their	   resolution	  were	  not	   good	  enough	   to	  obtain	   sufficient	   anomalous	  signal	  for	  substructure	  solution	  (Figure	  52).	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  Figure	  52.	  X-­‐ray	  diffraction	  pattern	  of	  selenomethionine	  CCHFV	  N	  protein	  crystals.	  A	  0.9° oscillation	  X-­‐ray	  diffraction	  pattern	  using	  beamline	  I02,	  collected	  at	  the	  peak	  absorbance	  of	  selenium	  using	  12,658	  eV	  X-­‐rays.	  The	  insert	  boarded	  in	  red	  shows	  the	  zoomed	  in	  image	  (x2)	  of	  the	  diffraction	  pattern	  boxed	  in	  red.	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3.9.3	  Heavy	  atom	  soaks	  into	  native	  crystals	  grown	  from	  CCHFV	  N	  protein	  Two	  derivative	  data	   sets	  were	   collected	   from	  CCHFV	  N	  protein	   crystals,	   one	  which	  had	   been	   soaked	   in	  mother	   liquor	   containing	   2	  mM	   platinum	   chloride	   for	   20	  min,	  back	  soaked	  for	  5	  min	  in	  mother	  liquor,	  and	  another	  with	  2	  mM	  thimerosal	  for	  30	  min,	  back	  soaked	  for	  10	  min	  in	  mother	  liquor.	  Although	  the	  platinum	  chloride	  derivative	  data	   set	   was	   integrated	   (Leslie,	   2006)	   and	   scaled	   (Evans,	   2006b)	   to	   2.8	   Å,	   no	  detectable	  anomalous	  signal	  could	  be	  found.	  	  	  The	   CCHFV	  N	   protein	   structure	  was	   solved	  with	   phases	   generated	   from	   a	   data	   set	  collected	   at	   3	   Å	   from	   crystals	   soaked	   with	   the	   mercury	   derivative	   thimerosal	   and	  extended	  to	  the	  native	  data	  set	  at	  2.1	  Å,	  using	  single	  isomorphous	  replacement	  with	  anomalous	   scattering	   (SIRAS).	   The	   CCHFV	   N	   protein	   derivative	   crystals	   were	  collected	   using	   12,658	   eV	   X-­‐rays	   wavelength	   of	   the	   0.9795	   Å	   with	   a	   Pilatus	   6M	  detector.	   In	   all	   8	   mercury	   sites	   in	   each	   AU	   were	   found,	   with	   three	   Hg	   atoms	  possessing	   sites	   in	   the	   globular	   domain	   and	   1	   Hg	   present	   within	   the	   arm	   of	   each	  CCHFV	  N	  protein	  molecule,	  with	  all	  Hg	  sites	  coordinated	  by	  cysteine	  residues	  (Figure	  53).	  The	  statistics	  for	  the	  fully	  refined	  structure	  are	  given	  in	  Table	  3.	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Native	  crystal Crystal	  soaked	  with	  thimerosal	  (8	  Hg	  sites/AU) Wavelength	  (Å) 0.9795 0.9795 Space	  group C2 C2 Cell	  parameters   a	  (Å) 150.4 149.4 b	  (Å) 72.1 72.5 c	  (Å) 101.2 101.8 β	  (°) 110.7 111.1 Total	  no.	  of	  reflections 185,069	  (27,462) 108,583	  (16,046) No.	  of	  unique	  reflections 56,441	  (8,347) 20,325	  (2,951) Resolution	  (Å) 2.10	  (2.21–2.10) 3.0	  (3.16–3.00) 
Rmerge	  (%) 4.4	  (46.7) 5.6	  (13.7) Completeness	  (%) 95.5	  (97.2) 99.0	  (99.4) Redundancy 3.3	  (3.3) 5.3	  (5.4) 
I/σ(I) 13.9	  (2.5) 19.1	  (9.6) 
VM	  (Å3/Da) 2.38 2.39 No.	  of	  molecules	  per	  AU 2 2 
Rcrystal 18.39  
Rfree 23.35  No.	  of	  reflections	  in	  working	  set 53,584  aFree	  R	  value	  set	  (%	  [no.	  of	  reflections]) 5.1	  (2,857)  No.	  of	  nonhydrogen	  atoms 7,672  No.	  of	  water	  molecules 313  Mean	  B	  value	  (Å2) 38.21  RMSD	  from	  ideality   Bonds	  (Å) 0.022  Angles	  (°) 1.559  Ramachandran	  statistics	  (%)   Preferred	  region 97.02  Allowed	  region 2.76  Outliers 0.22  MolProbity	  score	  (95th	  percentile) 1.65  	  aExcept	  where	  noted,	  numbers	  in	  parentheses	  are	  for	  the	  highest	  resolution	  shell.	  Table	  3.	  Data	  collection	  and	  refinement	  statistics	  for	  CCHFV	  N	  protein	  native	  and	  derivative	  crystals.	  The	  structure	  of	  the	  CCHFV	  N	  protein	  was	  determined	  to	  give	  insight	  into	  its	  various	  functions,	   including	   RNA	   binding,	   homo-­‐oligomerization,	   interaction	   with	   the	   viral	  glycoproteins	  to	  form	  the	  virus	  particle,	  and	  caspase-­‐3	  protease	  cleavage.	  The	  crystal	  structure	   of	   the	   full-­‐length	   CCHFV	   N	   protein	   (residues	   1	   to	   482)	   of	   CCHFV	   strain	  Baghdad-­‐12	  was	   determined	   in	   two	   space	   groups.	   Native	   crystals	   belonging	   to	   the	  monoclinic	  space	  group	  C2	  and	  orthorhombic	  P212121	  spacegroup	  with	  two	  and	  three	  CCHFV	   N	  monomers	   in	   the	   AU	   respectively.	   For	   the	  model	   from	   the	   C2	   data	   each	  monomer	  was	  assigned	  474	  residues,	  with	  residues	  183	  to	  191	  forming	  a	  disordered	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loop	  that	  is	  missing	  in	  the	  electron	  density	  for	  both	  protomers	  (Table	  3;	  Figure	  54).	  	  The	  Ramachandran	  plot	  for	  structural	  refinement	  can	  be	  found	  in	  figure	  99.	  
	  
	  
Figure	  54.	  Crystal	  structure	  of	  the	  CCHFV	  N	  protein	  solved	  from	  C2	  crystals.	  (A)	  The	  crystal	  structure	  of	  CCHFV	  N	  monomer	  is	  shown	  by	  cartoon	  representation.	  The	  globular	  domain	  is	  depicted	  with	  alpha	  helices	  coloured	  in	  light	  blue	  or	  density	  blue,	  which	  represent	  the	  N-­‐terminal	  and	  C-­‐terminal	  portions	  respectively.	  The	  arm	  portion	  of	  the	  CCHFV	  N	  protein	  is	  shown	  in	  marine	  blue.	  The	  C-­‐terminus	  of	  the	  globular	  domain	  is	  shown	  as	  an	  orange	  sphere,	  and	  the	  N-­‐terminus	  is	  shown	  as	  a	  red	  sphere.	  Coloured	  arrowheads	   point	   to	   the	   caspase-­‐3	   protease	   DEVD	   cleavage	   motif	   (yellow)	   and	   the	   segregation	   of	  helices	  17	  and	  18	  (green).	  The	  figure	  was	  generated	  using	  PyMol.	  	  N	  monomers	  consist	  of	  a	  globular	  core	  comprising	  23	  alpha	  helices	   (α1	   to	  α11	  and	  α18	   to	   α29),	   with	   a	   prominent	   additional	   structural	   element	   termed	   the	   “arm,”	  comprising	  two	   long	  alpha	  helices	  (α15	  and	  α17),	   that	  extends	  away	   from	  the	  core,	  with	   an	   exposed	   loop	   at	   the	   apex	   supported	   by	   a	   small	   three-­‐helix	   bundle	   (α12	   to	  α14)	  (Figure	  54).	  The	  C-­‐terminal	  half	  of	  the	  N	  protein	  provides	  the	  helices	  at	  the	  core	  of	  the	  globular	  domain,	  which	  in	  turn	  are	  surrounded	  by	  helices	  from	  the	  N-­‐terminal	  half.	   The	   monomers	   are	   packed	   in	   a	   head-­‐to-­‐tail	   arrangement,	   with	   the	   interface	  between	  monomers	  comprising	  helices	  α6	  and	  α7	  and	  helices	  α21	  and	  α22	  within	  the	  globular	  domain.  
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Native	  crystal Wavelength	  (Å) 0.9795 Space	  group P212121 Cell	  parameters  a	  (Å) 73.3 b	  (Å) 85.3 c	  (Å) 262.4 α	  (°)	   90 	  	  	  	  	  	  β	  (°)	   90 	  	  	  	  	  γ	  (°)	   90 Total	  no.	  of	  reflections 33923	  (2491) No.	  of	  unique	  reflections 9030	  (641) Resolution	  (Å) 4.71	  (4.83–4.71) 
Rmerge	  (%) 1.27	  (48.2) Completeness	  (%) 99.4	  (99.3) Redundancy 3.8	  (3.9) 
I/σ(I) 6.9	  (2.8) No.	  of	  molecules	  per	  AU 3 VM	  (Å3/Da)	   1.59	  
	  
Rfactor 19.70  
Rfree 32.01  










	  	  	  
	  	  






Superposition	  of	   the	  body	  domains	   revealed	   the	  position	  of	   the	   stalk	  domains	  with	  respect	  to	  the	  globular	  domain	  is	  shared	  between	  all	  of	  the	  three	  CCHFV	  N	  proteins,	  with	  an	  overall	  root	  mean	  square	  deviation	  (RMSD)	  of	  0.535	  between	  molecules	  A	  an	  B,	  0.576	  between	  molecules	  A	  and	  C,	  and	  0.589	  between	  molecules	  B	  and	  C	  (Figure	  57).	  
	  
Figure	  57.	   Superpositioning	  of	   the	   three	  molecules	  of	   the	  CCHFV	  N	  protein	   in	  P212121	  AU.	  The	   three	  molecules	   named	   A,	   B	   and	   C,	   are	   coloured	   in	   magenta,	   light	   green	   and	   turquoise	   respectively.	   The	  figure	  was	  generated	  using	  PyMol.	  
4.9.4	  Electrostatic	  surface	  potential	  The	  crystal	  structure	  of	  the	  CCHFV	  N	  protein	  allowed	  calculation	  of	  the	  electrostatic	  surface	   potential	   and	   revealed	   two	   positively	   charged	   regions.	   The	   first	   region	   is	  composed	   of	   residues	   K90,	   K91,	   K98,	   E112,	   E121,	   K132,	   K135,	   R140,	   S149,	   D171,	  R177,	  Q300,	  Y470	  K473,	  which	  form	  a	  continuous	  positively	  charged	  area	  located	  on	  the	  surface	  of	  the	  globular	  and	  under	  the	  arm	  domain,	  which	  is	  termed	  the	  “platform”	  (Figure	  58A).	  The	  additional	  region,	  composed	  of	  residues	  K342,	  K343,	  H453,	  K411,	  H456,	  E387,	  I304,	  W313	  is	  adjacent	  to	  a	  deep	  basic	  crevice,	  and	  is	  referred	  to	  as	  the	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“pocket”	   (Figure	   58B).	   These	   two	   regions	   comprise	   basic	   residues	   well	   conserved	  among	   all	   nairoviruses	   and	   therefore	   suggest	   a	   role	   in	   RNA	   binding	   (Wang	   et	   al.,	  2012)	  	  
	  	  
Figure	   58.	   Electrostatic	   potential	   analysis	   of	   the	   CCHFV	   N	   protein	   from	   Baghdad-­‐12	   (A)	   The	  electrostatic	   surface	   potential	   of	   N	   protein	   from	   Baghdad-­‐12	   (generated	   with	   APBS)	   suggests	   a	  positively	   charged	  RNA	  binding	   “platform”,	   solely	   located	  within	   the	   surface	   of	   the	   globular	   domain	  (Unni	   et	   al.,	   2011).	   (B)	   Rotation	   by	   180	   degrees	   suggests	   a	   smaller	   additional	   positively	   charged	  groove,	  termed	  the	  “pocket”.	  The	  figure	  was	  generated	  using	  APBS	  in	  PyMol.	  
3.10	  Similarity	  to	  other	  sNSV	  N	  proteins	  	  The	   Bunyaviridae	   family	   is	   diverse	   with	   significant	   genetic	   differences	   between	  members	  within	  each	  of	  the	  five	  established	  genera	  and	  not	  surprisingly	  the	  CCHFV	  N	  protein	   has	   no	  primary	   sequence	  homologs	  within	   the	   family	   or	  with	   other	   nsRNA	  virus	  N	  proteins.	  Therefore	  the	  tertiary	  fold	  of	  the	  CCHFV	  N	  protein	  crystal	  structure	  was	   analysed	   using	   the	   DALI	   server	   to	   gain	   insights	   into	   bunyavirus	   phylogenetic	  relationships.	  Alignment	  between	  the	  CCHFV	  and	  RVFV	  N	  globular	  domains	  revealed	  essentially	   no	   tertiary	   structural	   homology	   (Z	   score	   =	   1.7),	   and	   zero	   similarity	  was	  detected	  within	   the	  arm	  domain.	  Furthermore	  alignment	  using	   the	  DALI	   server	  did	  not	   find	   any	   structural	   homology	   between	   CCHFV	   N	   protein	   and	   any	   of	   the	  orthobunyavirus	   protein	   crystal	   structures	   (Ariza	   et	   al.,	   2013,	  Reguera	   et	   al.,	   2013,	  Dong	  et	  al.,	  2013b,	  Li	  et	  al.,	  2013,	  Niu	  et	  al.,	  2013).	  
Interestingly,	  the	  DALI	  server	  identified	  the	  highest	  scoring	  structural	  alignment	  with	  the	  N	  protein	  from	  the	  two	  segmented	  LASV	  (arenavirus)	  (Hastie	  et	  al.,	  2011a,	  Hastie	  et	  al.,	  2011b,	  Brunotte	  et	  al.,	  2011,	  Qi	  et	  al.,	  2010).	  The	  strongest	  structural	  similarity	  was	  found	  within	  the	  N-­‐terminal	  residues	  1	  to	  340,	  which	  comprise	  the	  RNA	  binding	  domain	  of	  LASV	  NP	  (Figure	  59)	  (Hastie	  et	  al.,	  2011b).	  Furthermore	  the	  DALI	  server	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identified	   structural	   homology	   for	   all	   forms	   of	   the	   LASV	   NP	   deposited	   in	   the	   PDB,	  with	  Z-­‐scores	  between	  12.4	  and	  15.3.	  Superimposition	  of	  the	  globular	  domains	  from	  the	  CCHFV	  N	  protein	  and	  RNA	  free	  LASV	  NP	  gave	  a	  Cα	  root	  mean	  square	  deviation	  of	  3.38	   Å	   for	   237	   residues	   with	   8.01%	   sequence	   identity.	   There	   was	   however	   a	  significant	   step	   down	   to	   the	   next	   highest	   score	   (Z-­‐score	   4.4;	   PDB	   1w63)	   to	   what	  appeared	  to	  be	  an	  unrelated	  structure.	  	  
	  
Figure	  59.	  Superposition	  of	  the	  Baghdad-­‐12	  CCHFV	  and	  LASV	  N/NP	  proteins.	  (A)	  Structural	  homology	  between	   that	   of	   CCHFV	   and	   LASV	  N/NP	   protein	   structures.	   The	   CCHFV	   protein	   is	   shown	   in	  marine	  blue.	  The	  LASV	  N	  structure	  is	  predominately	  shown	  in	  green,	  and	  the	  α5,	  loop/α6	  are	  numbered	  and	  coloured	   yellow.	   Hastie	   et	   al	   (Hastie	   et	   al.,	   2011b)	   reported	   this	   region	   moves	   upon	   RNA	   binding.	  Whilst	   α5	   is	   shared	   by	   both	  N	   proteins	   there	   is	   no	   structural	   equivalent	   of	   the	   α6	   RNA	   gate	   in	   the	  CCHFV	  N	  protein.	  The	  figure	  was	  generated	  using	  PyMol.	  
3.11	  The	  N-­‐N	  dimer	  interface	  	  The	  encapsidation	  of	   the	  genomic	  RNA	  by	  all	  sNSVs	   involved	  the	  assembly	  of	   the	  N	  protein	   into	   multimeric	   protein	   complexes.	   It	   is	   plausible	   that	   the	   interface	   seen	  between	  the	  2	  NCS	  related	  molecules	  in	  the	  C2	  AU	  represents	  a	  “real”	  dimer	  interface,	  
	  126	  
which	   is	   present	   after	   oligomerization	   on	   RNA.	   The	   same	   arrangement	   is	   seen	  between	   two	   of	   the	   three	   NCS	   molecules	   in	   the	   P212121	   spacegroup	   (Figure	   60).	  Analysis	  to	  support	  whether	  these	  two	  NCS	  related	  molecules	  represent	  a	  biologically	  relevant	  dimer,	  was	  undertaken	  by	  PISA	  (Krissinel	  and	  Henrick,	  2007).	  
Analysis	  of	   the	  dimer	   interface	   in	  both	  P212121	  and	  C2	  crystal	   forms	  using	  the	  PISA	  server	  (Krissinel	  and	  Henrick,	  2007)	  revealed	  an	  average	  buried	  surface	  area	  of	  1,015	  Å2,	  a	  ΔG	  value	  of	  −9.5	  kcal/mol,	  and	  a	  complexation	  significance	  score	  (CSS)	  of	  0.0	  (a	  score	  of	  1	  suggests	  a	  stable	  interface,	  and	  a	  score	  of	  0	  suggests	  a	  nonstable	  interface,	  i.e.,	  crystal	  packing	  and	  therefore	  not	  a	  dimer	  interface	  (Figure	  60).	  	  
	  
Figure	   60.	   Cartoon	   representation	   of	   two	   CCHFV	   N	   protomers	   within	   the	   C2	   crystal	   lattice.	   The	  interface	  between	  the	  two	  CCHFV	  N	  protein	  monomers	  was	   investigating	  using	  PISA.	  The	   figure	  was	  generated	  using	  PyMol.	  
3.12	  Consequences	  of	  cleavage	  of	  the	  DEVD	  caspase-­‐3	  protease	  recognition	  site	  The	   crystal	   structure	   of	   CCHFV	   N	   revealed	   the	   location	   of	   the	   DEVD	   motif	   is	  positioned	  at	  the	  apex	  of	  the	  arm	  domain	  (Figure	  54,	  yellow	  arrowhead).	  A	  reaction	  containing	  recombinant	  caspase-­‐3	  protease	  and	  purified	  wild-­‐type	  CCHFV	  N	  protein	  was	   set	   up,	   and	   cleavage	   at	   the	   DEVD	   site	  was	  monitored	   by	   analysis	   of	   digestion	  products	   separated	   using	   SDS-­‐PAGE	   (Figure	   61A).	   Surprisingly,	   caspase-­‐3	   protease	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cleavage	   of	   wild-­‐type	   N	   protein	   resulted	   in	   incomplete	   digestion	   even	   following	  overnight	  incubation	  at	  an	  equal	  molar	  ratio	  (Figure	  61A,	  lane	  4),	  indicating	  that	  the	  CCHFV	  N	  protein	  was	  a	  poor	  substrate	  for	  cleavage	  despite	  the	  apparent	  accessibility	  of	   the	   DEVD	  motif	   (Figure	   54).	   Caspase-­‐3	   protease	   activity	   was	   confirmed	   using	   a	  fluorogenic	   peptide	   derived	   from	   PARP	   (Figure	   62),	   and	   as	   expected,	   CCHFV	   N	  mutants	  with	  altered	  cleavage	  motifs	  (DEVE	  and	  DEVG)	  were	  uncleaved	  (Figure	  61B,	  lanes	  2	  and	  3).	  
	  




Figure	   62.	   Caspase-­‐3	   protease	   cleavage	   of	   fluorogenic	   substrate.	   3	   mM	   of	   caspase-­‐3	   protease	   was	  added	   to	  10	  mM	  (red	   line)	   and	  20	  mM	  (purple	   line)	  of	   fluorogenic	  peptide	  derived	   from	  PARP,	   and	  absorbance	  was	  measured	  at	  515	  nm.	  Negative	  controls	  including	  an	  assay	  using	  no	  substrate	  in	  which	  no	  absorbance	  was	  measured.	  The	  results	   indicate	   that	  upon	  cleavage	  by	  caspase-­‐3	  protease	  the	  CCHFV	  N	  protein	  remains	  intact,	  and	  this	  is	  most	  likely	  a	  consequence	  of	  the	  close	  contact	  of	  between	  the	  helical	  structural	  elements	  within	  the	  globular	  domain	  (Figure	  63).	  
	  
Figure	  63.	  Location	  of	  the	  caspase-­‐3	  protease	  cleavage	  site	  on	  the	  CCHFV	  N	  protein.	  The	  two	  halves	  of	  the	  CCHFV	  N	  protein	  generated	  by	  caspase-­‐3	  protease	  cleavage	  are	  represented	  by	  marine	  blue	  (amino	  acids	  1-­‐266)	  and	  light	  blue	  (amino	  acids	  267-­‐482).	  The	  figure	  was	  generated	  using	  PyMol.	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3.13	  Summary	  of	  the	  CCHFV	  N	  protein	  crystal	  structure	  results	  CCHFV	  N	  protein	   is	  composed	  of	  a	  globular	  core	  comprising	  15	  alpha	  helices	  (α1-­‐8;	  α14-­‐20)	   and	   a	  prominent	   additional	   structural	   element	   called	   the	   ‘arm’	   comprising	  two	  long	  alpha	  helices	  (α9-­‐10)	  extending	  away	  from	  the	  globular	  core,	  presenting	  an	  exposed	  loop	  at	  its	  apex,	  and	  supported	  by	  a	  small	  three	  helix	  bundle	  (α11-­‐13;	  Figure	  51).	  The	  C-­‐terminal	  half	  of	  N	  provides	  the	  helices	  at	  the	  core	  of	  the	  globular	  domain,	  and	  in	  turn	  is	  surrounded	  by	  helices	  from	  the	  N-­‐terminal	  half.	  	  
In	  the	  C2	  space	  group,	  the	  monomers	  are	  packed	  in	  a	  head-­‐to-­‐tail	  arrangement,	  with	  the	  AU	  dimer	  interface	  comprising	  helices	  α3,	  α6-­‐8	  within	  the	  globular	  domain.	  The	  
P212121	   space	   group	   also	   displays	   the	   same	   dimer	   interface,	   with	   an	   additional	  monomer	  alongside,	  making	  up	  three	  CCHFV	  N	  proteins	  in	  the	  AU	  (Figure	  55).	  
Electrostatic	  surface	  potential	  suggests	  a	  possible	  RNA	  binding	  ‘platform’	  adjacent	  to	  the	  arm.	  Structural	  comparisons	  indicate	  that	  the	  CCHFV	  N	  globular	  domain	  exhibits	  a	   higher	   degree	   of	   structural	   homology	  with	   the	  N-­‐terminal	   domain	   of	   LASV	  NP,	   a	  member	  of	  the	  Arenaviridae	  family,	  and	  appears	  essentially	  structurally	  un-­‐related	  to	  RVFV	  N	  protein,	  a	  member	  within	  the	  Bunyaviridae	  family.	  









3.14	  Discussion	  The	   initial	   aim	   of	   this	   project	   was	   to	   express	   and	   purify	   highly	   concentrated	  recombinant	   CCHFV	   N	   protein	   using	   E.	   coli.	   To	   address	   this	   aim	   an	   approach	   was	  implemented,	  and	  involved	  expression	  of	  recombinant	  CCHFV	  N	  protein	  N-­‐terminally	  linked	   to	   a	   His6-­‐SUMO	   tag.	   The	   decision	   to	   use	   the	   SUMO	   moiety	   was	   made	   to	  overcome	   any	   potential	   expression	   or	   solubility	   pitfalls,	   which	   are	   inherent	   in	  recombinant	   expression	   of	   mammalian	   proteins	   within	   E	   coli.	   The	   SUMO	   tag	   is	  cleaved	   by	   the	   SUMO	   protease,	   which	   is	   highly	   efficient	   and	   recognizes	   secondary	  structure,	  whilst	  leaving	  only	  a	  serine	  on	  the	  N-­‐terminus	  of	  the	  native	  protein.	  	  	  The	  next	  strategy	  of	  this	  project	  endeavored	  to	  better	  understand	  the	  functional	  and	  structural	   properties	   of	   the	   CCHFV	  N	   protein.	   Firstly	   by	   generating	   abundant	   near	  native	   CCHFV	   N	   protein	   it	   was	   demonstrated	   by	   SEC	   that	   CCHFV	   N	   protein	   exists	  predominately	   as	   a	   monomer	   in	   solution	   and	   lacks	   the	   propensity	   to	   form	   higher	  molecular	   weight	   oligomers	   like	   other	   members	   of	   the	   Bunyaviridae	   family.	   Next	  phenol/chloroform	  extraction	  of	  RNA	  revealed	  the	  CCHFV	  N	  protein	  monomer	  peak	  was	   not	   binding	   to	   E.	   coli	   RNA	   during	   the	   expression	   and	   purification	   processes.	  Finally	  X-­‐ray	  crystallography	  was	   implemented	  to	  characterize	   the	  atomic	  structure	  of	   the	   CCHFV	   N	   protein.	   The	   crystal	   structure	   of	   the	   CCHFV	   N	   protein	   revealed	  important	  details	  about	   important	   functions	  such	  as	  RNA	  binding	  and	  also	  revealed	  previously	  unrecognized	  evolutionary	  relationships	  with	  other	  nsRNA	  viruses.	  





3.14.2	  Expression	  and	  purification	  Expression	  of	  soluble	  CCHFV	  N	  protein	  was	  found	  to	  be	  optimum	  when	  inducing	  the	  culture	   at	   18	   °C	   with	   100	   µM	   IPTG.	   The	   Ni-­‐Superflow	   Plus	   resin	   purification	   was	  highly	  efficient	  in	  providing	  highly	  concentrated	  and	  pure	  CCHFV	  N	  protein,	  ready	  for	  second	  round	  purification	  using	  SEC.	  The	  Superdex	  S75	  gel	  based	  column	  separated	  CCHFV	   N	   protein	   away	   from	   contaminants,	   and	   also	   separated	   different	  molecular	  weight	  species	  of	  CCHFV	  N	  protein	  and	  the	  His6-­‐SUMO	  tag.	  The	  majority	  of	  the	  CCHFV	  N	  protein	  was	  monomeric,	  however	  larger	  dimer	  species	  were	  seen,	  and	  is	  consistent	  with	  its	  role	  of	  interacting	  with	  itself	  and	  forming	  large	  infectious	  RNP	  complexes.	  	  	  It	  is	  not	  uncommon	  for	  nsRNA	  viral	  N	  proteins	  to	  bind	  heterogeneous	  E.	  coli	  RNA	  co-­‐purified	  from	  the	  expression	  host	  (Ariza	  et	  al.,	  2013,	  Ferron	  et	  al.,	  2011).	  Crystallizing	  and	  solving	  the	  CCHFV	  N	  protein	  bound	  to	  E.	  coli	  RNA	  can	  be	  beneficial	  for	  elucidating	  important	   mechanisms	   such	   as	   oligomerization,	   RNA	   binding	   and	   RNP	   assembly.	  However	  one	  inherent	  problem	  arising	  from	  attempting	  to	  crystallize	  N	  protein	  with	  
E.	   coli	   RNA	   is	   the	   heterogeneity	   arising	   from	   different	   bacterial	   RNAs	   of	   various	  sequences	   and	   lengths	   binding	   to	   the	   N	   protein.	   The	   260/280	   nm	   ratio	   of	   the	  monomer	  SEC	  peak	  indicated	  the	  CCHFV	  N	  protein	  was	  RNA	  free,	  and	  this	  was	  further	  supported	  using	  the	  phenol/chloroform	  method	  for	  extraction	  of	  RNA.	  As	  there	  was	  no	  heterogeneous	  E.	  coli	  bound	   to	   the	  monomeric	  CCHFV	  N	  protein,	   it	  was	  deemed	  sufficient	   for	   crystallization	  because	   the	   sample	  was	   considered	  homogeneous,	   and	  therefore	  more	  likely	  to	  produce	  diffracting	  crystals.	  
3.14.3	  Crystallization	  and	  X-­‐ray	  diffraction	  of	  the	  CCHFV	  N	  protein	  This	  process	  allowed	   the	  expression	  of	  pure	  CCHFV	  N	  protein	   that	  was	  suitable	   for	  structural	   analysis	   using	   X-­‐ray	   crystallography.	   Factorial	   crystal	   screens	   yielded	  crystals	   from	   0.2	   M	   magnesium	   acetate	   tetrahydrate,	   0.1	   M	   sodium	   cacodylate	  trihydrate	  pH	  6.5,	  20%	  w/v	  PEG-­‐8,000.	  Crystals	  diffracted	  to	  4.5	  Å	  and	  where	  found	  to	   process	   P212121	  symmetry	   with	   the	   unit	   cell	   dimensions	   a	   =	   73.8,	   b	   =	   86.0,	   c	   =	  264.0	  Å,	  α=	  90°,	  β=	  90°,	  γ=	  90°.	   Sequential	   rounds	  of	  optimization	  were	  carried	  out	  using	  a	  range	  of	  PEGs,	  different	  buffers	  (MOPS,	  MES	  and	  BTP)	  and	  salts;	  ultimately,	  diffraction-­‐quality	  crystals	  were	  grown	  in	  0.2	  M	  NaCl,	  25%(v/v)	  PEG-­‐600,	  0.1	  M	  BTP	  pH	   6.5	   using	   the	   hanging-­‐drop	   vapour	   diffusion	   method.	   Optimization	   yielded	  crystals,	  which	  diffracted	   to	  2.1	  Å	  with	  C2	   symmetry	   and	  unit	   cells	   dimensions	  a	   =	  149.8,	  b	  =	  71.9,	  c	  =	  102.0	  Å,	  α=	  90°,	  β=	  111.2°,	  γ=	  90°.	  
	  132	  
	  The	  diffraction	  data	  were	  deemed	  sufficient	   to	  attempt	   to	  solve	   the	  phase	  problem.	  Solving	  the	  phases	  was	  undertaken	  experimentally	  as	  there	  was	  no	  sufficiently	  close	  homologue	   in	   the	   PDB	   suitable	   for	   successful	   molecular	   replacement.	   Structural	  determination	   was	   achieved	   by	   collecting	   X-­‐ray	   diffraction	   data	   at	   the	   mercury	  absorbance	  peak,	  from	  a	  CCHFV	  N	  protein	  crystal	  soaked	  with	  thimerosal.	  
3.14.4	  Structural	  comparison	  of	  the	  LASV	  NP	  The	  DALI	  server	  revealed	  the	  CCHFV	  N	  globular	  domain	  displays	  a	  higher	  degree	  of	  similarity	  with	  the	  N-­‐terminal	  RNA	  binding	  domain	  of	  the	  LASV	  NP,	  than	  to	  N	  protein	  within	  the	  Bunyaviridae	  family.	  Surprisingly,	  this	  suggests	  that	  CCHFV	  is	  more	  closely	  related	   to	   the	   arenavirus	   LASV	   (Figure	   64A)	   and	   more	   distantly	   to	   other	  bunyaviruses.	  However	  the	  hypothesis	  that	  CCHFV	  and	  LASV	  are	  more	  closely	  related	  is	  not	  supported	  by	  a	  phylogenetic	  analysis	  of	  N	  sequences	  of	  sNSVs	  performed	  using	  the	   Dayoff	   model	   in	   MEGA6	   (Figure	   64B),	   which	   suggests	   nairoviruses	   and	  arenaviruses	  are	  distantly	  related.	  Phylogenetic	  analysis	  of	  partial	  nucleotides	  from	  L	  segment	  of	  sNSVs	  by	  Vieth	  et	  al	  (Vieth	  et	  al.,	  2007)	  performed	  using	  the	  PHYLIP	  3.6	  program	   package	   (Felsenstein,	   2004),	   revealed	   a	   close	   relationship	   between	  nairoviruses	   and	   arenaviruses	   than	   to	   other	   bunyaviruses.	   Phylogenetic	   analysis	  using	   full	   length	   nucleotide	   sequences	   from	   the	   L	   segment	   performed	   by	   Muscle	  alignment	  and	   the	  Dayoff	  model	   in	  MEGA6	   (Figure	  63C)	  and	  ClustalW	  and	  ClustalX	  (Carter	   et	   al.,	   2012b)	   gave	   similar	   results,	   with	   trees	   showing	   bunyaviruses	   and	  arenaviruses	   as	   closely	   related	   based	   on	   the	   L	   protein.	   The	   phylogenetic	   analysis	  suggests	   the	   nairoviruses	   are	  more	   closely	   related	   to	   arenaviruses	   based	   on	   the	   L	  segment	  phylogeny,	  but	  are	  more	  closely	  related	  to	  members	  of	  its	  own	  family	  based	  on	   the	   S	   segment	  phylogeny	   (Figure	  64B	   and	  C).	   The	  phylogentic	   analysis	   of	   the	  N	  protien	   suggests	   the	   nairovirus	   and	   areanavirus	   are	   not	   closely	   related	   but	   most	  likely	   emerged	   through	   a	   once	   common	   ancestor	   and	   the	   their	   structully	   similar	  N	  proteins	  have	  evolved	  through	  divergent	  evolution.	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  Figure	  64.	   Superpositioning	  of	   the	  Baghdad-­‐12	  CCHFV	  N	  and	  LASV	  N/NP	  using	   the	   stereo	   cross	   eye	  and	  phylogenetic	  analysis	  of	  nsRNA	  viruses	  by	  N	  and	  L	  amino	  acid	  sequences	  using	  the	  MEGA6-­‐Beta2	  program.	  (A)	  Structural	  homology	  between	  that	  of	  CCHFV	  N	  and	  LASV	  NP	  crystal	  structures.	  A	  stereo	  cross	   eye	   of	   CCHFV	   N	   displayed	   in	   marine	   blue	   and	   the	   LASV	   NP	   shown	   in	   green.	   The	   figure	   was	  generated	   using	   PyMol.	   (B)	   and	   (C)	   The	   MEGA6-­‐Beta2	   program	   was	   used	   to	   align	   the	   amino	   acid	  sequences	  of	  14	  viral	  N	  and	  L	  proteins	  respectively,	  including	  those	  from	  seven	  (N	  protein	  phylogeny)	  and	   six	   (L	   protein	   phylogeny)	   bunyaviruses	   (labelled	   in	   purple),	   and	   four	   arenaviruses	   (labelled	   in	  green).	  Orthomyxoviruses	  are	   labelled	   in	  gold	  and	   the	   tenuivirus	   is	   labelled	   in	  blue.	   In	   the	  L	  protein	  phylogenetic	   plot	   (B),	   the	   sNSV	   rhabdovirus	   is	   labelled	   in	   light	   blue.	   The	   resultant	   phylogens	  were	  generated	  using	  M6	  Tree	  Explorer.	  The	  percentage	  each	  branch	  was	  obtained	  is	  indicated	  at	  the	  base	  of	  each	  branch.	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3.14.5	  Structural	  comparison	  between	  CCHFV	  N	  proteins	  from	  other	  strains	  
The	  structures	  of	   the	  CCHFV	  N	  protein	  monomer	  of	   strain	  YL04057	  (Guo	  et	  al.,	  2012)	  
and	  IbAr10200	  strain	  (Wang	  et	  al.,	  2012)	  were	  published	  recently.	  Guo	  et	  al	  (Guo	  et	  al.,	  
2012),	   revealed	   that	   in	  vitro	  CCHFV	  N	  protein	  has	  weak	  RNA	  binding	  affinity	  and	  has	  
DNA	   endonuclease	   activity	   with	   distinct	  metal	   dependence.	  Wang	   et	   al	   (Wang	   et	   al.,	  
2012),	   solved	   the	   CCHFV	   N	   structure	   in	   two	   conformations,	   which	   they	   suggest	  
resembles	  the	  oligomerized	  RNP	  form	  and	  monomeric	  form	  respectively.	  
3.14.6	  Structural	  comparison	  of	  CCHFV	  N	  proteins	  from	  strains	  Baghdad-­‐12	  and	  YL04057	  Superimposition	   of	   the	   two	   domains	   from	   strains	   YL04057	   (Guo	   et	   al.,	   2012)	   and	  Baghdad-­‐12	  (Carter	  et	  al.,	  2012b)	  revealed	  a	  high	  degree	  of	  similarity	   in	  their	  folds,	  with	  a	  Cα	  RMSD	  of	  0.975	  Å	   for	  357	  residues	  with	  92.16%	  sequence	   identity	   for	   the	  globular	  domain,	  and	  a	  Cα	  RMSD	  of	  0.642	  Å,	  for	  99	  residues,	  with	  77.78%	  identity,	  for	  the	  arm	  domain	  (Figure	  65A).	  
Superpositioning	   of	   the	   entire	   molecule	   revealed	   the	   conformation	   of	   the	   arm	  significantly	   changed	   position,	   with	   respect	   to	   the	   globular	   domain.	   The	  conformational	  change	  has	  caused	  the	  arm	  to	  rotate	  about	  180	  degrees	  and	  the	  apex	  of	  the	  loop	  to	  shift	  by	  a	  distance	  of	  39.59	  Å	  (at	  the	  Cα	  position	  of	  Asp266,	  at	  the	  apex	  of	  the	  arm,	  in	  each	  protein)	  (Figure	  65A).	  Closer	  inspection	  at	  the	  base	  of	  this	  region	  has	  shown	  that	   the	  helix	  supporting	  the	  arm	  domain	   in	  strain	  YL04057	  has	  twisted	  and	   divided	   into	   two	   shorter	   helices	   (α17	   and	   α18)	   in	   strain	   Baghdad-­‐12	   (Figure	  65A).	  





Figure	   65.	   (A)	   Superpositioning	   of	   the	   Baghdad-­‐12	   N	   and	   YL04057	   N	   protein	   globular	   domains.	  Superposition	   (center)	   of	   the	   Baghdad-­‐12	   N	   structure	   (marine	   blue)	   and	   the	   YL04057	   N	   structure	  (red)	  globular	  domains	   reveals	   the	  arm	  has	  a	   radically	  different	   conformation.	  Each	   region	  between	  the	  arm	  and	  globular	  domain	   for	   each	   strain	  has	  been	  expanded,	  with	   relevant	  helices	   labelled.	  The	  helices	  for	  Baghdad-­‐12	  are	  numbered	  as	  shown	  in	  panel	  B,	  whereas	  helices	  for	  YL04057	  are	  numbered	  according	   to	   the	   work	   of	   Guo	   et	   al	   (Guo	   et	   al.,	   2012).	   (B)	   Secondary	   structure	   represented	  schematically	   for	   both	   strains	   of	   CCHFV	   are	   matched	   with	   their	   respective	   primary	   amino	   acid	  sequences	   of	   the	   N	   protein.	   ALINE	   (Bond	   and	   Schuttelkopf,	   2009),	   was	   used	   to	   create	   this	   figure.	  Amino	  acid	  differences	  between	   strains	   are	  highlighted	   in	   red,	   residues	  unassigned	  electron	  density	  are	   highlighted	   in	   black,	   and	   twist	   between	   helices	   17	   and	   18	   (at	   Ser294)	   is	   labelled	   with	   a	   green	  arrow,	  and	  the	  DEVD	  motif	  is	  highlighted	  in	  yellow.	  Panel	  A	  was	  generated	  using	  PyMol.	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3.14.7	  Structural	  comparison	  of	  CCHFV	  N	  proteins	  from	  strains	  Baghdad-­‐12	  and	  
IbAr10200	  The	  overall	  architecture	  of	  the	  globular	  body	  and	  stalk	  from	  the	  CCHFV	  N	  Baghdad-­‐12	  strain	   from	   C2	   crystals	   is	   similar	   to	   that	   of	   the	   recently	   published	   CCHFV	   N	  IbAr10200	   (Figure	   66).	   	   Superposition	   of	   the	   globular	   domains	   of	   the	   Baghdad-­‐12	  and	  the	  monomeric	  CCHFV	  N	  protein	  from	  the	  IbAr10200	  strain,	  revealed	  an	  average	  Cα	   RMSD	   of	   0.559,	   with	   an	   overall	   similarity	   of	   95.4%	   in	   amino	   acid	   sequence.	  Superimposition	  of	  the	  arm	  domains	  of	  the	  Baghdad-­‐12	  and	  the	  monomeric	  CCHFV	  N	  protein	   from	  the	   IbAr10200	  strain,	   revealed	  an	  average	  Cα	  RMSD	  of	  0.732,	  with	  an	  overall	   similarity	   of	   94.5%	   in	   amino	   acid	   sequence	   similarity.	  Overall	   the	   sequence	  identity	   between	   the	   CCHFV	  N	  proteins	   from	  Baghdad-­‐12	   and	   IbAr10200	   is	   95.2%	  similar.	  
	  Figure	  66.	  Superpositioning	  of	  the	  crystal	  structure	  of	  the	  CCHFV	  N	  protein	  from	  Baghdad-­‐12	  (marine	  blue)	   and	   the	   monomer	   form	   of	   N	   from	   the	   IbAr10200	   strain	   (orange).	   Representation	   in	   ribbon	  format.	  An	  expanded	  view	  of	  the	  region	  between	  the	  arm	  and	  the	  globular	  domain	  from	  each	  strain	  is	  shown	  in	  the	  black	  box,	  with	  relevant	  helices	  labelled.	  The	  figure	  was	  generated	  using	  PyMol.	  	  Superposition	   of	   the	   two	   entire	   CCHFV	   N	   proteins	   from	   the	   IbAr10200	   strain	   and	  Baghdad-­‐12	   revealed	   they	   display	   different	   conformations	   in	   their	   stalk	   regions	  (Figure	  66).	  Interestingly	  the	  conformational	  change	  between	  CCHFV	  N	  protein	  from	  Baghdad-­‐12	  and	  the	  monomeric	  CCHFV	  N	  protein	  from	  the	  IbAr10200	  strain	  induces	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the	  nearly	   identical	  division	  of	  alpha	  helix	  17	  as	  described	  above	  (Figure	  65A).	  The	  arm	  is	  rotated	  by	  about	  180	  degrees,	  and	  the	  apex	  of	  the	  loop	  is	  shifted	  by	  a	  distance	  of	  40	  Å	  (at	  the	  Cα	  position	  of	  Asp266,	  at	  the	  apex	  of	  the	  arm,	  in	  each	  protein)	  (Figure	  65A	  and	  66).	  	  	  	  	  
	   	   	  
	  Figure	  67.	  Superpositioning	  of	  the	  crystal	  structure	  of	  the	  CCHFV	  N	  protein	  from	  Baghdad-­‐12	  and	  the	  oligomerized	  form	  of	  N	  protein	  from	  the	  IbAr10200	  strain.	  Representation	  in	  ribbon	  format	  Baghdad-­‐12	   (marine	   blue)	   and	   IbAr10200	   (oligomer)	   (yellow)	   CCHFV	   N	   proteins.	   An	   expanded	   view	   of	   the	  region	   between	   the	   arm	   and	   the	   globular	   domain	   for	   each	   strain	   is	   shown	   in	   the	   black	   box,	   with	  relevant	  helices	  labelled.	  The	  figure	  was	  generated	  using	  PyMol.	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Additionally	   superimposition	   of	   the	   oligomerized	   form	   of	   the	   IbAr10200	   CCHFV	   N	  protein	   and	   the	   Baghdad-­‐12	   CCHFV	   N	   protein	   (Figure	   67),	   revealed	   a	   less	   drastic	  conformational	  change	  and	  does	  not	   involve	  rotation	  and	  splitting	  of	  alpha	  helix	  17	  into	   two	   smaller	   helices,	   but	   instead	   the	   helix	   shifts	   its	   position	   30	   degrees	   into	   a	  more	  upright	  position	  (Figure	  67).	  	  
Figure	  68.	  Conformational	  differences	  in	  the	  arm	  domain	  of	  the	  CCHFV	  N	  protein.	  (A)	  Superposition	  of	  CCHFV	  N	   from	  IbAr10200	  (yellow,	   (oligomer))	  and	  (orange,	   (monomer)),	  Baghdad-­‐12	  (marine	  blue)	  and	  YL04057	   (red)	   strains	   in	   cartoon	   representation.	   (B)	   Top	   view	   of	   the	   aligned	   CCHFV	  N	  protein	  structures.	  The	  figure	  was	  generated	  using	  PyMol.	  
The	  flexibility	  of	  the	  arm	  domain	  may	  have	  important	  consequences	  for	  activities	  in	  critical	   CCHFV	   N	   protein	   functions	   such	   as	   RNA	   binding	   or	   oligomerization.	   For	  example	   the	   two	   different	   arms	   positions	   taken	   up	   by	   the	   CCHFV	   N	   protein	   from	  strains	  Baghdad-­‐12	  and	  YL04057	  may	   represent	   interchangeable	   forms	   involved	   in	  RNA	   binding,	   or	   oligomerization	   or	   perhaps	   are	   dictated	   by	   the	   different	   primary	  sequences	  of	  their	  respective	  strains	  (Figure	  65B).	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However	   as	   there	   are	   no	   differences	   in	   sequence	   within	   the	   helix	   where	   the	  conformational	   change	   occurs	   it	   is	   unlikely	   that	   strain	   differences	   account	   for	   the	  range	  of	  positions	  seen	  between	  the	  N	  proteins.	  Furthermore	  the	  two	  positions	  of	  the	  two	   arms	   and	   conformation	   of	   each	   helix	   linking	   each	   to	   the	   globular	   domains	  displayed	   in	   strain	   IbAr10200	   correspond	   very	   closely	   to	   the	   alternating	  conformations	   of	   the	   other	   two	   strains	   respectively.	   Therefore	   the	   single	   α-­‐helix	  linking	  the	  globular	  and	  arm	  domains	  is	  unlikely	  to	  provide	  a	  rigid	  link	  and	  is	  able	  to	  adopt	  a	  number	  of	  conformations,	  independent	  of	  the	  strain	  sequence	  (Figure	  68).	  
Although	  there	  is	  the	  possibility	  that	  these	  conformational	  differences	  may	  have	  been	  forced	  by	  crystal	  packing,	  it	  is	  likely	  that	  they	  are	  also	  reflected	  in	  solution,	  and	  have	  attained	  their	  position	  through	  the	  bacterial	  expression	  process.	  One	  consequence	  of	  the	  shifted	  arm	  position	  is	  an	  altered	  electrostatic	  surface	  potential,	  which	  may	  affect	  the	  RNA	  binding	  ability	  of	  the	  respective	  proteins.	  Such	  a	  shift	   in	  conformation	  may	  only	  be	  stimulated	  through	  the	  presence	  of	  RNA	  or	  as	  yet	  an	  unknown	  factor,	  similar	  to	   the	  proposed	  gating	  mechanism	  of	   the	  LASV	  NP	  (Figure	  23).	  One	  possible	  model	  for	   RNA	   binding	   could	   involve	   the	   arm	   representing	   part	   of	   a	   gating	   mechanism	  allowing	   a	   switch	   between	   RNA-­‐bound	   and	   unbound	   states.	   Furthermore	   it	   is	   also	  plausible	  that	  the	  switch	  in	  arm	  position	  is	  responsible	  for	  conversion	  of	  monomeric	  N	  into	  higher-­‐order	  complexes,	  which	  are	  required	  for	  RNP	  assembly.	  
3.14.8	  Comparison	  of	  electrostatic	  potential	  analysis	  of	  the	  CCHFV	  N	  proteins	  from	  




Figure	   69.	   Electrostatic	   potential	   analysis	   of	   the	   CCHFV	   N	   protein	   from	   Baghdad-­‐12,	   YL04057	   and	  IbAr10200	  strains.	  (A)	  The	  electrostatic	  surface	  potential	  of	  N	  protein	  from	  Baghdad-­‐12	  showing	  the	  positively	   charged	  RNA	  binding	   “platform”,	   solely	   located	  within	   the	   surface	   of	   the	   globular	   domain	  (Unni	   et	   al.,	   2011).	   (B)	   Rotation	   by	   180	   degrees	   showing	   the	   smaller	   additional	   positively	   charged	  groove,	  termed	  the	  “pocket.”	  (C)	  The	  electrostatic	  surface	  potential	  of	  N	  protein	  from	  Yl04057.	  (D)	  The	  electrostatic	  surface	  potential	  of	  the	  monomer	  form	  of	  N	  protein	  from	  IbAr10200.	  (E)	  The	  electrostatic	  surface	  potential	  of	  the	  oligomer	  form	  of	  N	  protein	  from	  IbAr10200.	  The	  scale	  bar	  shows	  the	  contour	  levels	  for	  the	  electrostatic	  potential	  at	  the	  solvent-­‐exposed	  surface,	  in	  kT/e.	  The	  figure	  was	  generated	  using	  APBS	  in	  PyMol	  (Unni	  et	  al.,	  2011).	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3.14.9	  Functional	  analysis	  of	  selected	  N	  protein	  residues	  by	  use	  of	  a	  CCHFV	  minigenome	  
system	  performed	  by	  Dr.	  Eric	  Bergeron,	  Dr.	  Cheryl	  Walter	  and	  Rebecca	  Surtees	  The	  central	  region	  of	  the	  protein	  protrudes	  from	  the	  globular	  domain	  and	  resembles	  an	   arm.	   The	   positively	   charged	   exposed	   surfaces	   identified	   on	   the	   exterior	   of	   the	  globular	  domain	  guided	  mutagenesis	  and	  revealed	   the	  strict	  requirement	  of	  several	  residues	   on	   these	   surfaces	   for	   CCHFV	   gene	   expression,	   suggesting	   involvement	   in	  RNA	  binding.	  
To	  characterize	  the	  role	  of	  the	  CCHFV	  N	  protein	  residues	  in	  both	  multimerization	  and	  RNA	  binding,	  the	  CCHFV	  minigenome	  system	  was	  used	  to	  examine	  a	  panel	  of	  CCHFV	  N	  proteins	  with	  various	  mutations	  within	  the	  proposed	  RNA	  binding	  surfaces	  (Figure	  70),	   caspase-­‐3	   protease	   cleavage	   site	   and	   the	   potential	   dimer	   interface,	   for	   their	  ability	  to	  promote	  CCHFV-­‐specific	  RNA	  synthesis.	  The	  CCHFV	  N	  mini-­‐genome	  system	  utilizes	  a	  luciferase	  based	  reporter	  gene	  expression,	  which	  is	  promoted	  by	  formation	  of	   RNP	   templates	   from	  RNA	   and	  N	   protein,	  which	   can	   be	  measured	   in	  mammalian	  cells.	   Expression	   of	   the	   luciferase	   reporter	   gene	   system	   in	   the	  minigenome	   system	  (Figure	  71)	  depends	  on	  the	  CCHFV	  N	  protein’s	  ability	  to	  bind	  RNA,	  interact	  with	  itself	  to	   encapsidate	   and	   replicate	   RNA;	   thus,	   any	   drop	   in	   genome	   activity	   likely	   results	  from	   changes	   in	   either	   RNA	   binding	   or	   multimerization	   activities	   (Figure	   71C).	  Expression	  of	  altered	  N	  proteins	  was	  examined	  by	  western	  blotting	  from	  equivalent	  quantities	  of	  cells	  expressing	  the	  minigenome	  system	  (Figure	  71D).	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Figure	  70.	  Identifying	  important	  RNA	  binding	  residues	  for	  analysis	  using	  the	  minigenome	  system.	  (A)	  Cartoon	  representation	  of	  Baghdad-­‐12	  CCHFV	  N	  crystal	  structure.	  Residues	  coloured	  red	  and	  labelled	  are	  those	  chosen	  based	  on	  the	  electrostatic	  surface	  potential.	  (B)	  The	  electrostatic	  surface	  potential	  of	  CCHFV	  N	  from	  Baghdad-­‐12	  (generated	  with	  APBS),	  displaying	  the	  RNA	  binding	  “platform”.	  The	  figure	  was	  generated	  using	  APBS	  in	  PyMol	  (Unni	  et	  al.,	  2011).	  Expansion	   of	   the	   putative	   RNA	   binding	   “platform”	   using	   electrostatic	   surface	  potential	  analysis	  identified	  nine	  residues	  (Figure	  70),	  which	  were	  mutated	  to	  alanine	  and	   analysed	   using	   the	   mini	   genome	   system.	   The	   genome	   activity	   of	   six	   of	   these	  mutants	  was	  unchanged,	  (K91A,	  K98A,	  E112A,	  R140A,	  S149A,	  and	  Y470A);	  however,	  the	   three	   remaining	  mutants	   showed	   genome	   activity	   that	  was	   either	   considerably	  reduced	  (K90A)	  or	  effectively	  abolished	  (K132A	  and	  Q300A)	  (Figure	  71C).	  Of	   those	  mutated	   positively	   charged	   residues	   within	   the	   RNA	   binding	   pocket,	   the	   H453A,	  K342A	   and	   K343A	   mutants	   displayed	   almost	   wild-­‐type	   activity.	   The	   H456A	   and	  K411A	  mutants	  on	  the	  other	  hand	  resulted	  in	  significantly	  reduced	  or	  abolished	  RNP	  activity,	   respectively	   (Figure	  71B).	  Attempts	   to	  analyse	   residues	  E387A,	   I304G,	   and	  W313A	  mutants,	  located	  in	  the	  pocket,	  using	  the	  mini-­‐genome	  system	  failed	  because	  they	  were	  poorly	  expressed	  or	  undetectable	  in	  transfected	  cells	  (Figure	  71D).	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Figure	  71.	  In	  vivo	  analysis	  of	  site-­‐directed	  CCHFV	  N	  protein	  mutants.	  (A)	  CCHFV	  N	  protein	  in	  cartoon	  representation,	  highlighted	  amino	  acids	  selected	  for	  mutation	  and	  analyse	  in	  the	  minigenome	  system.	  Residues	   highlighted	   in	   green	   represent	   the	   putative	   RNA	   binding	   located	   on	   the	   globular	   domain,	  residues	  highlighted	  in	  blue	  comprise	  the	  RNA	  binding	  pocket,	  and	  D269	  of	  the	  DEVD	  motif	  is	  shown	  in	  orange,	   and	   residues	   shown	   in	   red	   represent	   the	   dimer	   interface.	   Residues	   K132,	   Q300,	   and	   K411	  abolished	   minigenome	   activity	   and	   are	   highlighted	   in	   magenta.	   (B)	   Cartoon	   representation	   of	   the	  CCHFV	   N	   protein	   dimer	   present	   in	   both	   crystal	   forms,	   investigated	   using	   the	   minigenome	   system,	  suggests	  a	  putative	  dimer	  interface.	  (C)	  Bar	  chart	  coloured	  as	  described	  above	  showing	  reporter	  gene	  expression	  for	  mutants.	  The	  height	  of	  each	  bar	  is	  the	  percentage	  of	  that	  of	  wild	  type	  (WT)	  N.	  CCHFV	  M	  minigenome	  Renilla	  luciferase	  activities	  were	  normalized	  over	  the	  control	  firefly	  luciferase	  activity	  and	  are	  reported	  as	  percentages	  of	  wild-­‐type	  N	  activity.	  Error	  bars	  represent	  the	  standard	  deviation	  from	  3	  independent	   experiments.	   (D)	   SDS-­‐PAGE	   followed	   by	   Western	   blot	   analysis	   using	   a	   polyclonal	  antibody	   raised	   against	   the	   CCHFV	   N	   protein	   to	   assess	   respective	   expression	   levels	   of	   N	   protein	  mutants.	  Panels	  A	  and	  B	  were	  generated	  using	  PyMol	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The	   non-­‐crystallographic	   dimer	   interface	   (Figure	   71B),	  was	   also	   investigated	   using	  the	  mini	  genome	  system	  (Figure	  71B)	  and	  N	  proteins	  bearing	  mutations	  within	  this	  interface	   were	   generated	   using	   both	   single-­‐residue	   mutants	   (E108A	   and	   K114A	  mutants)	   and	   double-­‐residue	   mutants	   (K354A/E108A,	   K357A/E112A,	  K358A/R140A,	   and	  E361K/K114A	  mutants)	   (Figure	   71A,	   red	   residues).	  Not	   one	   of	  the	   single	   mutants	   or	   double	   mutants	   abrogated	   the	   activity	   of	   the	   mini-­‐genome	  system,	  which	   suggests	   these	   residues	   are	   likely	  not	   essential	   for	  CCHFV	  N	  protein	  oligomerization	  (Figure	  71B	  and	  C).	  	  
The	  double	  mutants	  K354A/E108A	  and	  K357/E112A	  did	  produce	  a	  reduction	  in	  RNP	  activity	  and	  perhaps	  these	  residues	  correspond	  to	  roles	  in	  RNP	  assembly,	  possibly	  by	  promoting	  oligomerization	  (Figure	  71C).	  Furthermore	  the	  mini-­‐genome	  system	  was	  used	  to	  explore	  the	  mutants	  with	  altered	  DEVD	  motifs	  (DEVG	  and	  DEVE),	  which	  are	  not	   cleavable	   by	   caspase-­‐3	   protease.	   None	   of	   these	   mutants	   abrogated	   the	   RNP	  formation	  and	  the	  mini-­‐genome	  activity	  was	  indistinguishable	  from	  that	  of	  wild-­‐type	  N	  (Figure	  71C).	  
3.14.10	  Potential	  for	  a	  gated	  RNA	  binding	  mechanism.	  The	  electrostatic	  charge	  distribution	  on	   the	  CCHFV	  N	  surface	  revealed	   two	  possible	  RNA	   binding	   regions:	   the	   platform	   and	   the	   pocket.	   Superpositioning	   of	   globular	  domains	  of	  CCHFV	  N	  from	  strains	  Baghdad-­‐12,	  YL04057,	  and	  IbAr10200,	  suggest	  that	  the	   arm	   is	   free	   to	   take-­‐up	   a	   range	  of	   conformations,	  which	   could	   significantly	   alter	  surface	   electrostatics	   and	   therefore	   RNA	   binding	   (Figure	   69A,	   B,	   C,	   D	   and	   E).	   The	  mobility	  of	   the	  arm	  could	  be	  allowed	  by	   the	   flexibility	  of	   the	   loop	  between	   the	  arm	  and	   the	   globular	   domain	   (residues	   183	   to	   191;	   not	   visible	   in	   either	   the	   YL04057,	  IbAr10200	  and	  Baghdad-­‐12	  N	  protein	  crystal	  structures),	  and	  perhaps	  allows	  the	  arm	  domain	  to	   form	  a	  “gate”	   in	  an	  RNA	  binding	  mechanism,	  similar	   to	   the	  LASV	  NP	  and	  RVFV	  N	  gates	  (Figure	  72).	  
The	  proposed	  RNA	  gating	  mechanism	  for	  LASV	  NP	  involves	  helices	  α5	  and	  α6,	  which	  are	   repositioned	   to	   allow	   the	   binding	   of	   RNA	   in	   a	   previously	   unexposed	   surface	  (Hastie	  et	  al.,	  2011b).	  Interestingly	  the	  position	  of	  helix	  α5	  in	  LASV	  NP	  corresponds	  to	  the	   beginning	   of	   the	   flexible	   loop	   leading	   to	   the	   CCHFV	   arm	   domain,	   suggesting	  CCHFV	  N	  may	  operate	  in	  a	  similar	  mechanism	  for	  RNA	  binding,	  and	  may	  involve	  the	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arm	  domain	  taking	  part	  in	  conformational	  switching	  between	  open	  and	  closed	  states	  (Figure	  72).	  







Figure	   72.	   RNA	   gated	   binding	  mechanism	   for	   LASV	   NP.	   The	   superimposition	   of	   two	   separate	   crystal	  structures	  of	  the	  LASV	  NP:	  N-­‐terminal	  coloured	  in	  purple	  (amino	  acids	  8-­‐336,	  PDB	  code:	  3T5Q),	  and	  N	  and	  C-­‐termini	  coloured	  in	  green	  (amino	  acids	  7-­‐569,	  PDB	  code:	  3MWT),	  shows	  the	  alpha	  helix	  six	  in	  two	  conformations.	  The	  change	  in	  conformation	  of	  alpha	  helix	  six	  (blue	  arrow),	  within	  the	  crystal	  structure	  of	   the	   N-­‐terminal	   of	   the	   LASV	   NP	   allowed	   the	   co-­‐crystallization	   of	   a	   short	   ssRNA	   molecule	   into	   the	  proposed	  RNA	  binding	  site	  and	  shows	  the	  flexibility	  of	  this	  region	  which	  could	  potentially	  be	  involved	  in	  a	  potential	  RNA	  gating	  mechanism	  for	  RNA	  binding.	  The	  figure	  was	  generated	  using	  PyMol.	  It	  could	  be	  possible	  that	  the	  RNA	  binding	  surfaces	  are	  not	  presented	  in	  the	  apo	  crystal	  structures	   and	   in	   order	   to	   reveal	   them	   a	   combination	   of	   arm	  movement	   and	   other	  structural	   rearrangements	   may	   be	   involved.	   The	   concept	   of	   the	   arm	   adopting	  different	  positions	  and	  allowing	  for	  structural	  rearrangement	  has	  been	  supported	  by	  comparison	  with	  the	  apo	  crystal	  structures	  of	  CCHFV	  N	  proteins	  from	  three	  different	  strains	   of	   CCHFV	   (Guo	   et	   al.,	   2012,	   Wang	   et	   al.,	   2012,	   Carter	   et	   al.,	   2012b).	  Superpositioning	   of	   the	   CCHFV	  N	  protein	   from	   strains	   IbAr10200,	  Baghdad-­‐12	   and	  YL04057,	   revealed	   that	   while	   the	   globular	   domains	   align	   very	   similarly,	   the	   arm	  domains	  assume	  very	  different	  positions	  (Figure	  68).	  	  
3.14.11	  CCHFV	  RNP	  architecture	  	  The	  crystal	  structures	  of	  the	  CCHFV	  N	  protein	  from	  strain	  IbAr10200	  supported	  the	  hypothesis	  that	  the	  flexibility	  of	  the	  arm	  domain	  is	  an	  important	  feature,	  which	  allows	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the	   N	   protein	   to	   function	   in	   important	   activities	   such	   as	   RNA	   binding	   and	  oligomerization	   to	   assemble	   the	   RNP	   (Wang	   et	   al.,	   2012).	   The	   CCHFV	   N	   protein	  crystal	  structure	  from	  Wang	  et	  al	  (Wang	  et	  al.,	  2012)	  revealed	  that	  running	  through	  the	  crystal	  along	  the	  crystallographic	  c	  axis	  was	  an	  antiparallel	  double	  superhelix	  of	  nine	  molecules	  per	   turn	  per	  helix	   (Figure	  73).	  One	   fundamental	  difference	  between	  the	  double	  helix	  arrangement	  of	  CCHFV	  N	  protein	  and	  the	  architecture	  of	  N	  protein	  seen	  in	  the	  phleboviruses,	  orthobunyaviruses,	  and	  nsNSVs	  such	  RSV	  and	  VSV,	   is	  the	  lack	   of	   either	   N-­‐	   and	   C-­‐terminal	   extensions	   contributing	   in	   binding	   to	   adjacent	   N	  proteins.	   Instead	   the	   arm	   domain	   and	   areas	   of	   the	   central	   portion	   of	   the	   globular	  domain	   drive	   the	   N-­‐N	   interaction	   in	   the	   Wang	   et	   al	   superhelix	   homo-­‐oligomer	  structure.	  	  
The	   homo-­‐oligomer	   arrangement	   of	   CCHFV	   N	   protein	   in	   the	   proposed	   RNP	   has	   a	  similar	  arrangement	  with	  the	  N	  protein	  structure	  of	  the	  IAV	  RNP	  complex	  visualized	  using	  ECT.	  Furthermore	   it	   is	  not	  uncommon	   for	  monomeric	  N	  protein	   to	  crystallize	  into	  an	  oligomerized	  form	  that	  is	  biologically	  relevant	  (Ferron	  et	  al.,	  2011),	  and	  it	  may	  be	   that	   the	   N	   protein/RNA	   complex	   is	   required	   for	   oligomerization	   to	   occur	   in	  solution.	  	  
Oligomerization	   of	   one	   CCHFV	   N	   protein	   helix	   in	   this	   model	   is	   driven	   by	   the	  interaction	  of	  the	  stalk	  with	  the	  base	  of	  the	  globular	  body	  of	  the	  adjacent	  protomer.	  Although	   the	   degree	   of	   bending	   within	   the	   helix	   means	   the	   contacts	   between	   the	  protomer	   are	   slightly	   different,	   all	   the	   interactions	   between	   the	   stalk	   and	   body	  involve	   extensive	   hydrogen	   bonds	   and	   van	   der	   Waals	   contacts	   between	   the	   same	  residues.	  In	  particular,	  the	  interactions	  observed	  between	  main	  chain	  residues	  352	  to	  354	  of	  the	  α17-­‐α18	  loop	  of	  the	  globular	  domain	  and	  residues	  266	  to	  269	  at	  the	  α12-­‐α13	   loop	   in	   the	  arm	  domain	  of	   the	  adjacent	  molecule,	  were	  previously	   identified	  as	  the	   caspase-­‐3	   protease	   cleavage	   site.	   None	   of	   these	   interactions	   are	   seen	   in	   the	  Baghdad-­‐12	  C2,	   or	  P212121	   CCHFV	  N	   protein	   crystal	   structures	   and	   analysis	   of	   the	  residues	  involved	  in	  the	  dimer	  interface	  seen	  in	  both	  forms	  argues	  against	  this	  being	  a	  functional	  element	  within	  the	  RNP,	  however	  an	  intermediate	  of	  RNP	  assembly	  can	  not	  be	  ruled	  out.	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Figure	   73.	   Crystal	   structure	   of	   the	   CCHFV	   N	   protein	   from	   strain	   IbAr10200	   showing	   homo-­‐oligomerization.	   (A)	   The	   antiparallel	   double	   superhelix	   of	   CCHFV	   N	   protein.	   The	   double	   helix	   is	  coloured	   yelloworange,	   except	   for	   three	   CCHFV	   N	   protomers	   in	   the	   antiparallel	   strand,	   which	   are	  coloured	   black.	   The	   two	   arrows	   point	   towards	   each	   direction	   of	   each	   antiparallel	   CCHFV	  N	   protein	  strand.	  (B)	  AU	  of	  the	  P31	  axis.	  Adapted	  from	  (Wang	  et	  al.,	  2012).	  The	  figure	  was	  generated	  using	  PyMol.	  
3.14.12	  PISA	  analysis	  of	  dimer	  interface	  in	  C2	  and	  P212121	  crystal	  structures	  The	  PISA	   results	   suggest	   that	   even	   the	   largest	   interface	   between	   the	   two	  CCHFV	  N	  protein	   in	   the	   AU	   of	   the	   Baghdad-­‐12	   C2	   and	   P212121	   crystal	   structures	   are	   not	  sufficient	   to	   generate	   a	   stable	   interface	   in	   solution.	   For	   comparison,	   the	   oligomeric	  interfaces	   present	   in	   the	  RVFV	  N	  protein	   structure	   have	   an	   average	   buried	   surface	  area	   of	   1,643	   Å2,	   a	   ΔG	   value	   of	   −18.5	   kcal/mol,	   and	   a	   CSS	   of	   1.0.	   However,	   lattice	  contacts	   within	   the	   same	   RVFV	   N	   protein	   crystal	   form	   present	   an	   average	   buried	  surface	  area	  of	  437	  Å2	  and	  a	  ΔG	  value	  of	  −3.9	  kcal/mol;	  thus,	  the	  CCHFV	  N	  interface	  was	   scored	   at	   values	   intermediate	   between	   the	   two.	   The	   PISA	   analysis	   therefore	  suggest	   this	   interface	   may	   not	   represent	   part	   of	   the	   authentic	   oligomerization	  domain,	  and	  this	   is	  also	  supported	  by	   there	  being	  no	  similar	   interface	   in	   the	  homo-­‐oligomer	   arrangement	   of	   CCHFV	   N	   protein	   proposed	   by	   Wang	   et	   al	   (Wang	   et	   al.,	  2012).	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3.14.13	  Conformational	  change	  in	  Wang	  et	  al	  CCHFV	  N	  protein	  crystal	  structures	  	  To	   further	   understand	   the	   RNA	   binding	   sites	   of	   the	   CCHFV	   N	   protein	   Wang	   et	   al	  attempted	   to	   co-­‐crystallize	   the	   N	   protein	   with	   ssRNA	   of	   primer-­‐lengths	   12	   to	   16	  nucleotides	   long,	   and	  unexpectedly	   crystallized	   the	  CCHFV	  N	  protein	  with	  only	  one	  CCHFV	   N	   protein	   in	   the	   AU	   (monomer)	   and	   without	   additional	   electron	   density	  resembling	  bound	  RNA.	  
The	  structure	  revealed	  a	  dramatic	  shift	  in	  the	  conformation	  in	  the	  arm	  domain	  of	  the	  CCHFV	   N	   protein,	   upon	   incubation	   with	   primer-­‐length	   ssRNAs.	   In	   particular	   the	  rotation	  of	  helices	  of	  α13	  and	  α14	   into	  a	  continuous	   long	  α-­‐helix	  at	   the	  hinge	  S294,	  resulting	   in	   the	   rotation	   of	   the	   stalk	   domain	   by	   ~168°.	   The	   same	   alternative	  conformation	   can	   be	   seen	   between	   CCHFV	  N	   protein	   from	   strains	   Baghdad-­‐12	   and	  YL04057	   at	   exactly	   the	   same	  position,	   S294.	   This	   rotation	   of	   the	   stalk	   domain	  was	  proposed	  to	  disrupt	   the	  head	  to	   tail	   interaction	  via	   the	  α12-­‐α13	   loop	  at	   the	  apex	  of	  the	  CCHFV	  N	  protein	  and	  also	  cause	  steric	  hindrance	  between	  the	  antiparallel	  dimers	  in	  the	  superhelical	  oligomer	  structure	  (Figure	  73).	  
3.14.14	  Caspase-­‐3	  cleavage	  of	  CCHFV	  N	  protein	  Wang	   et	   al	   revealed	   the	   DEVD	   site	   was	   located	   directly	   between	   the	   head-­‐to-­‐tail	  interactions	   of	   two	   CCHFV	   N	   proteins,	   and	   this	   location	   obscures	   binding	   and	  subsequent	   cleavage	   by	   the	   caspase-­‐3	   protease.	  Wang	   et	   al	   also	   reported	   that	   the	  monomeric	  form	  of	  the	  CCHFV	  N	  protein	  is	  more	  susceptible	  to	  cleavage	  upon	  adding	  a	   short	   ssRNA	   mimicking	   a	   primer	   to	   the	   oligomeric	   form	   of	   CCHFV	   N	   protein.	  Interestingly	  the	  work	  in	  this	  thesis	  agrees	  with	  Wang	  et	  al,	  and	  shows	  that	  Baghdad-­‐12	  CCHFV	  N	  protein	  structure	  displays	  a	  similar	  conformation	  to	  the	  oligomeric	  form	  of	   IbAr10200	  strain	  N	  protein,	  and	   is	  also	  a	  poor	  substrate,	  although	  susceptible	   to	  cleavage	  by	  caspase-­‐3	  protease	  over	  many	  hours.	  Unfortunately	  Wang	  et	  al	  (Wang	  et	  al.,	  2012)	  did	  not	  reveal	  how	  long	  their	  CCHFV	  N	  protein	  was	  incubated	  with	  caspase-­‐3	  protease.	  
As	  a	  result,	  Wang	  et	  al	  proposed	  the	  monomeric	  CCHFV	  N	  will	  be	  released	  from	  the	  ends	   of	   the	   double	   superhelical	   CCHFV	   N	   polymer,	   allowing	   the	   exposure	   of	   the	  caspase-­‐3	  protease	   cleavage	   site	   situated	   at	   the	   loop	   region	   at	   the	   apex	   of	   the	   arm	  domain	   to	  activated	  caspase-­‐3	  protease.	  The	  reason	   for	   the	   functional	   link	  between	  the	   apex	   of	   the	   arm	   domain	   becoming	   accessible	   to	   caspase-­‐3	   protease	   upon	   the	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presence	  of	  primer	   length	  RNA	   is	  uncertain.	   It	   is	  also	  uncertain	  whether	   the	  homo-­‐oligomers	  seen	  in	  the	  CCHFV	  N	  crystal	  structure	  for	  strain	  IbAr10200	  are	  biologically	  representative	   of	   authentic	   CCHFV	   RNPs	   from	   infected	   cells	   or	   alternatively	   an	  artefact	  of	  crystal	  packing.	  Directly	  visualizing	  infectious	  CCHFV	  RNPs	  using	  EM	  may	  provide	  clues	  into	  the	  assembly	  of	  the	  CCHFV	  N	  protein,	   like	  that	  which	  has	  already	  been	   achieved	   for	   the	  RNPs	  of	   orthobunyaviruses	   and	  phleboviruses	   (Ferron	   et	   al.,	  2011,	  Ariza	  et	  al.,	  2013,	  Li	  et	  al.,	  2013,	  Niu	  et	  al.,	  2013,	  Reguera	  et	  al.,	  2013,	  Dong	  et	  al.,	  2013b).	  
It	  was	  previously	  shown	  that	  stimulus	  of	  apoptosis	  and	  depletion	  of	  full	  length	  CCHFV	  N	  by	  caspase-­‐3	  protease	  cleavage	  via	  the	  DEVD	  motif,	  which	   is	  conserved	  across	  all	  strains	   of	   CCHFV	  would	   be	   detrimental	   to	   the	   replication	   cycle	   of	   the	   virus	   in	   host	  cells,	   and	   therefore	   represents	   a	   host	   cell	   mechanism	   against	   CCHFV	   infection	  (Karlberg	  et	  al.,	  2011).	  However	  the	  striking	  feature	  of	  the	  CCHFV	  N	  protein	  structure	  is	  the	  accessibility	  of	  the	  DEVD	  motif	  situated	  within	  the	  far	  end	  of	  the	  arm	  domain	  (Figure	   54).	   The	   exposed	   position	   of	   the	   DEVD	   motif	   of	   the	   monomer	   CCHFV	   N	  protein,	  and	  not	  being	  exposed	  within	  the	  RNP,	  together	  with	  its	  strict	  conservation	  in	   all	   CCHFV	   strains,	   suggests	   that	   cleavage	   of	   the	   CCHFV	   N	   protein	   is	   somehow	  beneficial	   to	   the	   virus,	   and	   not	   a	   host	   cell	   mechanism	   to	   protect	   the	   cellular	  environment	   from	   viral	   replication.	   Surely	   if	   cleavage	   by	   caspase-­‐3	   protease	   were	  beneficial	   to	   the	   host	   cell,	   then	   the	  DEVD	  would	   be	   quickly	   selected	   out	   of	   the	   fast	  mutating	   CCHFV	   genome	   through	   viral	   evolution.	   However	   importantly	   the	   DEVD	  motif	  could	  be	  maintained	  by	  other	  more	  important	  aspects	  of	  the	  viral	  life	  cycle	  and	  interestingly	   the	   DEVD	   motif	   has	   been	   shown	   to	   be	   involved	   in	   taking	   part	   in	  interaction	   between	  monomers	  within	   the	   homo-­‐oligomer	   helix	  model,	   which	  may	  have	   important	   implications	   for	   viral	   RNA	   synthesis,	   such	   as	   replication	   and	  transcription.	  Currently	  there	  is	  no	  evidence	  to	  suggest	  how	  much	  CCHFV	  N	  protein	  is	  free	  and	  not	  RNP	  associated	  within	  a	  cell.	  
The	  structural	  significance	  of	  the	  caspase-­‐3	  protease	  cleavage	  site	  within	  the	  CCHFV	  N	   protein	   was	   investigated	   to	   provide	   clues	   into	   the	   functional	   importance	   of	   this	  event	  during	  CCHFV	  infection.	  Therefore	  the	   fate	  of	   the	  CCHFV	  N	  protein	   fragments	  following	  cleavage	  was	  investigated,	  and	  performed	  by	  observing	  caspase-­‐3	  protease	  cleavage	   of	   the	   N	   protein	   in	   vitro.	   It	   was	   demonstrated	   that	   upon	   cleavage	   of	   the	  CCHFV	  N	  by	  recombinant	  caspase-­‐3	  protease	  the	  cleavage	  products	  remained	  closely	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associated	  as	  a	  single	  complex,	  perhaps	  resembling	  the	  native	  CCHFV	  N	  protein.	  The	  cleavage	   of	   the	   N	   protein	   could	   however	   induce	   altered	   tertiary	   or	   quaternary	  structure,	   which	   could	   have	   functional	   consequences,	   including	   the	   adoption	   of	  different	  oligomeric	  states	  or	  alterations	  in	  RNA	  binding	  affinity	  and	  interactions	  with	  viral/host	  cell	  protein	  partners.	  
One	  proposed	  reason	  for	  the	  caspase-­‐3	  protease	  cleavage	  of	  CCHFV	  N	  protein	  could	  involve	  reducing	  the	  overall	  rate	  of	  activated	  caspase-­‐3	  protease	  cleavage	  of	  cellular	  substrates	  during	  the	  onset	  of	  apoptosis	  by	  acting	  as	  a	  decoy.	  By	  the	  CCHFV	  N	  protein	  acting	   as	   an	   alternative	   caspase-­‐3	   protease	   substrate	   it	   could	   prevent	   the	  downstream-­‐mediated	   signaling	   pathways,	   including	   apoptosis	   and	   the	   interferon	  response,	   with	   important	   consequences	   for	   viral	   growth.	   Interestingly	   Wolff	   et	   al	  (Wolff	  et	  al.,	  2013)	  have	  recently	  demonstrated	  that	  infection	  with	  Junin	  virus	  (JUNV)	  (arenavirus)	   in	   cell	   culture	   leads	   to	   cleavage	   of	   the	   viral	  NP	   into	   discrete	   products	  resembling	  caspase-­‐3	  protease	  cleavage	  of	  the	  CCHFV	  N	  protein.	  Although	  in	  contrast	  JUNV	   infection	   does	   not	   induce	   apoptosis	   in	   cells,	   the	   JUNV	   NP	   has	   been	   shown	  importantly	  to	  function	  as	  a	  decoy	  substrate	  for	  caspase-­‐3	  protease	  cleavage	  in	  order	  to	  inhibit	  the	  onset	  apoptosis.	  The	  absence	  of	  apoptosis	  in	  JUNV	  infected	  cells	  could	  reflect	   the	   ability	   of	   the	  NP	   to	   be	   cleaved	   through	   two	   or	   possibly	  more	   identified	  caspase	  cleavage	  motifs,	  and	  it	  is	  therefore	  more	  potent	  at	  preventing	  apoptosis	  than	  the	  CCHFV	  N	  protein.	   Interestingly	   the	  purified	   JUNV	  particles	  have	  been	   shown	   to	  incorporate	   both	   the	   47	   kDa	   and	   40	   kDa	   cleavage	   products	   of	   the	  NP,	  whereas	   no	  cleaved	  N	  protein	   is	   present	   in	  CCHFV	   (Bergeron	  et	   al.,	   2007a),	   and	   suggests	   these	  truncated	  forms	  of	  JUNV	  NP	  may	  play	  additional	  roles	  in	  viral	  assembly	  or	  preventing	  apoptosis.	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3.14.15	  CCHFV	  N	  protein	  dsDNA	  specific	  endonuclease	  Guo	   et	   al	   (Guo	   et	   al.,	   2012),	   reported	   that	   the	   CCHFV	   N	   protein	   displayed	   dsDNA	  specific	  endonuclease	  activity,	  located	  within	  the	  globular	  domain,	  within	  the	  pocket	  of	  negatively	  charged	  amino	  acids	  identified	  using	  APBS	  (Unni	  et	  al.,	  2011).	  	  	  
	  
Figure	  74.	  CCHFV	  N	  protein	  putative	  dsDNA	  endonuclease	  active	  site.	  Residues	  located	  in	  the	  globular	  domain	   whose	   hydrophilic	   side	   chains	   are	   near	   the	   proposed	   small	   RNA	   binding	   “pocket”	   domain	  (Figure	  69B).	  The	  figure	  was	  generated	  using	  PyMol.	  The	  figure	  was	  adapted	  from	  Guo	  et	  al	  (Guo	  et	  al.,	  2012).	  The	  authors	  reported	  that	  endonuclease	  activity	  was	  specific	  for	  dsDNA	  and	  not	  RNA,	  was	  inhibited	  by	  EDTA,	  and	  active	  in	  the	  presence	  of	  divalent	  cations,	  including	  Co2+,	  Mg2+,	   and	  Mn2+.	  Guo	  et	   al	   also	   identified	  a	  putative	  active	   site,	  which	   consisted	   five	  amino	  acids,	  Q455,	  H451,	  E384,	  E387,	  and	  K411	  (Figure	  74),	  which	  when	  mutated	  to	  alanine	  abrogated	  endonuclease	  activity.	  	  The	  proposed	   site	   for	  dsDNA	  endonuclease	   activity	  of	  CCHFV	  N,	   argues	   against	   the	  positively	   charge	   pocket	   being	   involved	   in	   RNA	   binding,	   and	   points	   to	   an	   as	   yet	  unidentified	  function	  (Figure	  74).	  The	  endonuclease	  activity	  could	  be	  an	  artifact	  of	  in	  
vitro	   analysis,	   and	  analysis	   in	  vivo	  may	   reveal	   the	  CCHFV	  N	  protein	   acts	   as	   an	  RNA	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endonuclease,	  which	  would	  make	  more	  sense,	  as	  the	  CCHFV	  N	  protein	  does	  not	  locate	  to	  the	  nucleus,	  but	  resides	  in	  the	  cytoplasm.	  In	  this	  work	  residue	  K411	  favors	  a	  direct	  role	  in	  CCHFV	  gene	  expression	  and	  not	  the	  DNase	  activity	  proposed	  by	  Guo	  et	  al	  (Guo	  et	  al.,	  2012).	  
3.14.16	  Possible	  roles	  of	  the	  CCHFV	  N	  endonuclease	  If	  the	  endonuclease	  activity	  of	  the	  CCHFV	  N	  protein	  is	  real	  and	  important	  for	  the	  life	  cycle	  of	  the	  virus,	  it	  could	  play	  a	  similar	  role	  to	  the	  LASV	  NP.	  The	  LASV	  NP	  which	  has	  C-­‐terminal	   RNA	   3’	   to	   5’	   exoribonuclease	   activity,	   has	   been	   shown	   to	   suppress	  interferon	   induced	   innate	   immunity	   (Hastie	   et	   al.,	   2011a,	   Qi	   et	   al.,	   2010).	   Qi	   et	   al	  proposed	   the	   LASV	  NP	   prevents	   the	   virus-­‐induced	   IFN	   induction	   by	   degrading	   the	  PAMP	  RNAs	  that	  otherwise	  would	  trigger	  the	  viral	  sensors	  in	  the	  cells	  (Qi	  et	  al.,	  2010).	  Qi	  et	  al	  also	  reported	  that	  the	  LASV	  NP	  N-­‐terminal	  domain	  could	  digest	  both	  DNA	  and	  RNA	  substrates.	  It	  has	  been	  shown	  both	  LASV	  and	  CCHFV	  antagonize	  IRF-­‐3	  activation	  pathway	  leading	  to	  the	  host	  IFN	  response	  to	  infection	  (Akutsu	  et	  al.,	  2011,	  Kinsella	  et	  al.,	   2004,	   Martinez-­‐Sobrido	   et	   al.,	   2007),	   and	   evidence	   suggests	   they	   use	   different	  mechanisms.	  In	  contrast	  to	  immune	  suppression	  ability	  of	  the	  LASV	  NP,	  the	  CCHFV	  N	  protein	   has	   not	   been	   shown	   to	   have	   any	   significant	   effect	   on	   Sendai	   virus-­‐induced	  activation	  of	  the	  IFN-­‐β	  and	  IFN-­‐stimulated	  response	  (Guo	  et	  al.,	  2012).	  The	  possibility	  that	  CCHFV	  protein	  has	   IFN	   suppression	  ability	  using	   a	  different	  mechanism	   to	   the	  LASV	  NP	  and	  perhaps	  uses	  DNA	  endonuclease	  activity	  to	  perform	  this	  cannot	  be	  ruled	  out.	   An	   example	   of	   DNA	   exonuclease	   suppressing	   production	   of	   IFN	   has	   been	  demonstrated	   for	   the	   human	   TREX1	   protein.	   The	   human	   TREX1	   protein	   has	   been	  shown	  to	  degrade	  small	  single	  stranded	  DNAs	  and	  dsDNAs,	  which	  accumulate	  during	  cellular	   apoptosis.	   Failure	   to	   remove	   DNA	   fragments	   by	   defective	   TREX1	   has	   been	  reported	   to	   lead	   to	   cellular	   DNA	   receptor	   activation,	   triggering	   a	   persistent	  production	  of	  IFNs,	  which	  has	  been	  linked	  to	  some	  human	  autoimmune	  diseases	  (de	  Silva	  et	  al.,	  2007,	  Stetson	  et	  al.,	  2008,	  Crow	  and	  Rehwinkel,	  2009).	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4.	  Chapter	  4	  -­‐	  TSWV	  N	  protein	  expression,	  purification	  and	  crystallization	  
4.1	  Introduction	  	  	  
• TSWV	  is	  a	  member	  of	   the	  tospovirus	  genus,	  which	   is	   the	  only	  plant-­‐infecting	  genus	  of	   the	  Bunyaviridae	   family.	  Over	  800	  plant	  species	   in	  80	  plant	   families	  are	  susceptible	  to	  TSWV	  and	  infection	  rates	  of	  50-­‐90%	  lead	  to	  major	  losses	  in	  global	  commercial	  vegetable	  crops.	  Major	  crops	  susceptible	  to	  TSWV	  infection	  are	  tomato,	  pepper,	  lettuce,	  potato,	  papaya,	  peanut	  and	  tobacco.	  	  	  
• There	   is	   currently	   no	   high	   resolution	   structural	   information	   for	   any	   TSWV	  encoded	  protein	  to	   improve	  our	  knowledge	  of	   important	  aspects	  of	  the	  virus	  life	  cycle,	  such	  RNA	  replication	  and	  interaction	  with	  the	  host	  cell.	  	  The	   aim	   of	   this	   project	  was	   to	   attain	   high	   resolution	   structural	   information	   on	   the	  TSWV	  N	   protein	   using	   X-­‐ray	   crystallography.	   The	   first	   stage	   aimed	   to	   express	   and	  purify	  highly	  concentrated	  TSWV	  N	  protein	  suitable	  for	  crystallization	  trials.	  This	  was	  firstly	  achieved	  by	  finding	  a	  suitable	  recombinant	  expression	  tag	  and	  E.	  coli	  strain	  in	  which	   to	   produce	   abundant	   and	   soluble	   TSWV	   N	   protein.	   Next	   Ni-­‐Superflow	   Plus	  resin	   using	   His6	   trap	   methodology	   was	   used	   to	   purify	   the	   TSWV	   N	   recombinant	  protein	   away	   from	   E.	   coli	   contaminants.	   Whilst	   SEC	   was	   employed	   to	   look	   at	   the	  oligomeric	  state	  of	  the	  native	  TSWV	  N	  protein,	  it	  was	  also	  used	  to	  purify	  the	  TSWV	  N	  protein	   into	   a	   homogeneous	   state	   suitable	   for	   crystallization	   trials.	   Crucially	   for	  solving	   the	   atomic	   structure	   of	   the	   TSWV	   N	   protein,	   the	   project	   required	   growing	  reproducible	  TSWV	  N	  native	  protein	  crystals,	  which	  diffracted	  to	  high	  resolution,	  but	  also	  required	  a	  means	  to	  obtain	  phases	  of	  the	  diffracted	  X-­‐rays.	  	  	  	  	  	  	  	  	  	  
	  156	  
4.2	  Cloning	  Based	  on	  the	  successful	  expression	  and	  purification	  of	  the	  CCHFV	  N	  protein	  described	  in	   chapter	   3,	   a	   cDNA	   ORF	   representing	   the	   TSWV	   N	   protein	   was	   cloned	   into	   the	  pET28a-­‐SUMO	   plasmid	   vector	   with	   the	   aim	   of	   expressing	   a	   His6-­‐SUMO-­‐TSWV	   N	  protein.	  	  Briefly,	   PCR	   amplification	   of	   the	   TSWV	   N	   cDNA	   within	   the	   pET15b	   plasmid	   was	  performed	  using	  primers	  (appendix)	  designed	  to	  introducte	  BamHI	  and	  XhoI	  sites	  at	  the	  5’	  and	  3’	  ends	  respectively,	  and	  would	  flank	  the	  newly	  synthesized	  TSWV	  cDNA	  ORF.	  This	  new	  cDNA	  fragment	  was	   then	   inserted	   into	   the	  corresponding	  restriction	  sites	   within	   the	   pET28a-­‐SUMO	   multiple	   cloning	   site,	   so	   that	   when	   expressed	   the	  TSWV	   N	   protein	   would	   be	   fused	   to	   a	   His6-­‐SUMO	   tag	   via	   the	   N-­‐terminus.	   The	   tag	  would	  subsequently	  be	  cleaved	  to	  yield	  the	  whole	  TSWV	  N	  protein	  with	  a	  non-­‐native	  serine	  left	  on	  the	  N-­‐terminus.	  
	  Figure	  75.	  PCR	  amplification	  of	  the	  TSWV	  N	  cDNA	  from	  a	  pET-­‐15b	  plasmid	  construct.	  (A)	  1%	  agarose	  gel	   electrophoresis	   analysis	   PCR	   amplification	   of	   the	   TSWV	   N	   cDNA.	   The	   double	   pointed	   arrow	  underlines	   lanes	  analyzing	  gradient	  PCR	  reactions.	   (B)	  Amplified	  TSWV	  cDNA	  were	  pooled	   together,	  gel	  purified	  and	   cleaned	  up,	   ready	   for	   ligation	  with	  BamHI	  and	  XhoI	   double	  digested	  pET28a-­‐SUMO.	  Molecular	  weight	  standards	  (Bioline)	  (Lane	  S).	  Combined	  PCR	  amplification	  of	  the	  TSWV	  N	  cDNA	  in	  A	  (Lane	  1).	  	  	  Successful	  amplification	  of	  the	  TSWV	  N	  cDNA	  by	  PCR	  was	  confirmed	  by	  analysis	  using	  1%	  agarose	  gel	  electrophoresis,	  which	  revealed	  a	  band	  corresponding	  to	  the	  expected	  size	  of	  774	  bp	  for	  the	  TSWV	  N	  gene	  (Figure	  75A	  and	  B).	  BamHI	  and	  XhoI	  restriction	  enzymes	   were	   added	   to	   produce	   the	   respective	   sticky	   ends	   flanking	   the	   TSWV	   N	  cDNA	  required	  for	  ligation,	  the	  PCR	  product	  was	  cleaned	  up	  and	  concentrated	  (Zymo	  Research).	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The	  double	  digested	  PCR	  amplified	  TSWV	  N	  cDNA	  was	  subsequently	  1%	  agarose	  gel	  purified	   using	   a	   UV	   box,	   cleaned	   and	   concentrated	   to	   30	   ng	   μl-­‐1	   using	   a	   DNA	   gel	  cleaning	  kit	  (Qiagen).	  The	  TSWV	  N	  cDNA	  fragment	  was	  sufficient	  to	  be	  ligated	  to	  the	  double	   digested	   pET28a-­‐SUMO	  plasmid.	   The	   PCR	   fragment	   containing	   the	   TSWV	  N	  gene	  was	  ligated	  successfully	  and	  DNA	  sequencing	  confirmed	  the	  un-­‐mutated	  TSWV	  N	  ORF	  was	  in	  the	  correct	  position	  within	  the	  pET28a-­‐SUMO	  vector.	  
4.3	  Expression	  and	  purification	  of	  the	  TSWN	  N	  protein	  
4.3.1	  Purification	  of	  TSWV	  N	  protein	  with	  Ni-­‐Superflow	  Plus	  resin	  The	   expression	   and	   purification	   of	   the	   His6-­‐SUMO	   TSWV	   N	   construct	   was	   initially	  tested	  using	  Rosetta2	  cells	  and	  nickel	  resin	  using	  the	  spin	  protocol.	  The	  majority	  of	  the	   His6-­‐SUMO	   TSWV	   N	   fusion	   protein	   was	   successfully	   bound	   to	   the	   resin	   and	  subject	   to	   three	  washes	  producing	  highly	  pure	  protein,	  which	  eluted	  using	  300	  mM	  imidazole	  elution	  (Figure	  76).	  
	  Figure	  76.	  Analysis	  of	  elution	  profile	  of	  soluble	  His6-­‐SUMO	  TSWV	  N	  fusion	  protein	  purified	  using	  the	  spin	   protocol.	   SDS-­‐PAGE	   followed	   by	   Coomassie	   stain	   of	   soluble	   fraction	   (Lane1),	   Insoluble	   fraction	  (Lane2),	  Flowthrough	  (Lane	  3),	  Binding	  buffer	  wash	  (Lane	  4),	  50	  mM	  imidazole	  wash	  (Lane	  5),	  90	  mM	  imidazole	  elution	  (Lane	  6),	  300	  mM	  imidazole	  elution	  (Lane	  7).	  Molecular	  weight	  markers	  (kDa)	  (Lane	  S).	  	  	  
4.3.2	  Large-­‐scale	  purification	  of	  TSWV	  N	  protein	  with	  Ni-­‐Superflow	  Plus	  resin	  The	  results	  for	  the	  expression	  and	  purification	  using	  the	  spin	  protocol	  were	  used	  to	  scale	  up	  the	  production	  of	  pure	  TSWV	  N	  protein	  suitable	  for	  further	  purification	  using	  SEC	   and	   crystallization	   trials.	   The	   percentage	   of	   total	   soluble	   His6-­‐SUMO	   TSWV	   N	  protein	  capable	  of	  successfully	  binding	  and	  eluting	  from	  the	  Ni	  Superflow	  Plus	  resin	  was	   small	   (Figure	   77,	   lanes	   4	   and	   8).	   However	   this	   amount	   of	   TSWV	   N	   protein	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generated	   from	  the	  Ni-­‐Superflow	  Plus	  resin	  purification	  step	  was	  deemed	  sufficient	  for	  further	  rounds	  of	  purification	  using	  SEC.	  	  	  	  
	  Figure	  77.	  Analysis	  of	  elution	  profile	  of	  soluble	  His6-­‐SUMO	  TSWV	  N	  purified	  using	  Ni-­‐Superflow	  Plus	  resin.	  SDS-­‐PAGE	  followed	  by	  Coomassie	  stain	  of	  molecular	  weight	  markers	  (kDa)	  (Lane	  S),	   Insoluble	  fraction	  (Lane	  1),	  Cell	   lysate	   (Lane	  2),	  Soluble	   (Lane	  3),	  Flow	  through	  (Lane	  4),	  Binding	  buffer	  wash	  (Lane	  5),	  50	  mM	  imidazole	  wash	  (Lane	  6),	  90	  mM	  imidazole	  elution	  (Lane	  7),	  2	  M	  NaCl	  and	  300	  mM	  imidazole	  elution	  (Lane	  8).	  
4.3.3	  Purification	  of	  TSWV	  N	  protein	  using	  SEC	  Typically	  around	  60-­‐100	  mg	  of	  TSWV	  N	  protein	  from	  each	  2	  L	  culture	  was	  purified.	  The	   TSWV	   N	   protein	   sample	   purified	   using	   nickel-­‐affinity	   purification	   was	  concentrated	   to	  5	  ml,	   and	   injected	  onto	   a	   S75	  SEC	   column.	  The	  SEC	   chromatogram	  elution	   profile	   of	   the	   TSWV	   N	   protein	   produced	   one	   distinct	   peak.	   The	   oligomeric	  state	  of	  the	  TSWV	  N	  protein	  could	  not	  be	  determined	  because	  the	  main	  peak	  eluted	  close	   to	   the	  void	  volume	  of	   the	   column.	  The	  main	  peak	  did	  however	  display	  a	  very	  high	   260/280	   nm	   ratio,	   and	   indicated	   the	   TSWV	   N	   protein	   was	   bound	   to	   RNA,	  presumably	   from	   the	   E.	   coli	   expression	   host	   (Figure	   78).	   SDS-­‐PAGE	   followed	   by	  Coomassie	   stain	   confirmed	   the	   peak	   contained	   TSWV	   N	   protein,	   which	   was	   pure	  (Figure	  79).	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  Figure	  78.	  Analysis	  of	  the	  non-­‐RNase	  treated	  TSWV	  N	  protein	  using	  SEC.	  Bacterially	  expressed	  fusion	  TSWV	  N	  protein	  was	  purified	  by	  nickel-­‐affinity	   chromatography,	   after	  which	   the	  His6-­‐SUMO	  protein	  tag	  was	  removed	  by	  sumo	  protease	  and	  applied	  to	  a	  Superdex	  S75	  gel	  filtration	  column	  at	  a	  flow	  rate	  of	  2.5	  ml	  min−1.	  The	  elution	  profile	  of	  the	  TSWV	  N	  protein	  is	  shown	  in	  blue	  and	  dashed	  red	  at	  280	  nm	  and	  260	  nm	  wavelengths	  respectively.	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  Figure	   79.	   SDS-­‐PAGE	   analysis	   of	   the	   non-­‐RNase	   treated	   TSWV	  N	   protein	   purified	   using	   the	   S75	   gel	  filtration	   column.	   SDS-­‐PAGE	   followed	   by	   Coomassie	   stain.	   Black	   arrows	   in	   A	   and	   B	   indicate	   the	  direction	  of	  the	  elution	  profile	  of	  the	  main	  peak	  seen	  by	  the	  S75	  SEC	  elution	  profile	  in	  figure	  78.	  	  
4.3.4	  RNA	  binding	  of	  purified	  TSWV	  N	  protein	  The	   260/280	   nm	   ratio	   of	   the	   TSWV	   N	   protein	   eluted	   from	   the	   main	   SEC	   peak	  indicated	   it	   was	   co-­‐purifying	   with	   nucleic	   acid.	   To	   establish	   whether	   nucleic	   acids	  were	  binding	   to	   the	  TSWV	  N	  protein	  phenol/chloroform	  extraction	  was	  performed.	  Controls	   for	   the	   experiment	  were	   also	   run	   in	   adjacent	   lanes	   and	   included	   running	  both	  RNA	  harvested	  and	  RNase	  treated	  from	  the	  BUNV	  N	  protein.	  Phenol/chloroform	  RNA	   extraction	   confirmed	   the	  TSWV	  N	  protein	  was	   bound	   to	   bacterial	   RNA,	  which	  appeared	  on	  the	  1%	  agarose	  gel	  as	  a	  broad	  band,	  containing	  a	  range	  of	  different	  sized	  RNAs.	  The	  size	  range	  of	  the	  TSWV	  RNA	  band	  varied	  between	  approximately	  45	  bp	  to	  150	   bp	   (Figure	   80).	   RNA	   extraction	   analysis	   of	   the	   BUNV	   tetramer	  N	   protein	   peak	  (Mohl	   and	   Barr,	   2009)	   also	   displayed	   the	   expected	   sized	   band	   for	   RNA,	   which	  migrated	  faster	  than	  the	  RNA	  extracted	  from	  the	  TSWV	  N	  protein.	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  Figure	  80.	  RNA	  binding	  analysis	  of	   the	  TSWV	  N	  protein	  purified	  by	  SEC.	  RNA	  was	  harvested	   from	  N	  protein	   purified	   from	   the	   peak	   of	   TSWV	   protein	   SEC	   elution	   profile	   in	   figure	   78	   and	   subjected	   to	  electrophoresis	  on	  a	  1%	  agarose	  gel	  (Lane	  3),	  alongside	  ssRNA	  size	  markers	  (Lane	  S).	  Positive	  controls	  included	   BUNV	   N	   protein	   extracted	   from	   a	   SEC	   tetramer	   peak	   (Lane	   1),	   and	   the	   negative	   control	  included	  RNase	   treated	  BUNV	  N	  protein	   from	  the	  same	  SEC	  tetramer	  peak	  (Lane	  2).	  This	   figure	  was	  generated	  with	  the	  help	  of	  Dr.	  Cheryl	  Walter,	  University	  of	  Leeds.	  	  For	   every	   litre	   of	   culture	   the	   TSWV	  N	   protein	   sample	   purified	   using	   nickel-­‐affinity	  purification	  was	  treated	  with	  10	  µg	  of	  RNase	  to	  remove	  the	  bound	  RNA	  for	  30	  min	  at	  room	  temperature,	  concentrated	  to	  5ml,	  and	  finally	  injected	  onto	  a	  Superdex	  S75	  SEC	  column.	  The	  SEC	  chromatogram	  elution	  profile	  of	  the	  TSWV	  N	  protein	  produced	  four	  distinct	   peaks	   (Figure	   80).	   The	   second	   eluting	   peak	   (Figure	   81,	   peak	   2),	   based	   on	  molecular	  weight	  standards	  corresponded	  to	  a	  trimer.	  The	  oligomer	  state	  of	  the	  first	  peak	  (Figure	  81,	  peak	  1),	  most	  likely	  represents	  tetramers,	  however	  this	  could	  not	  be	  unambiguously	  established	  because	  the	  S75	  SEC	  column	  is	  not	  suited	  for	  separating	  complexes	  over	  90	  kDa.	  	  The	  SEC	  elution	  profile	  also	  produced	  a	  peak	  corresponding	  to	   a	   TSWV	   N	   monomer	   (Figure	   81,	   peak	   3),	   and	   a	   peak	   corresponding	   to	   SUMO	  protein	  (Figure	  81,	  peak	  4).	  The	  initial	  eluting	  peaks	  contained	  the	  majority	  TSWV	  N	  protein	  and	  the	  monomer	  peak	  contained	  very	  little	  TSWV	  N	  protein,	  as	  seen	  by	  using	  SDS-­‐PAGE	   and	   Coomassie	   stain	   analysis	   (Figure	   82).	   Even	   though	   RNase	   had	   been	  added	   before	   SEC	   purification	   all	   of	   the	   TSWV	  N	   protein	   elution	   peaks	   displayed	   a	  very	   high	   260/280	   nm	   ratio	   and	   indicated	   bacterial	   RNA	   remained	   bound	   to	   the	  TSWV	   N	   protein.
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  Figure	  81.	  Analysis	  of	  the	  RNase	  treated	  TSWV	  N	  protein	  using	  SEC.	  TSWV	  N	  protein	  purified	  by	  nickel-­‐affinity	  chromatography	  was	  subject	  to	  RNase	  treatment	  and	  applied	  to	  a	  Superdex	  S75	  gel	  filtration	  column	  at	  a	  flow	  rate	  of	  2.5	  ml	  min−1.	  The	  elution	  profile	  of	  the	  TSWV	  N	  protein	  is	  shown	  in	  blue	  and	  dashed	  red	  at	  280	  nm	  and	  260	  nm	  wavelengths	  respectively.	  	  	  
	  Figure	  82.	  Analysis	  of	  elution	  profile	  of	  RNase	  treated	  TSWV	  N	  protein	  following	  purification	  using	  a	  Superdex	   S75	   gel	   filtration	   column.	   SDS-­‐PAGE	   followed	   by	   Coomassie	   stain	   of	   fractions	   (A)	   and	   (B)	  double	  black	  arrows	  underline	  the	  lanes	  containing	  fractions	  from	  the	  first	  three	  peaks.	  (C)	  The	  double	  orange	  arrow	  underlines	  the	  lanes	  containing	  fractions	  with	  SUMO	  protein	  purified	  using	  SEC.	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4.3.5	  RNA	  binding	  analysis	  of	  RNase	  treated	  TSWV	  N	  protein	  purified	  using	  SEC	  The	   high	   260/280	   nm	   ratio	   of	   the	   TSWV	   N	   protein	   eluted	   from	   the	   first	   two	   SEC	  peaks	   was	   further	   analyzed	   using	   phenol/chloroform	   extraction,	   and	   subjected	   to	  electrophoresis	   on	   a	   1%	   TBE	   agarose	   gel	   alongside	   ssRNA	   size	   markers.	  Phenol/chloroform	  RNA	  extraction	  confirmed	  the	  TSWV	  N	  protein	  remained	  bound	  to	   bacterial	   RNA,	   even	   after	   RNase	   treatment.	   The	   RNA	   band	   from	   the	   first	   peak	  migrates	  more	  slowly	  than	  the	  RNA	  from	  the	  second	  peak	  (Figure	  83).	  
	  Figure	   83.	   RNA	   binding	   analysis	   of	   the	   RNase	   treated	   TSWV	   N	   protein	   purified	   by	   SEC.	   RNA	   was	  harvested	  from	  purified	  N	  protein	  from	  the	  first	  (Lane	  1)	  and	  second	  (Lane2)	  peaks	  of	  the	  SEC	  elution	  profile	   in	   figure	   81	   and	   subjected	   to	   electrophoresis	   on	   a	   1%	   agarose	   gel,	   alongside	   ssRNA	   size	  markers	  (Lane	  S).	  	  
4.3.6	  Purification	  of	  RNA	  free	  TSWV	  N	  protein	  using	  SEC	  Fractions	  collected	  from	  the	  center	  of	  the	  first	  two	  TSWV	  N	  protein	  SEC	  elution	  peaks	  1	  and	  2	  were	  pooled	  together	  respectively	  and	  concentrated	  until	  the	  concentration	  reached	  15	  mg	  ml-­‐1	   in	  approximately	  500	  µl	  volume	  (Figure	  81,	  peak	  1	  and	  2).	  The	  concentration	   and	   purity	   of	   the	   TSWV	  N	   protein	  was	   deemed	   sufficient	   to	   attempt	  crystallization	  trials	  using	  the	  sitting	  drop	  method.	  Only	  characteristically	  diffracting	  salt	   crystals	  were	  produced	  and	  no	  TSWV	  N/RNA	  crystals	  were	  grown	   from	  any	  of	  the	   factorial	   conditions,	   temperatures	   and	   drop	   concentrations	   screened.	   In	   an	  attempt	   to	   produce	   TSWV	   protein	   crystals	   capable	   of	   diffracting	   suitably	   for	  structural	   determination	   a	   strategy	   to	   remove	   the	   bacterial	   RNA	   from	   the	  TSWV	  N	  protein	   was	   developed.	   This	   involved	   altering	   the	   final	   elution	   step	   of	   the	   nickel-­‐affinity	   purification	   to	   include	  2	  M	  NaCl,	  which	  would	   aim	   to	   remove	   any	  bacterial	  RNA	   bound	   to	   the	   TSWV	   N	   protein	   by	   disrupting	   the	   electrostatic	   N	   protein/RNA	  interactions.	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Following	   this	   step	   the	   SEC	   exclusion	   running	   buffer	   also	   contained	   2	  M	  NaCl.	   The	  SEC	   chromatogram	   elution	   profile	   of	   the	   TSWV	   N	   protein	   produced	   three	   distinct	  peaks	  (Figure	  84A).	  The	  first	  large	  peak	  (peak	  1)	  displayed	  a	  very	  high	  260/280	  nm	  ratio	  and	  contains	  very	  little	  protein.	  This	  peak	  most	  likely	  represents	  high	  molecular	  weight	  RNA	  complexes	  removed	  from	  the	  TSWV	  N	  protein.	  The	  chromatogram	  profile	  and	   SDS-­‐PAGE	   analysis	   revealed	   the	   TSWN	   N	   protein	   was	   eluted	   from	   the	   size-­‐exclusion	   column	   in	   two	   oligomeric	   forms.	   Comparison	   of	   these	   two	   species	   with	  molecular	  weight	  standards	  indicated	  that	  the	  faster	  eluting	  peak	  2	  had	  an	  apparent	  mass	  of	  110	  kDa,	  and	  was	  likely	  N	  protein	  tetramer	  that	  has	  a	  predicted	  mass	  of	  112	  kDa	  (Figure	  84A).	  The	  slower	  eluting	  species	   in	  peak	  3	  had	  an	  apparent	  mass	  of	  80	  kDa,	  and	  was	  likely	  N	  trimer	  (Figure	  80A).	  The	  OD260nm/OD280nm	  ratio	  of	  the	  two	  peaks	  was	  measured	  to	  determine	  the	  presence	  of	  bound	  nucleic	  acid.	  The	  OD260nm/OD280nm	  ratios	  of	  0.7	   from	  peak	  3	  (Figure	  84A)	  and	  0.6	   from	  peak	  2	  (Figure	  84A)	  suggested	  the	  TSWV	  N	  protein	  was	  free	  of	  nucleic	  acid.	  Analysis	  of	  the	  fractions	  across	  the	  SEC	  profile	   of	   the	   two	  main	   peaks	   using	   SDS-­‐PAGE	   (Figure	   85B)	   revealed	   the	   TSWV	  N	  protein	  eluted	  with	  little	  contamination.	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  Figure	  84.	  Analysis	  of	   the	  RNA	  free	  TSWV	  N	  protein	  using	  SEC.	  (A)	  Bacterially	  expressed	  His6	  -­‐SUMO	  tagged	  TSWV	  N	  protein	  was	  purified	  by	  nickel-­‐affinity	  chromatography,	  after	  which	  the	  His6-­‐SUMO	  tag	  was	  removed	  by	  sumo	  protease	  and	  applied	  to	  a	  Superdex	  S200	  gel	  filtration	  column	  at	  a	  flow	  rate	  of	  1.5	  ml	  min−1.	  Endogenous	  E.	  coli	  RNA	  bound	  to	  the	  TSWV	  N	  protein	  was	  separated	  using	  2	  M	  NaCl.	  The	  elution	   profile	   of	   the	   TSWV	   N	   protein	   is	   shown	   in	   blue	   and	   dashed	   red	   at	   280	   nm	   and	   260nm	  wavelengths	   respectively.	  Molecular	  weight	   standards	   are	   shown	   in	   green.	   The	   following	  molecular	  mass	  standards	  (green	  line)	  are	  given	  in	  kDa:	  high	  molecular	  weight	  aggregates	  (Peak	  5)	  thyroglobulin	  670,	  (Peak	  6)	  β-­‐globulin	  158,	  (Peak	  7)	  ovalbumin	  44	  (Peak	  8),	  myoglobulin	  17	  (Peak	  9),	  and	  vitamin	  B12	   1.35	   (Peak	   10).	   (B)	   The	   trimer	   and	   tetramer	   S200	   peak	   fractions	   were	   concentrated	   to	   5	   ml	  respectively	   and	   injected	   onto	   a	   Superdex	   S75	   gel	   filtration	   column	   to	   further	   purify	   way	   any	  contaminants	  and	  buffer	  exchange	  the	  2	  M	  NaCl	  into	  a	  more	  suitable	  buffer	  for	  crystallization.	  	  	  
	  166	  
The	  trimer	  and	  tetramer	  peaks	  eluted	  from	  the	  S200	  column	  were	  subject	  to	  further	  purification	   and	   injected	   individually	   onto	   a	   S75	   Superdex	   preparative	   column	  (Figure	   84B).	   Peak	   2	   is	   TSWV	   N	   protein	   tetramer	   and	   peak	   3	   is	   TSWV	   N	   protein	  trimer.	  This	  step	  was	  included	  not	  only	  to	  exchange	  the	  sample	  into	  a	  more	  suitable	  buffer	   for	  crystallization	  but	  also	  to	   further	  purify	  away	  any	  contaminants	   left	   from	  the	  S200	  SEC	  run.	  	  
	  Figure	  85.	  Analysis	  of	  elution	  profile	  TSWV	  N	  protein	   following	  purification	  using	  Superdex	  S75	  and	  S200	  gel	  filtration	  columns.	  SDS-­‐PAGE	  followed	  by	  Coomassie	  stain	  of	  S200	  peak	  fractions	  (A)	  Peak	  1	  (Lanes	   1-­‐6),	   (B)	   Peak	   2	   (Lanes	   1-­‐7),	   and	   Peak	   3	   (Lanes	   8-­‐14),	   (C)	   Peak	   4	   (Lanes	   8-­‐14).	   (D)	   Peak	   4	  (Lanes	  8-­‐14),	  Cleaved	  TSWV	  N	  protein	  injected	  onto	  S200	  SEC	  column	  (Lane	  6),	  S75	  purified	  tetramer	  (Lane	  7),	  S75	  purified	  trimer	  (Lane	  8).	  Double	  pointed	  arrows	  indicate	  S200	  peaks	  figure	  84A	  .	  	  The	  elution	  profile	  chromatogram	  of	  the	  trimer	  and	  tetramer	  TSWV	  N	  protein	  using	  the	   S75	   column	   revealed	   an	   unexpected	   peak	   (Figure	   84B,	   peak	   1).	   The	  OD260nm/OD280nm	  ratio	   of	   this	   peak	   revealed	   it	   contained	   a	   high	  nucleic	   acid	   content	  and	  most	  likely	  contained	  RNA.	  Analysis	  of	  the	  OD260nm/OD280nm	  ratio	  of	  the	  SEC	  S75	  trimer	  and	  tetramer	  TSWV	  N	  peaks	  revealed	  substantially	  lower	  nucleic	  acid	  content	  compared	   to	   before	   they	   were	   applied	   to	   the	   S200	   Superdex	   column.	   The	  OD260nm/OD280nm	   ratio	   of	   peaks	   were	   0.5	   and	   strongly	   indicated	   the	   trimer	   and	  tetramer	  proteins	  were	  free	  of	  nucleic	  acid.	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4.4	  Crystallization	  of	  TSWV	  N	  protein	  
4.4.1	  Factorial	  crystal	  screens	  Fractions	   collected	   from	   the	   center	  of	   the	   S75	  purified	  TSWV	  N	  protein	   trimer	   and	  tetramer	  SEC	  elution	  peaks	  were	  pooled	  together	  respectively	  and	  concentrated	  until	  the	  concentration	  reached	  15	  mg	  ml-­‐1	   in	  approximately	  500	  µl	  volume	  (Figure	  85D,	  lanes	   7	   and	   8).	   The	   concentration	   and	   purity	   of	   the	   TSWV	   N	   protein	   was	   deemed	  sufficient	  to	  attempt	  crystallization	  trials	  using	  the	  sitting	  drop	  method.	  Crystals	  for	  the	   trimer	  species	  grew	   in	  0.1	  M	  HEPES	  pH	  7.5,	  4.3	  M	  sodium	  chloride,	  and	  0.01	  M	  zinc	   sulphate	   hydrate,	   0.1	   M	   MES	   monohydrate	   pH	   6.5,	   25%	   v/v	   PEG-­‐550	   MME	  (Figure	   86).	   Crystals	   for	   the	   tetramer	   TSWV	   N	   protein	   crystallized	   in	   0.01	   M	   zinc	  sulphate	  hydrate,	   0.1	  M	  MES	  monohydrate	  pH	  6.5,	   25%	  v/v	  PEG-­‐550	  MME	   (Figure	  87A)	  and	  0.2	  M	  trimethylamine	  N-­‐oxide	  dihydrate,	  0.1	  M	  Tris-­‐HCl	  pH	  8.5,	  20%	  w/v	  PEG-­‐2,000	  MME	  (Figure	  88A).	  
	  Figure	  86.	  Crystallization	  of	  trimer	  TSWV	  N	  protein	  using	  the	  sitting	  drop	  method	  of	  crystallization.	  Crystallization	  trials	  were	  carried	  out	  at	  25	  °C	  using	  the	  sitting	  drop	  vapour-­‐diffusion	  method.	  Crystals	  grown	   in	   condition	   27	   from	   the	   crystal	   screen	   2	   (Hampton	   Research)	   crystallization	   screening	   kit.	  (Scale	  bar	  =	  25	  μm).	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  Figure	   87.	   Crystallization	   of	   the	   TSWV	  N	   protein	   tetramer	   using	   the	   sitting	   drop	   and	   hanging	   drop	  method	  of	  crystallization.	  Crystallization	  trials	  were	  carried	  out	  at	  25	  °C	  using	  the	  sitting	  drop	  vapour-­‐diffusion	  method.	   (A)	  Crystals	  grown	   in	  condition	  27	   from	   the	  crystal	   screen	  2	   (Hampton	  Research)	  crystallization	   screening	   kit	   (Scale	   bar	   20	   μm)	   (B)	   Optimization	   was	   based	   on	   initial	   sitting	   drop	  screening	   conditions,	   which	   produced	   TSWV	   protein	   crystals	   diffracting	   to	   at	   least	   2.6	   Å	   and	   was	  carried	  out	  at	  25	  °C	  using	  hanging	  drop	  vapour-­‐diffusion	  method.	  Crystals	  grown	  in	  25%	  v/v	  PEG-­‐550	  MME,	  0.25	  M	  MES	  pH	  6.5.	  (Scale	  bar	  =	  100	  μm).	  
4.4.2	  Optimization	  of	  factorial	  tetramer	  TSWV	  N	  protein	  crystals	  To	  improve	  the	  quality	  of	  the	  factorial	  tetramer	  TSWV	  N	  protein	  crystals	  grown	  using	  the	   sitting	   drop	   method	   for	   crystallization,	   several	   rounds	   of	   optimization	   were	  carried	   out.	   This	   included	   omitting	   the	   zinc	   sulphate,	   testing	   different	   pHs	   and	  changing	   the	   percentage	   of	   PEG-­‐550	   MME.	   The	   best	   crystals	   were	   obtained	   from	  hanging	  drops	  prepared	  using	  25%	  v/v	  PEG-­‐550	  MME,	  0.25	  M	  MES	  pH	  6.5	   (Figure	  87B).	  	  
4.5	  X-­‐ray	  diffraction	  of	  TSWV	  N	  protein	  crystals	  
4.5.1	  Diffraction	  of	  factorial	  TSWV	  N	  protein	  crystals	  	  Factorial	   sitting	  drop	   crystallization	   screening	   yielded	  diffracting	   crystals	   from	   two	  conditions.	  Firstly	  sitting	  drop	  factorial	  crystals	  grown	  using	  0.2	  M	  trimethylamine	  N-­‐oxide	  dehydrate,	  0.1	  M	  Tris-­‐HCl	  pH	  8.5,	  20%	  w/v	  PEG-­‐2,000	  MME	  diffracted,	  but	  very	  weakly	   (Figure	   88B).	   Factorial	   crystals	   hits	   found	   in	   0.2	  M	   trimethylamine	  N-­‐oxide	  dihydrate,	  0.1	  M	  Tris-­‐HCl	  pH	  8.5,	  20%	  w/v	  PEG-­‐2,000	  MME,	  were	  not	  optimized	  for	  native	  TSWV	  N	  protein	  crystals.	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  Figure	   88.	   X-­‐ray	   diffraction	   pattern	   of	   a	   tetramer	   TSWV	   N	   protein	   crystal	   grown	   using	   0.2	   M	  trimethylamine	   N-­‐oxide	   dehydrate,	   0.1	  M	   Tris-­‐HCl	   pH	   8.5,	   20%	  w/v	   PEG-­‐2,000	  MME.	   	   (A)	   Crystals	  grown	  using	  the	  sitting	  drop	  method	  using	  0.2	  M	  Trimethylamine	  N-­‐oxide	  dehydrate,	  0.1	  M	  Tris	  pH	  8.5,	  20%	  w/v	  PEG-­‐2,000	  MME	  (Scale	  bar	  =	  25	  μm).	  	  (B)	  A	  0.5° oscillation	  image	  collected	  on	  beamline	  I24	  using	   12.8	   KeV	   X-­‐rays,	   in	  which	   reflections	   are	   observed	   to	   beyond	   9	   Å.	   The	   insert	   boarded	   in	   red	  shows	  the	  zoomed	  in	  image	  (x3)	  of	  the	  diffraction	  pattern	  boxed	  in	  red.	  	  Secondly	   initial	   factorial	   crystal	   hits	   grown	   in	   0.01	  M	   zinc	   sulphate	   hydrate,	   0.1	  M	  MES	   monohydrate	   pH	   6.5,	   25%	   v/v	   PEG-­‐550	   MME	   using	   the	   sitting	   drop	   vapour-­‐diffusion	   method,	   diffracted	   to	   a	   maximum	   Bragg	   spacing	   of	   4	  Å	   and	   belonged	   to	  space	  group	  group	  P21,	  with	  unit-­‐cell	  parameters	  a	  =	  72.4,	  b	  =	  105.9,	  c	  =	  79.8	  Å,	  α=	  90°,	  β=	  105.8°,	  γ=	  90°.	  Crystals	  optimised	   from	  this	  condition	  (see	  above)	  using	   the	  hanging	  drop	  vapour-­‐diffusion	  method	  (Figure	  87B)	  diffracted	  to	  a	  maximum	  Bragg	  spacing	   of	   2.6	  Å	   (Figure	   89).	   It	   was	   calculated	   by	   the	   strategy	   function	   within	   the	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MOSFLM	  package	  that	  rotating	  this	  P21	  space	  group	  crystal	  360°	  with	  0.5°	  oscillations	  was	  sufficient	   to	  collect	  a	   full	  X-­‐ray	  diffraction	  data	  set	  of	   the	  TSWV	  N	  protein,	  and	  which	  produced	  720	  images.	  The	  resulting	  data	  set	  was	  indexed	  and	  integrated	  using	  the	   XDS	   package	   (Kabsch,	   2010)	   using	   Xia2	   (Evans,	   2006b)	   from	   the	   Diamond	  synchrotron	   suite	   of	   automated	   programs.	   The	   data	   were	   scaled	   with	   a	   maximum	  Bragg	   spacing	   of	   2.55	   Å	  with	   an	   R-­‐merge	   of	   61.5%	   in	   the	   highest	   resolution	   shell.	  These	   crystals	  belonged	   to	   the	  P21	  spacegroup,	  with	   similar	  unit-­‐cell	   parameters	  as	  the	  factorial	  crystals	  (Table	  5).	  In	  the	  P21	  space	  group	  there	  are	  four	  TSWV	  N	  proteins	  N	  per	  AU,	  with	  a	  solvent	  content	  of	  53.16%.	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  Wavelength	  (Å) 0.98030  Space	  group P1211  Cell	  parameters   a	  (Å) 72.4  b	  (Å) 105.9  c	  (Å) 79.8  β	  (°) 105.8  Total	  no.	  of	  reflections 160,835	  (11,932)  No.	  of	  unique	  reflections 37735	  (2749)  Resolution	  (Å) 2.55	  (2.62–2.55)	    
Rmerge	  (%) 3	  (61.5)	    Completeness	  (%) 99.7	  (99.7)  Redundancy 4.3(4.3)  
I/σ(I) 21.2	  (2.3)  No.	  of	  molecules	  per	  AU 4  VM	  (Å3/Da)	   2.62	   	  Table	  5.	  Data	  collection	  and	  refinement	  statistics	  for	  tetramer	  TSWV	  N	  native	  crystals.	  






4.6	  Self-­‐rotation	  of	  TSWN	  N	  protein	  tetramer	  crystals	  Self-­‐rotation	   functions	   were	   calculated	   with	   the	  MOLREP	   program	   using	   the	   X-­‐ray	  diffraction	   data	   collected	   from	   tetramer	   TSWV	   N	   protein	   crystals	   (Vagin	   and	  Teplyakov,	   2010).	   The	   two	   strongest	   peaks	   for	   κ=180°	   at	  ϕ	   =	  180°	   and	  ϕ	   =	   0°	   are	  derived	  from	  the	  crystallographic	  twofold-­‐symmetry	  axes.	  The	  two	  additional	  peaks	  observed	  on	  the	  κ=	  180°	  plot	  correspond	  two	  two-­‐fold	  NCS	  peaks	  (Figure	  90).	  There	  is	  another	  NCS	  peak,	  slightly	  off	  origin	  represented	  in	  the	  κ=90°	  slice,	   indicating	  a	  4	  fold	  non-­‐crystallography	  symmetry	  axis.	  There	  was	  no	  evidence	  of	   three	   fold	  or	   six	  fold	   crystallographic	   symmetry	   for	   κ=120°	   (Figure	   90),	   or	   κ=60°	   (Figure	   90).	   The	  Matthews	  coefficient	  suggests	  a	  tetramer	  is	  the	  most	  likely	  component	  in	  the	  AU,	  with	  2.62	   Å3	   Da-­‐1	   with	   53.16%	   solvent	   (Matthews,	   1968).	   Considering	   that	   a	   probable	  tetramer	   was	   observed	   during	   SEC,	   in	   conjunction	   with	   self-­‐rotation	   analysis	  suggesting	   there	   is	   a	   four-­‐fold	   NCS	   axis	   present,	   a	   tetramer	   form	   is	   likely	   to	   be	  present	  in	  the	  AU.	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4.7	  Solving	  the	  TSWV	  N	  protein	  crystal	  X-­‐ray	  diffraction	  data	  
4.7.1	  Molecular	  replacement	  Determination	   of	   the	   initial	   phases	   by	   molecular-­‐replacement	   approaches	   using	  Phaser	  and	  MOLREP	  programs	  (McCoy	  et	  al.,	  2007,	  Vagin	  and	  Teplyakov,	  2010)	  with	  the	  RVFV	  N	  protein	  (Raymond	  et	  al.,	  2010;	  Ferron	  et	  al.,	  2011)	  as	  a	  search	  model	  was	  not	   successful.	   The	   crystal	   structures	   of	   the	   recently	   solved	   N	   proteins	   from	  orthobunyaviruses	  (Dong	  et	  al.,	  2013b,	  Dong	  et	  al.,	  2013a,	  Ariza	  et	  al.,	  2013,	  Li	  et	  al.,	  2013,	  Niu	  et	  al.,	  2013,	  Reguera	  et	  al.,	  2013),	  which	  have	  approximately	  20%	  sequence	  homology	   with	   the	   TSWV	   N	   protein,	   also	   failed	   as	   molecular	   replacement	   search	  models.	  The	  remainder	  of	  N	  proteins	  from	  nsNSV	  and	  sNSV	  for	  which	  there	  are	  high	  resolution	  structures	  also	  were	  not	  successful	   for	  molecular	  replacement.	  Using	   the	  NCBI	  BLAST	  tool,	  (Altschul	  et	  al.,	  1990)	  it	  was	  found	  that	  there	  was	  no	  model	  in	  the	  PDB	  with	  sequence	  similarity	  above	  20%	  compared	  to	  the	  TSWV	  N	  protein	  sequence.	  HHpred	   (Soding	   et	   al.,	   2005)	  was	   used	   to	   search	   for	   domain	   homology	   similarities	  based	   on	   the	   secondary	   structure	   prediction	   of	   the	  TSWV	  N	  protein	   and	   found	   the	  orthobunyaviruses	  N	  protein	   crystal	   structures	  matched	  with	   the	  highest	   similarity	  between	  residues	  15-­‐149	  (Figure	  91).	  However	   this	   fragment	  obtained	   from	  all	   the	  orthobunyavirus	   N	   protein	   crystal	   structures	   was	   unsuccessful	   in	   obtaining	   the	  suitable	  phases	  for	  structural	  determination	  of	  the	  TSWV	  N	  protein	  crystal	  structure.	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  Figure	  91.	  HHpred	  local	  alignment	  between	  the	  predicted	  secondary	  structure	  of	  the	  TSWV	  N	  protein	  and	   structures	   submitted	   onto	   the	   PDB.	   (A)	   The	   alignment	   with	   the	   highest	   identity	   was	   between	  residues	   1-­‐149	   of	   the	   LENV	   (orthobunyavirus),	   and	   residues	   15-­‐147	   of	   TSWV	   N.	   (B)	   The	   highest	  matched	  PDBs	   aligned	   to	   the	   predicated	   secondary	   structure	   of	   the	   TSWV	  N	  protein,	  which	   include	  orthobunyavirus	  N	  proteins	  and	  other	  non-­‐N	  proteins.	  	  HHpred	   also	   matched	   small	   sections	   of	   the	   predicted	   secondary	   structure	   of	   the	  TSWV	  N	  protein	  with	  non-­‐N	  proteins,	  which	  include	  but	  are	  not	  limited	  to	  lysozyme	  hydrolase	   (PDB	   code:	   4E97A),	   coliphage	   lambda	   transcription	   activator	   protein	   CII	  (PDB	  code:	  1XWR),	  and	  transcriptional	  coactivator/pterin	  dehydratase	  from	  Brucella	  
Melitensis	  (PDB	  code:	  3JST).	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  protein	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4.7.2	  Selenomethionine	  TSWV	  N	  protein	  Bacterial	  expression	  of	  the	  TSWV	  N	  containing	  selenomethionine	  was	  achieved	  using	  
E.	  coli	  cells,	  which	  are	  methionine	  auxotrophs,	  grown	  in	  M9	  minimal	  media.	  Using	  the	  same	  induction	  conditions	  for	  expression	  as	  for	  the	  native	  TSWV	  N	  protein	  sufficient	  amounts	  of	  protein	  were	  produced	  for	  crystallization.	  However	  the	  TSWV	  N	  protein,	  containing	   selenomethionine	  did	  not	   crystallize	   in	   the	   same	  condition	  as	   the	  native	  protein.	   Optimization	   of	   the	   crystallization	   was	   attempted,	   by	   changing	   pH,	  temperature,	  drop	  volumes,	  drop	  ratios,	  but	  TSWV	  N	  protein	  crystals	  using	  the	  native	  crystallization	  condition	  could	  not	  be	  reproduced	  using	  selenomethionine	  protein.	  	  Next	   the	   selenomethionine	   protein	   was	   re-­‐screened	   for	   crystallization	   at	   a	  concentration	  of	  15	  mg	  ml-­‐1	  using	  the	  sitting	  drop	  vapour	  diffusion	  method.	  Crystals	  grew	   in	  0.2	  M	   trimethylamine	  N-­‐oxide	  dihydrate,	   0.1	  M	  Tris-­‐HCl	  pH	  8.5,	   20%	  PEG-­‐2,000	   MME	   (Figure	   92).	   This	   condition	   has	   previously	   produced	   crystals	   for	   the	  native	   TSWV	   tetramer,	   however	   these	   crystals	   diffracted	   very	   weakly	   (Figure	   93).	  Optimization	  of	   this	   condition,	  using	  a	   range	  of	  different	  PEG	  MMEs,	   salts,	  different	  buffers	   (MOPS,	   BTP,	   and	   MES),	   temperatures	   and	   also	   omitting	   the	   0.2	   M	  trimethylamine	  N-­‐oxide	  dihydrate	  did	  not	   improve	  the	  size,	  quality	  or	  diffraction	  of	  these	  crystals.	  Additionally	  an	  additive	  screen	  (Hampton	  research)	  was	  implemented	  by	  adding	  10%	  v/v	  of	  each	  additive	  to	  the	  condition,	  and	  seeding	  was	  also	  attempted	  using	  crushed	  up	  native	  protein	  crystals.	  Both	  of	  these	  approaches	  failed	  to	  produce	  better	  diffracting	  crystals.	  	  
	  	  Figure	  92.	  Crystallization	  of	  tetramer	  TSWV	  N	  selenomethionine	  protein	  using	  the	  sitting	  drop	  vapour-­‐	  diffusion	   method	   at 25	   °C,	   and	   crystals	   were	   seen	   in	   condition	   62	   from	   the	   Index	   crystallization	  screening	  kit	  (Hampton	  Research).	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  Figure	  93.	  X-­‐ray	  diffraction	  pattern	  of	  a	  tetramer	  TSWV	  N	  selenomethionine	  crystal	  grown	  using	  0.2	  M	  trimethylamine	  N-­‐oxide	  dihydrate,	  0.1	  M	  Tris-­‐HCl	  pH	  8.5,	  20%	  w/v	  PEG-­‐2,000	  MME.	  A	  0.5° oscillation	  image	  collected	  on	  beamline	  I04-­‐1	  using	  13,477	  eV	  X-­‐rays,	  and	  reflections	  are	  observed	  to	  beyond	  9	  Å.	  The	  insert	  boarded	  in	  red	  shows	  the	  zoomed	  in	  image	  (x2)	  of	  the	  diffraction	  pattern	  boxed	  in	  red.	  
4.7.3	  Heavy	  atom	  soaks	  into	  native	  crystals	  grown	  from	  TSWV	  N	  protein	  X-­‐ray	   diffraction	  was	   collected	   from	  TSWV	  N	   crystals	   soaked	   in	  mother	   containing	  150	  mM	  NaCl	  for	  various	  periods	  and	  with	  various	  heavy	  atoms	  ranging	  in	  different	  concentrations.	  Heavy	   atom	   soaks	  were	   followed	   by	   a	   5	  min	   back	  wash	   to	   remove	  weak	  binding	  atoms	  (Table	  6).	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Heavy	  atom	   Concentrations	   Times	   Result	  	  Thimerosal	   100	  μM,	  1	  mM	  	   1	  min,	  5	  min	  and	  10	  min	   Diffraction	  poor	  Uranyl	  acetate	   100	  μM,	  1	  mM,	  10	  mM,	  20	  mM	   1	  min,	  5	  min,	  10	  min,	  60	  min,	  4	  hr,	  8	  hr	  
Diffracted	  to	  3	  Å	  resolution,	  bad	  anisotropy	  and	  no	  detectable	  anomalous	  signal	  Samarium	  nitrate	   100	  μM,	  1	  mM,	  100	  mM,	  	   30	  sec,	  1	  min,	  5	  min	   Crystals	  cracked,	  bad	  anisotropy,	  anomalous	  signal	  not	  sufficient	  for	  phasing,	  poor	  diffraction	  5	  Å	  Gold(I)	  potassium	  cyanide	   1	  mM,	  10	  mM,	  40	  mM	   30	  sec,	  1	  min,	  5	  min	   Poor	  diffraction,	  anisotropic,	  no	  anomalous	  signal	  Gold	  chloride	   1	  mM,	  10	  mM,	  20	  mM	   30	  sec,	  1	  min,	  5	  min	   Poor	  diffraction,	  anisotropic,	  no	  anomalous	  signal	  Rhubidium	  chloride	   1	  mM,	  10	  mM	   2	  min,	  10	  min	   Diffracted	  to	  3	  Å,	  no	  anomalous	  signal	  Mercury	  potassium	  iodide	   1	  mM,	  10	  mM	   2	  min,	  3	  min,	  5	  min,	  10	  min	   Diffraction	  poor	  Cerium	  (III)	  acetate,	   100	  μM,	  1	  mM	   1	  min,	  2	  min,	  5	   No	  diffraction	  
	  180	  
sesquihydrate	   min	  Potassium	  tetracyanoplatinate(II)	  trihydrate	  
100	  μM,	  1	  mM,	  10	  mM	   1	  min,	  2	  min,	  10	  min	   Poor	  diffraction	  
p-­‐Chloromercuriphenylsulfonic	  acid	  
1	  mM,	  2	  mM	   10	  sec,	  20	  sec	   Diffracted	  to	  8	  Å,	  anisotropic.	  
Mercury	  acetate	   2	  mM	   1	  min,	  3	  min,	  10	  min	   No	  diffraction	  Mercurochrome	   1	  mM,	  2	  mM,	  10	  mM	   1	  min,	  5	  min	   Good	  diffraction,	  no	  anomalous	  signal	  Potassium	  chloroplatinate	   1	  mM,	  2	  mM	   1	  min,	  5	  min,	  10	  min	   Diffracted	  to	  8	  Å,	  no	  anomalous	  signal	  Trimethyl	  lead	  acetate	   1	  mM,	  5	  mM	   2	  min,	  5	  min,	  15	  min	   Poor	  diffraction	  Lead	  nitrate	   4	  mM	   2	  min,	  5	  min,	  10	  min	   Bad	  diffraction	  4-­‐chloromercuribenzoic	  acid	   2	  mM,	  4	  mM	   2	  min,	  5	  min,	  10	  min	   Bad	  diffraction,	  anisotropic	  	  cis-­‐Platinum(II)	  diammine	  dichloride	   1	  mM,	  2	  mM,	  10	  mM	   2	  min,	  5	  min,	  20	  min	   Diffraction	  to	  4	  Å,	  anisotropic	  no	  anomalous	  signal	  5-­‐Amino-­‐246-­‐Triiodo	  Isophthalic	  Acid	   10	  mM	   1	  min,	  10	  min	   Did	  not	  diffract	  Hexadecyltrimethylammonium	  bromide	   1	  mM,	  10	  mM	   2	  min,	  3	  min,	  5	  min	   Bad	  diffraction,	  anisotropic	  Table	  6.	  List	  of	  heavy	  atoms	  used	  to	  soak	  into	  native	  TSWV	  N	  protein	  crystals.	  The	  table	  includes	  the	  concentrations	   of	   the	   heavy	   atoms	   and	   the	   times	   for	   each	   concentration,	   followed	   by	   a	   brief	  description	  of	  the	  X-­‐ray	  diffraction	  observed.	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Those	   crystals	   soaked	   with	   heavy	   atoms,	   uranyl	   acetate,	   samarium	   nitrate	   cis-­‐platinum	  (II)	  diammine	  dichloride	  were	  integrated	  (Leslie,	  2006)	  and	  scaled	  (Evans,	  2006b).	   Samarium	   nitrate	   soaked	   crystals	   produced	   the	   best	   diffracting	   crystals,	  (Figure	  94)	  however	  anomalous	  signal	  was	  only	  found	  at	  5	  Å	  resolution	  using	  AutoSol	  (Terwilliger	  et	  al.,	  2009),	  and	  was	  not	  sufficient	  to	  produce	  any	  discernible	  electron	  density	  maps	  to	  build	  an	  initial	  model.	  Considerable	  anisotropy	  was	  seen	  in	  all	  data	  sets	  collected	  from	  crystals	  soaked	  with	  heavy	  atoms.	  An	  example	  of	  the	  anisotropy	  from	   a	   samarium	   nitrate	   soaked	   crystal	   can	   be	   seen	   in	   figure	   95.	   Isomorphous	  difference	  maps	  were	   produced	   using	   Fourier	   differences	   by	   combining	   native	   and	  samarium	  nitrate	  derivative	  data	   sets	  using	  CAD	  (1994),	   and	  scaling	   them	   together	  using	   SCALIT	   (1994).	   Isomorphous	   difference	   maps	   can	   be	   used	   to	   find	   initial	  positions	   of	   heavy	   atoms	   in	   substructure	   solution,	   suitable	   for	   phase	   refinement,	  however	  no	  peaks	  using	  this	  method	  could	  be	  seen	  over	  four	  sigma.	  Additionally	  all	  images	  with	  high	  Rmerge	  were	  excluded	  from	  the	  samarium	  nitrate	  derivative	  data	  set,	  however	   this	   did	   not	   improve	   the	   quality	   of	   the	   data,	   and	   phase	   information	   still	  could	  not	  be	  found.	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  Figure	   94.	   X-­‐ray	   diffraction	   pattern	   of	   tetramer	   TSWV	   N	   protein	   crystal	   grown	   using	   10	   mM	   zinc	  sulphate,	  25%	  v/v	  PEG-­‐550	  MME,	  0.25	  M	  MES	  pH	  6.5,	  and	  soaked	  with	  100	  μM	  of	  samarium	  nitrate.	  The	  insert	  boarded	  in	  red	  shows	  the	  zoomed	  in	  image	  (x3)	  of	  the	  diffraction	  pattern	  boxed	  in	  red.	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4.8	  Discussion	  of	  TSWV	  N	  protein	  results	  chapter	  
4.8.1	  Introduction	  The	  overall	   aim	  of	   this	   project	  was	   to	   better	   understand	   the	   evolution	   of	   the	  plant	  infecting	   tospoviruses	   by	   comparing	   the	   high	   resolution	   TSWV	  N	   protein	   structure	  with	  the	  N	  proteins	  from	  the	  three	  animal	  infecting	  genera	  for	  which	  high	  resolution	  data	   are	   already	   available.	   A	   high	   resolution	   TSWV	   N	   protein	   would	   also	   provide	  important	  information	  about	  RNA	  binding,	  oligomerization	  and	  RNP	  formation.	  	  The	  initial	  goal	  was	  to	  express	  and	  purify	  highly	  concentrated	  recombinant	  TSWV	  N	  protein	  suitable	  for	  crystallization	  trials.	  To	  address	  this	  aim,	  the	  same	  approach	  used	  for	   expression	   and	   purification	   of	   CCHFV	   N	   protein	   was	   implemented	   to	   express	  recombinant	  TSWV	  N	  protein	  N-­‐terminally	  linked	  to	  a	  His6-­‐SUMO	  tag.	  	  	  By	  generating	  abundant	  near	  native	  TSWV	  N	  protein	  it	  was	  demonstrated	  by	  SEC	  that	  TSWV	  N	  protein	  has	  the	  propensity	  to	  bind	  E.	  coli	  RNA,	  which	  could	  be	  removed	  by	  including	   a	   high	   salt	  wash.	   The	  RNA	   free	  TSWV	  N	  protein	   exists	   as	   high	  molecular	  weight	  complexes,	  similar	  to	  other	  members	  of	  the	  Bunyaviridae	  family.	  Finally	  X-­‐ray	  crystallography	  was	  implemented	  to	  characterize	  the	  atomic	  structure	  of	  the	  TSWV	  N	  protein.	   Crystals	   diffracting	   to	  2.6	  Å	  were	  produced	   from	   the	  TSWV	  N	  protein,	   and	  displayed	  P21	  symmetry,	  with	  unit	  cell	  dimensions	  a	  =	  72.4,	  b	  =	  105.9,	  c	  =	  79.8	  Å,	  α=	  90°,	  β=	  105.8°,	  γ=	  90°.	  	  
5.8.2	  Expression	  and	  purification	  The	   results	   detailed	   in	   chapter	   4	   provide	   the	   overexpression	   and	   purification	  protocol	   for	  making	   soluble	   TSWV	  N	   protein	   suitable	   for	   crystallization.	   Chapter	   4	  also	   details	   the	   crystallization	   and	   high	   resolution	   X-­‐ray	   diffraction	   of	   the	   TSWV	  N	  protein.	  During	  writing	  of	  this	  thesis	  Komoda	  et	  al	  (Komoda	  et	  al.,	  2013),	  reported	  the	  expression	  of	   the	  TSWV	  N	  protein	  using	   an	  N-­‐terminal	   fused	   tag	   including	   a	  D-­‐box	  (MNHK),	  a	  His6	  tag	  (HHHHHH),	  and	  a	  TEV	  cleavage	  site	  (ENLYFQG).	  The	  near	  native	  TSWV	  N	  fusion	  protein	  was	  shown	  to	  form	  predominately	  trimers	  in	  solution	  and	  was	  crystallized	   in	   0.1	  M	  Na-­‐HEPES	   pH	  7.5,	   25%	   (w/v)	   PEG	   1,000,	   50	  mM	  NaCl	   by	   the	  hanging	  drop	  vapour-­‐diffusion	  method.	  The	  authors	  of	  this	  work	  also	  reported	  TSWV	  N	  protein	  crystals	  diffracted	  to	  3.25	  Å,	  and	  belonged	  to	  spacegroup	  P21	  with	  unit	  cell	  parameters	  a	  =	  66.8,	  b	  =	  97.2,	  c	  =	  72.0	  Å,	  α=	  90°,	  β=	  112.8°,	  γ=	  90°.	  Although	  Komoda	  et	   al	   have	   not	   yet	   published	   the	   structure	   they	   concluded	   they	  were	   able	   generate	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phases	   from	   selenomethionine	   TSWV	   N	   protein	   crystals	   (Komoda	   et	   al.,	   2013).	  Although	  this	  project	  has	  not	  been	  successful	   in	  generating	  phases	  and	  determining	  the	   three-­‐dimensional	   structure	   of	   the	   native	   TSWV	  N	   protein,	   it	   has	   established	   a	  protocol	  for	  overexpression	  and	  purification.	  	  
4.8.3	  RNA	  binding	  Initially	  the	  TSWV	  N	  protein	  was	  bound	  to	  E.	  coli	  RNA	  of	  various	  lengths,	  and	  existed	  as	   higher	   molecular	   weight	   oligomers,	   which	   eluted	   near	   the	   void	   volume	   of	   the	  Superdex	  S75	  SEC	  column.	  The	  length	  of	  the	  RNA	  based	  on	  molecular	  weight	  markers	  was	   between	   50	   and	   150	   nucleotides.	   Following	   RNase	   treatment	   the	   TSWV	   N	  protein	   still	   remained	   bound	   to	   RNA,	   and	   eluted	   as	   two	   predominant	   oligomeric	  profiles	   using	   SEC,	   and	   most	   likely	   corresponded	   to	   TSWV	   N	   trimer	   and	   tetramer	  proteins.	  The	  extracted	  RNA	   from	  both	  species	  displayed	   two	  distinct	  bands	  on	   the	  agarose	  gel,	  and	  each	  migrated	  below	  the	  50	  nucleotide	  marker	  at	  different	  speeds.	  The	   migration	   of	   the	   RNA	   from	   the	   first	   peak	   (Figure	   81),	   migrated	   to	   a	   similar	  distance	  to	  the	  RNA	  extracted	  from	  the	  similar	  sized	  BUNV	  N	  tetramer	  protein,	  which	  binds	  12	  nucleotides	  of	  RNA	  per	  N	  protein	  monomer,	  suggesting	  the	  TSWV	  N	  protein	  may	  bind	  RNA	  using	  similar	  stoichiometry.	  Interestingly	  the	  RNA	  bound	  to	  tetramer	  TSWV	   N	   protein,	   migrated	   more	   slowly	   than	   the	   RNA	   from	   the	   trimer	   TSWV	   N	  protein	   species,	   which	   suggests	   the	   RNA	   is	   protected	   from	   RNase,	   possibly	   by	   a	  hydrophobic	  cavity	  similar	  to	  that	  seen	  for	  orthobunyaviruses	  and	  phleboviruses.	  	  
4.8.4	  Crystallization,	  self-­‐rotation	  and	  phasing	  of	  the	  TSWV	  N	  protein	  	  Factorial	  screening	  of	  both	  the	  non-­‐RNase	  and	  RNase	  treated	  trimer/tetramer	  TSWV	  N	  protein	  failed	  and	  yielded	  no	  protein	  crystals.	  Co-­‐purification	  of	  bacterial	  expressed	  nsRNA	  virus	  N	  proteins	  and	  RNA	  is	  not	  uncommon	  (Ariza	  et	  al.,	  2013,	  Li	  et	  al.,	  2013),	  and	  can	  be	  beneficial	  for	  elucidating	  important	  mechanisms	  such	  as	  RNA	  binding	  and	  RNP	  assembly.	  However	  one	  inherent	  issue	  that	  arises	  from	  attempting	  to	  crystallize	  N	  protein	  with	  bacterial	  RNA	  is	  the	  heterogeneity	  problem	  arising	  from	  introducing	  different	  bacterial	  RNAs	  of	  various	  sequences	  and	  lengths	  into	  the	  crystal,	  which	  can	  reduce	  the	  quality	  of	  diffraction,	  or	  make	  crystallization	  less	  likely.	  	  To	  improve	  the	  probability	  of	  yielding	  diffracting	  protein	  crystals	  the	  E.	  coli	  RNA	  was	  removed	  and	  separated	  from	  the	  TSWV	  N	  protein	  using	  a	  high	  salt	  wash	  during	  the	  last	   step	   in	   the	  nickel-­‐affinity	   and	   first	   SEC	  purification	   respectively.	  Once	   the	  RNA	  has	  been	   removed	   the	  TSWV	  N	  protein	  exists	   as	   tetramers	  and	   trimers	   in	   solution,	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and	  both	  species	  can	  be	  crystallized.	  However	  only	  crystals	  from	  the	  tetramer	  sized	  TSWV	  N	  protein	  produced	  diffraction	  suitable	  for	  structural	  determination.	  	  Interestingly	   Komoda	   et	   al	   (Komoda	   et	   al.,	   2013)	   described	   the	   expression	   and	  purification	   of	   TSWV	   N	   protein	   forming	   trimers,	   which	   produced	   both	   native	   and	  selenomethionine	  protein	  crystals.	  One	  possibility	  is	  the	  crystallization	  of	  the	  trimer	  complex	  of	  TSWV	  N	  protein	  used	  by	  Komoda	  et	  al	  is	  more	  favorable	  for	  crystallization	  due	   to	   the	   extra	   uncleaved	   N-­‐terminal	   amino	   acids	   providing	   new	   crystal	   contacts	  between	   the	  monomers.	   Strikingly	   both	   crystals	   from	  TSWV	  N	   protein	   tetramer	   in	  this	  work	   and	   the	   trimer	   protein	   by	  Komoda	   et	   al	   (Komoda	   et	   al.,	   2013),	   have	  P21	  symmetry	  and	  display	  unit	  cells	  which	  are	  very	  similar.	  	  In	  contrast	  to	  the	  work	  by	  Komoda	  et	  al	  this	  work	  has	  been	  able	  to	  produce	  TSWN	  N	  protein	  free	  from	  any	  fusion	  or	  His6	  tags,	  and	  therefore	  is	  more	  biologically	  relevant.	  Once	   solved,	  having	  TSWV	  N	  protein	   free	  of	   any	  N-­‐terminal	   tags	  will	  provide	  more	  valuable	   information	   into	   such	   important	   functions	   such	   as	   RNA	   binding,	  oligomerization	   and	   possibly	  RNP	   formation.	   The	   native	   TSWV	  N	  protein	   structure	  will	  also	  provide	  higher	  resolution	  data	  and	  will	  improve	  the	  allocation	  of	  side	  chains	  during	   the	   refinement	   process.	   The	   TSWV	  N	   protein	   produced	   in	   this	  work	   is	   also	  suitable	  for	  further	  biochemical	  analysis	  such	  as	  fluorescence	  anisotropy	  to	  establish	  an	  RNA	  binding	  assay	  for	  the	  TSWV	  N	  protein	  in	  order	  to	  determine	  the	  best	  RNA	  for	  co-­‐crystallization.	  	  
	  For	  TSWV	  N	  protein,	  with	  a	  molecular	  weight	  of	  28,914	  Da,	  the	  Matthews	  coefficient	  (Matthews,	  1968),	  suggested	  four	  TSWV	  N	  proteins	  per	  AU.	  The	  self-­‐rotation	  analysis	  suggested	   the	  presence	  of	   two	   fold	   crystallographic	   symmetry,	  which	   relates	   to	   the	  
P21	  spacegroup.	  Additionally	  the	  self-­‐rotation	  revealed	  two	  two-­‐fold	  NCS	  axes	  on	  the	  κ=180°	  plot	  and	  a	  four-­‐fold	  NCS	  axis	  on	  the	  κ	  =	  90°	  plot,	  which	  suggests	  a	  tetramer	  is	  making	   up	   the	  AU	   (the	   four-­‐fold	   non-­‐crystallographic	   symmetry	   relates	   to	   the	   axis	  looking	   down	   into	   the	   tetramer	   and	   the	   two	   two-­‐fold	   NCS	   corresponds	   to	   the	  symmetry	  along	  the	  same	  axis	  (Figure	  96).	  Based	  on	  the	  Matthews	  co-­‐effiecient	  self-­‐and	  rotation	  analysis	  it	  is	  likely	  that	  a	  TSWV	  N	  protein	  tetramer	  occupies	  the	  AU	  and	  is	   made	   up	   of	   a	   dimer	   of	   dimers,	   possibly	   in	   a	   ring	   configuration,	   resembling	   the	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closely	   relating	   orthobunyavirus	   tetramer.	   Molecular	   replacement	   was	   attempted	  using	  the	  orthobunyavirus	  N	  protein	  tetramer,	  however	  this	  failed.	  	  
	  Figure	  96.	   Interpretation	  of	  TSWV	  N	  protein	  P21	  self-­‐rotation	   results.	  Most	  probable	  arrangement	  of	  the	  TSWV	  N	  protein	  tetramer	  based	  on	  the	  κ=180°	  and	  κ=90°	  plots.	  	  When	   combining	   diffraction	   data	   for	   MIRAS	   to	   solve	   the	   phases	   needed	   for	  substructure	   solution,	   derivative	   crystals	   soaked	   in	   heavy	   atoms	   need	   to	   be	  isomorphic,	   but	   heavy	   atom	   binding	   can	   often	   cause	   non-­‐isomorphism	   between	  derivative	   crystals.	   Future	   work	   using	   AutoSol	   to	   generate	   sufficient	   phase	  information	   for	   substructure	   solution	   could	   involve	   combining	   datasets	   and	  performing	   MIRAS	   using	   only	   isomorphous	   data	   sets	   collected	   from	   several	  derivative	   crystals	   soaked	   with	   several	   different	   heavy	   atoms	   (Terwilliger	   et	   al.,	  2009).	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  Figure	   97.	   Pairwise	   Sequence	   Alignment	   (PROTEIN)	   of	   the	   TSWV	   and	   LEAV	   N	   protein	   amino	   acid	  sequences.	  http://www.ebi.ac.uk/Tools/psa/emboss_needle/.	  	  No	   molecular	   replacement	   could	   be	   found	   using	   the	   CCHFV,	   RVFV,	   LASV,	   or	  orthobunyavirus	   N	   protein	   crystal	   structures.	   Interestingly	   an	   analysis	   of	   the	  secondary	   structure	   prediction	   of	   TSWV	   N	   protein	   using	   the	   HHpred	   server,	  identified	  the	  highest	  scoring	  structural	  alignment	  with	  structures	  published	  in	  PDB,	  was	   the	  orthobunyavirus	  N	  protein.	  This	   is	   not	   surprising	   considering	   the	  TSWV	  N	  and	  LEAV	  N	  proteins	  share	  similar	  sizes	  and	  belong	  to	  the	  same	  viral	  family	  (Figure	  97).	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Further	  analysis	  of	  the	  bunyavirus	  N	  protein	  from	  all	  genera	  has	  supported	  the	  close	  evolutionary	   relationship	   shared	   by	   orthobunyaviruses	   and	   tospoviruses	   (Figure	  64B).	   	   The	   predicted	   structural	   homology	   between	   the	   orthobunyaviruses	   and	  tospoviruses	  suggest	  it	   is	   likely	  their	  N	  proteins	  do	  share	  similar	  architecture	  in	  the	  overall	   fold;	   however	   this	   is	   not	   supported	   by	   sequence	   alignment,	  which	   revealed	  they	  share	  only	  18.8%	  sequence	  similarity	  (close	  to	  random)	  (Figure	  97).	  There	  could	  be	   two	   reasons	  why	   the	  molecular	   replacement	   has	   not	  worked,	   either	   they	   share	  some	   tertiary	   structure	   which	   is	   not	   similar	   enough	   for	   the	   orthobunyavirus	   N	  protein	   to	   generate	   the	   correct	   phases,	   or	   they	   possess	   completely	   different	   folds.	  Interestingly	   although	   the	   N-­‐terminal	   domain	   of	   LASV	   NP	   displayed	   structural	  homology	  to	  the	  globular	  domain	  of	  CCHFV	  N	  protein,	  it	  was	  not	  similar	  enough	  as	  a	  molecular	  replacement	  model	  to	  generate	  correct	  phases.	  	  	  The	  next	  stage	  of	  the	  project	  attempted	  to	  produce	  selenomethionine	  TSWV	  N	  protein	  crystals	  to	  generate	  anomalous	  signal	  needed	  to	  solve	  the	  TSWV	  N	  protein	  structure.	  Generation	  of	   the	  selenomethionine	  TSWV	  N	  protein	  entailed	  using	  the	  protocol	   for	  the	   expression	   and	   purification	   of	   native	   TSWV	   N	   protein,	   which	   was	   successful.	  However	  the	  derivative	  TSWV	  N	  protein	  could	  not	  reproduce	  crystals	  using	  the	  native	  condition.	  One	  crystallization	  condition	  (0.2	  M	  trimethylamine	  N-­‐oxide	  dihydrate,	  0.1	  M	   Tris-­‐HCl	   pH	   8.5,	   20%	   PEG-­‐2,000	  MME),	   which	  was	   originally	   found	   by	   factorial	  screening	   using	   the	   native	   protein	   did	   yield	   TSWV	   N	   selenomethionine	   crystals,	  however	   these	  were	   of	   a	  much	   poorer	   quality	   and	   displayed	   severe	   anisotropy.	   In	  replacing	   the	   sulphur	   atoms	   of	   the	  methionine	   side	   chains	   in	   the	   TSWV	  N	   protein	  with	  selenium	  a	  change	  to	  the	  properties	  of	  the	  TSWV	  N	  protein	  may	  have	  resulted,	  such	  as	  solubility	  or	  may	  have	  affected	  important	  crystal	  contacts.	  	  Heavy	   atom	   soaks	   introduced	   anisotropy	   into	   the	   native	   TSWV	   N	   protein	   crystals.	  Because	   proteins	   within	   a	   crystal	   are	   not	   equally	   ordered	   in	   all	   directions	   of	   the	  lattice,	   a	   direct	   consequence	   of	   this	   inherent	   anisotropic	   packing	   is	   that	   protein	  crystals	  do	  not	  usually	  diffract	  X-­‐rays	  equally	  well	  in	  all	  directions	  of	  the	  lattice.	  There	  was	   very	   little	   anisotropy	   in	   the	   diffraction	   patterns	   of	   the	   native	   TSWV	  N	   protein	  crystals,	  however	  all	  heavy	  atom	  soaks	  resulted	  in	  the	  crystallographic	  datasets	  being	  anisotropic	  and	  the	  diffraction	  spots	  were	  smeared.	  The	  failure	  to	  find	  the	  differences	  in	  intensity	  needed	  to	  find	  positions	  of	  the	  heavy	  atoms	  within	  the	  samarium	  nitrate	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crystals	   may	   be	   the	   combined	   result	   of	   low	   samarium	   occupancy,	   anisotropic	  disorder	  and	  poor	  diffraction	  spot	  quality	  (Figure	  94).	  Additionally	  a	   low	  symmetry	  spacegroup	   like	   P21,	   causes	   more	   of	   a	   challenge	   when	   sufficient	   redundancy	   is	  needed,	   coupled	   with	   overexposure	   of	   high	   intensity	   X-­‐rays	   and	   limiting	   radiation	  damage.	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5.	  Chapter	  5	  -­‐	  Overall	  conclusions	  and	  future	  directions	  
5.1	  Future	  directions	  for	  the	  CCHFV	  N	  protein	  	  The	  crystal	  structure	  of	  the	  CCHFV	  N	  protein	  has	  guided	  mutagenesis	  of	  the	  CCHFV	  N	  protein	   and	   pin	   pointed	   important	   amino	   acids,	   which	   may	   be	   involved	   in	   RNA	  binding	   and	  multimerization.	   Following	  mutation	   of	   the	   S	   segment,	   targeted	   amino	  acids	   can	  be	   analysed	  by	   testing	   the	   activity	   of	   functional	  RNPs	  within	  mammalian	  cells	  using	  the	  mini-­‐genome	  system.	  Furthermore	  the	  high	  resolution	  structure	  of	  the	  CCHFV	  N	  protein	  has	  allowed	  alternative	  roles	  of	  the	  CCHFV	  N	  protein	  to	  be	  analysed,	  including	   caspase-­‐3	   protease	   cleavage.	   Alternative	   roles	   of	   bunyavirus	   N	   proteins	  have	  also	  been	  demonstrated	  in	  the	  Hantavirus	  genus	  and	  include	  functions	  relating	  to	   viral	   gene	   expression,	   such	   as	   cap	   snatching	   and	   manipulation	   of	   the	   innate	  immune	  response	  within	  host	  cells.	  	  
The	  two	  CCHFV	  proteins	  found	  in	  the	  AU	  of	  the	  C2	  and	  P212121	  crystal	  forms	  could	  be	  authentic	   RNP	   interactions	   or	   they	   could	   be	   packing	   against	   each	   other	   simply	   as	  lattice	   contacts	  within	   the	   crystal.	   Analysis	   of	   fully	   assembled	  RNPs	   from	   the	  mini-­‐genome	  or	  deactivated	  RNPs	  from	  infectious	  CCHFV	  virus	  should	  be	  visualized	  using	  EM	  techniques,	  such	  as	  cryo-­‐EM,	  which	  could	  establish	  any	  clues	  to	  the	  nature	  of	  RNP	  assembly	  for	  CCHFV,	  and	  highlight	  similarities	  to	  those	  proposed	  for	  LASV,	  IAV,	  RSV,	  RVFV	  and	  BUNV.	  
The	   crystal	   structure	   of	   the	   CCHFV	   N	   protein	   has	   revealed	   its	   globular	   domain	  exhibits	   a	  high	  degree	  of	   similarity	  with	   the	  N-­‐terminal	  domain	  of	   the	  NP	   from	   the	  two	   segmented	   sNSV	   LASV,	   a	   member	   of	   the	   Arenaviridae	   family.	   Strikingly	   the	  CCHFV	  N	  protein	  displays	  very	  little	  tertiary	  structural	  similarity	  with	  any	  N	  protein	  within	  its	  own	  family,	  including	  orthobunyaviruses	  and	  phleboviruses	  for	  which	  high	  resolution	   structural	   data	   are	   available.	   The	   finding	   that	   orthobunyavirus	   and	  phlebovirus	   N	   proteins	   appear	   essentially	   structurally	   unrelated	   to	   the	   CCHFV	   N	  protein,	  which	  itself	  shows	  extremely	  high	  similarity	  with	  the	  LASV	  NP,	  agrees	  with	  important	  phylogenetic	   relationships	  between	  nairoviruses	  and	  arenaviruses	  which	  had	   previously	   been	   highlighted	   by	   Vieth	   et	   al	   (Vieth	   et	   al.,	   2007).	   However	   this	  observation	  is	  not	  further	  supported	  by	  the	  phylogenetic	  analysis	  of	  N	  protein	  amino	  acid	   sequences	   (Figure	   64B),	   and	   suggests	   the	   nairovirus	   and	   areanavirus	   are	   not	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closely	   related	   but	   do	   have	   structurally	   similar	   N	   proteins	   that	   most	   likely	   have	  evoled	  divergently	  through	  a	  once	  common	  ancestor.	  
Arenaviruses	  and	  nairoviruses	  also	  share	  unique	  aspects	  of	  cellular	  biology	  that	  are	  absent	   from	   the	   remaining	   genera	   in	   the	  Bunyaviridae	   family,	   such	   as	   glycoprotein	  precursor	   processing	   by	   SKI-­‐1	   proteases	   (Lenz	   et	   al.,	   2001,	   Vincent	   et	   al.,	   2003).	  Taken	  together	  this	  work	  confirms	  important	  phylogenetic	  evidence	  and	  provides	  the	  most	  convincing	  evidence	  yet	   that	  nairoviruses	  have	  an	  ancestor	   in	  common	  with	  a	  past	   member	   the	   of	   Arenaviridae	   family,	   and	   secondly	   suggests	   the	   accepted	  classification	   of	   bunyaviruses	   as	   three	   segmented	   RNA	   viruses	   may	   be	   over	  generalised	   and	   that	   the	   apparent	   diversity	   within	   the	   Bunyaviridae	   family	  highlighted	  by	  this	  work	  may	  have	  implications	  for	  taxonomic	  status.	  
The	   crystal	   structure	   of	   the	   CCHFV	   N	   protein	   also	   has	   revealed	   that	   caspase-­‐3	  protease	  DEVD	  motif	  is	  located	  at	  the	  apex	  of	  the	  arm	  domain.	  Not	  only	  is	  the	  DEVD	  motif	   conserved	   among	   CCHFV	   strains,	   but	   also	   the	   exposed	   nature	   of	   the	   DEVD	  motif,	  suggested	  cleavage	  would	  benefit	  the	  CCHFV	  life	  cycle,	  and	  does	  not	  represent	  a	  host	  cell	  defence	  mechanism	  against	  the	  virus.	  	  
The	   homo-­‐oligomeric	   form	   of	   the	   CCHFV	   N	   protein	   captured	   in	   the	   crystal	   form	  published	   by	  Wang	   et	   al	   (Wang	   et	   al.,	   2012),	   revealed	   the	   DEVD	   site	   was	   located	  directly	  at	  the	  point	  of	  the	  head-­‐to-­‐tail	  interactions	  of	  two	  CCHFV	  N	  proteins.	  Wang	  et	  al	  revealed	  that	  the	  DEVD	  motif	  would	  be	  protected	  within	  this	  location	  and	  obscures	  binding	  and	  subsequent	  cleavage	  by	  the	  caspase-­‐3	  protease.	  Wang	  et	  al	  also	  reported	  that	  the	  monomeric	  is	  more	  susceptible	  to	  cleavage	  by	  caspase-­‐3	  protein	  upon	  adding	  a	  short	  ssRNA	  mimicking	  a	  primer,	  and	  also	  observed	  increased	  RNP	  reporter	  activity	  when	  inhibiting	  cleavage	  by	  mutating	  the	  DEVD	  motif	  when	  measured	  in	  the	  context	  of	   the	  mini-­‐genome	   system.	  This	  work	  does	  however	  does	  not	   explain	   any	   reasons	  why	   they	  chose	   the	   length	  of	   the	  primer	  ssRNA	  mimic,	  or	  why	   it	  would	  change	   the	  conformation	   of	   the	   CCHFV	   N	   protein.	   Additionally	   they	   did	   not	   provide	   any	   link	  between	   primer	   ssRNA,	   caspase-­‐3	   motif	   and	   replication	   of	   the	   virus.	   Furthermore	  Wang	  et	  al	  also	   linked	  this	  result	  with	  their	  previous	  work,	  which	  reported	  that	  the	  cleavage	   of	   CCHFV	   N	   protein	   was	   abrogated	   by	   the	   inhibition	   of	   apoptosis	   and	  increased	   the	   yield	   of	   progeny	   virus	   by	   80–90%	   (Karlberg	   et	   al.,	   2011).	   This	  work	  
	  193	  
failed	   to	   point	   out	   that	   by	   inhibiting	   apoptosis	   there	   would	   be	   more	   viable	   cells	  available	  for	  virus	  infection	  and	  therefore	  more	  progeny	  viruses.	  
Unfortunately,	  the	  functional	  relevance	  of	  the	  DEVD	  motif	  cannot	  be	  tested	  within	  the	  context	   of	   in	  vivo	   CCHFV	   infection	   in	  mammalian	   cells,	   because	   the	  CCHFV	  genome	  cannot	  be	  manipulated	  and	  there	  is	  no	  current	  rescue	  system,	  similar	  to	  other	  nsRNA	  viruses	  such	  as	  IAV.	  
Interestingly	  caspase	  protease	  cleavage	  sites	  are	  not	  just	  limited	  to	  CCHFV	  N	  protein	  and	  LASV	  NP,	  but	  also	  include	  the	  NP	  of	  human-­‐infecting	  strains	  of	  IAV.	  The	  caspase	  cleavage	  site	  of	   IAV	  NP	  has	  been	  shown	   to	  possess	   important	   roles	   in	   the	  virus	   life	  cycle	   (Zhirnov	   et	   al.,	   1999,	   Zhirnov	   and	   Syrtzev,	   2009).	  Mutations,	   which	   abrogate	  caspase	  cleavage	  at	  an	  N-­‐terminal	  recognition	  site,	  abolished	  the	  ability	  of	  the	  virus	  to	  be	   rescued,	   whereas	   infectious	   virus	   with	   mutations	   located	   within	   a	   C-­‐terminal	  caspase	  cleavage	   site	   rapidly	   reverted	   to	   the	  wild	   type	  virus	   to	   restore	   cleavability.	  These	   findings	   indicate	   that	   such	   alterations	   are	   important	   to	   virus	   fitness	   and	  viability,	  and	  therefore	  pathogenesis,	  suggesting	  in	  addition	  to	  RNA	  binding	  a	  second	  functional	  role	  exists,	  which	  could	  be	  targeted	  by	  antivirals.	  
5.2	  Future	  directions	  for	  the	  TSWV	  N	  protein	  	  Despite	  attempts	  to	  generate	  correct	  phases	  for	  the	  TSWV	  N	  protein	  failing,	  this	  work	  did	   establish	   a	   reliable	   protocol	   for	   producing	   soluble	   and	   stable	   TSWV	   N	   protein	  suitable	  for	  crystallization	  and	  in	  vitro	  biochemical	  studies.	  This	  protocol	  was	  used	  to	  produce	   selenomethionine	   TSWV	   N	   protein	   successfully,	   however	   this	   derivative	  protein	  was	  unable	  to	  crystallize	  in	  the	  same	  condition	  as	  the	  native	  protein	  or	  all	  the	  alternative	   conditions	   that	  were	   tested.	   The	   failure	   to	   crystallize	   selenomethionine	  derivative	  TSWV	  N	  protein	  in	  the	  native	  condition	  is	  not	  actually	  an	  obstacle,	  because	  other	  strategies	  including	  re-­‐screening,	  seeding,	  and	  micro	  seeding	  (Zhu	  et	  al.,	  2005)	  can	  be	  employed	  to	  generate	  diffraction	  quality	  crystals	  needed	  to	  generate	  phases.	  However	  in	  this	  case	  the	  TSWV	  N	  selenomethionine	  protein	  was	  unable	  to	  crystallize	  in	   the	   native	   condition	   through	   seeding	   from	   native	   crystals	   and	   from	   those	  selenomethionine	   crystals	   grown	   from	   in	   0.2	  M	   trimethylamine	   N-­‐oxide	   dihydrate,	  0.1	  M	  Tris-­‐HCl	  pH	  8.5,	  20%	  PEG-­‐2,000	  MME.	  Additionally	  no	  selenomethioine	  TSWV	  N	   protein	   crystals	   were	   generated	   thorugh	   re-­‐screening	   factorial	   conditions,	  including	  using	  different	   temperatures	   and	  micro	   seeding	  using	   fresh	   crystals	   from	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native	  crystals	  and	  selenomethionine	  TSWV	  N	  protein	  crystals	  generated	  through	  the	  condition	  0.2	  M	  trimethylamine	  N-­‐oxide	  dihydrate,	  0.1	  M	  Tris-­‐HCl	  pH	  8.5,	  20%	  PEG-­‐2,000	  MME.	  	  In	   order	   to	   pursue	   this	   project	   to	   generate	   correct	   phases	   to	   solve	   the	   TSWV	   N	  protein	  crystal	  structure	  a	  number	  of	  avenues	  could	  be	  employed.	  Firstly	  the	  trimer	  TSWV	   N	   protein	   reported	   by	   Komoda	   et	   al	   (Komoda	   et	   al.,	   2013),	   was	   used	   to	  generate	  diffracting	  crystals	  from	  which	  phases	  were	  generated.	  The	  trimer	  TSWV	  N	  protein	  in	  this	  work	  did	  not	  generate	  any	  well	  diffracting	  crystals	  in	  factorial	  screens	  and	   instead	   the	   tetramer	   TSWV	   N	   protein	   crystals	   were	   pursued.	   By	   testing	   the	  condition	  by	  Komoda	  et	  al,	   selenomethionine	  trimer	  TSWV	  N	  protein	  crystals	  could	  be	  reproduced,	   from	  which	  phases	  could	  be	  obtained	  and	  the	  resulting	  model	  could	  be	  used	  in	  MR	  to	  solve	  the	  tetramer	  TSWV	  N	  protein	  diffraction	  data.	  	  	  Perhaps	   a	   more	   practical	   approach	   could	   involve	   attempting	   to	   screen	   the	   native	  TSWV	  N	  tetramer	  protein	  again	  for	  crystallization	  and	  attempt	  to	  find	  an	  alternative	  condition,	  which	   yields	   crystals	   possessing	   a	   higher	   quality	   of	   X-­‐ray	   diffraction.	   By	  using	   TSWV	   N	   tetramer	   protein	   crystals	   with	   a	   higher	   symmetry	   spacegroup,	   and	  higher	   resolution	   would	   be	   more	   beneficial	   for	   phasing:	   firstly	   less	   data	   will	   be	  needed	   to	   reach	   the	   needed	   redundancy	   required	   to	   unambiguously	   locate	   the	  positions	   of	   the	   heavy	   atoms	   and	   secondly	   improved	   resolution	   could	   be	   useful	   in	  attempting	   to	   solve	   for	   phases	   using	   anomalous	   scattering	   from	   the	   sulphur	   atoms	  within	  the	  TSWV	  N	  protein.	  
5.3	  Futurework	  Elucidation	  of	   the	   crystal	   structure	  of	  TSWV	  and	  CCHFV	  N	  protein/RNA	  complex	   is	  also	   needed	   to	   establish	   which	   amino	   acids	   take	   part	   in	   binding	   viral	   RNA.	  Fluorescence	   anisotropy	   could	   be	   used	   to	   establish	   an	   RNA	   binding	   assay	   for	   the	  CCHFV	   N	   protein,	   in	   order	   to	   determine	   the	   best	   RNA	   for	   co-­‐crystallization.	   Co-­‐crystallization	  of	  the	  TSWV	  and	  CCHFV	  N	  proteins	  with	  RNA	  would	  not	  only	  be	  more	  biologically	  more	  relevant	  than	  the	  apoprotein	  form,	  but	  also	  may	  provide	  previously	  unidentified	   interactions	   between	   promoters	   and	   clues	   into	   the	   TSWV	   and	   CCHFV	  RNP	   assembly.	   Fluorescence	   anisotropy	   has	   been	   used	   for	   the	   SBV	   and	   BUNV	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proteins	   and	   can	   also	   be	   used	   to	   analyse	   mutants	   designed	   after	   X-­‐ray	  crystallographic	  analysis.	  	  
Further	  work	  could	  also	  involve	  analysing	  recombinant	  TSWV	  N	  protein	  and	  digested	  endogenous	   viral	   RNPs	   by	   direct	   visualization	   using	   negative	   stain	   EM,	   there	   by	  generating	  single	  particle	  reconstructions	  to	  compare	  the	  oligomer	  state	  of	  each	  and	  establish	  whether	  either	  the	  tetramer	  or	  trimer	  proteins	  seen	  solution	  are	  in	  anyway	  biologically	  relevant,	  or	  just	  artefacts.	  This	  type	  of	  analysis	  could	  also	  determine	  how	  homogeneous	   the	  TSWV	  N	  protein	   is	   in	   solution,	  which	  could	  have	   implications	   for	  crystallization,	  especially	   for	   the	  selenomethionine	  protein.	  To	  establish	   the	  precise	  oligomeric	   state	   of	   the	   protein	  within	   the	   RNP	   viewing	   undigested	   authentic	   RNPs	  from	   infectious	   TSWV	   would	   be	   needed.	   Using	   negative	   stain	   EM,	   or	   cryo-­‐EM	   to	  directly	  visualize	  viral	  RNPs	  has	  been	  achieved	  for	  many	  nsRNA	  viruses	  and	  greatly	  improved	  the	  understanding	  in	  how	  RNPs	  assemble	  and	  how	  viral	  RNA	  is	  protected	  from	  the	  exterior	  environment	  of	  the	  cell.	  
The	   same	  methods	   used	   to	   express	   and	   purify	   the	   CCHFV	  N	   protein,	   could	   also	   be	  used	   to	   express,	   purify	   and	   crystallize	   other	   N	   proteins	   within	   the	   Bunyaviridae	  family,	  such	  as	  those	  within	  the	  Hantavirus	  genus.	  
5.4	  Bunyaviridae	  family	  RNPs	  conclusion	  The	  X-­‐ray	  crystallographic	  studies	  in	  this	  thesis	  have	  shed	  new	  light	  on	  the	  N/	  protein	  RNA	  and	  N/N	  protein	  interactions	  involved	  in	  CCHFV	  RNP	  formation.	  There	  are	  now	  published	  studies	  for	  which	  high	  resolution	  structures	  are	  available	  for	  the	  nairovirus,	  orthobunyavirus	   and	   phlebovirus	   N	   protein/RNA	   and	   N/N	   protein	   complexes.	  Comparison	   of	   bunyavirus	   N	   protein	   structures	   has	   revealed	   that	   they	   not	   only	  possess	  unique	  folds	  but	  also	  use	  different	  mechanisms	  for	  RNP	  formation.	  The	  most	  important	   conserved	   feature	   among	   the	   bunyavirus	   N	   proteins	   is	   their	   ability	   to	  possess	  a	  positively	  charged	  RNA	  binding	  groove.	  	  Cryo-­‐EM	  data	   of	   the	   orthobunyavirus	   RNP	   suggests	   a	   “beads	   on	   a	   string”	   complex,	  which	  takes	  up	  a	  compacted	  helical	  form	  for	  packing	  within	  the	  virus	  particle	  and	  a	  flexible	   form	   allowing	   the	  RNA	   to	   be	   become	   available	   for	  RNA	   synthesis.	   The	   two	  apparent	  conformations	  of	  the	  orthobunyavirus	  RNP	  are	  however	  in	  contention	  with	  the	  proposed	  model	  for	  phlebovirus	  RNP,	  which	  has	  only	  been	  shown	  to	  form	  flexible	  single	   RNP	   complexes.	   The	   larger	   size	   of	   the	   CCHFV	  N	   protein	   and	   absence	   of	   any	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apparent	   C-­‐	   and	   N-­‐terminal	   extensions	   may	   even	   further	   point	   towards	   less	  commonality	  between	  bunyavirus	  RNP	  complexes	  and	  indicate	  that	  RNP	  formation	  in	  the	  nairovirus	  genus	   is	  noticeably	  different.	   	  One	  possibility	   is	   the	  CCHFV	  N	  protein	  may	   employ	   the	   arm	   domain	   for	   oligomization	   as	   an	   alternative	   to	   the	   N-­‐	   and	   C-­‐terminal	   arms	   used	   by	   the	   phleboviruses	   and	   orthobunyaviruses.	   In	   fact	   the	  involvement	  of	   the	  arm	  domain	   in	  oligomerization	  has	  been	  observed	   in	   the	  homo-­‐oligomers	  shown	  within	  the	  crystal	  by	  Wang	  et	  al	   (Wang	  et	  al.,	  2012).	  The	  work	  by	  Wang	  et	  al	  (Wang	  et	  al.,	  2012),	  needs	  to	  be	  however	  validated	  by	  direct	  visualization	  of	  the	  endogenous	  nairovirus	  RNPs	  using	  cryo-­‐EM,	  as	  the	  observed	  homo-­‐oligomers	  could	  be	  artifacts	  of	  crystal	  packing.	  	  Both	  X-­‐ray	  crystallographic	  and	  cryo-­‐EM	  data	  of	  N	  proteins	  from	  nsNSVs	  and	  sNSVs	  (including	   bunyaviruses)	   have	   revealed	   they	   possess	   features	   with	   stricking	  similarities	   and	   differences.	   For	   example	   structural	   comparison	   of	   the	   N	   proteins	  from	   phleboviruses,	   orthobunyaviruses,	   RSV	   (nsNSV)	   and	   VSV	   (nsNSV),	   have	  revealed	   they	   share	   commonality	   in	   the	  way	   they	  protect	   the	  viral	  RNA,	  within	   the	  centre	  of	  the	  N-­‐	  and	  C-­‐	  terminal	  portions	  of	  the	  N	  protein.	  	  Recent	  reported	  structures	  of	  the	  phlebovirus	  N	  protein	  have	  shown	  they	  differ	  from	  their	   sNSV	  (IAV)	  and	  nsNSV	  (RSV	  and	  VSV)	  N	  protein	  counterparts,	  by	  displaying	  a	  non-­‐helical	   filament	   RNP	   structure.	   There	   is	   evidence	   however	   to	   suggest	   that	  orthobunyaviruses	   share	   similarity	   with	   the	   RSV,	   VSV	   and	   IAV	   N	   proteins	   by	  facilitating	  the	  formation	  of	  a	  helical	  structures	  to	  encapsidate	  their	  viral	  RNA.	  	  An	   additional	   major	   difference	   is	   the	   IAV	   NP	   facilitates	   oligomerization	   by	   a	   C-­‐terminal	  tail	  loop,	  whilst	  phleboviruses	  in	  contrast	  extend	  an	  N-­‐terminal	  arm	  towards	  the	   neighboring	   partner	   N	   protein.	   Contrastingly	   the	   orthobunyavirus	   N	   protein	  clearly	   possesses	   both	   an	  N-­‐	   and	   C-­‐terminal	   arm	   extensions,	  which	   is	   paralleled	   in	  RNP	  formation	  in	  nsNSVs	  (Tawar	  et	  al.,	  2009).	  Not	  surprisingly	  because	  of	  the	  clear	  structural	  differences	  between	  the	  inter-­‐N	  interactions	  amoung	  nsNSVs	  the	  N-­‐	  and	  C-­‐terminal	  extensions	  are	  not	  conserved	  between	  the	  bunyaviruses.	  	  Recent	  evidence	  from	  (Wang	  et	  al.,	  2012,	  Guo	  et	  al.,	  2012),	  including	  evidence	  within	  this	  thesis	  suggests	  the	  CCHFV	  N	  protein	  does	  not	  contain	  a	  cavity	  within	  the	  globular	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domains	   where	   the	   RNA	   is	   sequestered.	   The	   crystal	   structure	   of	   the	   CCHFV	   N	  proteins	   also	   reveals	   no	   discernible	   N-­‐	   and	   C-­‐terminal	   loops	   which	   would	   be	  suggestive	   of	   a	   role	   in	   oligomerization.	   The	   arm	  of	   the	   CCHFV	  N	  protein	   is	   a	   likely	  candidate	   for	   the	   main	   contributor	   to	   oligomerization,	   and	   the	   homo-­‐oligomer	  structure	  captured	  in	  a	  crystal	  structure	  by	  Wang	  et	  al	  (Wang	  et	  al.,	  2012)	  supports	  this.	   Furthermore	   the	   CCHFV	   and	   LASV	  N/NP	   proteins,	   share	   very	   close	   structural	  homology,	   and	   both	   display	   possible	   oligomerization	   domain	   arms,	   however	   the	  possibility	   that	   the	   CCHFV	   N	   protein	   requires	   N-­‐	   and	   C-­‐terminal	   extensions	   for	  oligomerization	  cannot	  be	  ruled	  out.	  	  	  	  	  The	  mechanism	  for	  nairovirus	  RNP	  formation	  likely	  has	  similarity	  to	  LASV,	  however	  more	   data	   is	   needed	   to	   fully	   uncover	   the	   exact	   steps	   involved.	   LASV	   has	   been	  proposed	   to	   undergo	   a	   conformational	   shift	   upon	   RNA	   binding,	   and	   it	   is	   this	   shift	  which	   has	   been	   suggested	   to	   facilitate	   subsequence	   oligomerization	   into	   the	  functional	  RNP	  complex.	  The	  nairovirus	  N	  protein	  may	  undergo	  a	  similar	   transition	  and	   reveal	   the	   appropriate	   RNA	   binding	   and	   oligomerization	   surfaces	   when	   the	  correct	   viral	   RNA	   sequences	   are	   present	   or	   alternatively	   by	   an	   as	   yet	   unknown	  cellular	  factor.	  	  Many	  questions	  can	  now	  be	  addressed	  from	  the	  advent	  of	  the	  orthobunyavirus	  RNP	  structure	  such	  as	  how	  does	  the	  N	  protein	  maintain	  a	  non-­‐aggregated	  state	  competent	  for	  RNP	  encapsidation	  and	  does	  it	  selectively	  package	  its	  viral	  genomic	  RNA	  over	  host	  RNA,	  and	   if	   so	  what	  mechanism	   is	  used	   to	  pack	   the	   three	  RNA	  segments.	  Moreover	  how	   does	   the	   orthobunyavirus	   adapt	   its	   structure	   to	   allow	   readout	   of	   nucleotide	  sequences	  by	  the	  polymerase	  during	  RNA	  synthesis?	  	  	  Such	   questions	   are	   also	   likely	   to	   be	   tackled	   for	   CCHFV	   and	   TSWV	   RNP	   formation	  using	  similar	  EM/X-­‐ray	  crystallography	  complementation	  approaches,	  and	  are	  crucial	  for	   our	   understanding	   of	   not	   just	   nairovirus	   and	   tospovirus	   biology,	   but	   also	   the	  biology	   of	   the	   Bunyaviridae	   family	   as	   a	   whole,	   which	   will	   likely	   lead	   improved	  prevention	  and	  therapeutic	  intervention.	  	  	  Although	   the	   studies	  within	   this	   thesis	   answer	   some	  key	  questions	   about	  CCHFV	  N	  protein	  RNA	  binding	  and	  oligomerization,	  there	  are	  still	  many	  questions	  that	  can	  be	  
	  198	  
posed.	   For	   example	   how	   does	   the	   CCHFV	  N	   protein	   facilitate	   oligomerization?	   One	  possibility	  is	  the	  principal	  involvement	  of	  the	  arm	  domain,	  like	  that	  that	  shown	  in	  the	  oligomer	  structure	  by	  Wang	  et	  al	  (Wang	  et	  al.,	  2012).	  Or	  alternatively	  it	  could	  use	  a	  similar	   mechanism	   to	   that	   of	   the	   phlebovirus	   and	   orthobunyavirus	   N	   protein’s	  involving	   the	   exposure	   of	   N-­‐	   and	   C-­‐terminal	   arms,	   through	   major	   conformational	  changes	  and	  also	  allow	  for	  the	  exposure	  of	  the	  RNA	  binding	  surfaces	  needed	  for	  RNP	  formation.	  Another	  question	  could	  be	  does	  the	  CCHFV	  N	  protein	  need	  RNA	  before	  it	  can	  oligomerize,	  and	   if	  so	  are	  their	  any	  nucleotide	  or	  amino	  acid	  specific	  sequences	  required	  to	  initiate	  RNA	  binding	  	  The	   greater	   our	   knowledge	   in	   the	  way	   these	  proteins	   function	   in	  RNA	  binding	   and	  participate	   in	   homo-­‐oligomerization,	   the	   better	   our	   chances	   of	   being	   able	   to	   target	  these	   important	   interactions.	   For	   now	   elucidation	   of	   the	   CCHFV	   N	   protein	   crystal	  structure	  can	  be	  used	  to	  design	  inhibitors	  using	  in	  silico	  based	  methods,	  which	  could	  potentially	   prevent	   RNA	   binding,	   the	   N-­‐N	   protein	   interaction	   to	   ultimately	   hinder	  RNP	   formation	   (Wade,	   1997).	   However	   a	   much	   more	   in-­‐depth	   understanding	   of	  nairovirus	  RNP	  formation	  is	  needed.	  Testing	  of	  these	  inhibitors	  could	  then	  be	  re-­‐laid	  back	   through	   the	   mini-­‐genome	   system	   and	   further	   uncover	   characteristics	   of	   the	  CCHFV	  N	  protein.	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6.	  Appendix	  	  
6.1	  Primers	  for	  all	  cloning	  	  
6.1.1	  CCHFV	  N	  gene	  cloning	  	  Forward	  5’	  ACT	  GAT	  GGA	  TCC	  ATG	  GAA	  AAC	  AAA	  ATC	  GAA	  GTG	  AAC	  AGT	  AAG	  G	  3’	  Reverse	  5’	  GCA	  ATC	  TCG	  AGT	  TAG	  ATG	  ATG	  TTG	  GCG	  CTG	  GTG	  GCA	  TTC	  C	  3’	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6.2	  Ramachandran	  plot	  of	  C2	  CCHFV	  N	  protein	  crystal	  structure	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